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ABSTRACT  
Aims: To investigate concordance for lifestyle – smoking, diet and physical activity - 
between married couples when one has developed coronary disease, and concordance for 
lifestyle change over one year in a nurse-led, multidisciplinary, family centred, prevention 
programme across six countries.  
Methods: In the EUROACTION trial consecutive coronary patients were recruited from 
hospitals, with their partners, to this programme. Concordance for smoking, diet and physical 
activity, and cardiovascular risk factors, was investigated at the initial assessment, at 16 
weeks and one year.  
Findings: 645 couples attended the initial assessment and 65% of couples returned at one 
year. At the time of the coronary event, there were nearly two times as many couples, than 
expected by chance, currently smoking. Couples were also concordant at baseline for 
saturated fat (r=0.41) fruit and vegetables (r=0.67) and for physical activity (r=0.25). With the 
exception of total cholesterol, cardiovascular risk factors in couples were all significantly 
correlated: body mass index (BMI) r=0.22; waist circumference (WC) r=0.12; systolic blood 
pressure (SBP) r=0.20; total cholesterol (TC) r=0.07; LDL-C r=0.13; HDL-C r=0.27 and 
fasting blood glucose (FBG) r=0.20  reflecting concordance for lifestyle. 
The smoking quit rate at one year was significantly higher at 74% in patients with a partner 
who was a non-smoker compared to 50% in patients with a partner who smoked (p=0.03). 
There was significant concordance for change at one year between patients and partners 
for: saturated fat r=0.43; fruit and vegetables r=0.61; physical activity r=0.40; BMI r=0.21; 
WC r=0.22; SBP r=0.13; TC r=0.21 and HDL-C r=0.34. Patients making the healthiest 
lifestyle changes were associated with partners making similarly healthy changes. 
Interpretation: Couples had an unhealthy concordant lifestyle at baseline but became 
healthier during the course of the preventive cardiology programme, with concordance for 
change between couples at both 16 weeks and one year. As couples are concordant for 
lifestyle, with observational evidence of concordance for change, we should focus on 
couples rather than patients alone. 
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“And at home by the fire, whenever you look up there I shall be - and 
whenever I look up, there will be you”. 
Gabriel Oak 
Far from the Madding Crowd by Thomas Hardy 1874 
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CHAPTER 1. INTRODUCTION 
In this chapter, the scene is set for this doctoral study in the context of the global burden of 
cardiovascular disease, the importance of adverse lifestyles in relation to morbidity and 
mortality and the impact of interventions which address lifestyle change. It also provides an 
introduction to the EUROACTION cluster randomised controlled trial, on which this 
observational study of concordance for lifestyle habits and concordance for change in 
married and cohabiting couples is based. A brief description of other family centred  
approaches described in the literature is provided, and a theoretical framework is proposed 
where concordance is a factor in behavioural change theory. The aims of my doctoral study 
are outlined and research questions defined. 
 
1. Background 
1.1. Global Burden of Disease 
In the1990 Global Burden of Disease Study, Murray and Lopez (1997b) established the 
importance of non-communicable diseases (NCD) in worldwide and regional patterns of 
death and disability identifying ischaemic heart disease (IHD) and cerebrovascular diseases 
as the top two leading causes of mortality in eight regions of the world. They projected 
(Murray and Lopez, 1997a) that mortality worldwide from communicable diseases would 
decline between 1990 and 2020 from 17.2 to 10.3 million, but that deaths from NCDs would 
increase from 28 to 50 million. 
According to the 2010 update of the WHO Global Burden of Disease Project, deaths from 
NCDs have now reached 34.5 million accounting for two thirds of deaths compared to one 
half of global deaths in 1990 (Lozano et al., 2012). 13 million of these deaths were from 
heart disease and stroke. In addition 9 million of these deaths were premature, occurring in 
people under the age of 60 years. 
CVD contributed 9% of the global disease burden as measured in disability adjusted life 
years (DALYS). Estimates for global disease burden showed that 68% of the 751 million 
years of living with disability (YLD) worldwide are attributable to NCDs, and CVD is 
responsible for 151, 377 million DALYs (years of life lost YLL added to YLD), 62, 587 million 
due to coronary disease and 46,491 million due to cerebrovascular disease. 
More than half of the deaths across Europe are attributed to CVD. Mortality rates remain 
higher in northern Europe than in Southern Europe. In Eastern Europe, in the formerly 
socialist economies, the probability of men dying between 15 and 60 years from non-
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communicable diseases (primarily CVD) is greater than anywhere else in the world. In low-
middle income countries of Europe, IHD accounts for a quarter of the total disease burden. 
80% of premature heart disease and strokes is preventable. In more affluent European 
countries, there was a decline in CHD and CVD mortality between the 1970s and 1990s, 
demonstrating the possibilities for prevention of deaths from the disease and for prolonging 
life healthily. 
1.2. Causes of Coronary Disease 
An important explanation for these adverse trends in NCDs, and CVD in particular, is the 
contribution of unhealthy lifestyles – tobacco smoking, poor diet and physical inactivity – 
which lead to overweight, central obesity, raised blood pressure, abnormal blood lipids and 
poor blood glucose regulation. All of these lifestyle and associated risk factors work 
synergistically to increase an individual’s absolute risk of developing and dying from 
atherosclerotic cardiovascular disease. 
The INTERHEART Study (Yusuf et al., 2004) confirmed that the risk factors for first 
myocardial infarction are similar in high, middle or low income countries alike. This case 
control study conducted in 52 countries representing all continents with human populations 
recruited 15, 152 cases and 14, 820 controls and measured nine risk factors: smoking, 
lipids, self-reported hypertension or diabetes, obesity, diet, physical activity, alcohol 
consumption and psychosocial factors. All risk factors combined accounted for 90.4% (99% 
CI 88.1 to 92.4) of the population attributable risk (PAR) for myocardial infarction. Abnormal 
lipid profile was the risk factor contributing most to PAR, especially in younger individuals 
(58.9%; 99% CI 50.9 to 66.5 in young v. 43.6%; 99%CI 36.6 to 50.8 in old), and this 
probably reflected lifestyle profile and obesity. A healthy lifestyle defined in this study as non 
smoking, consuming fruit and vegetables every day and taking regular physical activity was 
calculated to potentially reduce the risk of myocardial infarction by more than three quarters 
(OR 0.21; 99% CI 0.17 to 0.25). In addition the high PAR for all lifestyle factors combined 
was similar in all geographic regions ranging from 48.9% in Central and Eastern Europe to 
69.6% in Western Europe and Southeast Asia and Japan. In countries where abdominal 
obesity is more prevalent (mostly high and middle income countries) the PAR was greater 
than the risk for smoking compared to countries where it is less prevalent. For example, in 
Western Europe, the PAR for abdominal obesity is nearly 70% compared to a PAR of 39% 
for smoking, but in China it is 5% compared to 45% respectively. 
In a similarly designed case control study in 22 countries but this time investigating risk 
factors for both ischaemic and intra-cerebral haemorrhagic stroke (O'Donnell et al., 2010), 
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3000 cases and 3000 controls were identified with 78% of the cases being ischaemic strokes 
and the rest haemorrhagic strokes. Ten risk factors were identified to be associated with 
90% of the risk of stroke. However the most important were high blood pressure (OR 3.89; 
PAR 51.8%), current smoking (OR 2.09; PAR 18.9%), abdominal obesity (OR 1.42; PAR 
26.5%), diet score (OR 1.35; 18.8%) and regular physical activity (OR 0.69; 28.5%) which 
contributed more than 80% of the risk of both types of stroke. 
1.3. Interventions to reduce risk of recurrent disease 
The scientific evidence for lifestyle interventions with regard to smoking and diet in 
secondary prevention is based largely on observational data with very few trials investigating 
the potential benefits of smoking cessation and dietary interventions on CVD mortality. For 
physical activity and secondary prevention, the scientific data are more robust, largely based 
on the meta-analyses of RCTs of cardiac rehabilitation and secondary prevention. 
Stopping smoking, consuming cardio-protective foods and being physically active reduce the 
risk of developing cardiovascular disease in the first place but also reduce the risk of 
recurrence of coronary disease and improve survival (Perk et al., 2012). 
1.3.1. Smoking Cessation 
In an observational study using data from the Organisation to Assess Strategies in Acute 
Ischaemic Syndromes (OASIS 5) RCT in 18,809 patients following an acute coronary 
syndrome from 41 countries (Chow et al., 2010) investigated the effect of 30 days adherence 
to lifestyle recommendations for smoking, diet and physical activity on 6 month 
cardiovascular outcomes and all-cause mortality. Stopping smoking after a cardiac event is 
associated with a reduction in risk of recurrent CVD. In Chow’s study, at 6 months, the risk of 
MI (OR 0.57; 95% CI 0.36 to 0.89) and stroke (OR 0.40; 0.14 to 1.47) was reduced, although 
no mortality benefit was seen. However, in two systematic reviews of cohort studies 
investigating smoking cessation following myocardial infarction (MI) with a minimum follow-
up of 2 years, there were mortality benefits in both. The first (Wilson, 2000) reviewed twelve 
studies including 5878 smokers of whom 3161 stopped smoking. Critchley (2003) reviewed 
twenty cohort studies including a total of 12,603 smokers of whom 5659 stopped. Wilson 
showed a risk reduction of 46% with a pooled odds ratio of 0.54 (95% CI 0.46 to 0.62) whilst 
Critchley showed a risk reduction of 36% with a pooled relative risk of mortality reduction of 
0.64 (95% CI 0.58 to 0.71). The difference in these results may be in part due to the different 
studies included in each review, but also in the measure used for the meta-analyses. 
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A RCT of intensive smoking cessation in 209 smokers hospitalised with acute CVD 
(Mohiuddin et al., 2007) demonstrated at 24 month follow up that 12 weeks of behaviour 
modification and free pharmacotherapy compared to usual care (counselling and printed 
materials at discharge from hospital) was effective with 33% reporting continuous abstinence 
in intervention compared to 9% in usual care (p<0.0001). All cause mortality was also 
reduced with a rate of 2.8% in intervention compared to 12% in usual care, a relative risk 
reduction of 77% and an absolute risk reduction of 9.2%. 
1.3.2. Dietary Factors (Fatty acids, fruit and vegetables) 
The European Heart Network (EHN) published a substantial review (2011) of the scientific 
evidence for diet and physical activity in relation to cardiovascular disease prevention which 
is based on data from general populations and does not specifically focus on secondary 
prevention. The relationship between saturated fat, fruits and vegetables and fish and the 
subsequent risk of developing coronary disease is largely based on data from prospective 
cohort studies rather than RCTs. However, there have been three trials evaluating the 
relationship between a dietary intervention and risk of recurrent CVD. Two showed a 
reduction in mortality (Burr et al., 1989, de Lorgeril et al., 1994). The third (Singh et al., 
1992a) was discredited. The Diet and Reinfarction Trial (DART) (1989) randomised 2033 
men post MI to one of three different dietary advice regimens: one advising on a reduction of 
fat intake and on changing the ratio of saturated to polyunsaturated fat; the second on 
increasing oily fish intake; and the third on increasing cereal fibre intake. The oily fish group 
had a significant 29% reduction in two year all-cause mortality, whilst there was no 
difference in mortality for the other groups. The Lyon Diet Heart trial (1994) randomised 605 
patients following a first MI to either a diet similar to a traditional Mediterranean pattern of 
eating with low intake of total and saturated fat, an increase of plant omega 3 fatty acids and 
a high intake of fruit and vegetables, legumes and fibre compared to a prudent Western diet 
and reported initial results in1994. In 1999, 4 year results were published from this trial (de 
Lorgeril et al., 1999) showing benefits in mortality. For the primary endpoint (cardiac deaths 
and non-fatal MI) the risk ratio was 0.28 (0.15 to 0.53) and for the composite endpoint of all 
major and minor CVD events, it was 0.53 (0.38 to 0.74). 
Chow’s (2010) observational study also showed reductions in a composite endpoint (MI, 
stroke, death) associated with adherence to both a healthy diet and exercise following ACS 
(OR 0.52; 95% CI 0.4 to 0.69) compared to adhering to either dietary or exercise alone (OR 
0.85; 95% CI 0.73 to 0.99). 
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1.3.3. Cardiac Rehabilitation and Secondary Prevention Programmes 
Most of the scientific evidence for physical activity in secondary prevention comes from the 
systematic reviews and meta-analyses of cardiac rehabilitation. A systematic review of such 
trials was first conducted in 2001 (Jolliffe et al., 2001) and subsequently updated in 2004 
(Taylor et al., 2004) and again in 2011 (Heran et al., 2011). The objective was to measure 
the effect of exercise based programmes on total and cardiovascular mortality. In Heran’s 
most recent review, 47 trials with 6 months or more follow up included 10, 794 patients. 
Cardiac rehabilitation was shown to reduce total mortality (RR 0.87; 95% CI0.75 to 0.99) and 
cardiovascular mortality (RR = 0.74; 95% CI: 0.63 to 0.87). There was no difference in 
recurrent myocardial infarction, CABG or PTCA. 
Despite the traditional focus that cardiac rehabilitation places on exercise, it is questionable 
that all of its benefits are attributable to this component alone. Cardiac rehabilitation is a 
complex intervention incorporating other elements such as smoking cessation and dietary 
changes, risk factor management and psychological and educational support. Delivery of all 
of these components varied between programmes and countries. The most recent review 
(2011) showed no differences on outcomes between exercise only and comprehensive 
cardiac rehabilitation, and no difference according to the dose of exercise delivered between 
programmes. Therefore the reasons for the beneficial impact of cardiac rehabilitation 
programmes are several and it is not possible to say which of the different components 
contributed most to these improved outcomes. 
In the previous review (Taylor et al., 2004), the effect of cardiac rehabilitation on modifiable 
cardiac risk factors was also measured. This review included 48 trials and included 8940 
patients. Whilst the proportion of patients who reported smoking was significantly reduced 
with cardiac rehabilitation (OR = 0.64; 95% CI 0.50 to 0.83), other changes were significant 
but small. For example, for systolic blood pressure the weighted mean difference was –3.2 
mm Hg; 95% CI - 5.4 to - 0.9 mm Hg), and for total cholesterol it was –0.37 mmol/L (95% CI 
–0.63 to –0.11 mmol/L. There were no differences in low-density or high-density lipoprotein 
concentrations. These small risk factor changes would have limited impact on clinical events. 
Two systematic reviews (McAlister et al., 2001, Clark et al., 2005) were also conducted to 
assess the impact of secondary prevention programmes, with or without exercise. The meta-
analysis from the most recent review included 63 RCTs and 21 295 patients with coronary 
disease, with some overlap of the studies from the meta-analysis of cardiac rehabilitation. It 
found a risk ratio of 0.85 (95% CI, 0.77 to 0.94) for all-cause mortality, but this result 
improved over time from a risk ratio of 0.97 (CI, 0.82 to 1.14) at 12 months to 0.53 (CI, 0.35 
to 0.81) at 24 months; a 47% reduction in all cause mortality. The risk ratio was 0.83 (CI, 
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0.74 to 0.94) for recurrent myocardial infarction over a median follow-up of 12 months in 
contrast to cardiac rehabilitation which had no impact on myocardial infarction. The effects 
on mortality and myocardial infarction were similar for programmes whether they included 
both exercise and education, or just one of these components, thus demonstrating the 
complex nature of such programmes, the effect of which cannot be attributed to one of the 
components alone. 35 trials reported effects on cardiovascular risk factors and although 
summary effects are not reported in this review the effect sizes were generally considered to 
be small to moderate. 
1.3.4. Conclusions 
The overall benefit from complex interventions like cardiac rehabilitation and secondary 
prevention programmes in reducing all cause mortality is clear and is a result of an 
integrated multifactorial approach which draws on multidisciplinary and behavioural expertise 
from specialist nurses, dietitians and physical activity specialists. By working together they 
maximise the potential to achieve sustained behaviour changes in patients who have had a 
coronary event which will impact favourably on their cardiovascular risk factors and reduce 
the risk of disease recurrence and all cause mortality. 
In managing these patients all aspects of lifestyle need to be addressed: smoking cessation, 
dietary change and increasing physical activity. Chow’s study (2010) showed that making 
multiple behaviour changes had substantial benefits. Patients who did not stop smoking, 
change their diets or take exercise had an increased risk (OR 3.77 95% CI 2.4- to 5.91) of 
repeat cardiovascular events (myocardial infarction, stroke, death) compared to those who 
made all three changes (OR 1.62 95% CI 0.96 to 2.75). Interestingly, the study also showed 
that patients who adhere to one behaviour change are more likely to take on and adhere to 
other changes too. In those who quit smoking compared to those who did not, there were 
significantly higher rates of dietary (60.8% v. 47.2%) and exercise (49.9% v. 42.2%) 
adherence. However, this should be seen in the context of the difficulty that people have in 
making lifestyle changes. One third of those who had been smoking at baseline continued to 
smoke, and nearly 30% made no dietary or exercise changes. 
Changing health behaviours presents an enormous challenge to those individuals 
undertaking them and also to health professionals involved in helping people to change. 
Health behaviours develop over the course of an individual’s lifespan and are shaped by 
complex social and environmental factors including family and upbringing, marriage, social 
networks, culture, income, health status and the political environment. 
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1.4. The EUROACTION model of preventive cardiology care for coronary patients and 
their partners 
The context for my observational study of concordance for lifestyle between couples and 
concordance for change in a preventive cardiology programme is the EUROACTION cluster 
randomised controlled trial (Wood et al., 2004, Wood et al., 2008). This trial aimed to 
demonstrate whether a nurse-led multidisciplinary model of preventive care could help more 
coronary patients and their partners achieve the lifestyle, risk factor and therapeutic goals 
defined in the European prevention guidelines compared to usual care. The EUROACTION 
hospital study was set up in 6 countries and 12 hospital centres. 
Nurses and cardiologists recruited eligible patients and their partners. After a 
multidisciplinary assessment of lifestyle, risk factors, and drug treatment by a nurse, dietitian 
and physical activity specialist, couples attended at least eight sessions over a period of 16 
weeks where they had intensive behavioural support to achieve lifestyle changes from each 
member of the team. They also attended educational workshops and a supervised exercise 
class. The cardiologists initiated and uptitrated the cardioprotective drugs and nurses 
monitored risk factors and adherence to drug treatments at each session. At 16 weeks, 
patients and their partners were reassessed by the whole team and a report was sent to 
their family doctors. 
This model of preventive care was based on several important principles. The foundation of 
the programme was lifestyle change – smoking cessation, adoption of a cardio-protective 
diet and an increase in physical activity – as it is known that making and sustaining such 
changes reduces recurrence of disease and mortality. 
In order to achieve this objective, the strategy was firstly to draw on multidisciplinary 
expertise employing specialist nurses, dietitians and physical activity specialists. Secondly 
they were trained in behavioural strategies. Thirdly, they recruited the coronary patients to 
the programme with their spouses in the belief that behavioural changes are easier to 
achieve with the social support that a partner can provide, and that support will be 
maximised if the spouse is recruited to the programme and also understands the need to 
make these healthy lifestyle changes themselves. Spouses may also in their own right be at 
high cardiovascular risk and could benefit personally from the programme through the 
support and expertise offered by the multidisciplinary team. 
The EUROACTION preventive cardiology programme reduced the risk of cardiovascular 
disease compared with usual care mainly through lifestyle changes by families, who together 
made healthier food choices and became more physically active. These lifestyle changes led 
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to some weight loss and reduction in central obesity. The smoking cessation intervention 
reduced relapse in patients with coronary heart disease who had stopped smoking at the 
time of their initial hospitalisation, but this was of borderline significance. Blood pressure 
control was improved in the coronary patients, largely without the use of additional 
antihypertensive drug therapies. Control of blood cholesterol concentrations improved, 
although not significantly so compared to usual care. The use of cardioprotective drugs was 
high in the coronary patients in both arms of the trial. The smoking cessation intervention 
reduced relapse in patients with coronary heart disease, but this was of borderline 
significance. 
1.5. Multifactorial cardiovascular risk reduction programmes with family centred 
approaches. 
There are very few examples of evaluations of multifactorial family centred programmes, as 
opposed to individual patient studies, to address smoking, diet, physical activity and 
cardiovascular risk reduction in the literature. In addition to the EUROACTION cluster 
randomised controlled trial (Wood et al., 2008) described above, three other studies were 
identified and are described below (Dracup et al., 1984, Patterson et al., 1989, Pyke et al., 
1997). Only Dracup’s study evaluated a programme for coronary patients and their spouses. 
The others were primary prevention programmes. One other study evaluated a ‘spin-off’ 
effect describing the impact on the spouse of an individual who is attending a programme on 
their own (Sexton et al., 1987). After the EUROACTION trial was completed we set up and 
implemented a pilot for a community based integrated vascular prevention programme for 
both vascular patients and individuals at high cardiovascular risk together with their partners, 
but this did not use an experimental design to evaluate the results (Connolly et al., 2011). 
Dracup (1984) conducted a small RCT to evaluate adherence to lifestyle recommendations if 
female spouses were included in counselling for men attending cardiac rehabilitation post MI 
or CABG both in the shorter (10 weeks) and longer (6 months) term. For exercise, in the 
short term, couples where both partners were counselled and also where only the patient 
was counselled changed in the same direction with both taking more exercise together. But 
this was not sustained by the wives in the longer term. 
Both the British Family Heart Study (Wood et al., 1994) and the San Diego Family Health 
Project (Nader et al., 1989) were randomised controlled trials evaluating multifactorial 
programmes designed to promote cardiovascular health and reduce risk, one in families 
identified via school children, and the other in healthy couples identified via general practice. 
Patterson (1989) for the San Diego programme and Pyke (1997) for the British Family Heart 
Study conducted observational studies to evaluate concordance for changes in lifestyle and 
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risk factors between family members recruited to the intervention arms of these trials. At one 
year, significant aggregations of change in the 103 couples were seen for 3 day fat scores 
(0.51) and kilocalories of energy expended (0.43). In the British Family Heart Study, the 
primary outcome was the Dundee risk score which provides an overall measure of coronary 
risk over 5 years. The concordance analyses were based on the 1477 couples who were 
recruited to the intervention arm and on the 1204 who returned together at one year. 
Concordance for the initial total coronary risk score was 0.27, and for change in the score 
over one year, it was 0.20, both statistically significant. 
1.6. Theoretical frameworks for the influence of families on health behaviour change 
In this study of couple concordance for lifestyle behaviours that impact on cardiovascular 
risk, concordance is proposed to be an important contributing factor to a behaviour change 
strategy. The foundation of the EUROACTION preventive cardiology programme was the 
promotion of cardio-protective lifestyle habits in couples where coronary disease had 
presented for the first time using behavioural strategies and encouraging positive support 
mechanisms within the couple. 
 
Figure 1. Factors influencing motivation to change 
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with the expertise that the team members had to offer in smoking cessation, nutrition, 
physical activity and exercise, behavioural techniques would determine the quality and 
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elsewhere in more detail (Jennings, 2007, Jennings et al., 2009) and they were also outlined 
in the Health Professional Manual and at the EUROACTION central training for the multi-
disciplinary teams.  
Lifestyle change presents a challenge to both the individuals embarking on it and also to 
health professionals supporting them. There are several factors to take into account (See 
Figure 1). 
A new diagnosis of coronary disease has implications for understanding threats to health 
and may lead to misconceptions (Leventhal et al., 1992). Misconceptions about cause, for 
example stress being a major causal attribution, may blind patients to looking at other 
possible contributors to their diagnosis, like smoking, overweight or raised cholesterol. 
However, attributing a cause to an illness provides a sense of predictability and control  
(Turnquist et al., 1988). Perceptions about illness can determine the choice of coping 
strategies and affect adherence to treatment and medications, influence both positively and 
negatively the adoption of healthy behaviours, and may affect outcomes (Petrie et al., 1996, 
Hagger and Orbell, 2003, Cameron and Moss-Morris, 2004).  
On the other hand, patients who believe that their behaviour contributed to the cause of their 
illness, but that the illness is not amenable to control may feel guilty, develop low self esteem 
and poor psychological adjustment (Cameron and Moss-Morris, 2004).  
Perception of control is an important element of the belief system of patients with chronic 
disease and influences coping (Taylor et al., 1991), and adoption of and adherence to health 
protective behaviour (Helgeson, 1992, Petrie et al., 1996, Cooper et al., 1999). Patients who 
believe that they have little control over their illness are more inclined to employ passive 
coping strategies such as avoidance (Moss-Morris et al., 1996, Heijmans et al., 2004) and 
also to become dependent on health professionals. They are also less likely to attend 
cardiac rehabilitation (Petrie et al., 1996). 
Enhanced control depends on having information, being able to make decisions 
independently, being able to translate decisions into action, feeling that the outcomes of 
decisions are under one’s own control. It also depends on having developed sophisticated 
thought processes and strategies to reappraise negative circumstances in a more positive 
way (cognitive control) and on creating meaningfulness in the circumstances in which one 
finds oneself.  
Feeling in control depends on being able to internalise control rather than allowing control to 
be externalised. People with an internal locus for their control believe that they are in charge 
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of their lives, whereas an external locus of control is based on a belief in chance and the 
influence of ‘powerful others’ (Rotter, 1954, Wallston et al., 1976). An empowering approach 
in health promotion can contribute to the development of an internalised locus of control. 
In addition, the social and environmental background of an individual and their social 
network is an important factor with influences such as culture, cooking habits, legislation (eg 
smoking bans), cost of healthy foods, systems of service provision (cycle paths), provision of 
supportive services (prevention programme) and socio-economic status (Steptoe and 
Wardle, 2004) creating potential barriers and facilitators for change. 
 
Models have been proposed which describe the psychological basis for health behaviour, 
although these behaviours are not always adopted with health in mind. Cognition and 
motivation are driven by a much wider scope of influence than the desire for good health 
(Steptoe and Wardle, 2004). 
Empirical models of social cognition have been elaborated to explain health behaviour such 
as the Health Belief Model (Becker, 1974), Protection Motivation Theory (Rogers, 1983), the 
Theory of Reasoned Action (Ajzen, 1980), the Theory of Planned Behaviour (Ajzen, 1991), 
Health Locus of Control (Wallston et al., 1976), Social Learning Theory (Rotter, 1954), the 
theory of Self Efficacy (Bandura, 1982), the Transtheoretical Model (Prochaska and 
DiClemente, 1983, Prochaska et al., 1992, Prochaska and DiClemente, 1998), and the 
Health Action Model (Tones and Green, 2004) and each have contributed in different ways 
to the understanding of health behaviour. Performance of a given behaviour depends 
primarily on intention, and also on the expectations of significant others (de Wit and Stroebe, 
2004).  
Figure 2: SMART Goal setting 
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to their lives, and their beliefs about whether they are capable of achieving the change. Their 
perceptions of self efficacy are task specific and not global, and so relate to one element of 
their intentions.  
In attempting to translate intention into action, it is helpful, therefore, to make targets task 
specific and time limited (Sheeran et al., 2005). These specify how, when and where the 
action will be carried out.   
Therefore, in negotiating goals, small, short-term realistic and achievable goals should be 
set guided by SMART principles (Locke and Latham, 2002) (See Figure 2) with longer-term 
goals in sight. For example, in setting a dietary goal in someone who was not including any 
fish in their diet, different options can be proposed for including fish (fresh, tinned etc) and 
then a goal set to try fish once or twice during the week and to report back the following 
week. This could also apply to an addictive behaviour like smoking where a quit date is 
agreed and a plan made to prepare for it. Subsequently, progress can be reviewed and new 
goals set week on week. This allows regular monitoring and follow-up during the early 
relapse prone stages of change, for example the withdrawal from nicotine phase, where 
lapses can be discussed and eventual relapse to smoking may be prevented. Goals should 
be documented on a shared record in order to secure them as a contract between 
professional and client and to facilitate easier tracking of real progress.  
Figure 3. Theoretical framework for behaviour change 
 
In summary, the important psychological determinants for behavioural change are control 
(Leventhal et al., 1980, Helgeson, 1992, Petrie et al., 1996, Cooper et al., 1999, Tones and 
Green, 2004), intention (de Wit and Stroebe, 2004), expectations about outcome, and 
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specific targets (Sheeran et al., 2005). However, psychological determinants must also be 
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seen in the context of available support which can come from a partner or spouse, other 
family members, friends and professionals.  
The Health Action Model (Tones and Green, 2004) describes how beliefs, motivation, 
normative influences and aspects of self, lead people to develop intentions to adopt a given 
health behaviour. In a supportive environment, these intentions will be translated into action, 
because they become a relatively easy choice to make. The supportive environment helps 
patients to remove psychological, behavioural and environmental barriers. It is also available 
to help patients maintain the health behaviour that they have adopted and to develop 
strategies to deal with relapse. Figure 3 shows how these factors can work together to help 
people change behaviour most successfully. 
The role of the health professional is to empower and motivate whilst understanding that it is 
unrealistic to expect patients to automatically act on advice as it is given to change difficult 
behaviours which may be addictive and/or life-long. An empowering approach allows choice, 
raises critical awareness, is facilitative, shares decision-making and agenda setting, is 
honest and based on negotiation. It is not dictatorial, and does not use force, coercion, 
indoctrination, manipulation or hidden threats. This would only serve to undermine self-
efficacy and is unlikely to be successful in sustaining changes, particularly in the long term. 
Figure 4. The OARS Model for Communication 
 
With this framework in mind, health professionals working in multi-disciplinary teams can be 
taught practical skills and techniques which encourage individuals to change behaviours. 
The motivational interviewing techniques described by Miller (2008) are characterised by 
being client centred and directive. Motivational interviewing aims to explore motivation and, 
in particular, to identify ambivalence with regard to potentially changing problem behaviours. 
Of prime importance is the establishment of a therapeutic and empathic relationship 
between professional and client, which is based on a non-judgemental attitude on the part of 
•  Communication skills: OARS 
 -  Open ended questions 
 -  Affirm 
 -  Reflective listening: repeat, rephrase, 
paraphrase 
 -  Summarise 
 
!  Pick out key messages 
!  Clarify main issues 
!  Set an agenda – goal setting 
!  Express empathy 
!  Roll with resistance 
!  Support self-efficacy 
!  Avoid argumentation 
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the professional and on allowing the client to be in control of their agenda for change. 
Counselling skills are employed which are designed to encourage the client to talk through 
the issues from their perspective rather than the perspective of the professional. For 
example, the professional uses open ended rather than closed questions, and actively 
listens, reflects back and summarises to the client what they have heard (See Figure 4). 
Figure 5. Agenda setting chart 
 
This allows the professional to check their understanding of the client is correct and also it 
helps the client to realise in full what they have said, and to start to develop discrepancy in 
their view of their current behaviour and how they see their behaviour changing. The 
professional follows the client’s agenda and avoids getting into circular arguments, but 
instead works with their resistance to ensure that a sense of power and control to resolve 
barriers and to make decisions about change rests with the client. 
Various tools are available to maximise the use of motivational interviewing skills. An agenda 
setting chart (See Figure 5) helps in assessing whether a particular behaviour change, for 
example, stopping smoking, is a priority for change for an individual. In addition, stage of 
change and readiness to change can be assessed using the Transtheoretical model 
(Prochaska et al., 1992) change wheel (See Figure 6). The stages of change model helps 
professionals to understand where their patients are in relation to making a change, for 
example losing weight or quitting smoking. However, caution is required in ensuring that 
patients are not dichotomised too strictly as a ‘pre-contemplator’ and being unready to 
change without further exploring decisional balance and motivation. 
Motivation can be assessed by looking at the importance an individual places on making a 
change and how confident they feel in achieving it. Tools available to assess motivation and 
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self efficacy regarding particular behaviour changes include scaling questions (Rollnick et 
al., 1999) where individuals are asked to rate on a scale 0 (least) to 10 (most), the 
importance they attached to a change and, separately, to rate their confidence in their ability 
to achieve it (See Figure 7). Discrepancy between ratings of importance and confidence 
regarding a health behaviour change helps to draw out ambivalence or uncertainty regarding 
a change, which can be probed further by exploring decisional balance, i.e. the pros and 
cons of maintaining or changing a behaviour (See Figure 8). Dedicated time to follow up is 
required in using this intensive approach with a consistent team who can be available at 
regular programme sessions.  
Figure 6. Transtheoretical model stages of change assessment 
 
Figure 7. Scaling Questions 
 
 
 
Pre-contemplation –not 
interested in changing risky 
lifestyle 
Established change – 
stable safer lifestyle Action: 
making changes 
Maintaining  
change 
Relapsing 
Thinking about  
change 
Preparation: 
preparing to 
change 
Importance 
Confidence 
Readiness 
to change 
0------------------ I --------------- 10 
Not at all                               Very 
Confident                          Confident 
0------------------ I --------------- 10 
Not at all                               Very 
Important                                         Important 
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Figure 8. Exploring the Pros and Cons 
 
Using a behavioural strategy based on psychological theories depends on available support 
not only from professional experts, but also from partner or other family members or friends. 
Ways in which social support can positively influence illness progression and recovery 
varies. Health behaviours can be stimulated by the support of a spouse, for example, taking 
medications, stopping smoking (Murray et al., 1995), becoming physically active, eating 
healthily. The social support acts as an indirect mediator. Social support may improve self 
efficacy which in turn impacts on the adoption of healthy behaviours (Duncan and McAuley, 
1993, Langford et al., 1997). So, a resourceful and positive spouse is an important source of 
social support, and this support may be effective in terms of reduced mortality, indirect 
mediation of adoption of health behaviours, providing emotional and instrumental support, 
and building self esteem. 
 
The most important source of support is at home in a spouse. The spouse is intimately 
involved and emotionally tied in to the experience of the patient . The couple’s perceptions of 
illness and risk are important influences and will guide their reactions and behaviours and 
the importance each places on achievement of behaviour changes. 
Concordance within a couple, especially those who are most successful and stay together, is 
an important factor determining health behaviour. Couples may develop shared habits or 
choose each other on the basis of a habit that is detrimental to their health. When one of 
them develops an illness, the challenge is to kick that habit. Kicking it together is the most 
constructive and rewarding thing they can do to prolong life and optimise health. 
An important aspect of concordance for change in couples is undoubtedly the dynamics 
between partners in response to events and, in particular, to an illness in one partner. 
People who have experienced a life-threatening event like a myocardial infarction, are open 
to different influences including those from their doctor and other health professionals 
Current Behaviour 
Change 
The pros The cons 
The pros 
The cons 
Ambivalence & Decisional Balance  
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advising them to modify behaviours (like for example stopping smoking) in order to avoid 
recurrence of a further event or even death. They are also open to the support that these 
professionals can offer them to achieve these important changes.  
Various theories have been put forward to explain reasons for concordance (Epstein and 
Guttman, 1984, Zietsch et al., 2011) in couples and for the mechanisms for partners 
influencing each other’s health behaviours (Umberson, 1987). 
The theory that appears to have most support in the concordance literature is that of ‘non-
random mating’ although the mechanisms for this are not entirely understood (Watson et al., 
2004, Zietsch et al., 2011). Non-random mating can occur in one of two ways. Individuals 
may select a mate on the basis of a particular phenotype, e.g. smoking or exercise, or 
because of social homogamy, i.e. people are attracted to others from a similar social 
background where a particular phenotype is not common, for example alcohol use in some 
cultures. 
Alternatively, the explanation for concordance may be convergence in behaviours over the 
duration of a relationship. When partners marry, they share the same social and home 
environment and available finances (Smith and Zick, 1994). In fact, these theories are 
unlikely to be mutually exclusive. They may also differ for each phenotype. 
Another important mechanism, particularly in relation to concordance for health behaviours, 
is social control (Umberson 1987). This is exerted when one spouse tries to control the 
behaviours of the other, and is usually the female partner. Women more than men take 
responsibility for the organisation of the home environment for example in buying and 
preparing food. They also take responsibility for maintaining the health of their husbands, 
possibly by persuading them to stop smoking, to eat the right food, especially they have 
experienced a major threat to their health. Self efficacy (confidence to achieve these 
behaviours) will be enhanced when support from the spouse is offered in an appropriate 
way. 
Often the behaviours that need addressing are shared, and joint efforts are required to 
change. Both partners need to reflect, make important decisions about change and face 
challenges to take their lives in a different direction together.     
This study of concordance aims to explore further concordance for change in couples 
following the development of an illness and to quantify this concordance where professional 
support for change is available.                                                                                           
 
! 37!
Aims of the study 
2.1. Aims  
The aims of this research were (i) to evaluate concordance for lifestyle and associated risk 
factors in married couples, where one partner had developed coronary disease, participating 
in the EUROACTION preventive cardiology programme, and (ii) concordance for changing 
lifestyles together over one year, and (iii) to view these results in the context of a systematic 
review of the scientific literature I conducted on concordance for smoking, dietary and 
physical activity habits in couples, and patterns of change in couples behaviour over their 
marriage duration. 
My study investigated married couples recruited to the EUROACTION hospital preventive 
cardiology programme at the time when one partner had developed coronary disease for the 
first time. The aim of the study was to establish whether there was concordance for lifestyle 
habits in relation to smoking, diet and physical activity in these couples prior to this first 
coronary event, and whether, during the course of the 16 week programme, and also 8 
months after the end of the programme, there was concordance for change towards a 
healthier lifestyle. I also investigated concordance for cardiovascular risk factors - body mass 
index, waist circumference, blood pressure, lipid and glucose - as they are strongly 
influenced by smoking, diet and physical activity and so could provide objective evidence of 
lifestyle change which was largely self reported. In addition, concordance for psychosocial 
factors was investigated (emotions, perception of health related quality of life and 
understanding of the disease) in order to gain some insight into the dynamics of the couple 
in managing a new diagnosis of coronary disease in one of them. The results of these 
observational analyses from the EUROACTION study have been interpreted in light of my 
systematic review on concordance and concordance for change. 
2.2. Research Questions 
2.2.1. Is there concordance for lifestyle and the cardiovascular risk factors listed below in 
married couples recruited to a nurse-led, multi-disciplinary, family based preventive 
cardiology programme for coronary patients in six European countries? 
a. Self reported smoking behaviour 
b. Self reported diet: saturated fat and fruit and vegetables intake 
c. Self reported physical activity: 7 day recall of habitual physical activity and  
pedometer records 
d. body mass index (Kg/m2) 
e. waist measurement (cms) 
f. blood pressure: systolic (mmHg) 
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g. blood lipids: total cholesterol, HDL-cholesterol and calculated LDL-cholesterol 
(mmol/l) 
h. blood glucose (mmol/l) 
i. emotions: Hospital Anxiety and Depression Scale and Global Mood Scale scores 
j. health state: Euroqol EQ-VAS scores 
k. perceptions of coronary disease: Score derived from the Revised Illness 
Perception Questionnaire 
 
2.2.2. Is there concordance for change in lifestyle and risk factors in those participating 
couples at completion of the programme (16 weeks) and at one year after recruitment? 
 
Summary 
Cardiovascular disease burden is increasing worldwide and Europe is no exception. 
Unhealthy lifestyles – tobacco smoking, poor diet and physical activity – provide an 
important explanation for these adverse trends. There is scientific evidence to show that 
interventions to address adverse lifestyles can have a major benefit in terms of reducing 
morbidity and mortality. Family centred programmes focussing on lifestyle have 
demonstrated some success in reducing cardiovascular risk in couples. The mechanism for 
this may be concordance for lifestyle factors in couples and important dynamics for change 
during the course of marriage and as a result of illness. This doctoral study aims to 
investigate concordance for smoking, dietary and physical activity habits in couples where 
one partner has developed coronary disease for the first time and concordance for change 
during the course of their attendance at a cardiovascular prevention and rehabilitation 
programme and in the longer term. 
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CHAPTER 2. METHODS 
This chapter will place my doctoral study in context vis-à-vis the methodology for the 
EUROACTION cluster randomised controlled trial. Methods and tools for assessing smoking 
diet and physical activity will be described as well as the intervention programme. Methods 
for conducting the literature review will also be detailed. 
1. Search strategy for systematic review of the literature on concordance and 
concordance for change in lifestyle in couples 
In order to strengthen the discussion of the results of my concordance study, I conducted a 
systematic review of the literature on concordance for lifestyle habits in married and 
cohabiting couples including smoking, diet and physical activity in couples, and concordance 
for change. Whilst this review was not conducted using a methodology for systematic 
reviews described in the literature, like for example a Cochrane review, it was nevertheless 
conducted in a systematic fashion in order to ensure picking up the fullness of literature on 
the topic. The methodology for conducting the review is described below. 
1.1. Concordance for smoking in couples 
Studies which evaluated the association of smoking behaviour in married or cohabiting 
couples were identified via the OVIDSP database search interface using the following search 
terms and strategy: two searches were conducted separately using the terms shown below. 
Subsequently, the two searches were combined. 
1. married couples OR spouses OR married partners 
2. cigarrette smoking OR tobacco smoking OR smoking cessation OR smoking habit 
3. 1 AND 2 
This produced 149 references, which included smoking concordance, concordance for 
change and other aspects of partner dynamics in smoking cessation. In addition, the 
reference lists of appropriate papers were scanned for further references. Finally, for the 
topic of concordance in couples for smoking behaviour, 42 references were identified. 
Investigating concordance was conducted in a variety of ways in the identified studies. The 
assessment of smoking status generated either binary, ranked ordinal or continuous data 
depending on how it was classified. Binary data were generated using the following 
classifications: 
• Current smoking: YES or NO 
• Ever smoked regularly: YES or NO 
• Current/ex smoker OR never smoker 
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• Current smoker OR ex/never smoker 
Ranked ordinal data were generated were generated using the following classifications: 
• Current, former, never 
• Current, occasional, ex/never 
Continuous data were generated with the variable – number of cigarettes smoked per day. 
The evaluation of concordance was conducted using a variety of statistical measures, i.e. 
correlation (appropriate for either categorical or continuous data), odds ratios or percentage 
agreement. Many of the studies also compared concordance with a surrogate such as 
randomly assigned pairs or with what would be expected by chance or if there were no 
association between couples for smoking behaviour. Some studies presented one overall 
result, whilst others created a coefficient or odds ratio for different comparisons of the data 
or different groups within the study population. 
Studies evaluating patterns of change in couples with regard to smoking either used 
longitudinal data to compare similarities in smoking behaviour at two or more time points, or 
used cross-sectional data to compare patters of smoking and smoking cessation in married 
and non-married individuals. There were also a number of small intervention studies 
comparing smoking cessation with and without partner support, but this was not necessarily 
confined to spousal support. 
1.2. Concordance for dietary habits in couples 
Studies which evaluated the association of dietary habits in married and cohabiting couples 
were identified via the OVIDSP database search interface using the following search terms 
and strategy: two searches were conducted separately using the search terms shown below. 
Subsequently, the two searches were combined. 
1. married couples OR spouses OR married partners 
2. cardioprotective food OR mediterranean diet OR food habits 
3. 1 AND 2 
This produced 49 references which included dietary concordance, concordance for change 
and other aspects of couple dynamics with regard to food habits. In addition, the reference 
lists of appropriate papers were scanned for further references. Finally for the topic of 
concordance in couples for dietary habits, 19 references were identified. The data reported 
are only those for consumption of fat, fruit and vegetables. 
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Various methods were used to assess dietary intake, including seven day food diaries 
(Eastwood et al., 1982, Nelson et al., 1980), food frequency questionnaires (Di Castelnuovo 
et al., 2007, Izumi et al., 2004, Kolonel and Lee, 1981, Lee and Kolonel, 1981, Lyu et al., 
2004, Macario and Sorensen, 1998, Schafer et al., 1995) and radio opaque markers in 
faecal constituents (Eastwood et al., 1982). One study (Hannon et al., 2003) asked 
respondents to report on how much fat they included in their diet and rate it on a four point 
Likert scale, and how many servings of fruit and vegetables they consumed per day. In this 
study, the questions used to assess intake were validated in a parallel study using a 36 item 
food frequency questionnaire and dietary analysis. Macken and colleagues (Macken et al., 
2000) asked respondents to rate the amount of fat they consumed in their diet on a 10 point 
visual analogue scale. Food frequency questionnaires varied in the number of items they 
included, for example, in the Chinese study (Lyu et al., 2004), the questionnaire included 
473 Chinese items, whereas in the Japanese study (Izumi et al., 2004), nine were included. 
Five of the studies performed dietary analysis of their frequency data to ascertain 
percentage of fat in the diet (Eastwood et al., 1982, Lee and Kolonel, 1981, Lyu et al., 2004, 
Nelson et al., 1980, Schafer et al., 1995). In seven of these studies, dietary concordance 
was evaluated with correlation, in two, percentage agreement was measured and in two, no 
formal concordance statistic was used. 
In assessing patterns of change in diet in couples, one study was identified which formally 
assessed concordance for change during a family centred intervention. These data came 
from a randomised controlled trial of a lifestyle and risk factor management programme. 
There were also two studies which looked at dietary change or support for change in wives 
of men who have had an acute cardiac event, and two that looked at the effect that an 
intervention directed at one partner has on the other partner, irrespective of whether they are 
actively involved in the intervention. There were efforts made, also, to examine the dynamics 
of food monitoring intake food and the role of women. 
1.3. Concordance for physical activity and exercise habits in couples 
Studies for physical activity concordance were identified via the OVIDSP database search 
interface. Two searches were conducted separately using the search terms shown below. 
Subsequently, the two searches were combined. 
1. married couples OR spouses OR married partners 
2. physical activity habits OR exercise habits OR physical activity OR exercise 
3. 1 AND 2 
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This produced 214 references, which included physical activity concordance, concordance 
for change and other aspects of couple dynamics with regard to physical activity. In addition, 
the reference lists of appropriate papers were scanned for further references. Finally, for the 
topic of concordance in couples for physical activity habits, 29 references were identified. 
More than half of the studies came from the US (6) and Canada (5). The other studies came 
from Europe (Belgium, Finland, Italy, Netherlands, Norway, Portugal, UK) with the exception 
of one, which was from China. For the most part, physical activity in leisure time (LTPA), in 
sport or in exercise was measured rather than habitual physical activity (which encompasses 
all activity and energy expended during the usual activities of daily living). However, one 
study measured daily sedentary behaviour (defined as no regular participation in LTPA or 
exercise), two measured fitness, and two included occupational activity in addition to LTPA. 
Habitual physical activity was a measure in three of studies. The rigour applied to the 
measures of physical activity varied between studies with some performing more detailed 
assessments than others. For example the Chinese study (Jurj et al., 2006) based its 
assessment on one question, which asked whether or not respondents had participated in 
exercise or sport once per week for 3 months continuously over the past five years. In 
contrast, the Canadian studies were more rigorous, for example with one study (Perusse et 
al., 1989) employing a 3 day activity record which included one weekend day and measuring 
frequency, intensity and duration of activity and assigning metabolic equivalents (METs) to 
all activities reported in order to measure energy expenditure. 
In many of these studies, concordance in spouses for physical activity behaviour is not the 
major outcome of the research. In some cases, for example, familial aggregation across 
generations, genetics versus environmental factors and the influence of psycho-social 
factors is the topic of interest, but spousal concordance has also been reported as part of the 
research. 
The majority (fourteen) of the studies use correlation for their concordance analyses and the 
rest applied ORs (one a standardised risk ratio) or percentage agreement although one of 
these did not apply the kappa statistic or a comparison with surrogate or randomly assigned 
couples to their analyses. 
1.4. Concordance for change in lifestyle habits in couples 
As a result of their positive findings, many of the researchers conducting the studies 
reviewed above recommend involving family members in behaviour change initiatives. 
However, there are few examples in the literature of evaluations of such an approach. In 
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addition to the studies found from the search strategies used above, a fourth search was 
conducted. 
1. Married couple(s) OR spouse(s) OR married partner(s) 
2. Cardiac rehabilitation program( ) OR cardiovascular disease prevention program( ) 
3. 1 AND 2 
This revealed thirteen studies, only one of which described a trial of a couple centred 
programme focussing on behavioural change (Dracup et al., 1984). Four of the studies 
focussed on information and social support needs and psychological distress in partners of 
coronary patients post cardiac event, but did not describe a programme to meet these 
needs. When the term ‘family’ was added to Search 1 and then combined with Search 2, 
ninety-nine studies were identified which included the principal results paper for the 
EUROACTION cluster randomised controlled trial (Wood et al., 2008), but otherwise, no 
additional examples of programme evaluations. 
1.5. Statistical measures of concordance for lifestyle habits in couples 
The evaluation of concordance was conducted using a variety of statistical measures, i.e. 
correlation, odds or risk ratios or percentage agreement. Many of the studies also compared 
concordance with surrogate or randomly assigned pairs or with what would be expected by 
chance if there were no association between couples for behaviours. Some studies 
presented one overall result, whilst others created a coefficient or odds ratio for different 
comparisons of the data or different groups within the study population. 
Measures of concordance used in the included studies for each lifestyle habit are described 
and defined in Table 1 below. 
Table 1. Measures of Concordance. 
Correlation coefficients Abbreviation What is measures 
Inter-class (eg. Pearson’s product- 
moment) 
r Association between continuous variables that are linear 
and normally distributed. 
Intra-class ICC Strength of resemblance of units within same group (eg. 
twin compared to other twins) 
Polychoric PCC Correlation between two theorised normally distributed 
continuous latent (inferred) variables, from two 
observed ordinal variables 
Tetrachoric rtc A type of polychoric correlation used for dichotomous 
variables 
Spearman’s rank rs Measure of association between two variables where data 
are not normally distributed 
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In order to measure change patterns in couples over marriage duration or in relation to 
external influences, such as illness in one partner, formal concordance measures were 
rarely used. Instead, imaginative use of cross-sectional and longitudinal was in evidence. 
Also, data from randomised controlled were sometimes used, however, there were no 
examples of randomised controlled trials being conducted in order to assess concordance 
for change in couples, only a few small studies which compared interventions with partner 
support to the same intervention without partner support. 
2. Study Design 
2.1. The EUROACTION Cluster randomised controlled trial 
EUROACTION was a European matched paired cluster randomised controlled trial which 
was carried out in 12 hospitals and 12 general practices in eight countries in Europe 
(Denmark, France, Italy, the Netherlands, Poland, Spain, Sweden, and the United Kingdom) 
(Wood et al., 2004, Wood et al., 2008) (See Figure 9). The aim of the trial was to 
demonstrate that a nurse-led, multidisciplinary, family based model of preventive cardiology 
care in hospital for patients with coronary disease and their families, and in general practice 
for individuals at high total risk of developing cardiovascular disease (CVD) and their 
families, could achieve the European Society of Cardiology recommended lifestyle, risk 
Tau B τb 
 
Non parametric measure of association based on the 
number of concordances and discordances in paired 
observations. 
Phi (mean square contingency 
coefficient) 
rphi Measure of association for 2 binary variables when the 
two nominal variables under consideration have exactly 2 
possible values 
Contingency C Measure of association for 2 binary variables when there 
are 3 or more values for each nominal variable as long as 
there are an equal number of possible values 
Cohen’s kappa Κ 
 
Measure of inter-rater agreement. More robust than 
simple percent agreement. Claims to take into account 
chance agreement. 
   
Ratios   
Odds ratio OR Measure of effect size, describing the strength 
of association or non-independence between two 
binary variables!
Relative risk or risk ratio RR Measures the risk of an occurrence (eg quitting smoking) 
in one group divided by the risk of the same in the other 
group 
Observed over expected ratio  Ratio calculated by dividing observed values by what 
would be expected by chance alone 
Percentage agreement % agreement Percentage agreement between an event happening in 
one group compared to it happening in another. E.g. % 
wives currently smoking in wives compared to same in 
husbands. Sometimes compared to what it would be in 
surrogate pairs to make the analysis more robust. 
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factor and therapeutic targets for CVD prevention (See Figure 10) (Wood et al., 1998, De 
Backer et al., 2003) in every day clinical practice. 
 
Figure 9. EUROACTION Study Design 
 
 
Objectives of the trial: 
a. to demonstrate the immediate impact of a 16 week cardiovascular prevention and 
rehabilitation programme located in district general hospitals on lifestyle, risk factors, 
therapeutic management, health related quality of life (HRQoL) and illness 
perceptions of coronary patients and their families 
b. to demonstrate the impact on cardiovascular risk of a postal intervention coordinated 
from the hospital led preventive cardiology programme on all first degree relatives of 
recruited coronary patients with premature disease 
c. to demonstrate the longer term impact beyond the lifespan of the programme for all 
coronary patients, partners and first degree relatives at 1 year 
d. to demonstrate the impact of a nurse led preventive cardiology programme located in 
general practice on lifestyle, risk factors, therapeutic management, health related 
quality of life (HRQoL) and risk perceptions of individuals and their partners at one 
year 
e. to follow up all patients with coronary disease, high risk individuals and their partners, 
and first degree relatives of patients with premature coronary disease for 
Identification of one pair of comparable hospitals/general practices 
Randomisation 
 
Intervention 
 
Usual care 
Baseline identification of patients 
Initial assessment of all eligible patients and 
their partners 
Initial assessment of a sub-sample of patients 
16 week preventive cardiology programme 
for patients and their families  
16 week assessment of all eligible patients 
and their partners (hospital only) 
16 week assessment of a sub-sample of 
patients (hospital only) 
 
1 year follow-up assessment of all eligible 
patients and their partners 
 
1 year follow-up assessment of all eligible 
patients and their partners 
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cardiovascular non-fatal events and cardiovascular and all-cause mortality in order to 
determine the relationship between the programme and event free survival. 
 
Figure 10. European lifestyle, risk factor and therapeutic targets 
 
 
Two comparable district general hospitals were identified in France, Italy, Poland, Spain, 
Sweden, and the United Kingdom matched according to the following criteria: size, serving 
population, number of cardiologists, number of cardiac admissions, number of cardiac beds 
and provision of preventive and rehabilitative care. In addition, a retrospective audit of 
comparability of patients admitted to each centre was conducted on the period one year prior 
to the study launch in relation to age, gender and distribution of diagnostic categories. Once 
the centres were matched and their comparability established, they were randomised within 
their country pairs to either receive the EUROACTION programme or to be monitored for 
their usual care. General practices were also identified for their comparability with regard to 
size, serving populations and provision of preventive care. In addition a retrospective audit 
was conducted in terms of age, gender and drug prescriptions of the patient populations 
prior to randomizing the centres to either the intervention or usual care arms of the study. 
The systems of primary care in both Sweden and France were deemed by their National 
Coordinators as unsuitable at that time for conducting the study and therefore two additional 
countries were identified: the Netherlands and Denmark.  
•  Not smoking 
•  Eating a cardio-protective diet 
•  Being physically active 
•  Achieving and maintaining a healthy shape (waist circumference below  94cm for men 
and below 80cm for women) and weight (Body Mass Index below 25 kg/m2) 
•  Blood pressure below 140/90 mmHg (and for those with diabetes below 130/85 mmHg) 
•  Total cholesterol below 5.0 mmol/L, LDL cholesterol below 3.0 mmol/L 
•  Blood glucose below 6.1 mmol/l and good glycaemic control in all persons with diabetes 
•  To ensure that each of the following classes of cardio-protective medications are 
prescribed as clinically indicated, at the doses used in the clinical trials, for all coronary 
patients and to encourage long term compliance with these therapies: 
o  Anti-platelet therapy 
o  Beta-blockers 
o  ACE inhibitors or AII receptor blockers 
o  Lipid lowering therapy (statins) 
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2.2. Ethical Procedures 
Local Research Ethics Committee review and approval at each centre was a requirement for 
the study in order to ensure the rights, safety, dignity and well-being of research participants 
was protected and the integrity, quality and transparency of research design.  This review 
would also ensure that research staff and participants were to be informed fully about the 
purpose, methods and intended possible uses of the research, what their participation in the 
research entailed and what risks, if any, would be involved.  
Ethical review also ensures confidentiality of information supplied by research participants 
and respect for anonymity, that they understand that their participation is voluntary and free 
from coercion, avoidance of harm in all instances, and that any conflicts of interest or 
partiality are explicit. 
The National Coordinators in each country applied for ethics approval to conduct the study in 
each hospital and primary care centre. Written, informed consent was obtained from each 
participant by means of a signed declaration which was stored in the patient file. Prior to the 
enrolment of the first patient in each country, the National Coordinators sent to the Co-
ordinating Centre a signed declaration identifying the lead investigator, nominated operators 
and other trial personnel, a signed copy of the Ethics Committee approval and a sample of the 
patient-consent forms and information sheet as approved by the local Ethics Committee. 
 
2.3. Observational Study of Concordance 
My study has investigated the extent to which patients who were recruited with their partner 
to the programme in the intervention hospitals were concordant for lifestyle, risk factors and 
psychosocial status and the extent to which they were concordant for the changes they 
made during the course of the programme. The hospitals were based in France (Institut 
Hospitalier Jacques Cartier, Massy, Paris), Italy (Boldrini Hospital, Thiene), Poland (Szpital 
Powiatowy, Chrzanowie, Krakow), Spain (Hospital Universitario Dr. Peset, Valencia), 
Sweden (Halmstad Hospital, Halmstad) and the United Kingdom (Stoke Mandeville Hospital, 
Aylesbury, Buckinghamshire). 
 
3. Study Population 
3.1. The study population for the cluster randomised controlled trial 
Consecutive adult patients under the age of 80 were prospectively identified by the study 
nurses working in both the intervention and usual care hospitals at the time of their hospital 
admission or out-patient appointment according to the following criteria: clinically confirmed 
incident cases of either, acute myocardial infarction (AMI), with ST-elevation or non-ST-
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elevation, unstable angina or stable angina. Patients were excluded if they were considered 
ineligible for a prevention and rehabilitation programme, i.e. suffering from severe heart 
failure, severe physical disability, and/or severe cognitive dysfunction.  Patients were 
recruited to the trial whether or not they had a spouse. First degree relatives of patients who 
presented to the study with a diagnosis of premature coronary disease (under the age of 55 
years for a man and 65 years for a woman) were also recruited. 
3.2. Couples included in the observational study of concordance 
Following prospective identification, the study nurses recorded information from the patients’ 
medical notes on diagnosis and treatment at discharge from hospital onto the case record 
form (Appendix I. page 250). Personal contact details were also recorded so that patients 
could be invited to attend with their partner, an assessment with the EUROACTION 
cardiovascular prevention and rehabilitation team. 
If the patient had been hospitalised, they were informed during their admission, about the 
EUROACTION programme by their cardiologist and hospital nurse. The EUROACTION 
study nurses visited patients during their hospital admission, preferably when the partner 
was present, in order to provide more information about the study and the 16 week family 
centred programme. If they gave their consent, they were given written information and an 
appointment to attend the baseline assessment with the team. The partners of all patients 
were also invited to attend the assessment with the team and then to join the prevention and 
rehabilitation programme. 
If the nurses were unable to see the patient prior to the assessment, they invited the patients 
with a standard letter which was addressed to both the patients and their partners. Following 
recruitment, the GP was informed by letter. 
4. The EUROACTION assessment 
At the start of the programme each couple had a detailed assessment of their total 
cardiovascular risk to which the nurse, dietitian and physical activity specialist from the 
programme multi-disciplinary team contributed. CVD has a multifactorial aetiology and risk 
factors a multiplicative effect (Alderman, 1993, Jackson et al., 2005), therefore, a holistic 
approach to prevention is an imperative and should be based on a comprehensive 
assessment of lifestyle (smoking, diet and physical activity), body weight and fat distribution, 
blood pressure, lipid profile, glucose regulation and psychosocial status. An individual with a 
number of modest risk factors may be at considerably greater risk than another person with 
only one very high risk factor. 
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Figure 11. Timing of the Assessments 
 
The baseline assessment formed the starting point of the programme allowing identification 
of problems and goals to be set. Once the intensive lifestyle and risk factor programme was 
completed (16 weeks), a second assessment was held to evaluate the immediate impact of 
the programme. A final assessment at one year was held to evaluate long term maintenance 
of risk factor management (See Figure 11). Figure 12 shows how the EUROACTION 
multidisciplinary assessment worked in practice. In a morning, for example, three couples 
could be seen by each member of the team, the nurse, the dietitian and the physical activity 
specialist. This worked by allowing each team member to work in three different work areas 
at the same time. Once the nurse had completed the assessment of Couple 1, the dietitian 
the assessment of Couple 2 and the physical activity specialist the assessment of Couple 3, 
they each moved on to the next couple and so on until each couple had been assessed by 
each member of the team. 
Figure 12. Logistics of the Assessment 
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The assessment was carried out using standardised methodologies and equipment which 
was supplied by the central coordinating centre. Study nurses, dietitians and physical activity 
specialists were centrally trained in how to perform the assessment and how to use the 
equipment. They were also given a Health Professional Manual written and reproduced by 
the Central Coordinating Team. The elements of the assessment can be seen in Table 2. 
 
 
Table 2: Elements of the EUROACTION hospital assessment 
Factor being 
Assessed 
Tool used 
Smoking 
(Appendix 1 
p250) 
! Self reported smoking habit  
! Breath Carbon Monoxide validation of self report (Bedfont 
micro-smokerlyser - model EC 50 Micro III) 
! Fagerstrom Test for Nicotine dependence (Heatherton et al., 
1991)  
! Stage of change regarding stopping smoking (Prochaska and 
DiClemente, 1984) 
Diet (Appendix III 
p295) 
 
! Questionnaire on food habits  
! 2 x 24hr dietary recall (macronutrient analysis) (Slimani et al., 
1999) 
! Stage of change for diet 
Physical Activity 
(Appendix V 
p324) 
! 7 day physical activity recall (7D-PAR) (Blair et al., 1985)  
! Pedometer (Digiwalker Yamax SW-200) (Welk et al., 2000) 
! International Physical Activity Questionnaire (IPAQ) (Craig et 
al., 2003) 
! Short-form-36 questionnaire (functional limitations profile) 
(Ware and Sherbourne, 1992)  
! 10 metre Incremental Shuttle Walk Test (functional capacity) 
(Singh et al., 1992b, MacSween et al., 2001)  
! Stage of change for physical activity 
Body weight 
history and 
anthropometrics 
(Appendix III 
p295) 
! Self report questions on weight history  
! Weight and height using standardised equipment (Seca 707 
digital scales with measuring stick), and BMI calculated using 
the following formula: weight (kg)/height (m2). 
! Stage of change for weight 
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Central Obesity 
(Appendix III 
p295) 
! Waist measurement was measured using a metallic tape 
measure and a standardised method described below  
Psychosocial 
Status (Appendix 
II p286) 
 
! Health beliefs questionnaire  
! Illness perception questionnaire (Moss-Morris et al., 2002)  
! Hospital Anxiety and Depression Scale (Zigmond and Snaith, 
1983)  
! Global Mood Scale (Denollet, 1993)  
! EQ-5D and EQ-VAS (Euroqol) (Schweikert et al., 2006)  
Blood Pressure 
(Appendix I p250) 
! Self report questions  
! Standardised method described below using Omron 711 
automatic sphygmomanometer. 
Blood Cholesterol 
(Appendix I p250) 
! Self report questions  
! Full fasting lipid profile (Total, HDL, calculated LDL 
cholesterol and triglycerides) 
Blood Glucose 
and diabetes 
(Appendix I p250) 
! Self report questions  
! Fasting and random plasma glucose 
! Glycated haemoglobin 
! Oral glucose tolerance test (OGTT) performed in a random 
sub-sample of coronary patients 
Cardio-protective 
medications and 
adherence 
(Appendix I p250) 
1. Anti-platelets 
2. Beta-blockers 
3. ACE inhibitors and angiotensin II receptor blockers 
4. Lipid lowering medications 
5. Anticoagulants 
6. Hypoglycaemic agents 
7. Nicotine replacement therapy and bupropion 
8. Antiobesity drugs 
 
The team recorded their findings on the assessment documentation which was specifically 
designed for the study and incorporated the case record forms (See Appendices I, III and V). 
Patients and partners were also given pre-assessment self administered questionnaire 
packs (Appendix II) to complete. All documentation was held in a programme record folder 
kept by the team in their offices. This record was used to track progress towards reaching 
lifestyle and risk factor goals. The team members communicated the findings of their 
assessments to each other in order to gather a holistic picture of the lifestyle of both patient 
and partner in the context of their family situation and available social support. This ensured 
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that goal setting was in accordance with a picture of total cardiovascular risk and sensitive to 
the patients’ and partners’ agenda for behaviour change. 
4.1. Assessment of lifestyle habits (smoking, diet and physical activity) 
The aim of the baseline assessment of smoking, diet and physical activity was to establish 
the habits adopted by the patient and partner prior to the cardiac event of the patient that 
prompted the recruitment of the couple to the study. An acute cardiac event can in itself 
stimulate abrupt changes in lifestyle, like for example stopping smoking. Therefore, 
questions on the case record form requested what habits were adopted in the month or year 
prior to the recruiting cardiac event of the patient. Table 3 shows examples of these 
questions. 
Table 3:  Assessment of lifestyle habits of patients and partners prior to the cardiac event of the 
patient 
Nurse Patient Was the patient smoking in the month PRIOR to the recruiting 
coronary event? 
 Partner Was the partner/relative smoking in the month PRIOR to 
the index patient’s event? 
Dietitian Patient Example for fruit from the Food Habit Questionnaire: 
In the month PRIOR to the recruiting coronary event how often 
did you eat fruit? 
 
 Partner In the month PRIOR to the index patient’s event how often did 
the partner/relative eat fruit? 
 
Physiotherapist Patient In a typical week (over 7 successive days) in the year PRIOR 
to the recruiting coronary event record below all the activities 
that the patient did for at least 10 minutes at a time. 
 Partner In a typical week (over 7 successive days) in the year PRIOR 
to the recruiting coronary event record below all the activities 
that the partner/relative did for at least 10 minutes at a time. 
 
4.1.1. Assessment of smoking 
At baseline, the current status and history of smoking and quit attempts were assessed by 
the nurses with interview-administered questions to the patient and partner (See Appendix I 
p250). Questions on duration of smoking and quantities smoked per day enabled 
assessment of lifetime exposure to tobacco. Data for the baseline concordance analyses 
were based on whether the patient or partner were smoking in the month prior to the cardiac 
event of the patient provided, for example for the patient, by response to question N4d on 
the patient assessment document and/or whether they were smoking at the time of the 
assessment provided by the response to N4e. Any self-report of current smoking was 
validated with a breath carbon monoxide (CO) measurement (See Appendix I question N7). 
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Self reported assessment of smoking status and history is simple, inexpensive, non-invasive 
and time efficient (Stevens and Munoz, 2004), however it relies on honesty and accurate 
recall of the respondent. Validation of current smoking status with a biomarker increases 
accuracy (Becoña and Vázquez, 1998). In the EUROACTION study expired (CO) 
measurement was used to validate self-reported smoking status. This is one of the 
commonest methods in clinical use. Measuring breath CO is non-invasive, practical and 
economical to administer and also produces an instant result. 
CO is present in large quantities in cigarette smoke. When cigarette smoke has been 
inhaled, the concentration of carbon monoxide in the breath exhaled after breath holding 
correlates closely with carboxyhaemoglobin concentrations (Jarvis et al., 1980). Following 
inhalation, CO displaces oxygen in the erythrocyte to form carboxyhaemoglobin (COHb) and 
therefore exhaled CO may be measured to assess smoking status. While some exposure to 
CO may occur in normal day-to-day life, due to environmental pollution, passive smoking, 
and occupational exposure, the most likely cause of high levels in the breath is tobacco 
smoking. 
The Bedfont EC 50 Micro III hand held breath CO monitor was used to measure exhaled CO 
as it was the most sophisticated and reliable hand held monitor in the Bedfont micro range at 
the time. Hand held monitors have been available since the late 1980s. Compared to the 
previously used Ecolyzer, the EC50 was shown to have a stable sensor requiring less 
frequent calibration, at relatively low cost and with the increased benefits of portability and a 
digital display (Irving et al., 1988). 
 
The protocol for breath CO measurement can be seen in Figure 13. The patient or partner 
were asked to take in a breath and hold it for 15 seconds, and then to blow out steadily 
through a mouthpiece which was attached to the breath analyser emptying the lungs as 
much as possible. The reading was taken from the LCD in part per million (ppm). An expired 
CO level of ≤ 6 ppm was considered to be consistent with a non-smoking status for the study 
as this has been shown to be consistent with a true non-smoking status with  an estimated 
sensitivity and specificity of 94% (detection of smokers) and 89% (detection of non-smokers) 
respectively (Middleton and Morice, 2000). 
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Figure 13. Protocol for Bedfont EC50 Micro III smokerlyzer (ppm in breath) 
 
Limitations in using this method include the increase that can occur in breath CO levels in 
inflammatory lung diseases, including bronchiectasis, asthma and COPD (Zayasu et al., 
1997, Horvath et al., 1998, Sato et al., 2003) with mean values of about 7 ppm being 
reported; and also the short half life of CO which is between 5 and 6 hours (Crowley et al., 
1989, Low et al., 2004). CO may remain in blood for up to 24 hours depending on gender, 
physical activity and ventilation rate (Castleden and Cole, 1974) which means that only 
smoking from the last 12 hours will be detected. This makes identification of light and erratic 
smokers more difficult (Becoña and Vázquez, 1998). 
Other biochemical markers are available but are more expensive and often invasive. 
Nicotine, cotinine, thiocyanate levels can be measured in blood plasma, urine or saliva. 
None of these tests provide an immediate result. Measuring cotinine (a major metabolite of 
nicotine) or nicotine also have the disadvantage of showing false positives if measured when 
a person is using nicotine products to aid cessation. 
4.1.2. Assessment of diet 
The EUROACTION dietitians aimed to assess to what extent both patients and partners 
were consuming cardio-protective foods based on a traditional Mediterranean diet, which is 
associated with a lower cardiovascular risk. Selection of appropriate tools to assess self-
reported dietary intake was a particular challenge as all have their limitations, usually related 
to under reporting (Black and Cole, 2001). Like any self-report method, it depends on 
accurate recall of all foods eaten on the part of the respondent and no misinterpretation by 
the interviewer. 
This instrument has been calibrated before dispatch to you. A clean 
mouthpiece is to be used for each individual. You must study the 
manufacturer’s instruction manual carefully to ensure you completely 
understand the procedure to be followed, as subject compliance is the 
key to an accurate reading. Only one reading is taken unless the first 
measurement is not completed satisfactorily. 
 
•  Switch on the micro-smokerlyzer and wait for LCD reading to become 
zero (you may also zero the instrument with the screwdriver 
provided). 
•  Fit a clean mouthpiece to the T piece. 
•  Ask the individual to take a deep breath, hold it for 15-20 seconds, 
and then breathe out steadily and gently through the mouthpiece, 
emptying the lungs as much as possible. 
•  Wait for the maximum reading to show on the LCD. 
•  Record the measurement as soon as it has settled on a reading. 
•  Clear the system for the next patient either by removing the T piece 
and exposing the sensor to room air, or taking the next breath sample 
through a clean mouthpiece. The fresh sample will remove previous 
readings. 
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The ‘gold standard’ for dietary assessment is a seven day diary with dietary analysis (Nelson 
et al., 1993) as it provides information on frequency and quantity of food and fluid intake. 
However, it requires a large amount of professional time and money. Respondents are also 
required to commit time for diary completion over a given period. 
4.1.2.1. The Food Habits Questionnaire 
For the EUROACTION study, the dietetic coordinator from the central team developed an 
interview led Food Habits Questionnaire (FHQ) which was designed to assess frequency 
and quantity of consumption of cardio-protective food groups associated with the following 
key dietary messages from the European Cardiovascular Prevention Guidelines (Wood et 
al., 1998). 
1. Increase omega 3 fatty acid intake by eating oily fish 3 times a week, 
2. Increase fruit and vegetable intake to 400g per day 
3. Reduce saturated fat intake to less than 10% of total energy intake and replace 
with monounsaturated fat. 
This questionnaire was easy and quick to administer and did not require additional work from 
the respondent. It included 12 questions with 90 food items with a focus on fish, fruits, 
vegetables and types of fats used. It reported on foods recommended in the UK Dietary 
Guidelines for Secondary Prevention of Heart Disease (Mead et al., 2006). The questions 
were based on those used in the Low Income Diet and nutrition survey which was carried 
out on behalf of the Food Standards Agency in the UK (Nelson et al., 2007). Portion size 
was estimated with the aid of a photographic food atlas. Using photos has been shown to 
improve accuracy (Nelson et al., 1996). Figure 14 shows an example of how the questions 
were formulated in order to assess type of food and the quantity eaten. 
4.1.2.2. 24 Hour Dietary Recall 
Whilst the FHQ allowed for a focus on cardio-protective foods, and was enhanced by the 
adding of portion size estimation with a photographic food atlas, it was limited because of its 
inability to pick up all foods eaten. Therefore in addition to the FHQ, the dietitians were 
centrally trained to conduct in all patients and partners two 24 hour recalls of all foods eaten 
using a triple pass interviewing methodology (Slimani et al., 1999). This standardised 
methodology uses systematic repetition of open-ended questions to ensure that all food and 
drink consumed in the 24 hours prior to the interview is recalled and described. One 24 hour 
recall is limited by its inability to show day to day changes in habits, under and over 
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estimation of intake, and misreporting. These limitations can partly be overcome by 
repeating the 24hr recall (Margetts and Nelson, 2001). 
Figure 14. Example of a question from the Food Habits Questionnnaire 
In the month PRIOR to the recruiting coronary event, how often did you eat vegetables? 
(DO NOT include potatoes or baked beans. DO include ALL fresh, frozen, tinned and 
dried and salad vegetables.) 
 
Never or < 
once/month 
 
1-3 
days/month 
1-2 
days/week 
3-4 
days/week 
5-6 
days/week 
Every 
day 
Amount/day 
on days 
eaten 
       
grammes 
 
The triple pass interviewing method was carried out as follows: In the first instance, 
respondents were asked to report everything they had eaten on a specific day between 
midnight and midnight. There was no interruption from the dietitian during this first report. 
The dietitian then asked the respondents to add any additional forgotten foods. Secondly, 
the dietitian reviewed the report with the respondent to get more detail on quantity and 
method of food preparation using the 24 hour recall tool which identifies type, state, cut, 
cooking method and amount eaten (See Figure 15 and Appendix III p295). Food prompter 
sheets (See Appendix IV p312) were also used to identify foods or drinks consumed in 
combination, like for example milk and/or sugar in coffee, or sandwiches and recipes. The 
quantity consumed is assessed using household measures and with the help of the 
photographic food atlas. Finally the dietitian relayed the report back to the respondent in 
chronological order and prompted for any missed foods or drinks. Commonly forgotten foods 
are soft drinks, alcohol, sweets, snacks, condiments and dietary supplements. Clarification 
was also gained on any ambiguities regarding types and quantity of foods eaten. As the 24 
hour recall tends to underestimate food and nutrient intakes, in addition to using the 
standardised triple pass interviewing methodology and repeating the recall, the Goldberg 
equation was also used to check the validity of the recall because it allows for under-
reporting (Black, 2000). 
Dietary analysis of the recalls was subsequently performed on a sub-sample of patients and 
their partners randomly selected by the EUROACTION Access electronic database in order 
to establish percentage energy intake of macronutritients shown in the study outcome 
measures (See Figure 16). Including all patients and partners in the macronutrient analysis 
would have been too labour intensive and expensive.  In order to decide on the size of the 
sub-sample, a power calculation was conducted based on sufficient power to detect a 
difference in a selected macronutrient at one year between the intervention and usual care 
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arms of the hospital study. It was estimated that there would be a 4% difference in saturated 
fat intake (15% usual care and 11% intervention) at one year. In order to detect this 
difference a sample size of 48 would be required per arm at 5% significance level and 90% 
power. One in four of the recruited families were randomly selected, although this was 
increased to one in two halfway through the trial due to slower than anticipated recruitment 
rates. 
Figure 15. 24 hour recall tool 
 
In order to complete the dietary analysis of the 24 hour recalls, local dietary analysis 
computer programmes were used which were tailored for each country’s culture. To ensure 
the programmes in each country were comparable with regard to macronutrients, the central 
dietetic coordinator gave a simple 7 day diet of basic food ingredients to the local dietitians in 
each country to analyse prior to the start of the study and then compared them. 
4.1.2.3. Selection of dietary variables for this thesis 
For the purpose of this doctoral thesis, which has aimed to get a picture of concordance in 
relation to total cardiovascular risk, which takes into account the multi-factorial nature of 
CVD, only two elements of the Mediterranean diet have been taken into consideration. To 
have included all the elements of diet in addition to other lifestyle elements (smoking and 
physical activity), CVD risk factors (overweight/obesity, blood pressure, lipids and glucose) 
and psycho-social factors, would have made the analyses extraordinarily complex.  A focus 
has therefore been placed on fruit and vegetable intake and saturated fat intake. These 
dietary components have been chosen because they reflect two of the three most important 
key dietary messages from the European Guidelines on cardiovascular disease prevention 
communicated to patients and partners participating in the programme. Data on fruit and 
Type of food 
Salmon 
Peas 
Beef 
Potatoes 
State of food 
Canned 
Frozen 
Fresh Cut of food 
Fillet 
Whole 
Small pieces 
Cooking method 
Fried 
Roasted 
Boiled 
Steamed Amount eaten 
1 apple 
2 Slices of meat 
2 Tablespoons 
1 cup 
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vegetable intake were derived from the FHQ provided by responses to questions shown in 
Appendix III p295 (example for patients). The data on saturated fat intake were derived from 
the 24 hour dietary recalls. 
Figure 16. Macronutrient Analysis!
 
4.1.3. Assessment of physical activity and exercise 
The EUROACTION physiotherapists and physical activity specialists aimed to assess the 
physical activity status of all participating patients and partners with a view to establishing to 
what extent they were meeting the European recommendation for physical activity, i.e. 
moderate intensity physical activity for 30 minutes on 5 or more days per week which was 
the primary outcome for physical activity for the study. Physical activity behaviour is 
complicated and dynamic and thus presents challenges in its measurement. A number of 
measures were used because there is no single variable that can reliably describe and 
predict physical activity. The aim was to gain an insight into each patient and partner’s level 
of participation in physical activity, their physical fitness and their physical ability, as well as 
looking at perceptions and beliefs of physical activity and degree of exposure to professional 
support and advice. 
Many methods are available to measure physical activity and exercise. The gold standard 
research measure is the isotopic doubly labelled water method which measures movement 
as it occurs by measuring hydrogen and carbon utilisation to assess energy expenditure. 
The measurement takes place over a pre-defined period of several days, is costly and 
Energy (kcals) 
Percentage total fat % of total energy 
Percentage saturated fat % of total energy 
Percentage mono-unsaturated fat % of total energy 
 
Percentage poly-unsaturated fat % of total energy 
 
Percentage total protein % of total energy 
 
Percentage total carbo-hydrates % of total energy 
Ethanol g/day 
Fibre g/day 
Dietary cholesterol Mg/day 
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impractical to use in a clinical setting.  It is also limited by its inability to characterise type or 
patterns of physical activity over a measurement period. 
 
For the EUROACTION study, measures that could be used in a clinical setting were required 
because this was a demonstration project implemented in a clinical setting and was 
designed to show that the programme could be applied in every day clinical practice.  Other 
considerations when selecting measures were their reliability and validity, and their 
sensitivity to picking up change over the course of the intervention and the one year follow 
up period. Ideally, the measures would not stimulate changes in physical activity behaviour 
in the study population (Sallis et al., 1985). 
 
The comprehensive EUROACTION physical activity assessment was designed by the 
central physiotherapy coordinator. The assessment included measurement of self reported 
physical activity using the seven day physical activity recall diary (7-day PAR) (Blair et al., 
1985, Sallis et al., 1985) (See Appendix V, questions P1a – example for patients) and the 
long format interview administered International Physical Activity Questionnaire (IPAQ) 
(Craig et al., 2003). Functional capacity or cardio-respiratory fitness was measured using the 
10 metre Incremental Shuttle Walk Test (ISWT) (Singh et al., 1992b), and restriction of 
physical activity was measured using the Functional Limitations Profile from the validated 
SF36 (Ware and Sherbourne, 1992) generic Health Related Quality of Life (HRQoL) 
questionnaire. A pedometer was also used as an objective measure of the level of physical 
activity undertaken (Yamax Digi-Walker SW200 pedometer) (Welk et al., 2000). 
Data for the concordance analyses for this thesis were provided by responses to the 7-day 
PAR and recorded steps per day from the pedometers worn by the patients and partners. 
Data from the IPAQ, 10 meter ISWT and SF36 Functional Limitation Profile were not used 
for the following reasons. Whilst analyses on functional capacity and fitness from the ISWT 
would have been useful in validating self-reported habitual physical activity, this test was not 
conducted in partners and therefore analyses of concordance with patients were not 
possible. Data from the IPAQ (a second self report measure to validate the self report from 
the 7-day PAR) and the SF36 functional limitations profile were not used for these analyses 
because, firstly, an objective measure of physical activity levels was provided by the 
pedometer data which helped to validate self report, and secondly, these data would have 
added unnecessary complexity to the analyses which were primarily aimed at getting a 
picture of concordance in relation to total cardiovascular risk. The analyses of physical 
activity were undertaken to demonstrate to what extent patients and partners were 
concordant in their physical activity habits at baseline and to what extent they moved in the 
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same direction together to increase their physical activity levels during the course of the 
programme and in the longer term. 
4.1.3.1. Seven day activity recall questionnaire (7-day PAR) 
The 7-day PAR is an interview administered questionnaire which assesses self reported 
leisure and work time physical activity over the period of one week. Blair, Sallis and 
colleagues described the development and validation of this recall tool in relation to the 
Stanford five cities project in 1985 (Blair et al., 1985, Sallis et al., 1985). The questionnaire is 
interviewer led, using the triple pass methodology, in order to allow for probing for detaiIed 
information on the activities reported over a seven day period. 
In validating their 7-day PAR tool Sallis pointed out the limitations of this tool which include 
the reliability and validity of self report, accurate recall and the possibility of over-estimation 
of activity levels. In addition, interviewers need to be trained and the time requirement of 20 
minutes per person is discouraging in some cases.  They found reporting of regular vigorous 
activity to be unreliable and ambiguity in classifying regular activities. There is also a 
problem in establishing a representative week because of the variations that may exist 
between seasons etc. Reliability of the questionnaire was found to vary by sex and body 
mass. 
However, the tool is easy to administer, is inexpensive and does not require too much of the 
respondent. It can estimate total energy expenditure in a day, is able to describe patterns of 
physical activity, and specify the types of activities. Reliability is adequate, and it is 
appropriate for evaluating changes in physical activity habits over time. 
 
In the EUROACTION study, the questionnaire was administered by the physical activity 
specialist from each of the six local country teams. At the baseline assessment, the patients 
and partners were asked to recall a typical week during the course of the year prior to the 
assessment in order to establish their habitual physical activity patterns prior to the 
development of coronary disease in the patient. In addition, they were asked to recall 
activities over the seven days prior to the assessment visit. Subsequently, this same 
question was asked at both the 16 week and one year assessments in order to assess 
change over time. In the first instance they were asked to recall all activities that they had 
undertaken for more than ten minutes at a time. Then the physical activity specialists probed 
for more detail on these activities in relation to their frequency, intensity, and duration. 
Respondents expressed intensity using the following terms: light (felt easy, no shortness of 
breath), moderate (felt comfortable, makes you feel warm, slightly out of breath but able to 
speak a sentence), and hard (felt hard, felt short of breath and sweaty). 
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From these responses, a MET value was attributed to each activity according to the reported 
intensity data using the MET tables provided (See Appendix VI p339). MET or metabolic 
equivalent quantifies the amount of energy required to carry out an activity. It is expressed 
as a multiple of the resting metabolic rate which is equal to 1 MET (quiet sitting). Once the 
activity was given a MET value, the following calculation was applied in order to ascertain 
the number of kcals expended per day: 
time / duration (in hours) x Frequency x Intensity (METS) 
In addition, two classifications of physical activity were applied: the Schoenborn activity 
classification, and the Casperson and Powell classification. These classifications categorised 
the respondents activity levels as follows.  Schoenborn: sedentary (0.1-1.4 kcal/kg/day), 
moderately active (1.5-2.9 kcal/kg/day) or very active (3.0+ kcal/kg/day). The Casperson and 
Powell classification is shown below in Figure 17. 
Figure 17. Casperson and Powell classification of physical activity 
 
 
 
 
 
 
 
To distinguish between ‘regularly active, not intensive’ and ‘regularly active intensive’ a 
further calculation was required to assess whether the METS that the respondent was 
working at was greater or less than 60% of their estimated maximum cardiovascular capacity 
using the age and sex specific equation below: 
Men: maximum capacity (METS) = [60-0.55 x age (years)] ÷ 3.5 
Women: maximum capacity (METS) = [48-37 x age (years)] ÷ 3.5 
60% maximum capacity = maximum capacity x 0.6 
 
Finally, in order to establish whether or not the respondent was achieving the target 
specified in the European recommendations, the completed table for this question was 
reviewed as a whole. The following criteria were applied: 5 times a week plus aerobic in 
nature plus at least moderate intensity plus for at least 30 minutes duration. 
Sedentary: No leisure time physical activity =1 
Irregularly active: Activity performed < 3times/wk, <20 min bout or 
both 
=2 
Regularly active, 
not intensive: 
≥ 3 times/wk, ≥ 20 min bout and either < 60% of 
maximum cardiovascular respiratory capacity** 
=3 
Regularly active 
intensive: 
≥ 3 times/wk, ≥ 20 min bout and either ≥ 60% of 
maximum cardiovascular respiratory capacity** 
and involving dynamic activity of the large muscle 
groups 
=4 
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4.1.3.2. Pedometer motion sensor device 
Patients and partners were asked to wear a motion sensor device as an additional measure 
of current physical activity participation and energy expenditure, which objectively validates 
the self-reported activity in the 7-day PAR. The gold standard in these devices is an 
accelerometer, however accelerometers are costly and so the more affordable pedometer 
was selected as a more limited but suitable alternative. 
 
Steps are counted when the internal mechanism of the device is triggered by the vertical up 
and down movement of the body, for example, when walking or running. When these 
devices first came on the market, they were associated with substantial error in 
measurement, however improved technology has led to the development of more reliable 
monitors such as the Digiwalker (Yamax SW-200) model used for this study (Welk et al., 
2000, Bassett et al., 1996) which  has consistently been shown to be the most accurate at 
predicting steps, distance, and gross kilocalories for walking (Crouter et al., 2003, Schneider 
et al., 2004). 
Limitations of pedometers include their inability to pick up changes in speed and intensity of 
activity so would not for example show a difference between walking and running and in fact 
may pick up more steps from walking due to shorter stride length. Neither is duration picked 
up because of the lack of a time indicator. Pedometers will not pick up activities such as 
swimming or bicycling. It is also possible for the wearer to tamper with the device. 
Pedometers are thus limited to walking based activity. 
All patients and partners were provided with a pedometer, verbal and written instructions and 
a record sheet (See Appendix VII p341) at the baseline, 16 weeks and one year 
assessment. They were asked to wear the pedometer for seven days at each time-point. 
4.2. Assessment of Cardiovascular Risk Factors 
The aim of the baseline assessment of cardiovascular risk factors was to elaborate on any 
history of overweight, obesity, hypertension, dyslipidaemia or diabetes mellitus reported in 
the medical notes, knowledge and understanding on the part of the patients and partners of 
these risk factors and finally to take physical measurements body weight, height (in order to 
calculate body mass index), blood pressure, lipid profile and blood glucose. These physical 
measurements were repeated at the 16 week assessment and one year follow-up visits. 
Physical measurements were made using standardised methodology and equipment in 
order to reduce variability. 
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4.2.1.    Assessment of overweight and obesity 
The dietitians were responsible for identifying overweight/obesity and central obesity in 
patients and partners according to the body mass index (BMI) and waist circumference 
parameters provided by the European Guidelines: 
• Overweight is defined as a BMI of ≥ 25 kg/m2. 
• Obesity is defined as a BMI of ≥ 30 kg/m2. 
• Central obesity is defined at two levels 
o A waist circumference of ≥ 94cm in men and ≥ 80 cm in women (indication to lose 
weight) 
o A waist circumference of ≥ 102cm in men and ≥ 88 cm in women (requires 
professional support to lose weight) 
These European definitions are based on the levels defined by the World Health 
Organisation (See Figure 18). At the baseline assessment, patients and partners were asked 
whether they had been advised to lose weight in the year prior to and since the recruiting 
cardiac event of the patient and whether they had had attempted to do so (See Appendix III 
p295). 
Figure 18: Parameters for anthropometric measures 
Classification of adults according to BMI (WHO, 2000) 
Classification BMI Risk of co-morbidities 
Underweight <18.50 Low (but risk of other clinical problems 
increased) 
Normal range 18.5 – 24.99 Average 
Overweight ≥ 25.00  
Pre-obese 25.00-29.99 Increased 
Obese class I 30.00-34.99 Moderate 
Obese class II 35.00-39.99 Severe 
Obese class IIII ≥ 40.00 Very severe 
 
Sex-specific waist circumference and risk of metabolic complications associated with obesity in 
Caucasians. 
 Waist circumference (cm) 
Risk of metabolic 
complications 
Men Women 
Increased ≥ 94 ≥ 80 
Substantially increased ≥ 102 ≥ 88 
Classification for waist hip ratio (WHR) 
Ideal WHR < 1.0 < 0.85 
Percentage body fat 
Acceptable percentage body 
fat 
18-25% 25-31% 
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The dietitians were centrally trained to take anthropometric measurements using a 
standardised methodology and standardised equipment in order to reduce variability. Weight 
was measured in kilogrammes (kg) with shoes and outdoor clothes removed, and keys, 
phones, wallets and other items removed from pockets. Both feet were placed firmly on the 
centre of the scales (Seca 707 digital scales). Height was measured in centimetres (cm) with 
the SECA 707 measuring stick without shoes, with the heels together and with the so-called 
Frankfurt plane of the head in a horizontal position. The patient/partner was asked to breathe 
in deeply and reach up to a maximum height with the legs stretched and the feet flat on the 
ground. Height was measured whilst the patient/partner were standing on the scales. BMI 
was calculated using the following formula: weight(kg)/height (m)2. 
Waist was measured in cm with a metal tape measure on bare skin or over underclothes. 
The measurement was taken using the methodology described by the World Health 
Organisation, i.e. midway between the lower rib margin and the iliac crest. The level of the 
lowest rib margin was marked and the iliac crest palpated in the mid-axillary line. The tape 
was applied horizontally midway between these markings and the measurement taken. The 
patient/partner were requested to stand straight with both feet together (supporting 
themselves on a piece of furniture if they were unable to balance) and to look straight ahead. 
They were asked to relax and breathe normally throughout. At the time of taking the 
measurement, they were asked to breathe out gently in order to avoid muscle contraction or 
breath holding. 
Measurements were repeated at the 16 weeks and one year assessment. Measurements 
were rounded up to the nearest cm or kg for the purposes of recording on the assessment 
document (See Appendix III p 295). If patients were identified as overweight or obese, the 
dietitians assessed motivation to lose weight and initiated a weight loss programme and 
regular monitoring and follow up. 
4.2.2. Assessment of Blood Pressure 
The nurses were responsible for identifying raised blood pressure in patients and partners 
according to levels specified in the European Guidelines: 
• Raised blood pressure (SBP) was defined as ≥ 140 mmHg or ≥ 130 mmHg in diabetes 
• Raised diastolic blood pressure (DBP) was defined as ≥ 90 mmHg or ≥ 85 mmHg in 
diabetes 
These cutoffs were based on a combination of the definitions of hypertension specified by 
the WHO, the International Society of Hypertension Guidelines and on the unifactorial trials 
of blood pressure lowering which indicated the levels of blood pressure lowering associated 
with reduced morbidity and mortality. These cutoffs are to some extent arbitrary because, as 
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blood pressure rises from what is considered to be a normal range, it is continuously related 
to rising cardiovascular risk. However, in people who have a high total cardiovascular risk, 
either because they already have atherosclerotic disease or they at high risk of developing it, 
such cutoffs facilitate the development of treatment thresholds which indicate where it is 
necessary to start therapeutic management of blood pressure to a treatment target.  These 
treatment targets have been determined by trials demonstrating the level at which it is 
beneficial to lower blood pressure. The European guidelines (Wood et al., 1998, De Backer 
et al., 2003) provided treatment goals which formed the basis of the treatment protocols 
which the nurses and cardiologists followed for the EUROACTION programme (See 
Appendix VIII p344). 
At the baseline assessment, patients and partners were asked whether they had been told in 
the year prior to and since the recruiting cardiac event of the patient that they had raised 
blood pressure and whether they had had been advised to adopt dietary changes or to take 
medication to lower their blood pressure (See Appendix I p250, questions N8-N13 – 
example for patients). Automatic Omron 711 sphygmomanometers were provided by the 
central coordinating centre with regular and large sized cuffs. The nurses were trained to 
measure blood pressure using a standardised methodology which was outlined in the Health 
Professional Manual (See Figure 19). 
Figure 19. Omron 711 blood pressure monitor 
1. Ask the individual to adopt a relaxed posture. 
2. Remove tight clothing from the upper arm. Do not roll sleeves up too tight as this 
may cause constriction to the upper arm preventing accurate readings. Please 
use the correct cuff size. 
3. The individual should be sat with the right arm on a table, the palm facing 
upwards. The legs must be uncrossed and feet placed flat on the floor throughout 
the procedure. 
4. Apply the cuff tightly around the upper arm so that the bottom edge of the cuff is 
positioned 1-2cm above the elbow joint 
5. Ensure the centre of the bladder is over the brachial artery. 
6. Maintain the arm at heart height. 
7. The machine is sensitive to movement and this includes talking, so ask the 
individual to sit quietly during the measurements. 
8. Place the monitor as far away as possible from your computer as it is sensitive to 
the vibrations from other equipment. 
9. Refer to the manufacturer’s instruction manual for the operations technique. 
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Two blood pressure readings were taken. If there were more than 10 mmHg between the 
first systolic and/or diastolic reading and the second, then the measurements were repeated 
in the same way at least five minutes later. Both of these measurements were recorded on 
the assessment document. The nurses followed a blood pressure management protocol 
outlined in the Health Professional Manual which guided them in the monitoring of blood 
pressure management during the course of the 16 week programme. Measurements were 
repeated and recorded on the case record form at the 16 weeks and one year assessment. 
4.2.3. Assessment of blood lipids 
The nurses were responsible for identifying abnormal lipid profiles in patients and partners 
according to levels specified in the European Guidelines from 1998: 
• Raised total cholesterol (TC) was defined as ≥ 5 millimoles per litre (mmol/l) 
• Raised low density lipoprotein cholesterol (LDL-C) was defined as ≥ 3 mmol/l 
During the course of the study period, the European guidelines were updated (De Backer et 
al., 2003) following further evidence of lipid lowering. 
These cutoffs are to some extent arbitrary because, as total cholesterol rises from, it is 
continuously related to rising cardiovascular risk. However, in people who have a high total 
cardiovascular risk, either because they already have atherosclerotic disease or they at high 
risk of developing it, such cutoffs facilitate the development of treatment thresholds which 
indicate where it is necessary to start therapeutic management of lipids to a treatment target.  
These treatment targets have been determined by trials demonstrating the level at which it is 
beneficial to lower total and LDL-cholesterol. The European guidelines provide treatment 
goals which formed the basis of the treatment protocols which the nurses and cardiologists 
followed for the EUROACTION programme (See Appendix VIII p344). 
At the baseline assessment, patients and partners were asked whether they had been told in 
the year prior to and since the recruiting cardiac event of the patient that they had abnormal 
lipid levels and whether they had had been advised to adopt dietary changes or to take 
medication to modify their lipids (See Appendix I p250, questions N14-N18 – patient 
example). Whilst blood was sent for analysis in all patients to a central laboratory in Glasgow 
in order to standardise measurement, it was only sent in a random-subsample of 25% in 
partners. In the intervention arm, blood was also sent to the local centre laboratories in all 
patients and partners in order to inform management of lipids to goal. For my concordance 
study, the local analyses have been used because of the increased number of results in the 
partner population. A fasting blood sample was taken after a 12 hour fast in order to 
measure the lipid profile (total, LDL, HDL cholesterol and triglycerides) in all patients and 
partners. Lipids were managed according to the protocol outlined in the Health Professional 
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Manual (See Appendix VIII p344). Measurements were repeated and recorded on the case 
record form at the 16 weeks and one year assessment. 
4.2.4. Assessment of blood glucose 
The nurses were responsible for identifying abnormal glucose regulation in patients and 
partners according to levels specified in the European Guidelines. These levels were based 
on the American Diabetes Association criteria: 
• Diabetes Mellitus was defined as a fasting blood glucose  > 6.1 mmol/l  on repeated 
examinations or using plasma glucose determinations, >7.0 mmol/l 
• Impaired glucose tolerance was defined as, after a 75g glucose load, a two-hour blood 
glucose level between 6.7 – 10.0 mmol/l or two-hour plasma glucose level between 7.8 – 
11.1 mmol/l 
These cutoffs are to some extent arbitrary because, as blood glucose rises from what is 
considered to be a normal range, it is continuously related to rising cardiovascular risk. 
However, in people who have a high total cardiovascular risk, either because they already 
have atherosclerotic disease or they at high risk of developing it, such cutoffs facilitate the 
development of treatment thresholds which indicate where it is necessary to start therapeutic 
management of blood glucose to a treatment target.  These treatment targets have been 
determined by trials demonstrating the level at which it is beneficial to lower blood glucose. 
The European guidelines provide treatment goals which formed the basis of the treatment 
protocols which the nurses and cardiologists followed for the EUROACTION programme 
(See Appendix VIII p344). 
The prevalence of dysglcaemia in people with acute coronary syndrome is between a 
quarter to one third and therefore screening for diabetes in this group is a priority. An oral 
glucose tolerance test (OGTT) was performed in all patients and partners with impaired 
fasting glycaemia which is the gold standard for diagnosis of diabetes. 
At the baseline assessment, patients and partners were asked whether they had been told in 
the year prior to and since the recruiting cardiac event of the patient that they had diabetes 
or impaired glucose tolerance or fasting glycaemia and whether they had been advised to 
adopt dietary changes or to take medication to modify their blood glucose (See Appendix I 
p250, questions N19-24). 
As for lipids, the blood analyses from the local laboratory were used for my concordance 
study. A fasting blood sample was taken after a 12 hour fast in order to measure fasting 
blood glucose in all patients and partners. Glucose was managed according to the protocol 
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outlined in the Health Professional Manual. Measurements were repeated and recorded on 
the case record form at the 16 weeks and one year assessment. 
4.3. Assessment of Psycho-social Factors 
It has become of increasing importance to gain an understanding of coping mechanisms and 
quality of life in the context of living with a chronic condition, and to assess these aspects in 
relation to cost of interventions and associated benefits. Psycho-social functioning has 
therefore become an important outcome in evaluation of health care interventions, albeit 
usually a secondary, rather than a primary outcome. This reflects a biopsychosocial 
perspective in modern health care. 
In 1993, the WHO stipulated that the aim of cardiac rehabilitation was to promote secondary 
prevention and improve HRQoL, thus, there is a need for standardised measures to evaluate 
these outcomes. In order to measure psycho-social functioning in the EUROACTION study, 
a variety of validated patient reported outcome measures were selected which would allow 
the assessment, in both patients and partners, of understanding and beliefs related to 
coronary disease and cardiovascular risk, positive and negative emotional state, physical, 
social and occupational functioning, somatic sensation and overall health state. 
Many tools have been developed going back as far as the 1970’s (Garratt et al., 2002). 
Some are generic and measure all the different dimensions of health related quality of life 
(HRQoL), and others are dimension or disease specific. In selecting an appropriate measure 
of HRQoL for the EUROACTION assessment, a major consideration was the additional 
burden on the patients and partners that these self administered questionnaires would place 
on top of an already detailed and lengthy interview and physical assessment. Tools selected 
were user friendly, valid, reliable and responsive to change. These tools were also selected 
because they had been validated for use in a coronary population and were available in all 
six European languages. 
Positive and negative emotional states were measured with two tools: The Hospital Anxiety 
and Depression Scale (HADS) (Zigmond and Snaith, 1983) and the Global Mood Scale 
(GMS) (Denollet, 1993). Restrictions to physical activity and exercise were measured as part 
of the physical activity assessment using the Functional imitations Profile from the Short-
form 36 (SF-36) (Ware and Sherbourne, 1992). The Euroqol EQ-5D and EQ-VAS utility 
measure (www.euroqol.org/) provided an overall perception of health state with a visual 
analogue scale and also provided a summary of five different dimensions of HRQoL (i) 
mobility, (ii) self care, (iii) usual activities, (iv) pain and discomfort, and (v) anxiety and 
depression. Understanding and beliefs around coronary disease were assessed using a 
! 69!
modified version of the Illness Perception Questionnaire (Moss-Morris et al., 2002) adapted 
for both patients and partners, and some questions on health belliefs.  All of these self 
administered questionnaires were integrated into pack which was sent to patients and 
partners to complete prior to the baseline, 16 week and one year assessments (See 
Appendix II p286 (patient example for baseline). In addition, questions on social status 
including educational and occupational status were included in the assessment document 
(See Appendix I p250, questions N29-N33). 
Concordance analyses for psycho-social functioning in this study have drawn on data from 
the HADS, GMS, IPQ-R and EQ-5D. The objective was to correlate in couples, perception of 
overall health state, feelings of anxiety, depressive emotions, positive mood and 
understanding of coronary disease and change in these aspects during the course of the 
programme and in the long term. 
4.3.1. Emotions 
There is evidence now to demonstrate that emotions are an important measure in the 
context of evaluation of cardiac rehabilitation and HRQoL outcomes. Emotional distress is 
associated with poor recovery, worsening prognosis and increased mortality in coronary 
patients (Frasure-Smith et al., 1995), and positive mood states are closely related to 
improved quality of life (Hevey et al., 2004, Denollet and De Vries, 2006).  These two 
opposing emotional experiences are both largely independent. Positive affect emotions are 
demonstrated in energy levels and social engagement, whereas negative affect emotions 
are characterised by health complaints, mental stress and fatigue. Most cardiac patients do 
not have a psychiatric condition or other psychopathology, and therefore it is important to 
measure both positive and negative emotions to get a more complete picture of outcome. 
4.3.1.1.  Global Mood Scale (GMS) 
The GMS measures both positive and negative affect mood states. It was developed and 
validated in 1993 (Denollet) in male coronary patients and later in 2006 in the general 
working population also by Denollet. The GMS is brief, easily administered, easily completed 
and easily scored. It has 10 negative and 10 positive affect items designed to measure 
subjective moods and feelings in the recent past rather than investigate emotional reactions 
to specific events. The GMS was developed in response to the need for a disease specific 
measurement of emotional distress in patients with coronary disease. Scales in use at the 
time were not sensitive to the coronary patient’s emotional experience of their condition and 
they were often too long and impractical for a clinical setting. 
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In the EUROACTION study, only the positive affect items of the scale were used (Figure 20) 
in order to reduce the burden of too many self administered questions and encourage full 
completion. Negative emotions were assessed using a different tool which is described 
below.  Patients and partners were asked to indicate, for each descriptor, on a 5-point likert 
scale ranging from ‘not at all’ to ‘extremely’, to what extent they had felt this way ‘lately’. The 
maximum score possible was 40 which would have indicated a top score for all items. The 
lowest possible score was 0. 
Figure 20. Global Mood Scale (Positive items) 
 
One of the aims of cardiac rehabilitation is to promote well-being (WHO, 1993). In one study 
which investigated the responsiveness of tools to measure HRQoL in the context of cardiac 
rehabilitation (Hevey et al., 2004), the positive affect subscale of the GMS emerged as the 
most responsive subscale. Improved mood as indicated by a positive change in GMS scores 
during cardiac rehabilitation may indicate that this treatment enhances perceived control 
over the condition which may reduce distress (Denollet, 1993). 
4.3.1.2. Hospital Anxiety and Depression Scale (HADS)  (Zigmond and Snaith, 1983) 
The HADS was originally developed and validated in 1983 in a hospital outpatient setting. It 
has become an internationally validated and widely used tool, not only to screen for anxiety 
and depression in different populations and settings, but also for use in HRQoL outcome 
research. 
Given the high prevalence of psychological distress among cardiac patients, particularly 
following an acute event (Ladwig et al., 1994, Frasure-Smith et al., 1995, Moser and Dracup, 
To what extent 
have you felt this 
way lately 
Not at all A little bit Moderately Quite a bit Extremely 
Active 0 1 2 3 4 
Dynamic 0 1 2 3 4 
Bright 0 1 2 3 4 
Hard-working 0 1 2 3 4 
Lively 0 1 2 3 4 
Enterprising 0 1 2 3 4 
Relaxed 0 1 2 3 4 
Sociable 0 1 2 3 4 
Cheerful 0 1 2 3 4 
Self-confident 0 1 2 3 4 
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1996, Martin et al., 2003), it has been a priority to find a valid and reliable tool for screening 
which is also responsive and can demonstrate effectiveness of interventions to reduce 
distress. The HADS has been validated in cardiac patients, although this has been the 
subject of much discussion in the literature (Herrmann, 1997, McGee et al., 1999, Martin et 
al., 2003, Hevey et al., 2004). In 1997, Hermann conducted a review of 200 studies of 
international experience with the HADS used in patients with a variety of diseases (including 
myocardial ischaemia) and reported that it provides clinically meaningful results as a 
screening tool for anxiety and depression, and is a valid, reliable and responsive tool with 
the potential to predict psycho-social and physical outcome. Hermann also points out that 
the questionnaire does not include psychopathological symptoms which may make it more 
acceptable to a non-psychiatric population.  In addition, it does not include physical 
symptoms which could cause confounding especially in a population with a physical disease 
where physical symptoms are experienced. 
In 2002 Martin and colleagues conducted a confirmatory factor analysis of the HADS as a 
screening tool in patients following acute myocardial infarction (AMI) and established that the 
sensitivity of the questionnaire to show change in anxiety and depression levels over time 
was excellent and also that it was reliable. In addition, they found that the different subscales 
significantly correlated suggesting that anxiety and depression are related dimensions in 
post AMI patients. Hevey (2004) in a study that evaluated HRQoL outcome measures for 
cardiac rehabilitation and McGee (1999) updated 2012 in a systematic review of the same 
did not come to the same conclusions but instead questioned the responsiveness of the 
HADS and its internal reliability. A recent systematic review (Cosco et al., 2012) and meta-
confirmatory factor analysis (Norton et al., 2012 in press) has recommended that the HADS 
is more appropriate as a measure of general distress because when differing statistical 
methods are applied, it has not been possible to confirm that it can differentiate between the 
two constructs of anxiety and depression in a consistent way. The HADS has also been 
validated in general practice and the general population (Bjelland et al., 2002, Olsson et al., 
2005). 
For the EUROACTION study, the HADS was selected to assess psychological distress. The 
questionnaire has 14 items which are divided equally between depression and anxiety, 
although these items are mixed up within the questionnaire (See Appendix II p286). The 
questionnaire is easily self-administered and contains some reversal items in order to avoid 
the possibility of a response set where respondents may be tempted to answer a series of 
questions on a certain direction regardless of their content. Examples of reversal items can 
be seen in item numbers 2, 4, 7, 9, 12 and 14. 
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Responses are given on a four point scale between 0-3, 3 being indicative of a higher level 
of anxiety or depression. The questionnaire generates two summary scores, one for anxiety 
and one for depression, although it is possible to sum the two scores to create a total HADS 
score of psychological distress. There are seven items for each dimension with a possible 
highest score of 21 for each. The lowest possible score for each dimension is 0. A score 
below 7 for each dimension is considered to be normal. A score between 7 and 10 indicates 
moderate levels of anxiety or depression. A score of 11 indicates severe symptoms of 
anxiety and depression which may warrant further investigation, although these should be 
seen in context (e.g. diagnosis, events etc). It is important to note that the HADS is not a 
diagnostic tool for depression. 
4.3.2. Summary Measure of Health Status: EQ-5D (EQ-5D and EQ-VAS) 
The EQ-5D, developed by the Euroqol Group (www.euroqol.org/) provided a standardised 
utility measure for the study and a means of capturing health state, firstly, with a five 
dimensional generic questionnaire and secondly, with a visual analogue scale which records 
self-rated health on a vertical scale from 0 to 100. Utility measures of HRQoL provide a 
means of generating clinical and economic appraisals in research. The value of an 
intervention can be assessed in terms of a combination of quality of life and length of life or 
quality adjusted life years (QALYs). The EQ-5D generates a single index value for health 
status. It has been shown to be valid and reliable in the general population and in many 
disease specific populations. Schweikert (2006) demonstrated its validity and reliability in 
patients who have experienced acute coronary syndrome attending cardiac rehabilitation. 
It is easily self-administered. The tool has two parts the EQ-5D and the EQ-VAS. The EQ-5D 
has five items which assess the respondent’s perception of their health related quality of life 
according to five dimensions: (i) mobility, (ii) self care, (iii) usual activities, (iv) pain and 
discomfort, and (v) anxiety and depression. The EQ-5D self classifier identifies the level of 
problems (if any) on each of the 5 dimensions and generates a weighted index. For each of 
the 5 items, the respondent is asked to choose out of 3 options for which he/she gets a 
score of 1, 2 or 3. For example, relating to mobility, the respondent is asked to select from 
the following: 
I have no problems walking about 
I have some problems walking about 
I am confined to bed 
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Where the respondent has no problems with mobility he scores 1 and where he/she is 
confined to bed the score is 3. Once the five items have been completed, a five digit number 
is generated which can then be computed to produce a weighted index. 
The EQ-VAS is a visual analogue scale which assesses the respondent’s perception of their 
health state at a given moment in time where 0 is the worst imaginable state and 100 is the 
best. The patient's rating of their health status using the EQ Visual Analogue Scale at 
different time points can show changes in their perception of their health status over time. 
4.3.3. Understanding and beliefs about coronary disease: The Illness Perception 
Questionnaire (IPQ-R) 
People with any illness may have idiosyncratic beliefs which have been derived from a 
variety of sources including what they have interpreted from health professionals’ 
communications with them and from their own lay and cultural beliefs. People try to 
understand threats to their health, such as a new diagnosis of coronary disease, by 
developing cognitive representations to explain them (Lau et al., 1989, Leventhal et al., 
1992) which go on to determine their coping mechanisms. These representations are 
activated by symptoms, diagnoses and risk perception. They include beliefs about the label 
or ‘identity’ of a diagnosis and associated symptoms; what caused it; how long it is expected 
to last or its ‘timeline’; the ‘consequences’ or the severity of the illness and its impact on 
physical, psychological and social functioning; whether the illness has a ‘cure’ or to what 
extent it is amenable to ‘control’. 
As explained in Chapter 1 Section 1.6, illness cognitions can be a cause of emotional 
distress, provoke guilt, low self esteem and poor psychological adjustment, lead to a delay in 
seeking medical attention, affect adherence to treatment and medications, influence both 
positively and negatively the adoption of healthy behaviours and may affect outcomes 
(Petrie et al., 1996, Hagger and Orbell, 2003, Cameron and Moss-Morris, 2004). 
Illness representations develop early on in an illness at the time of diagnosis (Petrie et al., 
1996). It makes sense therefore to assess these perceptions at the time of hospital 
admission and during the early recovery period and to intervene with clear, consistent 
messages and to promote control beliefs and self-efficacy/management. The EUROACTION 
programme promoted adoption and maintenance of positive health behaviours and self 
management by educating patients and their families about their coronary disease and its 
management, correcting misconceptions and promoting feelings of control resulting in the 
development of a less threatening view of the illness. 
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Illness perceptions were assessed using the Illness Perception Questionnaire which was 
developed in order to provide an assessment questionnaire which was theoretically based 
and psychometrically sound (Weinman et al., 1996, Moss-Morris et al., 2002). This 
questionnaire is based on the five components described above (identitiy, cause, timeline, 
consequences, control). It has been validated in different patient populations including those 
with coronary disease (Petrie et al., 1996, Cooper et al., 1999), and also in spouses 
(Weinman et al., 2000) and thus can be adapted to a wide variety of acute and chronic 
conditions. The IPQ-R is a long questionnaire with over 80 items and would have 
substantially increased the burden of self administered questions if it had been used in its full 
form for the EUROACTION study. All of the original sub-scales were maintained except the 
identity sub-scale. The acute/chronic timeline, cyclical timeline, consequences, illness 
coherence, personal control, treatment control and emotional sub-scales were condensed 
with one item being selected from each of these subscales (Figure 21). The items selected 
from each sub-scale of the IPQ-R were chosen because they had the highest factor loading 
from the two principal components analyses conducted to validate the factor structure which 
determined which of the items best represented each of the dimensions. 
Items selected for the causal component were again based on the principal components 
analysis and chosen for the highest factor loading in each category (psychological attributes, 
risk factors, immunity, accident or chance). Patients and partners were not asked to list in 
rank-order their perceptions of the causes of the disease as they were in the original 
questionnaire. 
Participants recorded their responses according to a five point Likert scale ranging from: 
‘strongly agree’ to ‘strongly disagree’ (Appendix II p286). I devised a scoring system for 
seven of the subscales: timeline, consequences, control/cure, illness coherence and 
emotional. Illness perception total score is calculated as the sum of the seven individual 
components with scores assigned so that a higher score corresponds to a less threatening 
perception of the illness. The score for each item ranges between 0 and 4 giving a possible 
total score of 28 (see below).   
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Figure 21: Items selected from each IPQ-R subscale for use in the EUROACTION study. 
! Timeline acute/chronic subscale 
o “My illness will last for a long time” = patient 
o “Heart disease will last for a long time” = family 
! Timeline cyclical subscale 
o “My symptoms come and go in cycles” = patient 
o “Heart disease symptoms…” = family 
! Consequences subscale 
o “Why illness has major consequences on my life” 
o “heart disease has major consequences on a person’ life” = 
family 
! Personal control subscale 
o “Nothing I do will affect my illness” 
o “Nothing a person does will affect their heart disease” = family 
! Treatment control subscale 
o “My treatment can control my illness” = patient 
o “Treatment can control heart disease” = family 
! Illness coherence subscale 
o “My illness is a mystery to me/I don’t understand my illness” 
o “Heart disease is a mystery to me/I don’t understand heart 
disease” 
! Emotional Representations subscale 
o “When I think about my illness I get upset” 
o “When I think about having heart disease I get upset” 
! Psychological attributes subscale 
o “Worries or family problems caused my illness” 
o “Worry or family problems could cause heart disease for me” = 
family 
! Risk factors subscale 
o “My illness is hereditary – it runs in my family” = patient 
o “I could have heart disease because it is hereditary – it runs in 
my family” = family 
o “My illness is because of my diet or eating habits” = patient 
o “I could have heart disease because of my diet or eating 
habits” = family 
o “My illness is because of smoking” [add note first extra box to 
tick for people to say ‘non-smoker’] 
o “I could have heart disease because of smoking” (family) (+ 
box ‘non-smoking’) 
o “My illness is because of drinking alcohol” 
o “I could have heart disease because of drinking alcohol” 
! Immunity subscale 
o “My illness is because of a germ or virus” 
o “I could have heart disease because of a germ or virus” 
! Accident or chance subscale 
o “My illness is because of chance or bad luck” 
o “I could have heart disease because of chance or bad luck” 
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The questionnaire includes some reversal items. 
a. My illness will last for a long time: 4-0 
b. My symptoms come and go: 4-0 
c. My illness has major consequences: 0-4 
d. Nothing I do will affect my illness: 0-4 
e. My treatment can control my illness: 4-0 
f. My illness is a mystery to me: 0-4 
g. When I think about my illness I get upset: 0-4 
 
4.4. Application of the multidisciplinary assessment to the EUROACTION intervention 
The multiple tools required to assess the families’ risk highlight the complex nature of the 
disease and hence challenges for treatment. EUROACTION set out to demonstrate that total 
risk management following the European guidelines on the prevention of cardiovascular 
disease could be implemented by trained clinicians in every day clinical practice. Therefore, 
every effort was made to make the assessment and collection of data as clinically practical 
as possible. This meant that the use of expensive, time consuming assessment 
methodologies could not be used even if they had the potential to provide more accurate 
data, for example using blood, saliva or urinary cotinine to validate smoking status self 
report, or using gold standard seven day diet dairies to measure food intake, or the isotopic 
doubly labelled water method to measure physical activity expended. 
The baseline assessment provided a picture of total cardiovascular risk in patients and 
partners on which the team could build an individualised programme of risk reduction using 
behavioural change strategies and therapeutic management. The assessment provided an 
awareness raising experience for participating patients and partners and helped them to 
understand the nature of their multi-factorial risk of CVD. 
5. The EUROACTION Preventive Cardiology Programme for coronary patients 
and their partners 
5.1. The nurse-led multidisciplinary family centred approach 
The programme for was held in district general hospitals and was coordinated by one whole 
time equivalent (WTE) specialist nurse who was supported by a second nurse (0.75WTE, 
dietitian (0.5 WTE) and physiotherapist or physical activity specialist (0.5 WTE). This team 
provided intensive support to modify lifestyle and manage risk factors to target. The 
coordinating nurse did not have any duties outside those of working on the programme. 
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The programme was based on the principles shown in Figure 22 and was implemented 
according to the evidence based Recommendations of the Second Joint Task Force of 
European and other Societies on Coronary Prevention (Wood et al., 1998), updated during 
the course of the study (De Backer et al., 2003). The programme adopted a high risk 
strategy for prevention recruiting priority groups identified in the guidelines. For the hospital 
programme, coronary patients and the first degree relatives of patients presenting with 
premature disease were included. In addition, the spouses of all patients were recruited to 
the programme in the belief. 
The foundation of the programme was modifying risk through the promotion of healthy 
lifestyle habits: no smoking, a cardio-protective diet and increased physical activity in daily 
life which impacts on weight management, blood pressure control, lipid profile modification 
and prevention of diabetes. Responsibilities for each member of the team were as follows 
(Figure 23). The nurses led the delivery of the smoking cessation intervention, the dietitian 
for the dietary and weight management intervention, and the physiotherapist for the physical 
activity intervention. In addition, the nurses monitored manage blood pressure, lipids and 
glucose following protocols (See Appendix VIII) to guide the management of these risk 
factors to goal. The Cardiologist attended regular meetings with the team and prescribed 
and titrated cardio-protective medication as necessary. 
The practice of this approach involved certain key elements: 
1. Identification of all eligible patients 
2. Invitation of both patient and their partner to join the programme (and first degree 
relatives where appropriate) 
3. A comprehensive multidisciplinary assessment of both the patient and their partner of 
all aspects of lifestyle, risk factors, cardio-protective medications, health related 
quality of life, health beliefs, illness and risk perception 
4. Goal setting in negotiation with both patient and partner 
5. A professional lifestyle approach for smoking, diet and physical activity which impacts 
on risk factor management as a whole (weight, BP, lipids and glucose) 
6. Prescription and uptitration of cardio-protective medications by cardiologist/general 
practitioner/nurse prescriber 
7. Regular attendance on the programme by the patient and their partner 
8. Regular multidisciplinary meeting of the core team with the cardiologist to discuss the 
progress of each couple and an update of the plan of care (lifestyle and medications) 
which is recorded in the medical notes to be addressed at the next programme 
attendance 
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Figure 22. The Principles of the EUROACTION Preventive Cardiology Programme 
 
• Implemented according to evidence based guidelines 
• Directed at priority groups who will benefit the most 
• Family centred 
• Lifestyle change is the foundation: smoking, diet and physical activity to 
address total cardiovascular risk 
• Draws on expertise from different disciplines (specialist nurses, 
dietitians, physical activity specialists) in an interdisciplinary model of 
preventive cardiology practice 
• Has effective mechanisms for prescribing cardio-protective medications 
to support management of blood pressure, lipids and glucose to goal 
• Does not require specialist facilities 
 
 
9. Core team to follow up each couple when they attend the programme to agree 
lifestyle plan and to give prescriptions where appropriate 
10. Supervised exercise programme 
11. Group health promotion work shops 
 
Figure 23. Responsibilities of the multi-disciplinary team members 
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The local country teams were trained by the central co-ordinating multidisciplinary team at a 
5 day course. Subsequently this team provided on-going support and follow-up through 
regular site visits throughout the course of the study. 
5.2. Programme set, up, coordination and structure. 
5.2.1. The Care Pathway (See Figure 24). 
Following the baseline assessment, where initial priorities were identified, couples attended 
the weekly programme meetings over a period 16 weeks. They attended a minimum of eight 
sessions during this period. Prior to the weekly sessions, the programme team would meet 
to discuss progress for all participating patients and partners and review goals for lifestyle 
change and risk factor management. The Cardiologist would be included in this meeting 
where therapeutic management was also discussed and reviewed. During a typical weekly 
programme session, as couples arrived, they would be reviewed as a couple by a member 
of the team, who would review progress towards reaching goals set the previous week, relay 
results of blood tests, take measurements of blood pressure, weight or waist as necessary to 
chart progress, and arrange to take a fasting blood test on a morning if necessary for 
reviewing progress with lipid and glucose management. 
This review process (See Figure 25) would include negotiating new goals to be reviewed at 
the next visit of each couple. Progress was charted both in the programme record for each 
couple ready for discussion at the weekly team meeting, and on a patient and partner held 
Record Card. 
Figure 24. The process and delivery of care for the EUROACTION programme 
 
Attendance by couple at 
multidisciplinary initial assessment of 
lifestyle, CVD risk factors and psycho-
social factors. 
Identify priorities 
Identification and recruitment of patients 
from inpatient admissions and outpatient 
services 
Attendance at 16 week multidisciplinary Preventive 
Cardiology Programme 
•  Empowering couples to change their lifestyle: smoking, diet 
and physical activity to reduce total CVD risk 
•  Weight, blood pressure, blood cholesterol  and blood 
glucose management 
•  Adherence with cardio-protective medication 
•  Social support: Individual and group approach 
•  Supervised hospital and home physical activity programme 
•  Health promotion workshop programme 
16 week assessment One year follow up 
 
 
 
Meeting of programme 
team and Cardiologist 
to review progress of 
couples through the 
programme 
On-going goal setting 
and review 
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Figure 25. Monitoring progress in couples through the programme: Review Cycle 
 
Also included at these programme sessions was an eight week rolling programme of health 
promotion workshops which were co-ordinated by the lead nurse and an exercise training 
programme which was led by the physiotherapist. These weekly group meetings provided 
the opportunity for the programme participants to meet with each of the team members in 
order to gain expert advice, support and follow up with lifestyle goals, monitoring of risk 
factor management, prescription and/or up-titration of medications, advice on symptom 
management and referral to other services where appropriate, e.g. psychologist or 
cardiologist. In addition there were learning and experiential opportunities provided by the 
workshop and exercise programme. Not least was the opportunity for the participants to 
learn together, to share experiences and achievements as a result of the programme. 
On completion of the programme the patient and partner attended a further assessment 
which was much like the initial assessment in order to evaluate the immediate impact of the 
programme on their cardiovascular risk. The results of this assessment were sent to the 
family physician to encourage continuation of appropriate treatment and maintenance of risk 
reduction in the long term. A final follow up assessment took place one year after recruitment 
to the programme, also conducted in the same way as the baseline assessment. 
5.2.2. Programme and Study Support Structure 
The structure of support is shown in Figure 26. The Research Nurse Coordinator held 
weekly meetings with the central team in relation to setting up the study and monitoring 
ongoing activities. The roles and responsibilities for each member of the central coordinating  
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couple together: 
identify priorities  
Programme 
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Check progress 
weekly and review 
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factors 
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couple 
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Figure 26. Support Structure for the Programme and Study 
 
 
 
 
 
 
 
team are shown in the figure. Recruitment of the local country teams was coordinated by the 
Research Nurse Coordinator and Dietary and Physiotherapy Coordinators in collaboration 
with the local Principal Investigators. 
5.2.3. Work Scheduling 
As the dietitian and physical activity specialists were 0.5 WTE members of the team, the first 
and most important task was to establish on which days the team were available to work 
together. The interdisciplinary, patient and family centred team working philosophy of the 
Coordinating Team 
European Research Nurse Coordinator 
Dietetic and Physiotherapy Coordinators 
Research Fellows 
COUNTRY TEAMS 
UK 
Nurses 
Dietitian 
Physical activity 
specialist 
PI (Cardiologist) 
SWEDEN 
Nurses 
Dietitian 
Physical activity 
specialist 
PI (Cardiologist) 
SPAIN 
Nurses 
Dietitian 
Physical activity 
specialist 
PI (Cardiologist) 
POLAND 
Nurses 
Dietitian 
Physical activity 
specialist 
PI (Cardiologist) 
ITALY 
Nurses 
Dietitian 
Physical activity 
specialist 
PI (Cardiologist) 
FRANCE 
Nurses 
Dietitian 
Physical activity 
specialist 
PI (Cardiologist) 
ROLES AND RESPONSIBILITES 
1. Centre Recruitment: Research Nurse Coordinator and Research Fellow 
2. Staff recruitment:  
a. Research Nurse Coordinator and PI for nurses 
b. Dietetic Coordinator and PI for dietitians 
c. Physiotherapy Coordinator and PI for physical activity specialists 
3. Training: Central training meeting for country teams organised by Research Nurse Coordinator and Dietetic 
and Physiotherapy Coordinators  
4. Monitoring and support provided by Research Nurse Coordinator, Dietetic and Physiotherapy Coordinators 
to the Country Teams through visits, emails and telephone calls 
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programme required the whole team to be available when the couples attended the 
assessments and weekly programme sessions. 
Couples attending the programme would include both retired and working people. Therefore, 
the teams were encouraged to arrange sessions in the evening as well as during the day for 
increased flexibility. As blood testing for the assessments and for lipid and glucose 
monitoring during the programme was usually required on fasting samples, the nurses also 
had to be available for early morning appointments to conduct blood tests. 
Figure 27 shows an example of a work schedule which was given to the country teams to 
use as a template for creating their own work schedules. A workshop at the central training 
meeting gave the teams an opportunity to start this process of creating and negotiating their 
work schedule together.      
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Figure 27. Template work schedule for the EUROACTION Cardiovascular Prevention and 
Rehabilitation Programme Multi-disciplinary Team 
 Am Pm 
Monday* 1. Identification and recruitment of patients 
2. Administration and data entry 
3. Postal packs for relatives 
Tuesday* 
Dietitian and Physiotherapist 
present (part day) 
1. MDT meeting 
2. Baseline clinic § 
• Couple 1 
• Couple 2 
• Couple 3 
• Couple 4 
Assessment clinic 16 weeks 
 
 
Wed* 
Dietitian and physiotherapist 
present (part day) 
• Assessment clinic 16 
weeks 
• Programme preparation 
 
 
Programme session: 
• Review of progress 
• Supervised exercise 
session 
• HP workshop 
• Supervised exercise 
session 
Thurs* 
Dietitian and physiotherapist 
present am 
Programme session: 
• Review of progress 
• Supervised exercise 
session 
• HP workshop 
• Supervised exercise 
session 
1. Identification of patients 
2. Administration and data 
entry 
 
 
Friday* 
Dietitian and physiotherapist 
present (part day) 
Baseline clinic § 
• Couple 1 
• Couple 2 
• Couple 3 
• Couple 4 
Assessment clinic 16 weeks 
 
 
 
• Early morning blood tests or individual appointments as required § 8 couples per week = 
recruitment target 
 
5.3. The lifestyle intervention 
In addition to being trained to understand and apply behavioural strategies, health care 
professionals involved in the delivery of a preventive cardiology programme need expert 
knowledge and training in smoking cessation, implementing a cardioprotective diet, adapting 
physical activity and exercise (taking functional capacity and physical limitation into account), 
and reducing weight. 
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The local country teams attended a 5 day training which was led by the coordinating centre 
multidisciplinary team at Imperial College London. The training included how to carry out the 
EUROACTION multidisciplinary assessment, to use behavioural strategies, to use specialist 
expertise to and deliver smoking cessation, dietary management, to run a supervised 
exercise programme and to advise on appropriate physical activity in daily life. 
Adverse lifestyle behaviours, identified at the baseline assessment, were addressed by the 
team using the behavioural strategies described in Chapter 1, Section 1.6 and included 
individualised goal setting, intensive support and follow up, and teaching in how to self-
monitor with the aid of a personal record card to track progress. The patient and partner 
were asked to bring their card with them to each attendance at the programme sessions 
which lasted 2 to 3 hours. Importantly, the teams worked with the couples to maximise the 
two-way positive social support available between patient and partner who both actively 
participated in the programme. 
5.3.1. Smoking cessation 
The nurses in each country team were responsible for delivering smoking cessation as an 
integral part of the programme’s total risk management approach. 
The programme offered several opportunities for a successful quit attempt and prevention of 
relapse. As patients and partners were attending the programme regularly, usually every 
week or every other week over a 16 week period, this gave the nurses the opportunity to 
actively monitor quit attempts that were initiated during the course of the programme, and 
also to monitor patients who had quit spontaneously in response to their cardiac event. 
In addition, the active recruitment of partners to the programme offered the possibility of 
positive social support. The nurses were thus able to establish if other members of the 
household were smoking and enlist their support for the patient’s quit attempt whether or not 
they decided to try and quit themselves. 
Given the addictive qualities of nicotine, especially in highly dependent smokers, the 
EUROACTION team nurses and the cardiologists supporting the programmes were strongly 
recommended to prescribe nicotine replace therapy (NRT) and bupropion to support 
smoking cessation. Varenicline was not available at the time. These pharmacological agents 
provide relief from withdrawal during the most difficult 4 week period following a quit attempt. 
Both NRT and bupropion are associated with more success in smoking cessation than 
placebo (Hughes et al., 2007, Stead et al., 2008), especially when used in conjunction with 
counselling support. 
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The nurses were trained to explore motivation to quit in patients and partners who were still 
smoking when they came to the baseline assessment. In those who decided to make an 
attempt to quit, the nurses encouraged them to set a quit date and to completely abstain 
from smoking thereafter. Progress was then monitored at each attendance or over the 
phone. The whole team would be aware when a patient or partner had recently quit and 
would provide encouragement and support at each visit to the programme. They measured 
physical dependence on nicotine using the Fagerstrom Test for Nicotine Dependence 
(Heatherton et al., 1991) which was included on the assessment document (See Appendix I 
p250). The questionnaire has six items which are scored by a point system giving a total 
score of 0-10. The dependency score is recorded as: low =1-4; moderate = 5-6; or high = 7. 
Those with a higher score have a higher dependency. The most important items included in 
this assessment are the ‘time of the first cigarette of the day’ and the ‘number of cigarettes 
smoked per day’, the first in particular being a predictor of outcome in cessation (Baker et 
al., 2007). These questions help in differentiating between the behaviour of highly dependent 
smokers to that of low dependent smokers. Those smokers with a higher dependency on 
nicotine will almost definitely benefit from pharmacological support to aid a quit attempt. 
Following a first myocardial infarction, many people will quit spontaneously. Therefore the 
priority in a Cardiovascular Prevention and Rehabilitation programme will be to sustain the 
abstention from tobacco and prevent relapse to smoking and to encourage and support the 
partners of these patients to quit if they were still smoking at the time of the baseline 
assessment. The advantage of the 16 week programme was that it gave the nurses the 
opportunity to closely monitor those patients and partners who had recently quit either at the 
time of the recruiting cardiac event or during the course of the programme. Patients who had 
recently quit also had the support of their spouses who were recruited to the programme. 
5.3.2. Helping families to improve dietary habits 
The dietitians based their advice on a detailed diet history taken during the baseline 
assessment of the patient and partner. This assessment was best conducted with both 
patient and partner together so that the main person in the household responsible for buying 
and preparing food was present. 
Professional advice on food and food choices was given in order to compose a diet 
associated with the lowest risk of cardiovascular disease, to translate the key messages 
(Figure 28) arising from the European recommendations into practical advice, particularly 
with regard to reducing saturated fat, and increasing consumption of fruit, vegetables and 
fish, and to tailor this advice to individual cultures. Tailoring of advice was guided by the 
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specific needs of each individual by taking account factors such as body weight, blood 
pressure, lipid profile, blood glucose and diabetes. 
Figure 28. Key Dietary Messages 
 
Following the first assessment, the dietitian negotiated with patients and partners where they 
were prepared to make initial changes to their diet. Whilst the dietitian gave professional 
advice on the principles of a cardio-protective diet based on the key dietary messages, goals 
were set realistically with the family’s current dietary intake and patterns in mind. Weekly 
meetings provided the opportunity of setting small, short term goals with a view to 
progression towards meeting the key recommendations in the longer term. All goal setting 
was recorded on the personal record card to encourage self-monitoring and to track 
progress. 
As a core member of the team, the dietitian was always present at the weekly programme 
sessions and thus available to provide follow-up, support and advice. She also delivered a 
dietary and weight management workshop which also included education on how to 
understand food labelling. This was part of the 8 week rolling health promotion workshop 
programme. 
The family approach provided opportunity for positive social support from the spouse. As the 
lifestyle intervention was family based, the dietitian targeted the main person in the 
household responsible for buying and preparing food, and advised the ‘family’ rather than 
the ‘individual’ on the principles of a cardio-protective diet. 
5.3.3. Helping families to become more physically active 
The aim of the physical activity intervention was to help patients and their partners to 
increase their physical activity safely to the level associated with the lowest risk of CVD. The 
advice was to choose enjoyable activities which fit into a daily routine, preferably 30–45 min, 
Key Messages: 
 
•  Eat fish 3 times a week, one being oily fish if 
diagnosed with coronary heart disease. Eat oily fish 
2-3 times a week if diagnosed with myocardial 
infarction. 
•  Decrease intake of saturated fat and replaced with 
monounsaturated fat 
•  Eat 5 portions of fruit and vegetables each day 
•  Increase in take of soluble fibre 
•  Maintain a healthy weight and shape 
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4–5 times weekly at 60–75% of the average maximum heart rate of the participant. Following 
the assessment of physical activity habits, limitations to physical activity, functional capacity, 
motivation and interests, the physiotherapist tailored exercise and physical activity advice to 
each couple’s readiness to change, their needs, interests and ability, and negotiated realistic 
goals that were monitored and reviewed regularly following SMART principles and using the 
Personal Record Card to track progress. The active involvement of family members was 
emphasised, aiming to draw on an important social support mechanism to empower the 
couple to continue a physically active lifestyle in the longer term. 
The pedometer was used as a motivational tool and as a means of self-monitoring progress. 
Targets were set and reviewed every week. As walking is often recommended as a means 
of achieving physical activity guidelines, pedometers provide a good means of monitoring 
progress. There are difficulties in establishing guidelines for setting targets for number of 
steps to be taken in a day due to the inability of the pedometer to pick up intensity and thus 
distinguish between light, moderate and vigorous activity. However, pedometers are 
practical and easy in a number of settings and they also have the added advantage of 
providing a way of motivating people to be more physically active. 
The individualised physical activity plan for each participant was integrated into a supervised 
eight week, progressive endurance exercise training programme which was led by the 
physiotherapist. This programme aimed to progressively increase the cardiovascular 
endurance with aerobic exercise over a 16 week period and exercised individuals between 
60% and 75% of a predetermined asymptomatic maximum heart rate. The programme 
adopted a circuit, an example of which is shown in Figure 29. This allowed greater flexibility 
of working with a group of people having mixed physical capacity. Participants could either 
move in and out of aerobic training (interval approach) or maintain continuous aerobic 
activity. The interval approach allowed those with reduced capacity to spend time in ‘active 
recovery’ (to rest whilst still maintaining a degree of activity with light resistance work. The 
circuit offered a variety of exercises that could be adapted to accommodate individual needs 
and abilities as well as allowing individuals to progress at their own rate. Depending on the 
level of any individual participant, they were able to endure differing periods of continuous 
aerobic exercise before spending time in active recovery. In addition to increasing the ability 
to sustain aerobic exercise and thus improve cardiovascular endurance (fitness), the 
programme gave individuals the confidence to regulate themselves in safe and effective 
independent exercise. The exercise programme intentionally did not use equipment so it 
could be easily replicated at home encouraged participants to achieve the frequency of 
exercise training associated with greater gains in physical fitness. 
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5.4. Multi-disciplinary Collaboration for the Control of Overweight and Obesity, Blood 
Pressure, Lipids, Glucose and the Prescription of Cardio-protective Therapies 
The cornerstone of the programme was lifestyle change – stopping smoking, improving diet 
and increasing physical activity. The expectation was that this would impact on weight, blood 
pressure, lipids and diabetes (See Figure 30). Therapeutic management was used when 
necessary according to protocols which were developed according to the recommendations 
in the guidelines. 
5.4.1. Managing overweight and obesity 
The dietitian was responsible for monitoring weight management although the intervention 
was a combined dietetic and physical activity effort. An image of the BMI chart was used as 
an educational tool to explain overweight to couples. Goal setting was based on losing 
weight and waist rather than reducing BMI. At the baseline assessment, patients and 
partners were asked about history of a weight problem, history of past attempts to lose 
weight, perceptions of factors affecting weight loss like depression, smoking and medical 
problems (thyroid, arthritis), family factors (overweight partner, overweight in family), 
motivation to lose weight. 
The aim was to help patients and partners to achieve the European recommendations (BMI 
between 18.5 – 24.9 kg/m² and waist below 94 cm in men and 80cm in women). Having 
identified overweight or obese patients and partners, the dietitian explored priorities and 
motivation regarding weight loss. Realistic goals were negotiated. Health benefits have been 
demonstrated with a 10% reduction of total body weight on an initial weight of 100kg (Jung, 
1997) (See Figure 30). Therefore, in the first instance, the dietitian set an initial goal of 10% 
weight loss in the overweight and obese. 
Education was also given on the benefits of weight loss on other risk factors, for example 
blood pressure lowering and management of diabetes. 
After setting the initial target of 10% weight loss, patients and partners were encouraged to 
self monitor and were asked to keep a diary of their eating habits, their weight and how 
much physical activity and exercise they were doing. In educating patients and families 
about weight loss, the dietitian placed particular importance on changing the energy balance 
to enable weight loss, i.e. encouraging more physical activity in order to increase energy 
output and reducing high energy food intake. In practical terms, patients and family members 
were advised to reduce food portion size and intake of foods dense in kilocalories (See 
Figure 30). 
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Figure 29. Star circuit design 
 
The dietitian was available at the weekly programme sessions to monitor weight and waist in 
those who were trying to lose weight. At each visit the dietitian measured their weight and 
waist, and checked and discussed their food record with them. These follow up visits 
provided the opportunity to motivate, support and provide encouragement to persevere with 
their weight loss attempt. 
In addition, the dietitian led the weight management workshop which included teaching on 
how to read food labels, and advised on local facilities available in the community to provide 
support to people trying to lose weight. 
 
Figure 30. Lifestyle management of blood pressure, lipids and glucose 
Blood Pressure " Reduction of salt intake < 6g/day 
" Reduce total fat and saturated fat intake 
" Reduction in alcohol intake 
" Increase potassium and calcium intake from fruit and 
vegetable intake (5 or more portions per day) 
" Weight loss in the overweight and obese 
" Increase physical activity 
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Lipids Reduction of LDL: 
" Decrease Saturated fatty acids and Trans fatty acids 
" Choose PUFA, MUFA and Soluble Fibre 
" Weight loss in the overweight and the obese 
" Consider plant stenol/sterol esters 
 
Increasing HDL: 
" Increase physical activity  
" Weight loss in the overweight and the obese 
" Improve glycaemic control in diabetics 
" Moderate alcohol consumption 
" Smoking cessation 
 
Reduction of Triglycerides: 
" Increase physical activity 
" Weight Loss in the overweight and obese 
" Improved glycaemic control 
" Reduced alcohol consumption 
" Reduced sugar consumption 
" Increase oily fish consumption 
 
Obesity " Reduce total calorie intake 
" Increase physical activity 
" Set realistic weight loss target (10% in 6 months) 
 
Diabetes and Impaired 
Glucose Tolerance 
 
" Ensure regular intake of low glycaemic index foods 
" Promote a cardio-protective diet 
" Increase physical activity 
" Weight loss in the overweight and obese 
 
Figure 31. Benefits of 10% weight loss 
• Mortality • >20% fall in total mortality 
• >30% fall in diabetes 
related deaths 
• >40% fall in obesity related 
cancer deaths  
• Blood Pressure • Fall of 10 mm Hg systolic 
• Fall of 20 mm Hg diastolic 
• Lipids • Fall of 10% in total 
cholesterol 
• Fall of 15% in LDL-C 
• Fall of 30% in triglycerides 
• Increases of 8% in HDL-C 
• Diabetes • Reduces risk of developing 
diabetes by 15% 
• Fall of 30-50% in fasting 
glucose 
• Fall of 15% in HbA1c 
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Figure 32. Balancing Nutrition:  Food Plates 
 
 
Traditional meal Healthy ‘balanced’ meal 
 
Weight reducing meal 
Unhealthy meal portions Changing the proportions of food in 
this way leads to a healthier 
meal 
Changing the proportions in this 
way will reduce energy intake, 
help you lose weight, but allow 
you to eat the same amount of 
food 
Tips: 
• Cook more vegetables than you would normally prepare. 
• Put vegetables on your plate first so that they take up half the plate. 
• Followed by starch such as potatoes/rice. 
• Followed by fish/meat/cheese portion last, therefore reducing your intake of these products. 
 
 
 
5.4.2. Managing blood Pressure, lipids and glucose 
The aim was to help patients and families manage blood pressure, blood cholesterol and 
blood glucose to the goals recommended by the joint European Societies prevention 
guidelines: 
• Blood pressure < 140/90 mmHg and130/85 mmHg for individuals with diabetes 
• Total cholesterol < 5 mmol/L (190 mg/dl). LDL cholesterol < 3 mmol/l (115 mg/dl; 
Blood glucose < 6.1 mmols/L (110 mg/dL)). 
 
This was a multidisciplinary effort in which the dietetic and physical activity intervention 
formed an integral part. A protocols was provided in the Health Professional Manual based 
on Figure 29 to guide the team in lifestyle advice for management of these risk factors. The 
nurses were responsible for monitoring these risk factors and following the therapeutic 
management protocols outlined in Appendix VIII p344 and provided in the Health 
Professional Manual. 
The blood pressure, blood cholesterol and blood glucose were measured at the initial 
assessment, and the nurses consulted the cardiologist if they were above target level. The 
cardiologist initiated or up-titrated medication as appropriate. The nurse measured the blood 
Meat
&
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pressure at weekly intervals during the course of programme attendance, and blood 
cholesterol at monthly intervals until the target was reached. Once drug treatment was 
started, weekly monitoring continued until the blood pressure was reduced below target. An 
oral glucose tolerance test was performed if the fasting glucose was >6.1 mmol/l in order to 
diagnose new diabetes, impaired glucose tolerance or impaired fasting glycaemia. Patients 
and partners diagnosed with diabetes or dysglycaemia were managed according to the 
diabetic target for blood pressure, as well as the cholesterol and glycaemic targets defined 
above. People who were diagnosed with new diabetes were also referred to the 
diabetologist. 
The nurses checked that all appropriate cardio-protective medications were prescribed; 
antiplatelet therapy; betablockers; ACE inhibitors/Angiotensin II receptor blockers; and lipid-
lowering drugs. The nurse checked the dose of these drugs to make sure they were 
evidence based. The nurse liaised with the cardiologist to initiate a prescription or up-titrate 
the dose of these medications. The nurse also provided education and information to 
patients and partners about their medications to facilitate compliance. 
5.5. Educational Interventions 
At the weekly group sessions, couples attended a rolling programme of educational and 
interactive workshops. Each couple was also given a Family Information Pack which was 
tailored to their particular needs. The pack was designed as a loose-leaf folder in three 
sections. The first section described the programme and explained its objectives. The 
second section contained information about addressing lifestyle and cardiovascular risk 
factors, for example tips on how to quit smoking successfully and how to improve eating 
habits. The third section included information about the atherosclerotic disease process, 
about revascularising interventions, about recovery and also about drug therapies to 
manage conditions and risk factors. As the sheets were loose in the folders, they could be 
included or left out as appropriate before they were given to the couple. This avoided the 
problem of over loading with information and also including irrelevant information not tailored 
to the couple’s needs. 
The information in the packs was designed to complement the information given at the 
health promotion workshop programme sessions and information given during interactions 
with the team. 
The EUROACTION nurses in the programme were responsible for co-ordinating a rolling 
programme of health promotion workshops for the patients and their families. These 
workshops were primarily designed to provide information and advice about lifestyle and 
! 93!
other cardiovascular risk factors, cardio-protective medications, and cardiovascular disease 
(see Figure 33). They also formed an important part of the group support provided by the 
programme due to their interactive nature. 
In addition to running some of the workshops themselves, the hospital teams and general 
practice nurses invited other professionals to facilitate some workshops, for example, in 
some cases, a pharmacist was invited to lead the session on cardio-protective medications. 
In planning the workshop content, the hospital teams and general practice nurses were 
provided with sample lesson plans and they were encouraged to be sensitive to the needs of 
each group and to their own cultural particularities. They were also advised to use the 
teaching resources from their own heart foundations or other organisations, and to use 
whatever audio visual equipment they had at their disposal, for example flip charts, posters, 
overhead projectors with acetates or power-point. 
During their training emphasis was placed on using teaching techniques appropriate for 
adults with mixed ability, to draw on the wealth of experience from the adults attending the 
workshops, to encourage interaction and the sharing of experiences and to ensure that 
content of the workshops was always relevant to the participants. 
Figure 33.  The Health Promotion Workshop Programme 
 
 
 
 
The Hospital Programme 
8 workshops 
1.  Coronary heart disease and cardiac procedures.  
2.  Adopting healthy lifestyle habits: Not Smoking 
3.  Adopting healthy lifestyle habits: Healthy Eating 
4.  Adopting healthy lifestyle habits: Becoming Physically Active 
5.  Other risk factors: Blood pressure, blood cholesterol and blood glucose:  
how lifestyle change and medication help. 
1.  Understanding cardio-protective medications.  
2.  Living with coronary heart disease. 
a.  Recovering from cardiac events and procedures 
b.  Sexual activity and CHD 
c.  Returning to Work 
3.  Coping emotionally with coronary heart disease. 
a.  Managing stress and learning how to relax 
b.  Anxiety and depression - positive thinking 
! 94!
6. Statistical analyses 
6.1. Statistical power 
The statistical analyses for the EUROACTION study are based on intention to treat for pre-
specified primary outcomes (See Figure 10). Sample size calculations were based on those 
used in the EUROASPIRE II study (EUROASPIRE, 2001b). A sample size of 400 patients in 
both intervention and usual-care centres in each country was sufficient for detection of a 
10% reduction in smoking, a 5% average reduction in body weight or systolic blood 
pressure, and a 10% reduction in mean total cholesterol concentration at the p=0·05 
significance level with 80% power. The cluster coefficient for smoking was 0·200, 
bodyweight 0·011, systolic blood pressure 0·030, and total cholesterol concentration 0·062. 
My study which quantifies concordance in couples participating in the intervention arm of the 
EUROACTION study did not require power calculations as it is not testing a hypothesis, 
making a randomised comparison or measuring concordance according to pre-specified 
confidence intervals. Analyses were based only on couples who attended the baseline 
assessment together and not the remaining patients who attended alone 
 
6.2. Statistical tests 
Descriptive analyses of baseline characteristics will be presented, demographics, diagnostic 
category, lifestyle habits prior to the patient’s cardiac event, risk factors at the time of the 
event and psychosocial status at the time of the event. 
6.2.1. Baseline characteristics described in relation to: 
i. Gender (% m and f) 
i. Age (mean) 
ii. Nationality (% from each country) 
iii. Patient’s diagnosis (% acute MI, UA, SA) 
iv. Employment (% retired, unemployed, employed) 
v. Education (% reaching primary, secondary and university education) 
vi. Lifestyle (what the patient and partner were doing in the month prior to the 
patient’s cardiac event which prompted recruitment to the study 
a. Smoking (%) 
b. Diet: mean saturated fat intake (g/day calculated from dietary analysis 
of 2 x 24 hour dietary recalls), fruit and vegetable intake (skewed 
distribution - median and IQR calculated from the food frequency 
questionnaire) 
c. Physical activity levels calculated from 3 different measures – skewed 
distribution so medians and IQRs calculated for following: k/cals per 
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day expended calculated from the 7DAR; MET minutes/week 
calculated from the IPAQ, steps taken per day calculated from the 
completed records of patients and partners wearing pedometers 
vii. CVD risk factors 
a. Overweight and obesity: mean waist circumference in cm and SD 
(men and women separately), mean BMI (kg/m2) and SD 
b. Blood pressure – mean SBP and SD 
c. Lipids – mean total cholesterol and SD 
d. Glucose – mean fasting blood glucose and SD 
viii. Psycho-social functioning (skewed distributions so medians and IQRs 
calculated 
a. Illness perception score from IPQ-R 
b. Health state score from EQ-VAS 
c. Mood score from GMS 
d. Anxiety and depression scores from HADS 
ix. Prevalence (%): achieving smoking, dietary, physical activity and risk factor 
goals at baseline, 16 weeks and one year 
6.2.2. Concordance analyses 
Variables used for the concordance analyses were for the most part continuous, although 
the smoking variables were categorical. 
6.2.2.1. Categorical variables (smoking: current, ex, never). Observed over expected 
ratios were calculated by dividing the actual observed values (e.g. numbers of 
couples where both partners smoked) by the number that would be expected by 
chance, i.e. if there were no relationship between smoking in married partners). 
6.2.2.2. Continuous variables for diet, physical activity, CVD risk factors and psycho-
social variables (e.g. grammes of fruit and vegetables per day, kcals energy 
expended per day at baseline). The Pearson correlation coefficient was used to 
measure the extent of association between continuous risk factor measurements 
in couples. Spearman’s Rank correlation coefficient was used for data with 
skewed distribution). 
6.2.2.3. Concordance for change with quitting smoking (categorical variable). Smoking 
quit rates (%) at 16 weeks and one year in one partner were compared according 
to quit rates in the other partner. 
6.2.2.4. Concordance for change in continuous variables (diet, physical activity, CVD risk 
and psycho-social factors) between baseline and 16 weeks and one year. 
Correlation coefficients were used as above. In addition, patients were divided 
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into quintiles of change for each variable, and mean change in partners was 
grouped according to the extent of change in corresponding patients. 
 
6.3. Data management 
The findings of the assessments were entered onto the EUROACTION database by the local 
study nurses, dietitians and physiotherapists and exported regularly to the London 
coordinating centre. The research student was responsible for monitoring data sent by the 
study nurses from all centres, and for assisting with data cleaning queries. 
Summary 
In summary, my observational study of concordance was conducted in the coronary patient 
population and their partners who were recruited to the intervention arm of the hospital part 
of the EUROACTION cluster randomised controlled trial. At the start of the study these 
couples had a detailed assessment of their lifestyle, cardiovascular risk factors and 
psychosocial health prior to starting the cardiovascular prevention and rehabilitation 
programme together. The programme was designed to provide expert tailored support to 
these couples by a nurse-led multi-disciplinary team in order to reduce risk of recurrence of 
cardiac events or development of disease in partners free of disease. 
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CHAPTER 3.    RESULTS 
In this chapter, in addition to presenting the results of my observational study of 
concordance for lifestyle, cardiovascular risk factors and psycho-social health, I will also 
present the results of my review of the published literature on concordance for lifestyle and 
concordance for change in married and cohabiting couples. Results of the review are 
presented first for smoking, second for diet and third for physical activity.  
1. A systematic review of the scientific literature on concordance and concordance 
for change for smoking, diet and physical activity in married and cohabiting 
couples 
The results of the systematic review of concordance for lifestyle habits in couples and 
concordance for change conducted as part of my study are presented in the tables below for 
each lifestyle habit (smoking, diet and physical activity). The tables categorise the papers 
according to how they measured concordance, using, for example, correlation, odds or risk 
ratios or percentage agreement; and how they measured patterns of change in behaviours 
over marriage duration or in relation to influences, for example, the impact of a coronary 
event in one partner on the smoking, dietary and physical activity habits of both partners. 
1.1. Concordance for smoking in couples 
Forty-two studies which evaluated the association of smoking behaviour in married or 
cohabiting couples are shown in Tables 4, 5, and 6. Two studies, which did not formally 
evaluate concordance but looked at similarities in prevalence of smoking in couples are 
shown in Table  7. Patterns of change in smoking behaviour in couples are shown in Table 
9). Table 8 includes the findings of two systematic reviews of concordance in couples for 
health and health behaviours (Meyler et al., 2007), and for major coronary risk factors (Di 
Castelnuovo et al., 2009). Di Castenuovo’s review included 16 of the studies identified in my 
review. The remaining eight were not included either because they were conducted since the 
publication of his review, or because they did not fulfil their inclusion criteria. 
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SMOKING 
Table 4. Studies using correlation to measure smoking concordance (ordered according to effect size) 
First author 
and year 
Study Design Correlation 
coefficient 
Effect size Measure of smoking Population 
Kolonel 1981 Cross sectional survey (home 
visits) of concordance for 
smoking, alcohol and dietary 
intake. 
Pearson (inter-
class) 
0.03 (whole 
sample) 
0.07 (in those 
couples where 
both smoked) 
Number cigarettes smoked/day 281 healthy couples 
Honolulu, Hawai 
Barrett-
Connor 1982 
Cross-sectional survey of risk 
factors for heart disease Interview 
using a standardized 
questionnaire and clarification of 
discordant responses by 
telephone 
Tau B 
(observed couples 
compared with 
randomly assigned 
couples) 
0.183* Former, current, never 1971 healthy couples 
San Diego, US 
Haynes 
1983 
Framingham Cohort study. Data 
from examinations 8/9 
Pearson 0.21* Number cigarettes smoked/day 285 healthy couples 
(90% married >20 
years) Framingham, 
US 
Speers 1986 Cross-sectional data from 
surveys conducted in 1978 and 
1982 measuring prevalence of 
hypertension and influencing 
factors (smoking, diet, exercise) 
in 2.1m adults. 
Kendall Tau B 0.24* Agreement in smoking status 
(same/different) 
1260 healthy couples 
Connecticut, US 
Di 
Castelnuovo 
2007 
Concordance using cross-
sectional survey data conducted 
between 2001 and 2003 of 
cardiovascular risk and lifestyle 
and risk factors. Standardised 
questionnaire and 
measurements. 
Pearson 0.26* Never/ex/current 802 healthy couples 
Italy, UK and Belgium 
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Hunt 1989 Data from second of two cross-
sectional surveys conducted 
1980-1983 and 1983-1985 to 
measure concordance for lifestyle 
in twins and parents. 
Intra-class 0.31* Current yes/no 301 healthy couples 
(parents of twins) 
Utah, US 
Sutton 1980 Cross-sectional data (home visits) 
to measure concordance for 
smoking in couples by marriage 
duration. 
Pearson 0.33* Number cigs/day 403 healthy couples 
(68 engaged, 112 
newly wed, 223 > 6 
years) Edinburgh, 
Scotland 
Macken  
2000 
Cross-sectional design to 
examine concordance for 
coronary risk factors in couples 
(home visit 8-10 weeks post 
discharge) 
Phi 0.39* Current smoking – yes/no 
History of smoking – yes/no 
177 male coronary 
patients post AMI, 
CABG, PTCA and 
wives Nebraska, US 
Tambs 1992 Cohort. Nord-Trøndelag Health 
Study from 1984 to 1986 
(screening for hypertension, 
diabetes and lung disease).      
Government census information. 
Polychoric over 9 
classifications of 
marriage duration 
(< 1 year - > 20 
years) 
<1y 0.34; 1-3y 
0.36; 3-5y 0.29; 
5-10y 0.32; 10-
15y 0.32; 15-20y 
0.33; >20y (age 
<60) 0.31; >20y 
(age 60-69) 0.32; 
>20y (age > 69) 
0.29§ 
 
Number cigarettes smoked/day 20, 751 healthy 
couples, Oslo, Norway 
Kuo 2007 Cross-sectional data used to 
measure concordance for 
smoking across generations of 
twins and spouses, parents and 
grandparents  - postal 
questionnaire 
Not stated 0.39-0.55 (twins 
and spouses) 
0.19-0.48 
(parents and 
grandparents)* 
Never/ex/current Healthy couples 
(3,885 twins and 
spouses, parent pairs 
and grandparent pairs 
of twins) Australia 
Ask 2012 Cohort. Nord-Trøndelag Health 
Study from 1984 to 1986 and 
Polychoric 
(calculated between 
0.48* Pseudo 
pairs 0.05 
Current yes/no 
 
19,599 healthy 
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prospective registry information 
about when and with whom 
people entered marriage or 
cohabitation between 1970 and 
2000. 
Investigated concordance for 
smoking, exercise and alcohol 
and extent to which it was due to 
assortative mating 
2 continuous latent 
variables from 2 
observed ordinal 
variables) 
smoking 
Couples entering 
marriage 
before/after data 
collection: 
0.33/0.47 
smoking 
0.38 (12 years 
prior), 0.55 (entry 
into marriage), 
0.33 (after 39 
years duration) 
couples Oslo, Norway 
Perusse 
1986 
Cross-sectional – Canada Fitness 
Survey 1981 
Contingency 
correlation 
coefficient 
0.61* Non-smokers (including 
ex)/occasional/regular 
4,678 healthy couples 
Canada 
* p<0.05 
Table 5. Studies using odds ratios to measure smoking concordance (ordered according to effect size) 
First author 
and year 
Study Design OR/RR Effect size Measure of smoking Population 
Stimpson 2006 Cross-sectional 1993 - 
1994 
RR 1.42 
2.15 
Ever smoked with ever smoked 
Wife’s risk of smoking if husband 
ever smoked 
553 healthy older Mexican American 
couples California, Colorado, Texas, 
US 
Pyke 1997 Observational data from 
RCT 
(FU 1 year) 
ORs 
 
 
 
 
2.3 
1.3 
1.5 
Current with current 
Never with never 
Ex with ex 
1477 healthy couples UK 
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Jurj 2006 Prospective Cohort – 
Shanghai Womens’ 
Health Study(baseline 
cross-sectional survey 
data collected 1997-2000) 
OR 2.4 
 
Complete agreement on ever 
smoked regularly for at least 6 
months 
66,130 healthy couples Shanghai 
China 
Bloch 2003 Cross sectional study of 
spousal concordance for 
CVD risk factors across 
socio economic groups 
OR 3.26 
 
Regular/occasional or ex/never 365 healthy couples Rio de Janeiro, 
Brazil 
Hippisley-Cox 
2002 
Cross-sectional study in 
General Practice 
OR 4.44 
 
Non/current/former. Odds of being 
a smoker if your partner was a 
current or former smoker 
compared to a non-smoker. 
8386 healthy couples UK 
 
Table 6. Studies using other measures to evaluate smoking concordance (ordered according to year of publication) 
First author 
and year 
Study Design Measure Effect size Measure of smoking Population 
Sackett 1975 Cross-sectional data from 
Framingham Cohort study. 
 
% concordant 66%* > 1 pack/day 1259 Healthy 
couples 
Framingham, US 
Venters 1984 Cross sectional data from 
Minnesota Heart Survey 
designed to explain the decline 
in CHD mortality  (home and 
centre visits) 
% agreement 
(observed/expected) 
Surrogate pairs 
74%/63%* Smoking status 1568 married and 
non married 
individuals 
560 healthy 
couples 
Minnesota, US 
Brenn 1997 Cross sectional 1977-1978 % agreement 
(observed/expected) 
63.5%/49.4%* 
 
Complete agreement on ever 
smoked regularly for at least 6 
months 
1530 healthy 
couples Finnmark, 
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Norway 
Izumi 2004 Cross-sectional from Saitama 
Cohort Study, Japan – 
Incidence of cancer 1986-2000! % agreement (observed/expected) 22.1%/19.9%*  Regular/occasional or ex/never 2601 healthy couples, Saitama, Japan 
* p<0.05 
Table 7. Studies measuring prevalence of smoking in couples but not formally evaluating smoking concordance 
First author 
and year 
Study Design Measure Results Measure of smoking Population 
Goble 1997 Family Atherosclerosis 
Risk Intervention Study. 
Randomised controlled 
trial – report of baseline 
results 
Prevalence. Data 
collected 3-4 months post 
event (interview). 
Compared with 1989 
National Heart Foundation 
Risk Factor Prevalence 
Study using t-test and 
ANOVA. 
Patients smoking: 
6% (m) 5% (f) 
27% (m) and 18% (f) quit 
<12 months ago. 
21% (m) and 46% (f) 
never smoked. 
Relatives v. national 
smoking: 
Male: 32% v.  27%* 
Female: 25% v. 21%* 
Current/ex/never smoker 628/895 cardiac patients 
<70 years screened. 
1723/2835 siblings and 
spouses screened, 
Australia 
Wood 1997 Case control study of 
coronary risk factors to 
compare risk factor 
profile in wives of men 
with CHD compared to 
wives of healthy men 
Prevalence. 31% wives smoking age 
25-44 compared to 14%* 
controls. 19% wives are 
ex-smokers age >45 
compared to 28% 
controls. No cigarettes 
smokers quit following 
husband’s MI. 
Current/ex/never smoker 
 
117 cases acute myocardial 
infarction in men under 65 
years and 89 female 
partners plus 133 age and 
gender matched healthy 
female controls,  
Southampton, UK 
* p<0.05 
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Table 8. Systematic reviews evaluating smoking concordance 
First author and 
year 
Study Design Methods Results Effect size (meta-
analysis) 
Population 
Meyler 2007 Systematic review of 
concordance for 
mental, and physical 
health and health 
behaviours in couples 
Database searches, 
reference lists, talking to 
concordance researchers 
19 studies – diet, 
smoking, alcohol, drugs, 
lifestyle 
 Married and cohabiting 
couples 
Di Castelnuovo 
2009 
Systematic review 
and 2 meta-analyses 
of spousal 
concordance for 
major coronary risk 
factors 
Database searches of 
published studies 
following criteria until 
March 2008 
71 papers selected 
from 207 cohorts of pairs 
and 424,613 correlations 
in more than 100,000 
couples 
Smoking: 
Correlation: 0.23 
OR: 3.25 
Married and cohabiting 
couples 
* p<0.05 !
Table 9. Studies investigating patterns of change in smoking concordance over marriage duration and as a result of other influencing factors 
First author 
and year 
Study Design Results Measure of smoking Population and country 
Venters 1984 Cross sectional data 
from Minnesota Heart 
Survey designed to 
explain the decline in 
CHD mortality  (home 
and centre visits) 
Divorced/separated more likely to be smokers 
than married, eg 50% separated females were 
smokers compared to 23.2% married. 
79 pairs ex-smokers, married pairs more similar 
than surrogate pairs in year of quit. 
In married pairs ≤ 50 years 65.3% quit within 3 
years of each other compared to 19.4% 
surrogate pairs. 
In actual pairs > 50 years 20% quit within 3 years 
Year of quit date. 
 
1568 married and non married 
individuals 
560 healthy couples 
Minnesota, US 
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of each other compared to 8.7% surrogate pairs. 
Both p<0.01. 
For older couples, difference is not significant – 
may be generational. Older women more likely to 
have never smoked and men less likely to have 
been influenced by their wives’ smoking 
behaviour. 
Distant quit year in ex-smokers married to never 
smokers. Never smokers may choose those who 
want to quit and help them do it. 
Dracup 1984 RCT to evaluate the 
effect of group 
counseling and 
spouse involvement 
on adherence of 
cardiac patients with 
prescribed 
behavioural regimens. 
10 week series of 90 
minute group 
discussions.  3 
groups:       
Experimental 1 – 17 
patients and their 
spouses – counseling 
for both. 
Experimental 2 – 22 
patients and their 
spouses – counseling 
for cardiac patients 
only.         Control – 
No differences for smoking. Only 2 patients 
smoking on entry and continued at 6 months. 36 
had a < 1 year history and none were smoking at 
6 months (not validated). 
 
 
 
 
Smoking yes/no 
Data collected at BL, 10 weeks, 
6 months. 
58 married or cohabiting 
couples attending 4 outpatient 
cardiac rehabilitation centres 
(28 post MI, 30 CABG), 
California, US 
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19 cardiac patients 
and their spouses – 
no counselling 
 
Mermelstein  
1986 
 
2 prospective studies 
of partner support for 
quitting smoking 
(second = cross 
validation). 
Smokers participating 
in cessation 
programmes run by 
University of Oregon 
Smoking Control 
Programme. Recruited 
by advertising. 
Study 1: random 
assignment to spouse 
training or no spouse 
training. 
Study 2: same except 
also included a 3rd 
treatment group – 
single smokers. 
Structured 6 week 
cessation programme. 
Quit date week 4. 
Assessment week 6 
and FU 6 months. FU 
End of treatment 61% abstinent Study 1 
compared with 58% Study 2. At 6 months 25% 
and 31%. 1 year (no bio-marker validation) 36% 
and 33%. 
% BL rate smoking: Study 1 51% end of 
treatment to 75% at 1 year and 20% to 77%. 
High levels of partner support and and perceived 
availability of general support were important for 
initial cessation and short term maintenance. 
Presence of smokers in social network had 
negative impact on abstinence later. 
Study 2 was unable to replicate the results from 
Study 1 on high levels of partner support – 
probably because Study 2 included far less 
married subjects. 
 
Self reported 7 day abstinence, 
% BL smoking rate.  Breath CO 
< 8ppm and saliva thiocyanate < 
95  micro mm at end of treatment 
and 6 month only 
Perceived availability of support 
(ISEL) – intake, end of treatment 
and 6 months 
Support (PIQ) – intake, end of 
treatment, 6 month (not Study 
Group 3) 
Social network measures – 
intake 
 
 
Smokers married and living 
with partner (Study 1) and  not 
necessarily married (Study 2 - 
included 28 single smokers). 
Oregon, US 
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telephone 1, 2, 3 and 
12 months after 
treatment to 
participant and an 
informant. 
Sexton 1987 Multiple Risk Factor 
Intervention Trial 
(MRFIT) RCT (started 
1972). 
‘Natural experiment’ 
4/22 clinics in trial. 
64% UC wives and 
36% intervention. 
Effort was made to 
include intervention 
wives in activities. 
% smoking 25% INT v. 31% UC* 
Number cigarettes/day 17 INT v. 22 UC* 
BL to final visit mean 4.8 cigarettes fewer/day 
INT compared to 0.5 in UC*. In smokers mean 
reduction 12.4 INT to 1.7 UC* 
Number cigarettes/day. 
All data collected at time of 
husband’s final visit. 
Intervention wives compared 
with UC wives. 
No data collected at baseline 
from wives except that reported 
by husbands, eg cigarette 
smoking. 
220 volunteer wives of 
participants (men with no 
manifest CHD), Baltimore, 
Miami, Newark, Piscataway – 
US 
 
 
 
Hanson 1990 Data from ‘Men born 
1914’ Cohort Study – 
social support for 
quitting smoking. 
First exam 1969 – 
cohort defined 4 times 
every 3 months to 
avoid inviting 
deceased persons 
Men with non-smoking women were more likely 
to be former smokers (63.9%) than those living 
alone (47.6%) or with smoking women (36.9%) *. 
Regression analysis (former smoking = 
dependent variable) OR 3.3 likelihood of having 
stopped smoking if spouse was non-smoking v. 
smoking. 
Current, former, never smoking 
habits of both men and spouses 
assessed. Validation with blood 
COHb. 
 
 
400/621 men born 1914. 94 
non-participants completed a 
short questionnaire (phone or 
home visit). Malmo, Sweden 
 
! 108!
Ginsberg 1992 Investigated partner 
support 
Subjects randomly 
assigned to 3-6 
member groups 
(Nicotine gum; 
nicotine gum + 
psychol 
ogicaltreatment; 
nicotine gum + 
psychological 
treatment + partner 
support. 
Assessed pre-
treatment, weeks 4, 
12, 26 and 52. 
No differences in abstinence rates found 
between different groups. Analyses conducted 
by partner closeness. Nicotine gum + 
pychological treatment + close (external) 
partners did better than those with not so close 
(external) partners, but the reverse was true of 
the nicotine gum + psychological treatment + 
partner support group. 
Validated breath CO. PIQ. 99 smokers (no CVD) 
recruited by advertising 
during1985-86, ? country 
 
Roski 1996 
 
RCT spouse support 
for quitting (8 week 
smoking cessation 
programme recruited 
by advertisement with 
a spouse) 
8 week 15 sessions 
and telephone support 
at 3, 9 and 21 months. 
3 year follow up. 
 
One third had a partner who smokes. 
70% said < half close friends smoke. 
40% said almost no co-workers smoke. 
Whilst the PIQ-ALL (positive and negative 
spouse behaviours) were negatively associated 
with abstinence at 1, 2 and 3 years, largely due 
to the PIQ-NEG scores. Lower frequency of 
negative social support from spouse (eg 
undermining by nagging and policing) associated 
with a greater likelihood of abstinence at these 
time points. 
Ratio of positive: negative PIQ score associated 
Partner Interaction Questionnaire 
10 positive and negative items. 
Cohort of 690 quitters 
Minnesota, US 
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with continuous abstinence at all time points. 
Pyke 1997 Observational data 
from RCT 
(FU 1 year) 
72% response (76% m and 74% f smokers and 
88% m, 89% f non smokers) 
Quit rate 12% where both smoked at BL, 19% if 
only one smoked*. (Corrected analyses 
assuming non-returners smoking unchanged 8% 
and 14%*) 
Where only man (wife) smoked, quit rate was 
15% (8%) if both smoked compared to 22% 
(15%) if only man (wife) smoked*. 
Quit rate where both smoked at BL, 63% 5/8 
men if partner also quit, but only 11% if she had 
not 11/96*. 
In women quit rates 31% 5/16 when partner also 
quit but only 3/88 if he had not. 
Quit rates in patients and 
spouses in relation to quit rates 
in the other partner. 
1477 healthy couples UK 
Macken 2000 Cross-sectional 
design to examine 
concordance for 
coronary risk factors in 
couples (home visit 8-
10 weeks post 
discharge) 
Out of 172 with smoking history data, more than 
half were concordant for history of smoking with 
nearly 40% saying they had both ever smoked. 
Re current smoking (data reported for 119 
couples), remembering that this is reported post 
event, 76% couples are concordant with nearly 
65% reporting that they are both not smoking. 
Among the 29 discordant pairs, it was usually 
wife who continued to smoke (25). 
Current smoking – yes/no 
History of smoking – yes/no 
177 male coronary patients 
post AMI, CABG, PTCA and 
wives Nebraska, US 
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Franks 2002 
 
 
Longitudinal data from 
1st 2 waves of Health 
and Retirement Study 
1992-1994 – middle 
aged smokers 
(resistant group) 
Most of the married smokers continued to smoke 
(72%). 
Married smokers more likely (40.4%*) to be 
married to a smoker than to a non-smoker 
(12.6%*). Smokers less likely to be married to a 
never smoker (51.1%*) than non-smokers 
(83.6%*).  Smokers more likely to have a spouse 
who quit (6.1%*) compared to non-smokers 
(2.5%*). Smokers more likely to have a spouse 
start smoking (2.4%*) compared to non-smokers 
(1.4%*). 
In 150 men who quit 62% more likely to be 
married to non-smokers than smokers (23%). 
13% of the wives of these 150 men who quit, 
also quit. 
In 95 women who quit. 49% husbands non-
smokers compared to 37% smokers. 12% 
husbands quit. 
In 631 men and 499 women who continued to 
smoke, 5% wives and 4% husbands quit. 
Both partners quit in 5% of the couples. 
Men more likely to quit if married to a female 
never smoker (OR 2.2), or a quitter (OR 4.9). Not 
as strong for women (OR 1.1 and 3.7 
respectively). 
Out of 9602 married and non-married individuals, 
in married individuals, most were either former 
(39%) or never (37%) smokers. In the divorced 
Prospective study of the 
1375/1700 married individuals 
who reported that they were 
current smokers in 1992 – 
measured correspondence for 
change in smoking status in the 
couples where matching data on 
smoking status were available in 
1994. 
Non-smoker yes/no 1992 
Spouse quit or started smoking 
between 1992-1994 yes/no 
Smoking status by marital status. 
 
9602 respondents, 1375 
married middle aged smokers 
and 4421 married non-
smokers, US 
! 111!
individuals, most were smokers (39%) or former 
smokers (33%). 
Park E, 2004 
 
 
Systematic review and 
meta-analysis of 
RCTs of smoking 
interventions 
assessing partner 
support. 9 studies 
 
Peto OR 1.08, 12+ months 1. 
Sensitivity analysis showed that support from live 
in partners may be more effective than that from 
other partner forms. Peto OR not shown. 
Peto odds ratio 
Abstinence 6-9 months and 12+ 
months 
 
 
Manchon-
Walsh 2007 
Effect of partner 
smoking status on 
cessation success 
28.3% in people with smoking partner and 46.5% 
i*n those with a non-smoking partner. More 
pronounced in women than men. 
12 month abstinence Spain 
Falba 2008 
 
 
Longitudinal study 
data from The Health 
and Retirement Study 
waves 3 (1992) and 5 
(1996) 
In male smokers (at wave 3): 35% of wives 
never smokers; in female smokers 12% of 
husbands never smokers 
Wave 5:                                                           In 
male quitters (29%), 61% of wives either former 
or never smokers; in female quitters (22%) 45% 
of husbands either former or never smokers. 
In quitters (men 29% women 22%) 27% of male 
spouses and 19% female spouses quit. OR 
7.53* for men to quit smoking if wife stopped 
(reference is that wife continued to smoke), 3.77* 
if wife was former and 1.87* if she never 
Smoking YES/NO (Asked at 
wave 5 only those who were 
smokers at wave 3), 
6072 married individuals 
Michigan, US 
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smoked. OR 8.52* for women to quit smoking if 
husband stopped (reference is that husband 
continued to smoke), 1.10 if husband was former 
and 1.79 if he never smoked. 
In continuing smokers (men 71% women 78%) 
36% of wives and 38% husbands continued to 
smoke. In the same, only 7% of wives quit and 
7% of husbands. 
Timing of change cannot be established, or 
whether changes were simultaneous or who 
initiated them. Divorced or separated couples not 
included. Discordant couples may be more likely 
to divorce. 
Christakis 
2008 
 
 
Framingham offspring 
cohort. 7 assessments 
between 1971 and 
2003 
Spouse quitting decreased a chance of the other 
smoking by 67% 
Clusters of smokers extended to 
3 degrees of separation 
Framingahm, US 
Thomas 2009 
 
 
Investigation of 
partner support for 
smoking cessation 
84% spouses very or extremely interested in 
helping their spouse to quit. 
90% very or extremely interested in learning how 
to do it 
SPM (Support Provided 
Measure) 
84 couples where patient was 
smoker, Mayo Clinic, US 
 
Vilchinsky 
2011 
Prospective 
longitudinal – male 
perceptions of 
received support from 
wives – smoking 
cessation 
36% response rate 
37/86 smoking at BL = 43%. 
24/37 quit at 6m = 65% 
At 6 months smoking cessation of patients was 
Ways of giving support 
questionnaire completed by 
patients and partners 
Smoking self reported 
Status of arteries and damage to 
86 male cardiac patients post 
first MI and wives, Israel 
post MI is more effective than 
over protectiveness and 
buffering. 
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BL, 1 month and 6 
months. 
significantly predicted by the interaction between 
wives’ active engagement and patients’ 
perception of their wives’ active engagement. 
OR 42.47 (1.57, 1148.87)*. 
Logistic regression. In men whose perceptions of 
wives’ active engagement with angio scores 
were high, the wives’ active engagement was 
significantly associated with better odds for 
patients’ smoking cessation (OR 29.75 (2.09, 
423.62) p<0.05 
heart – Echo score and angio 
score 
 
Mechanism probably is related 
to an increase in self-efficacy 
Rohrbaugh 
2012 
Couple intervention for 
health compromised 
smokers (use of 
personal pronoun – 
‘we talk’) 
50% achieved abstinence for 6 months and 40% 
for one year. 
Pre-treatment couple interaction ‘we talk’ by 
patient spouse predicted 12 month abstinence in 
health comp smokers. 
‘We talk’ by both partners during course of 
intervention also predicted 12 month abstinence 
as well. 
30 consecutive days point 
prevalence, and % smoke free 
days over 12 months. Pronoun 
use over 5 minute periods pre 
and post light up of pre-treatment 
marital interaction task; during 3 
five minute segments of the 4th 
early quit phase and last 
consolidation phase. 
20 health compromised (heart 
or lung disease or at least 2 
risk factors for CHD) smokers 
and their partners, Arizona US 
 
Park 2012 Cochrane systematic 
review and meta-
analysis of RCTs of 
enhancing partner 
support for smoking 
cessation 
RR 0.99 6-9 months 
RR 1.02 12 month+ 
RR 
Abstinence 6-9 months and 12 
months+ 
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1.2. Concordance for dietary habits in couples 
The literature is sparser for studies evaluating the association of dietary habits in 
married and cohabiting couples. Nineteen studies were identified and are shown in 
Tables 10, 11, 12 and 13. The tables show only the results for consumption of fat, 
fruit and vegetables. !
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DIET 
Table 10. Studies using correlation to measure dietary concordance (ordered by date of publication) 
First author 
and year 
Study design Correlation 
coefficient 
Effect size Dietary measure Population 
Nelson 1980 
(unpublished) 
Cross-sectional Pearson Fat 0.38* 
 
Dietary analysis of 7 day food 
diary. 
82 healthy couples, 
Cambridge, UK 
Kolonel 1981 Cross-sectional survey (home 
visits) of concordance for 
smoking and alcohol and dietary 
intake 
Inter-class 
(Pearson) 
0.33 – 0.55 food items 
(range) 
0.32 milk 
0.39 fresh fruits 
0.35 raw vegetables § 
Food frequency questionnaire. 
11 food items (number of 
times/per week), milk 
(glasses/week) 
281 healthy couples 
(Caucasians, Japanese, 
Chinese, Filipinos and 
Hawailans/ 
mixed race), 
Honolulu, Hawai 
Lee 1982 Cross-sectional data collected 
1977-1979 as part of an ongoing 
survey conducted by Hawai 
Department of Health 
Intra-class (ICC  
equivalent to 
kappa) 
Spearman’s 
rank (SR) 
Absolute intake           ICC 
0.35-0.59 
SR 0.45-0.59 
Per kg bodyweight 
ICC 0.41-0.76 
SR 0.42-0.57 Animal fat 
(absolute) 
ICC 0.43 
SR 0.57 
(Per kg bodyweight) 
IntraCC 0.49 
SR 0.52 § 
Dietary analysis of food 
frequency questionnaire. 83 
food items 
827 healthy couples 
(Caucasians, Japanese, 
Chinese, Filipinos and 
Hawailans/ 
mixed race), 
Honolulu, Hawai 
Eastwood 1982 Cross-sectional survey of diet 
and lipids in couples 
Spearman’s 
rank 
Foods (range) 0.10-0.88* 
Dairy 0.44 * 
Milk 0.10 
Vegetables 0.66* 
Fruit 0.45* 
Dietary analysis (range) 
0.16-0.64* 
Dietary analysis 7 day diary. 
Radio opaque markers in faecal 
samples 
23 healthy couples (first 
marriages 20-50 years) 
Edinburgh, Scotland 
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Fat 0.53* 
Fat in faecal constituents 
0.49* 
Macken  2000 Cross-sectional design to 
examine concordance for 
coronary disease risk factors in 
couples (home vists 8-10 weeks 
post discharge) 
Pearson Fat 0.44* 
 
Amount of fat in diet 10-mm 
VAS 
177 male coronary 
patients post AMI, CABG, 
PTCA and wives 
Nebraska, US 
Lyu 2004 Cross-sectional pilot study for 
larger family study. Recruitment 
between 1998 and 1999 from 
outpatient clinics 
Pearson Fat g 0.436* 
Fat % 0.156 
Sat fat g 0.41* 
PUFAs 0.388* 
MUFAs 0.434* 
Dietary analysis of food 
frequency questionnaire. 473 
Chinese food items. 
82 wives and their 
husbands attending 
outpatients, urban Taipei, 
Taiwan 
Di Castelnuovo 
2007 
Concordance study using cross-
sectional survey data conducted 
between 2001 and 2003 of 
cardiovascular risk, lifestyle abd 
risk factors. Standardised 
questionnaires and 
measurements. 
Pearson Lipids 0.34* Dietary analysis (% calories 
from lipids). EPIC questionnaire. 
 
802 healthy couples Italy, 
UK and Belgium 
* p<0.05    § significance not stated 
Table 11. Studies using percentage agreement to evaluate dietary concordance (ordered by year of publication ) 
First author and year Study design Measure Effect size Dietary measure Population 
Macario 1998 Cross-sectional survey to 
investigate similarities in 
fruit and vegetable 
consumption in spouses 
% agreement and 
kappa statistic 
66.6% agreement fruit 
0.299 
68.5% agreement 
vegetables 0.367 
Food frequency 
questionnaire. 52 food items 
questionnaire to measure 
number of fruit and vegetable 
servings per day 
211 health centre 
employees and 
spouses, 
Massachusets, US 
Izumi 2004 Cross-sectional survey 
from Saitama Cohort 
% agreement 
(observed/expected) 
From highest to lowest 
Greens 60%/41%* 
Fruit 56%/38%* 
Food frequency 
questionnaire. 9 food items 
2601 healthy 
couples, Saitam, 
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Study, Japan – incidence 
of cancer 1986-2000 
Yellow veg. 61%/43%* 
Meat 63%/47%* 
Fish 65%/49%* 
Soy 60%/44%* 
Vegetables 59%/44%* 
Eggs 56%/41%* 
Dairy (lowest) 49%/34%* 
(daily – ≤ 1/wk) Japan 
* p<0.05 
Table 12.  Studies not using a formal concordance measure (ordered according to year of publication) 
First author and 
year 
Study design Measure Effect size Dietary measure Population 
Schafer 1995 Cross-sectional survey to 
investigate effect of 
womens’ low fat diets on 
husbands 
Comparison of % 
calories from fat in 
husbands and wives 
38.6% calories from 
fat for husbands 
compared to 36.5% 
for wives 
Dietary analysis (% calories 
from fat) of food frequency 
questionnaire. 98 food items. 
155 healthy couples Iowa, 
US 
Hannon 2003 
 
Cross-sectional data from 
Eating for a Healthy Life 
RCT designed to increase 
fruit and veg and decrease 
fat consumption among 
members of religious 
organisations (RO’s). 
Comparison Low intake of fruit, 
vegetables and fat in 
FFP associated with 
same in spouses 
(1.42 servings fruit & 
veg and1.72 on fat 
likert scale) and high 
intake in FFP 
associated with same 
in spouses (4.68 and 
3.75). 
4 point likert scale for fat 
consumption (Very little of the 
time – all of the time). 
Number of servings per day for 
fruit and vegetables. 
282 family food preparers 
(FFP) members of religious 
organisations and their 
spouses, Seattle, US 
 
Table 13. Studies investigating patterns of change in dietary concordance over marriage duration and as a result of other influencing factors 
(ordered according to year of publication) 
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First author 
and year 
Study Design Results Dietary measure Population and 
country 
Bramwell L 
1986 
Wives’ experiences in support 
role post 1st MI in husband 
82% reported little or no difficulty with dietary management. 
Dynamics between couple early stages post a first event in 
husband. Lots going on besides help with lifestyle changes, 
eg worrying about recovery and what role to take, lack of 
communication from husband. 
Semi-structured interview at home 2-3 weeks post husband’s 
discharge. 
82/113 wives, Ontario, 
Canada 
Sexton 1987 
 
Multiple Risk Factor 
Intervention Trial (MRFIT) RCT 
(started 1972). 
‘Natural experiment’ 4/22 
clinics in trial. 64% UC wives 
and 36% intervention. 
Effort was made to include 
intervention wives in activities. 
Food rating score 16.8 v. 13.1 (higher worse) 
Diet knowledge 27 v. 30.2 (higher better) 
TC 223 mg/dl UC v. 203.8 Int 
LDL-C 142.1 v. 127 
 
Food record rating (3 day record – goals = 8% calories sat fat, 
10% from poly and 250mg dietary cholesterol) and dietary 
knowledge score (11 item questionnaire – fat, sodium and 
calories). 
Cholesterol levels 
All data collected at time of husband’s final visit except some 
data on wives reported by husbands at baseline 
Intervention wives compared with UC wives. 
220 volunteer wives of 
participants (men with 
no manifest CHD), 
Baltimore, Miami, 
Newark, Piscataway – 
US 
 
 
 
Patterson 
1989 
 
Observational data from RCT. 
Data from intervention families 
attending a structured 12 week 
family centred cardiovascular 
health promotion programme 
and 6 maintenance sessions 
over 9 months. 
3 day fat scores (0.51*) 
3 day salt scores (0.38*) 
No significant concordance for change seen in randomly 
assigned families. 
Concordance for change (Pearson r) in couples compared with 
randomly assigned families. 
101 families identified 
via elementary schools 
San Diego, California, 
US. 
 
Shattuck 1992 Data from Women’s Health 
Trial – RCT. Effect of women’s 
low fat diets on their husbands 
Random selection of wives and 
husbands from original trial.  
Intervention (15 months of 
education and behavioural 
strategies) aimed to reduce fat 
intake in women to 20% of BL 
kcals. Husbands not included. 
0.34* correlation fat intake between husbands and wives. 
Absolute Δ 4%* points fat intake between INT husbands 
(188) 33% energy from fat compared to CONTROL (180) 
37%. 
Wife’s fat intake significantly explained the intervention 
effect on the husbands. 
Significant Δ in total change score (1-12 – no. changes 
made in right direction) – 6 INT v. 4.4 CONTROL. 
100 item semi quantitative FFQ to both wives and husbands. 
Food intake over last 3 months. 
FU 12 months after intervention. 
225 husbands from 
each arm of trial, US 
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 Husbands of INT wives who prepared separate meals for 
themselves consumed a diet 3.6%* points higher in fat than 
husbands of INT wives who did not. 
>70% of women in both arms said they had at least 90% 
responsibility for food purchase and prep. 
Passive acceptance of lower fat diet by husband rather 
than an active attempt to eat less fat himself 
Russel 1994 Part of a larger cohort study. 
Case control study to assess 
whether family members 
where father has had 
premature MI (<56 years) 
comply with healthier diet. 
Recruitment between 1988 – 
1990 
 
In MI group – median 2.2 years since MI (skewed to 0-3 
years).                                                                          
Significant differences in all elements of diets of fathers 
with MI compared to control, eg fat 32.5% total energy v. 
37% in controls*. For wives significant differences only for 
energy, carbs, fat and sat fat.                                                   
Comparison of diets in MI families when sample was 
divided into different time points post MI (≤ 1 year to > 5 
years):        Fathers sustain changes eg sat fat 10.1% total 
energy at ≤ 1 year compared to 10.7% total energy at > 5 
years p=0.3939.  Wives do not sustain changes eg sat fat 
11.1% energy at ≤ 1 year compared to 12.1% total energy 
at 1 year p=0.0409.       In comparison of sat fat intake 
between husbands and wives in MI and control groups, 
whilst the changes in the wives were not as great as for the 
fathers, there are nevertheless significant differences for 
both fathers and spouses in favour of reduced sat fat intake 
for MI group. Eg 46% in MI group men consuming < 10% of 
energy sat fat compared to 11% in control group. For wives 
24% compared to 13% control group.        Also there were 
no significant differences in time since MI in the husband 
and wife groups. So this suggests that sat fat changes were 
maintained in long term – one of the most important key 
messages. 
Dietary history questionnaire and dietary analysis (Health 
habits and history questionnaire) 
Energy (kcals) 
Total carbs (% energy) 
Fat (% energy) 
Sat fat (% energy) 
Cholesterol (mg/1000 kcals) 
P:S ratio 
 
136 families where 
father has MI 237 
control families 
Cincinnati, Ohio, US 
Macken 2000 Cross-sectional design to 
examine concordance for 
coronary disease risk factors in 
couples (home vists 8-10 
weeks post discharge) 
Whilst there is highly significant concordance for fat (0.44) 
intake in couples, husbands nevertheless report using less 
fat (68.3 v. 64.1 VAS) than their wives. 
Amount of fat in diet 10-mm VAS 177 male coronary 
patients post AMI, 
CABG, PTCA and wives 
Nebraska, US 
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Bove 2003 Longitudinal qualitative 
Food choices newly married 
couples 
Food projects. Taking on the role of ‘Food Director’ with the 
aim of changing the other’s eating preferences. More often 
a role taken on by women and not men. Usually related to 
healthy eating issues. The Director may even try to 
influence the other’s diet when they are not together, eg 
putting healthy lunch choices in the fridge, packing the 
other’s lunch box, quizzing them about what they have 
eaten when away from them (Director).                                                             
Tendency to cause conflict. 
In depth semi-structured personal interviews during 1997 and 
1998 – at time of marriage and 1 year later 
20 newly married 
couples recruited by 
advertising (20 women 
and 14 men), New York 
state 
 
Homish 2008 Longitudinal study of early 
years marriage. Adult 
Development Study 
Wives’ premarital dietary habits had a prospective 
association with husbands’ healthy eating (RR 1.12*) and 
unhealthy eating (RR1.11*) habits throughout first four 
years of marriage. 
The same was true of the husbands’ premarital dietary 
habits which had a prospective association with the wives’ 
healthy eating (RR 1.12*) and unhealthy eating (RR 1.12*) 
habits throughout first four years of marriage. 
Both appear to influence each other equally. Young 
couples (mean age 28.7 men and 26.8 women). Women 
may be more likely to influence behaviours in older couples 
especially where illness is apparent – monitor role. 
Self-administered questionnaires to each partner to complete 
separately just before marriage, 1, 2, and 4 years. 
Healthy eating - 5 questions for healthy eating and 5 for 
unhealthy eating. How often in past month were fresh 
vegetables eaten (not potatoes), fresh fruits (not juices), poultry 
without skin, fish or seafood (not fried), chose foods specifically 
because they were low in fat, cholesterol or sodium. 
Frequency of eating fried food, fast food,  poultry with skin, 
eggs. 
634 couples in first 
marriage, US 
 
Franks 2012 Cross-sectional data from 
employees and retirees and 
their spouses participating in 
an on-going health screening 
programme 
40% husbands and wives in same stage of change for 
adopting a healthier diet. 
Concordance for eating a healthier diet ICC 0.29* 
 
 
Health questionnaire.                                                             Diet 
3 items: About how many servings of each of the following 
types of food do you eat in a normal day? 0 (less than 1 serving 
) to 6 (6 or more servings ). Serving size chart.    Participants 
also asked whether they “avoided fried and high-fat foods, 
including high-fat snacks”                                     Stage of 
behaviour change: “no plans to make this change,” “plan to 
start in next 6 months,” “plan to start in next 30 days,” “started 
doing it in last 6 months,” or “made this change over 6 months 
ago.”                                                                           Self 
efficacy assessed for each behaviour separately – very 
confident or not very confident                                                
ICC – more similar to each other than to other men and women 
in sample 
1899 couples, Midwest, 
US 
!
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1.3. Concordance for physical activity habits in couples 
Twenty-nine studies investigating concordance in couples for physical activity and 
exercise are shown in Tables 14, 15, 16 and 17. !
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PHYSICAL ACTIVITY AND EXERCISE 
Table 14. Studies using correlation to measure physical activity concordance (ordered by year of publication) 
First author 
and year 
Study design Correlation 
coefficient 
Effect size Physical activity measure Population 
Godin 1985 Cross-sectional study 
investigating spousal influence 
regarding exercise 
 not stated Intention 0.29* 
Current physical 
activity 0.24* 
 
Godin’s current physical activity 
habits questionnaire and Fishbein 
and Ajzen measure of intention 
(unlikely to likely likert scale) 
210 healthy parents 
of children from junior 
high school, Toronto, 
Canada 
Speers 1986 Cross-sectional data from 
surveys conducted in 1978 
and1982 measuring prevalence 
of hypertension and influencing 
factors (smoking, diet and 
exercise) in 2.1m adults 
Kendall Tau B 0.17* Exercise (riding a bike, performing 
calisthenics, jogging, lifting weights, 
swimming, walking for 15 minutes 
or more regularly during past week) 
YES/NO 
1260 healthy couples, 
Connecticut, US 
Perusse 1987 Cross-sectional study of 
concordance for physical fitness 
in families 
Intra-class and 
inter-class 
(Pearson) 
 
Intra-class 
Output 0.25* 
Endurance 0.27* 
Strength 0.27* 
Pearson 
Output 0.21* 
Endurance 0.30* 
Strength 0.22* 
Sub-maximal power output, 
muscular strength and endurance 
349 healthy couples, 
Quebec, Canada 
Perusse 1988 Cross-sectional data from 
Canada Fitness Survey 1981 
used to look at family 
resemblance in lifestyle 
components 
ICC, inter CC Energy expenditure 
ICC 0.28* InterCC 0.28 
Duration ICC 0.30* 
InterCC 0.30* 
Activity level 0.60* 
Habitual physical activity 
(frequency, duration, intensity). 
Leisure energy expenditure. METS 
assigned to activities. 
4,678 healthy 
couples, Canada 
Perusse 1989 Cross-sectional survey 
conducted 1978 – 1981 to 
investigate relationship of 
genetic and environmental 
Inter CC Level of habitual 
activity 0.18* 
Exercise participation 
0.16* 
Habitual physical activity – 3 day 
activity record including one 
weekend day 
272 healthy couples, 
Quebec, Canada 
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factors across generations for 
physical activity 
 
Boomsma 1989 Cross-sectional study to 
investigate resemblance of twins 
and parents in sports 
participation and heart rate. 
PHI and 
tetrachoric 
PHI 0.24* 
Tetrachoric 0.38* 
Sports in the past 3 months 90 healthy couples, 
parents of twins, 
Amsterdam, 
Netherlands 
Hunt 1989 Data from second of two cross-
sectional surveys conducted 
1980-1983 and 1983-1985 to 
measure concordance for 
lifestyle in twins and parents 
Pearson 0.18* 
 
Number of days/week strenuous 
exercise 
301 healthy couples, 
Utah, US 
Tambs 1992 Cohort. Nord-Trøndelag Health 
Study from 1984 to 1986 
(screening for hypertension, 
diabetes and lung disease).      
Government census information. 
Polychoric over 
9 classifications 
of marriage 
duration (< 1 
year - > 20 
years) 
<1y 0.28; 1-3y 0.23; 3-
5y 0.21; 5-10y 0.25; 
10-15y 0.28; 15-20y 
0.29; >20y (age <60) 
0.30; >20y (age 60-69) 
0.31; >20y (age > 69) 
0.38§ 
Exercise frequency (never-nearly 
every day), intensity (1-3), duration 
(1-4). Sum score. 
23,033 healthy 
couples, Oslo, 
Norway 
Aarnio 1997 Central Population Registry of 
Finland. Family aggregation of 
leisure time physical activity 
over 3 generations 
Pearson 0.19* LTPA (2 questionnaires) 
Walking, rapid walking, light 
jogging, running (none - ≥ 4 hrs). 
2nd in more detail. METs assigned. 
1240 health couples 
– parents of twins, 
Finland 
Macken 2000 Cross-sectional design to 
examine concordance for 
coronary risk factors in couples 
(home visit 8-10 weesk post 
discharge) 
Pearson and 
PHI 
Holms method 
of adjusting for 
multiple 
hypotheses 
74% concordant for 
exercise regularly with 
118 saying yes and 9 
saying no. 
In discordant pairs, 
usually patient who 
exercised and the 
spouse not. PHI 
exercise yes/no 0.20. 
Pearson 0.33* 
Exercise regularly YES/NO 
Frequency (times/week) 
Duration (minutes/session) 
Distance (miles/session) 
 
177 male patients 
post AMI, PTCA or 
CABG and wives, 
Nebraska, US 
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miles/session; 0.20 
minutes/session; 0.30* 
times/week 
Di Castelnuovo 
2007 
Concordance using cross-
sectional survey data conducted 
between 2001 and 2003 of 
cardiovascular risk and lifestyle 
and risk factors. Standardised 
questionnaire and 
measurements 
Pearson 0.18* (their lowest 
correlation) 
Standardised questionnaire 
categorised people into 
low/med/high 
802 healthy couples 
Italy, UK and Belgium 
Seabra 2008 Cross-sectional study to 
investigate concordance for 
physical activity in families 
F ratios and 
FCOR 
0.21* overall physical 
activity index 
0.29* leisure 
Baecke questionnaire (school, 
work, sport, leisure) – 5 point likert 
scale 
2375 nuclear families, 
Portugal 
De Moor 2011 Cross-sectional survey data on 
leisure time physical activity 
from The voluntary Netherlands 
Twins Registry (twins, parents, 
siblings, spouses) – data from 
spouses of twins used to 
investigate causes of spouse 
correlation and reasons for 
assortative mating regarding 
exercise participation. 
Tetrachoric 0.41 parents 
0.44 adult twin 
couples. No increase 
in duration over 
marriage. 
 
0.61 <5 yrs; 0.34 5-10 
yrs, 0.42 10-15 yrs, 
0.47  ≥15 yrs. 
 
Phenotypic assortment 
- ? explanation 
LTPA only. Exercise YES/NO (4 
METs, 60 mins/week for at least 10 
months) – type, frequency, duration 
2 cohorts: parents of 
adolescent twins 
(3138); 1107 adult 
twins and spouses, 
Netherlands 
Ask 2012 Cohort. Nord-Trøndelag Health 
Study from 1984 to 1986 and 
prospective registry information 
about when and with whom 
people entered marriage or 
cohabitation between 1970 and 
2000. 
Investigated concordance for 
Polychoric 0.32 observed 
compared to 0.02 
pseudo pairs. 
 
0.22 (12 years prior); 
0.30, 0.41 (39+ years) 
 
Convergence occurs 
both before and after 
Exercise frequency (never-nearly 
every day), intensity (1-3), duration 
(1-4). Sum score. 
1551 health couples, 
(includes future 
couples) Oslo, 
Norway 
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smoking, exercise and alcohol 
and extent to which it was due to 
assortative mating 
entry into relationship. 
Slight divergence a 
few years in. 
 
 
* p<0.05    § significance not stated 
Table 15. Studies applying an odds ratio to measure physical activity concordance (by year of publication) 
First author and 
year 
Study design Ratio Effect size Measure of physical activity Population 
Katmarzyk 2000 Data from Canada Fitness 
Survey -Familial risk for being 
fit or unfit 
SRR 
(Standardised 
Risk Ratio) in 
spouses 
compared to 
probands in 
upper (fit) and 
lower 
percentiles 
(unfit) for each 
indicator 
SRR in spouses for 
probands ≥ 95th 
percentile/≤ below 5th 
percentile 
1.63/1.54 work capacity 
2.38/1.83 strength 
2.63/1.13 endurance 
2.59/1.42 trunk flex 
Work capacity (step test), strength 
(grip), endurance (sit-ups) and trunk 
flexibility. 
2580 healthy 
couples, Canada 
Santariano 2002 
 
Cross-sectional data from  
longitudinal study of age 
related changes in physical 
functioning.!
Determinants of leisure time 
physical activity LTPA in older 
adults and to assess whether 
LTPA is independently 
associated with same in 
partners 
OR (Cochran-
Mantel-
Haenszel 
application to 
repeated 
measures). 
Comparison 
with surrogate 
pairs 
Significant association 
found. 
3.94 for mod vig women 
to be married to mod vig 
man 
6.55 for highly vig women 
to be married to highly vig 
man 
1.52 for mod vig man to 
be married to a < brisk 
activity woman 
Similar picture other way 
round 
LTPA 22 item interview administered 
questionnaire. METS assigned. 
Doe LTPA in one predict LTPA in other 
partner? 
511 healthy older 
couples > 55 years 
(Sonoma, California, 
US 
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Jurj 2006 Cross-sectional data from 
prospective cohort – Shanghai 
Women’s Health Study. Data 
collected 1997-2000 
OR 2.00 for husbands 
currently participating in 
reg ex to be associated 
with wives doing same 
Regular participation in sports and 
exercise over past 5 years (once/week 
for > 3 months continuously) YES/NO 
66,130 healthy 
couples Shanghai 
China 
 
Table 16. Studies applying percentage agreement to evaluate physical activity concordance (ordered by year of publication) 
First author and year Study design Measure Effect size Physical activity measure Population 
Venters 1984 Cross sectional data from 
Minnesota Heart Survey 
designed to explain the 
decline in CHD mortality  
(home and centre visits) 
% agreement 
(observed/expected) 
60% observed exact 
correspondence 
compared to 49% 
expected (11% 
difference)?* 
Daily sedentary behaviour 
(no regular participation in 
work or LTPA) 
560 healthy couples, 
Minnesota, US 
Ju 2011 Cross-sectional study of 
couples working together 
in dry cleaners 
% agreement (but no 
kappa or 
observed/expected) 
61% concordant for 
LTPA 
Pedometer 54% couples 
in same activity 
classification (Tudor-
Locke – low and 
somewhat active 
combined to create 3 
groups: sed; 
low/somewhat active; 
active)?* 
LTPA,HPA, OPA self report 
(interview administered 
questionnaire and 
pedometer) 
70 healthy Korean 
couples working in 
drycleaners, 
Chicago, US 
* p<0.05 
Table 17. Studies investigating patterns of change in physical activity and exercise concordance over marriage duration and as a result of other 
influencing factors  (ordered by year of publication) 
First author 
and year 
Study Design Results Measure of physical activity/exercise Population and country 
Heinzelmann 
1970 
Cross-sectional data 
from pilot studies to 
Claimed that the least important factor 
that influenced participation was desire 
Exercise participation (not described in detail) 239 men volunteers, 
Minnesota, Wisconsin, 
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examine relationship in 
physical activity and 
cardiovascular risk. 
Investigated response 
to physical activity 
programmes. 
to please wives 
80% men whose wives had positive 
attitude exhibited good to excellent 
attendance in contrast to 40% where 
wives were neutral 
Pennsylvania, US 
Dishman 
1982 
Review of the 
determinants of 
physical activity and 
exercise 
Found 9 studies showing a positive 
association between spouse support 
and physical activity and exercise. No 
studies were found showing a negative 
or no association. 
Re spouse support, supervised 
programmes are categorized as having 
a ++ probability because they are 
repeatedly documented as a positive 
determinant whereas the evidence for 
spouse support being associated with 
spontaneous change in activity is 
weaker and only given a +. 
Organised review around discussion of supervised 
exercise programmes and spontaneous changes in 
levels of physical activity. 
Included cross-sectional, correlational and 
experimental studies. 
US 
Dracup 1984 RCT to evaluate the 
effect of group 
counseling and spouse 
involvement on 
adherence of cardiac 
patients with 
prescribed behavioural 
regimens. 
10 week series of 90 
minute group 
discussions.  3 groups:       
Experimental 1 – 17 
Experimental 1: Patients - BL/10 wks 
+1.45; BL/6 m +2.32. Spouses – BL/10 
wks + 11.28; BL/6 m -0.51. 
Experimental 2: Patients – BL/10 wks 
+4.95; BL/6m -3.85. Spouses – 
BL/10wks +7.73; BL/6m -6.55 
Control: Patients – BL/10wks -1.29; 
BL/6m -13.27. Spouses – BL/10wks -
30.29; BL 6m -47.51 
Measures of compliance: weekly exercise (amount 
of time spent exercising at a prescribed target HR). 
Assessed in the presence of spouses in order to 
increase truthfulness of self-report. 
Data collected at BL, 10 weeks, 6 months. 
58 married or cohabiting 
couples attending 4 
outpatient cardiac 
rehabilitation centres (28 
post MI, 30 CABG), 
California, US 
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patients and their 
spouses – counseling 
for both. Experimental 
2 – 22 patients and 
their spouses – 
counseling for cardiac 
patients only.         
Control – 19 cardiac 
patients and their 
spouses – no 
counseling 
All NS (although stated as being <0.05). 
 
Bramwell 
1986 
 
 
Wives’ experiences in 
support role post 1st MI 
in husband 
32% said husbands carried out exercise 
routines independently. 24% 
encouraged exercise by going for walks 
with their husbands. 
24% said that they had to actively 
encourage their husbands to rest. 35% 
said their husbands decided for 
themselves when to rest. 
Dynamics between couple early stages 
post a first event in husband. Lots going 
on besides help with lifestyle changes, 
eg worrying about recovery and what 
role to take, lack of communication from 
husband. 
Semi-structured interview at home 2-3 weeks post 
husband’s discharge. 
82/113 wives, Ontario, 
Canada 
Patterson 
1989 
 
Observational data 
from RCT. Data from 
intervention families 
attending a structured 
12 week family centred 
cardiovascular health 
kcals expended (0.43 p<0.01) 
No significant concordance for change 
seen in randomly assigned families. 
Concordance for change (Pearson r) in couples 
compared with randomly assigned families. 
 
7 day physical activity recall (7-D PAR) 
101 families identified via 
elementary schools San 
Diego, California, US. 
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promotion programme 
and 6 maintenance 
sessions over 9 
months. 
Wallace 
1995 
Experimental design 
12 month adherence 
to fitness programme 
with or without spouse 
Married pairs v. married singles – 
monthly attendance significantly higher 
(54.2% v. 40.3%) 
Married pairs v. married singles – 
dropout significantly lower 6.3% v. 43% 
50% of dropouts left because of family 
responsibilities and lack of spousal 
support 
25% dropped out to continue exercising 
alone 
No difference in self motivation 
Monthly attendance significantly 
correlated in married pairs 
Adherence (monthly attendance based on mean 
attendance for each month) Compliance to exercise 
prescription. Dropout, reasons, self motivation. 
16 Married pairs and 
married singles (16 m and 
14 f) who were 
spontaneous participants in 
a fitness programme, 
Indiana, US 
Macken 2000 Cross-sectional design 
to examine 
concordance for 
coronary risk factors in 
couples (home visit 8-
10 weeks post 
discharge) 
118/171 (69%) said they both exercised 
regularly (compared to 25% engaged in 
recommended amount of physical 
activity in general population at time). 36 
(21%) men exercised alone – not 
supported by spouse. 9 (5%) both did 
not exercise regularly. 
Behavioural risk factor surveillance system.                                         
Exercise regularly (yes/no). Exercise frequency 
(number times/week), duration (minutes/session), 
distance (miles/session).                                   
Holm’s method of adjusting for multiple hypotheses. 
177 male coronary patients 
post AMI, CABG, PTCA 
and wives Nebraska, US 
Hong 2005 Cross-sectional study 
to investigate support 
from spouse for 
exercise in cardiac 
In 49 couples with similar exercise 
behaviour, 84% of patients and spouses 
were in later stages of change (action or 
maintenance). Dyadic changes were 
Separate interviews. Exercise support provided, 
received and exercise similarity. 49 couples with 
similar exercise behaviour were compared with 
99 (38% of eligible) cardiac 
rehabilitation patients and 
spouses, US 
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patients post MI, 
CABG or PTCA 
effective in this group (significant and 
positive, beta = 0.52 relationship 
between provision and receipt of 
support) 
In 50 couples with different exercise 
habits, 72% were in later stages with 
spouses in earlier stages. Partner 
effects non-significant in this group (beta 
0.08). 
couples with different exercise behaviour. 
Homish 2008 
 
Longitudinal study of 
early years marriage. 
Adult Development 
Study 
Wives’ premarital exercise habits had a 
prospective association with husbands’ 
exercise (OR 2.16*)  throughout first four 
years of marriage. 
The same was true of the husbands’ 
premarital exercise habits which had a 
prospective association with the wives’ 
exercise (OR 2.10 *) throughout first four 
years of marriage. 
Both appear to influence each other 
equally. Young couples (mean age 28.7 
men and 26.8 women). Women may be 
more likely to influence behaviours in 
older couples especially where illness is 
apparent – monitor role. 
Self-administered questionnaires to each partner to 
complete separately just before marriage, 1, 2, and 
4 years. 
Regular exercise yes/no (validated with a 
questionnaire assessing schedule in past year on 6 
item scale) 
 
634 couples in first 
marriage, US 
 
Falba 2008 Longitudinal study 
data from The Health 
and Retirement Study 
waves 3 (1992) and 5 
(1996) 
Adjusted OR for men to start exercising  
if wife started 1.49*) (reference is that 
wife never exercises), 1.60* if wife 
exercises regularly and 0.85 if she stops 
exercising. 
On average over the past 12 months have you 
participated in vigorous physical activity or exercise 
3 times/week or more? (Vigorous is defined in the 
questionnaire). Asked at waves 3 and 5. Outcome 
is a change from no to yes. 
6072 married individuals 
Michigan, US 
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Adjusted OR for women to start 
exercising  if husband started 1.58*) 
(reference is that husband never 
exercises), 1.93* if husband regularly 
exercises and 0.71 if he stops 
exercising. 
Not possible to see timing of change to 
establish whether changes were 
simultaneous or who initiated them. 
Don’t include divorced or separated 
couples. Discordant couples may be 
more likely to divorce. 
Franks 2012 
 
Cross-sectional data 
from employees and 
retirees and their 
spouses participating 
in an on-going health 
screening programme 
34% husbands and wives in same stage 
of change for getting more exercise. 
Concordance for getting more exercise 
ICC 0.15* 
 
 
Health questionnaire.                       Physical activity 
2 items (scale 1 day to 7 days)                                                        
1. “How many days per week do you get a total of 
30 minutes or more of moderate-intensity  physical 
activity? Combine the time you spend on all 
activities during the day?” Examples include 
walking, dancing, mowing, slow cycling, softball, or 
golf.                           2. “How many days per week 
do you participate in 20 minutes or more of vigorous 
exercise?” Examples include brisk walking, running, 
fast cycling, swimming, or aerobics. 
Stage of behaviour change: “no plans to make this 
change,” “plan to start in next 6 months,” “plan to 
start in next 30 days,” “started doing it in last 6 
months,” or “made this change over 6 months ago.”       
Self efficacy – very confident or not very confident                                                
ICC – more similar to each other than to other men 
and women in sample 
1899 couples, Midwest, US 
!
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2. Results of the observational study of concordance in coronary patients and their 
partners participating in the EUROACTION study. 
This section describes the results of my concordance study in the couples participating in 
the EUROACTION study and shows baseline characteristics, lifestyle (smoking, diet and 
physical activity) and risk factor (anthropometrics, blood pressure, lipids and glucose) 
profiles at baseline, concordance at baseline, changes in profiles at 16 weeks and one year 
and concordance for change at these time points. Results are also shown for psyco-social 
measures. 
2.1. Flow of couples through the study 
Figure 34. Study Population. 
 
In the six hospital centres randomised to the intervention arm of the EUROACTION cluster 
randomised controlled trial (RCT) 1589 eligible patients were consecutively identified and 
two thirds attended the baseline assessment (Figure 34). 828 (78%) patients who attended 
the baseline assessment reported living with a partner or spouse. Of these patients, 619 
were men and 209 were women. A larger proportion of female partners attended than male 
partners (See Table 18). In total, 645 (78%) couples attended the baseline assessment 
and they form the basis of the study population for this observational study set within the 
context of the EUROACTION cluster RCT. 
Table 18.  Gender characteristics of the study population 
 
 
ALL ELIGIBLE CORONARY 
PATIENTS 1589 
Attended baselinel 
assessment 1061 (67%) 
Lives with a partner 828 
(78%) 
Baseline 
assessment - 
couples 
 
645 (78%) 
 
Baseline 
assessment 
patients 
alone  
 
183 (22%) 
 
Couples 645 
n (%) 
Partners (645) 
(n) 
Proportion of eligible 
partners 
Male patients 517 (80%) Female (517) 84% 
Female patients 128 (20%) Male (128) 61% 
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Figure 35. Participation of couples throughout the programme 
 
Two thirds of the couples who attended the baseline assessment returned at 16 weeks for 
the discharge assessment (See Figure 35). However, 113 patients from the original 645 
couples attended without their partner. Neither the patient nor the partner from the 
remaining 92 couples attended the assessment at 16 weeks. At one year, two thirds of the 
original 645 couples attended the assessment. As can be seen in Figure 2, the majority of 
these couples had attended the assessment at 16 weeks, but 29 of the 113 patients who 
had attended the 16 week assessment alone, returned with their partner at one year and 
20 of the 92 couples who did not attend the 16 week assessment returned together at one 
year. 148 patients returned alone for this assessment without their partner. 78 of the 
couples did not attend the one year assessment. Younger couples were more likely to drop 
out. Of the 92 couples who dropped out of the programme and did not return to the 16 
week assessment, the mean age was lower (56.1 [SD 11.5] years for patients and 54.6 
[SD 12.1] years for partners) than in the 440 couples who did attend (61.8 [SD 9.0] years 
for patients and 59.7 [SD 9.6] years for partners). 
2.2. Descriptive analyses of the baseline characteristics of the study population 
A summary of the characteristics of the 645 couples attending the baseline assessment 
can be seen in Table 19. The 517 male patients had a lower mean age than the 128 
female patients. The age of the patients correlated closely with that of their partners 
(r=0.87), with male patients tending to be older than their partners, and female patients 
tending to be younger than their partners (See Figure 36). 
645 couples 
440 couples 
 
Initial 
Assessment 
(IA) 
16 weeks 
Assessment 
1 year 
Assessment 
couples 
370 
patients 
59 
neither  
11 
couples  
29 
patients  
71 
neither  
13 
couples  
20 
patients 
18 
neither  
54 
113 patients 
alone 
92 neither patient 
nor partner attended 
couples 
419 
patients 
148 
neither 
78 
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Figure 36. Correlation of age between patients and partners in 645 couples attending the baseline 
assessment 
 
Table 19. Baseline characteristics of the study population 
 
Baseline Characteristics Patients Partners 
Number (% male) 645 (80) 645 (20) 
 
Mean Age (SD) 
M F M F 
60 (9.8) 61.5 (9.8) 64.2 (10) 57 ((9.9) 
Nationality   
UK     n (%) 135 (21) 
Spain     n (%) 124 (19) 
Italy     n (%) 176 (27) 
France     n (%) 49 (8) 
Sweden     n (%) 87 (14) 
Poland     n (%) 74 (11) 
Employment status   
Employed     n (%) 287 (45%) 246 (38%) 
Unemployed     n (%) 15 (2%) 14 (2%) 
Houseperson     n (%) 22 (3%) 104 (16%) 
Full time education     n (%) 1 (0%) 1 (0%) 
Retired     n (%) 319 (50% 276 (43%) 
Educational status   
Primary school     n (%) 251 (39%) 267 (42%) 
Secondary school     n (%) 220 (34%) 225 (35%) 
Intermediate level     n (%) 85 (13%) 83 (13%) 
University     n (%) 83 (13%) 64 (10%) 
Recruiting diagnosis of patient   
AMI     n (%) 317 (49%) 22 (3%) 
Unstable Angina     n (%) 111 (17%) 11 (2%) 
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Stable Angina     n (%) 206 (32%) 24 (4%) 
Prevalence of prescribing of cardio-
protective medications 
  
Aspirin/anti-platelet agent 616 (97%) 60 (11%) 
Beta-blockers/calcium channel 
blockers 
553 (87%) 121 (21%) 
ACE inhibitors/ARBS 364 (64%) 101 (17%) 
Diuretics 95 (19%) 51 (9%) 
Other antihypertensive agents 11 (2%) 11 (2%) 
Statins/other lipid lowering agents 525 (88%) 71 (13%) 
Insulin/oral hypoglycaemic agents 80 (17%) 37 (7%) 
Lifestyle habits   
Smoking (%)* 
n (%) 
 
 
190 (29.5) 
 
 
133 (20.6) 
Saturated fat intake 
Mean % of total energy (SD)* 
 
10.4 (3.4) 
 
10.3 (3.9) 
Fruit and vegetable intake 
median g (IQR)* 
 
394 (230, 600) 
 
400 (250, 600) 
Moderate intensity physical activity 
Kcals/day 
median (IQR)** 
 
1.6 (0, 5.0) 
 
2.0 (0.3, 5.2) 
Steps per day 
median (IQR) 
 
5948 (3837, 9013) 
 
7074 (4599, 9842) 
 
Mean waist circumference cm (SD) 
M F M F 
97.9 
(10.3) 
91.2 
(12.9) 
97.0 
(9.4) 
86.4 (12.6) 
Mean BMI kg/m2 (SD) 28.3 (4.2) 27.5 (5.0) 
Mean SBP mmHg (SD) 127 (20.4) 135.8 (22.3) 
Mean TC mmol/l (SD) 4.39 (1.08) 5.68 (1.06) 
Mean glucose mmol/l (SD) 5.9 (1.9) 5.4 (1.3) 
IPQ-R score median (IQR) 15 (14, 17) 15 (13, 17) 
EQ-VAS score median (IQR) 70 (55, 80) 80 (70, 90) 
GMS score median (IQR) 20 (15, 26) 21 (17, 26.5) 
Anxiety score median (IQR) 5 (3, 8) 6 (4, 9) 
Depression Score median (IQR) 4 (2, 7) 4 (2, 7)` 
 
* In the month prior to the recruiting cardiac event of the patient 
**In the year prior to the recruiting cardiac event of the patient 
The couples came from six European countries (See Table 20), France, Italy, Poland, 
Spain, Sweden and the United Kingdom. Two thirds of the couples came from Italy (27%), 
UK (21%) and Spain (19%). Italy and Spain were the most successful at recruiting partners 
with three quarters of their recruited patients attending with their spouse, and France and 
Poland the least successful with 43% and 32% of patients attending with a spouse 
respectively. 
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Table 20. Participation of couples per country 
Centre No. of patients who came 
to the BL assessment in 
main EUROACTION 
study hospital arm 
No. of couples 
attending BL 
assessment 
Partner 
response rate 
per country 
 
Partner 
contribution to 
study 
 
 n % N % % 
Italy 240 23 176 73 27 
Spain 165 15 124 75 19 
Poland 198 19 74 32 11 
Sweden 140 13 87 62 14 
France 114 11 49 43 8 
UK 204 19 135 66 21 
Total 1061 100 645 
(78%) 
 100 
BL = baseline 
For the most part, the patients were retired from work (50%) or in employment (45%) with a 
very small minority reporting being a house person (3%) (See Table 19). This breakdown 
was somewhat different for the partners with 16% reporting being a house person. 2% of 
patients and partners reported being unemployed.  Around one third of patients (34%) and 
partners (35%) had been educated to secondary school level with around 40% being 
educated to primary school only. 
Amongst the patients, nearly one half were recruited following hospital admission for an 
acute myocardial infarction, and about a fifth with unstable angina. A third was recruited 
with stable angina (See Table 19). The prevalence of coronary disease in partners was just 
under 10%. 16% of the patients and 9% of the partners had known diabetes at baseline. 
Among the 645 couples attending the baseline assessment, in 254 (39%) couples, either 
the patient and/or the partner reported smoking in the month prior to the patient’s cardiac 
event (See Table 21) whether or not either of them had quit by the time of the baseline 
assessment.  The reported prevalence of cigarette smoking in patients was 30% and in 
partners it was 21% (See Table 22) indicating that 70% of patients and 79% of partners 
were meeting the European goal (not smoking) in the month running up to the patient’s 
cardiac event (See Table 23). Male patients and male partners had a higher smoking 
prevalence than female patients and female partners (See Table 22). 
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Table 21. Prevalence of smoking in couples at baseline** 
  Partners 
  Smoking Not smoking Total 
Patients Smoking 69* 36% 121* 64% 190 
100% 
52%  24%   
 
Not 
smoking 
 
64* 
14%  
391 
 
86% 
 
455 
48%  76%   
 
Total 
 
133 
100% 
 
512 
 
645 
* One or both members of the couple are smoking (254 couples) 
** Smoking habit at the time of the patient’s cardiac event 
Table 22. Prevalence of smoking in patients and partners at baseline** 
Current Smokers 
Patients Partners 
 n %  N % 
Male 169 32.7 Female 98 19.0 
Female 21 16.4 Male 35 27.3 
Total 190 29.5 Total 133 20.6 
** Smoking habit at the time of the patient’s cardiac event 
In the month prior to the patient’s recruiting cardiac event, fruit and vegetable consumption, 
as reported on the Food Habit Questionnaire (FHQ), was similar in both patients and 
partners with a median of 394g/day reported in patients and 400g/day in 640 partners (See 
Table 19). The box and whisker plot in Figure 37 shows the data distribution in more detail 
indicating the median, the interquartile range and data extremes to the 2½% and 97½% 
values. In addition data for individuals beyond these are shown on the plots as dots. The 
European recommendation for fruit and vegetable consumption is a minimum of 400g per 
day. One half of the patients (50%) and partners (52%) were meeting this goal (See Table 
23). In the random sub-sample of 89 couples whose 24 hour dietary recalls were subjected 
to dietary analysis, mean consumption of saturated fat was similar in both patients and 
partners, 10.4% of total energy and 10.3% of total energy respectively (See Table 19) and 
data distribution can be seen in the box and whisker plot in Figure 38. According to the 
European recommendation, saturated fat consumption should not exceed 10% of total 
energy intake, which was achieved at baseline by 44% of both patients and partners (See 
Table 23). 
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Table 23. Proportion of patients and partners meeting the European guidelines at baseline, 16 
weeks and one year 
Variable Time Patients Partners 
  N % n % 
Not smoking Baseline 645 70.5 645 79.4 
16-weeks 552 89.7 442 85.5 
1-year 567 90.1 420 88.8 
      
Fruit & Vegetables 
≥400 g/day 
Baseline 645 49.8 640 52.2 
16-weeks 554 73.1 431 70.5 
1-year 568 78.4 426 70.9 
      
<10% of total energy 
from saturated fat 
Baseline 89 43.8 89 43.8 
16-weeks 78 64.1 63 54.0 
1-year 220 57.3 173 60.1 
      
≥30 mins of moderate 
activity 5+ times/wk 
Baseline 642 25.4 636 29.7 
16-weeks 551 67.9 439 53.3 
1-year 565 58.8 429 47.8 
      
BMI < 25 kg/m2 Baseline 644 21.0 636 33.5 
16-weeks 552 24.3 427 36.8 
1-year 567 25.2 408 36.5 
      
Waist Circumference 
(M:<94cm, F:<80cm) 
Baseline 643 31.1 634 33.1 
16-weeks 553 38.3 426 33.1 
1-year 567 35.8 408 31.4 
      
BP < 140/90 
(Diabetics:<135/80) 
Baseline 645 63.3 645 50.7 
16-weeks 553 66.9 440 62.5 
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1-year 563 62.9 414 61.9 
      
Total Cholesterol 
< 4.5 mmol/l 
Baseline 607 60.8 515 13.2 
16-weeks 532 60.9 405 13.8 
1-year 547 58.9 394 16.2 
      
LDL-C 
< 2.5 mmol/l 
Baseline 600 49.5 508 11.6 
16-weeks 524 53.6 402 11.2 
1-year 351 53.4 392 16.6 
      
Glucose regulation 
• < 6 mmol/l (non 
diabetics) 
• HbA1c < 6.5% or 
glucose < 6 mmols/l 
(diabetics) 
 
Baseline 600 76.2 491 88.1 
16-weeks 527 78.2 386 88.6 
1-year 543 74.2 381 89.2 
 
 
Figure 37. Box and whisker plot showing median consumption of fruit and vegetables indicating IQR 
and outliers. 
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Figure 38. Box and whisker plot showing mean saturated fat consumption indicating IQR and 
outliers 
 
In the year prior to the recruiting cardiac event, patients reported in their 7-day Physical 
Activity Recall (7-D PAR) questionnaires expending a median of 1.6 kcals/day of moderate 
intensity physical activity, and partners a median of 2 kcals/day (See Table 19). Figure 39 
shows the full distribution of the data. Data from the 7-D PAR was used to calculate the 
proportions meeting the European recommendation for physical activity which is a 
minimum of 30 minutes of moderate intensity physical activity on at least five days of the 
week. This was achieved by 25% of patients and 30% of partners (See Table 23). Records 
from pedometers given to patients and partners at the baseline assessment showed a 
median of 5948 steps/day taken in patients and 7074 steps/day in partners (See Table 19) 
which places both in a ‘low active’ category (Tudor-Locke and Bassett, 2004). Using this 
system of classifying levels of physical activity, taking less than 5000 steps per day would 
be considered as sedentary and taking more than 10,000 would be active (see Figure 41). 
The full data distribution can be seen in Figure 40. 
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Figure 39.  Box and whisker plot showing median kcals energy expended indicating IQR and outliers 
 
Figure 40.  Box and whisker plot showing median steps indicating IQR and outliers 
 
Figure 41. Purpose: Steps per Day Classification 
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• <Under 5000 steps/day "sedentary lifestyle 
index“ 
• 5,000-7,499 steps/day "low active.“ 
• 7,500-9,999 "somewhat active“ 
• 10,000 steps/day "active".  
>12,500 steps/day "highly active". 
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Mean measurements of body mass index (BMI), waist circumference (WC), blood 
pressure, total cholesterol and blood glucose at baseline can be seen in Table 19 and the 
proportions at goal for these parameters in Table 23. Mean BMI was 28.3 kg/m2 for 
patients and 27.5 kg/m2 for partners. Mean WC in male patients was 98cm and in female 
patients 91 cm. For male partners it was 97 cm and for female partners it was 86.4 cm. 
One fifth of patients and one third of partners were achieving the goal for BMI and one third 
of patients and partners were achieving the goal for waist circumference (See Table 23). 
Mean systolic blood pressure (SBP) was 127 mmHg for patients and 135.8 mmHg for 
partners. Two thirds of patients and one half of partners were achieving the European goal 
for blood pressure. Mean total cholesterol (TC) was 4.39 mmol/l for patients and 5.68 
mmol/l for partners. 60.8% of patients and 13.2% of partners were achieving the goal for 
total cholesterol. Mean fasting blood glucose (FBG) was 5.9 mmol/l for patients and 5.4 
mmol/l for partners]. 
Prescribing of cardio-protective drug therapies in both patients and partners at the time of 
the patients’ discharge from hospital can be seen in Table 19. As expected a high 
proportion of patients were already taking prescribed cardio-protective medications at the 
time they attended the initial assessment. In partners prescribing was much lower. For 
example 13% were on lipid modifying medications compared to 88% of patients, and 21% 
of the partners were taking beta-blockers or calcium channel blockers compared with 87% 
of patients. 
At baseline (See Table 19), the median score for health related quality of life (EQ-VAS) 
was 70/100 for patients and 80/100 for partners where a higher score represents a better 
perceived state of health. The median score for positive mood (GMS) score was 20/40 for 
patients and 21/40 for partners where a higher score represents a more positive mood.  
The median anxiety score (HADS) was 5/21 for patients and 6/21 for partners where a 
higher score represents higher anxiety levels. For depression the median score (HADS) 
was 4 for both patients and partners. A normal score for anxiety or depression would fall 
below 7. The median illness perception score (IPQ-R) is out of 28 was 15/28 for both 
patients and partners where a higher score represents the least threatening perception of 
the illness. Figures 42-46 show the distribution of scores for each measure. 
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Figure 42.  Box and whisker plot showing median IPQ-R scores indicating IQR and outliers 
 
 
Figure 43.  Box and whisker plot showing median EQ-VAS scores indicating IQR and outliers 
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Figure 44.  Box and whisker plot showing median GMS scores indicating IQR and outliers 
 
 
Figure 45.  Box and whisker plot showing median HADS-A scores indicating IQR and 
outliers 
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Figure 46.  Box and whisker plot showing median HADS-D scores indicating IQR and 
outliers 
 
 
2.3. Concordance for lifestyle habits, cardiovascular risk factors, and psycho-
social factors at baseline 
2.3.1. Lifestyle 
2.3.1.1. Smoking 
The observed smoking status of both patients and partners was compared with what would 
be expected if one assumed there to be no association between both of their smoking 
habits (See Table 24). The observed over expected ratios were strongest where there was 
concordance, i.e where both members of the couple were smokers: 1.76; where both were 
ex-smokers:  1.18; and where both were never smokers: 1.14. Where there was 
discordance, the observed to expected ratios were weaker, for example, where the patient 
was a smoker but the partner was an ex-smoker: 0.67, or the patient was a never smoker 
and the partner was a smoker: 0.55. 
Table 24. Concordance for smoking amongst patients and partners at baseline 
Partner 
 Current Ex Never  
Patient O E O/E O E O/E O E O/E Total 
Current 69 39.2 1.76 26 38.9 0.67 95 111.9 0.85 190 
Ex 41 52.0 0.79 62 52.6 1.18 149 148.5 1.00 252 
Never 23 41.9 0.55 44 41.5 1.06 136 119.6 1.14 203 
Total 133   132   380   645 
O=Observed, E=Expected.      P=0.0001 
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2.3.1.2. Diet 
In 88 couples from the dietary analysis random sub-sample, the Pearson correlation 
coefficient was calculated for saturated fat intake. A positive significant correlation was 
observed (r=0.43 See Table 25) which can be seen in the scatter plot in Figure 47. The 
same was true for fruit and vegetable intake reported on the Food Habit Questionnaire, 
where a stronger correlation was observed (r=0.67) (Table 25 and Figure 48). 
Table 25: Concordance between patients and partners for dietary consumption of saturated fat, fruit 
and vegetables at baseline 
Component of 
diet 
N Correlation 
coefficient 
p-value 
Saturated fat 88 0.43 <0.0001 
Fruit and 
vegetables 
640 0.67 <0.0001 
 
2.3.1.3. Physical Activity 
The Pearson correlation coefficient for kcals of moderate intensity physical activity reported 
by couples on the 7D-PAR was positive and significant (r=0.25 see Table 26 and Figure 
49) as it was for their pedometer recordings (r=0.34 See Table 26). 
Table 26: Concordance for physical activity habits at baseline between patients and partners 
Measure of physical activity N Correlation 
coefficient 
p-value 
Moderate intensity physical activity 
(kcal/day) 
605 0.25 <0.0001 
Steps per day 469 0.34 <0.0001 
 
Figure 47: Correlation at baseline between patients and partners for saturated fat consumption 
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Figure 48: Correlation at baseline between patients and partners for fruit and vegetable 
consumption 
 
Figure 49: Correlation at baseline between patients and partners for kcals of moderate intensity 
physical activity 
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2.3.2. Cardiovascular Risk Factors 
Table 27. Concordance between patients and partners for cardiovascular risk factors at baseline 
Risk 
factor 
Nos. Correlation 
coefficient 
 
Waist 634 r = 0.12 p=0.004 
BMI 636 r = 0.22 p<0.0001 
SBP 645 r = 0.20 p<0.0001 
DBP 645 r = 0.18 p<0.0001 
TC 514 r = 0.07 p=0.09 
LDL-C 502 r = 0.13 p=0.004 
HDL-C 510 r = 0.27 P<0.0001 
Glucose 510 r = 0.20 P<0.0001 
 
The Pearson correlation coefficient was calculated at baseline for waist circumference in 
634 couples and for BMI in 645 couples (See Table 27 and Figures 50 and 51). Both 
showed positive and significant correlations: r=0.12 and r=0.22 respectively. The same was 
true for 645 couples for systolic (r=0.20) and diastolic (r=0.18) blood pressure (See Table 
27 Figure 52). The analyses for concordance for lipid and glucose measurements in 
couples were based on 514 couples for total cholesterol, 502 for LDL-C, 510 for HDL-C 
and 510 for glucose. The Pearson correlation coefficient was positive but low and not 
significant for total cholesterol (r=0.07) and LDL-C (r=0.06) (See Table 27 and Figures 53 
and 54. For HDL-C and glucose the correlation coefficients were positive and significant, 
r=0.27 and 0.14 respectively, (See Table 27 and Figures 55 and 56). 
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Figure 50: Correlation at baseline between patients and partners for waist circumference 
 
Figure 51: Correlation at baseline between patients and partners for body mass index (BMI) 
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Figure 52: Correlation at baseline between patients and partners for systolic blood pressure (SBP) 
 
Figure 53: Correlation at baseline between patients and partners for total cholesterol 
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Figure 54: Correlation at baseline between patients and partners for LDL cholesterol (LDL-C) 
 
Figure 55: Correlation at baseline between patients and partners for HDL cholesterol (HDL-C) 
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Pearson correlation coefficient r=0.27, p<0.0001  (n=510) 
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Figure 56: Correlation at baseline between patients and partners for blood glucose 
 
2.3.3. Psychosocial factors 
Illness Perception (IPQ-R) and Health Related Quality of Life (HRQoL) 
The Spearman's rank correlation coefficient was used to look at concordance for illness 
perception and HRQoL as these variables have limited ranges where the regular 
correlation coefficient may over-estimate the extent of the correlation. 
Table 28: Concordance between patients and partners for HRQoL and IPQ-R at baseline 
 N Spearman rank 
correlation 
coefficient 
p-value 
IPQ-R 589 0.22 <0.0001 
EQ-VAS 543 0.28 <0.0001 
GMS 565 0.27 <0.0001 
HADS-A 555 0.16 0.0001 
HADS-D 551 0.29 <0.0001 
 
All of the correlations for these measures were positive and significant (See Table 28 and 
Figures 57-61). In the 589 couples completing the IPQ-R it was 0.22, in the 543 completing 
the EQ-VAS it was 0.28, in the 565 completing the GMS it was 0.27. In the 555 completing 
the HADS-A and 551 the HADS-D the correlations were 0.16 and 0.29 respectively. 
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Figure 57: Correlation at baseline between patients and partners for illness perception (IPQ-R) 
 
Figure 58: Correlation at baseline between patients and partners for Health State (EQ-VAS) 
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Figure 59: Correlation at baseline between patients and partners for mood (GMS) 
 
Figure 60: Correlation at baseline between patients and partners for anxiety (HADS-A) 
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Figure 61: Correlation at baseline between patients and partners for anxiety (HADS-D) 
 
2.4. Concordance for change in lifestyle habits at 16 weeks and one year 
2.4.1. Lifestyle 
2.4.1.1. Smoking 
150 (59%) out of the original 254 couples, where either the patient and/or the partner were 
smokers at baseline, returned at 16 weeks and 141 (55%) returned at one year. However, 
113 of the patients returned alone at 16 weeks and 148 returned alone at one year. No 
partners returned alone. 
Of the 440 couples who came to the assessment at 16 weeks, only a quarter of the 
patients and about a sixth of the partners had been smokers at baseline (See Table 29). Of 
the 92 couples who did not return for their 16 week assessment, 44% of the patients and 
30% of the partners were smokers at baseline. Smokers were more likely to drop out of the 
programme. The 113 patients who came to the assessment at 16 weeks alone have not 
been included in this comparison. 
In couples where both were smokers in the month prior to the cardiac event of the patient, 
as assessed at the baseline visit, 49% returned at 16 weeks and the smoking cessation 
rate was 56% in patients and 24% in partners. 48% of these couples seen at baseline 
returned at one year and the smoking cessation rate was 58% and 39% in partners. In 
couples where only one member was a smoker in the month prior to the cardiac event of 
the patient, as assessed at the baseline visit, 63% returned at 16 weeks and the smoking 
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cessation rate was 76% in patients and 20% in partners. 58% of these couples seen at 
baseline returned at 
Table 29. Baseline smoking status of the 440 couples that returned for the 16 week assessment 
compared with the 92 couples who did not. 
 
one year and the smoking cessation rate was 74% in patients and 28% in partners (See 
Table 30).  More patients returned at 16 weeks and one year if they had been the only 
smoker at the time of their cardiac event compared to if their partner had also been 
smoking at this time. The smoking cessation rate at 16 weeks and one year was higher in 
patients who had been smoking alone at baseline compared to in those whose partner was 
smoking at baseline. On the contrary, the smoking cessation rate appears to be higher in 
partners where the patient was also smoking at baseline although the numbers are smaller. 
Those who had been smoking at baseline and did not return to the follow-up assessments 
were, in all likelihood, still smoking and this needs to be taken into consideration when 
interpreting these results. 
In the EUROACTION couples, where both partners were smoking (69 couples in the 
EUROACTION study) at baseline, the quit rate in both patients and partners differed 
according to whether or not the other quit too. The quit rate in patients was higher at both 
16 weeks (59%) and one year (62%) if the partner quit too compared to if they did not (0% 
and 17% respectively. There was a similar picture the other way around, with all of the 
partners quitting if the patient quit compared 61% if they did not at 16 weeks and 62% 
quitting at one year if the patient also quit compared to 17% if they did not. This should be 
seen in the context of a poorer response rate of couples where both partners smoked at 
  Attended 16 week assessment 
 
440 couples 
Did not attend 16 week 
Assessment 
92 couples 
Current  No. % No. % 
 Patients 109 25 41 44 
 partners 75 17 28 30 
Ex      
 Patients 183 42 29 31 
 partners 98 22 15 16 
Never      
 Patients 148 34 22 25 
 partners 267 61 49 54 
Total  440  92  
! !
! 158!
baseline at both time points (49% at 16 weeks and 48% at one year) compared to where 
only one partner smoked (63% at 16 weeks and 58% at one year). 
Table 30. Smoking quit* rates at 16 weeks and one year in patients and partners according to 
smoking habit of each spouse at baseline (BL) 
 Response rate of 
smokers at 16 
weeks 
Quit rate 
16 weeks 
 Response rate of 
smokers at 1 year 
Quit rate 
1 year 
 
Both Smoking at 
BL 
n 
 
 
% 
 
 
n 
 
 
% 
 Smoking at 
BL 
n 
 
 
% 
 
 
N 
 
 
% 
 
Only one 
smoker 
116 63 65/116 56  108 58 63/108 60  
Both smoked 68 49 27/68 43  66 48 32/66 48  
Patients           
Patient only 
smoked 
75 62 57/75 76  72 60 53/72 74  
Both smoked 34 49 19/34 56 † 33 48 19/33 58 ‡ 
Partners           
Partner only 
smoked 
41 64 8/41 20  36 56 10/36 28  
Both smoked 34 53 8/34 24  33 52 13/33 39  
*reported smoking cessation was validated with a breath CO ≤ 6ppm       †p = 0.06            ‡p = 0.03 
2.4.1.2. Diet 
At 16 weeks, out of the 645 couples who attended the baseline assessment, data are 
available for 554 patients and 431 partners for the food habit questionnaire, and at one 
year, for 568 patients and 426 partners. At 16 weeks, fruit and vegetable consumption had 
increased from the baseline by 187g to a median of 581g (Q1 380, Q3 750) in patients and 
by 130g to a median of 530g (Q1 365, Q3 750) in partners (See Table 31 and Figure 37). 
As shown in the figure, the outliers are at the upper end of the distribution. At one year, this 
increase in consumption was sustained and enhanced with an increase of 206g to 600g 
(Q1 414, Q3 750) in patients and of 154g to 554g (Q1 364, Q3 750) in partners. These 
increases were reflected in proportions of patients and partners achieving the European 
goal for fruit and vegetable consumption (See Table 23) which increased from 50% at 
baseline for patients to 73% at 16 weeks and 78% at one year. In partners 52% were 
achieving the goal and baseline and this increased to 71% at 16 weeks and one year. 
At 16 weeks, there were 78 patients and 63 partners included in the random sub-sample 
for the dietary analysis of 24 hour dietary recalls. Mean consumption of saturated fat had 
decreased from the baseline by 1.5% to 8.9% of total energy (SD 2.8) in patients and by 
0.9%% to 9.4% of total energy (SD 2.8) in partners (See Table 31 and Figure 38). At one 
year there were 220 patients and 173 partners included for the dietary analysis of 24 hour 
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dietary recalls. Reduction of mean consumption of saturated fat was sustained with a 
reduction of 0.9% to 9.5% of total energy (SD 3.4) in patients and of 1% to 9.3% of total 
energy (SD 3.1) in partners. These increases were reflected in proportions of patients and 
partners achieving the European goal for saturated fat consumption (See Table 23) which 
increased from 44% at baseline for patients to 64% at 16 weeks and 57% at one year. In 
partners 44% were achieving the goal and baseline and this increased to 54% at 16 weeks 
and 60% at one year. 
Table 31: Dietary intake of saturated fat and fruit and vegetables in patients and partners at 
baseline, 16 weeks and one year 
Component of 
diet 
Patient (n=645) Partners (n=645) 
Saturated fat (mean % of total energy) 
 % SD n % SD N 
Baseline 10.4 3.4 89 10.3 3.9 89 
16-weeks 8.9 2.8 78 9.4 2.8 63 
1-year 9.5 3.4 220 9.3 3.1 173 
Fruit and vegetables (median g/day) 
 g IQR n g IQR N 
Baseline 394 230,600 645 400 250,600 640 
16-weeks 581 380,750 554 530 365,750 431 
1-year 600 414,750 568 554 364,750 426 
 
Concordance for change between baseline and 16 weeks and baseline and one year for 
fruit, vegetable and saturated fat consumption can be seen in Table 32. In 431 couples, the 
correlation coefficient for change in fruit and vegetable consumption between baseline and 
16 weeks was positive (r = 0.65) and significant. This concordance for change was still 
apparent at one year (r = 0.61) in 423 couples. In 61 couples from the random sub-sample, 
the correlation coefficient for change in saturated fat consumption between baseline and 16 
weeks was positive (r = 0.42) and significant, and also still apparent at one year (r = 0.43) 
in 68 couples. 
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Table 32: Concordance between patients and partners for change in dietary consumption of 
saturated fat, fruit and vegetables from baseline (BL) assessment to 16 weeks, and to one year 
 
 
Mean changes in these dietary factors in partners were also examined in relation to 
quintiles of change in patients (See Figures 62-65). Change was calculated as 16 weeks 
follow-up measurement minus the baseline measurement, and also as one year follow-up 
measurement minus the baseline measurement. The distribution of change in patients for 
fruit and vegetable consumption and saturated fat consumption in patients has been 
grouped into fifths, and then the mean change for the partners in each group has been 
calculated. 
Figure 62:  Mean changes (with 95% CI) in partners for fruit and vegetable consumption grouped 
according to the extent of change in the corresponding patients (BL to 16 weeks). 
 
At 16 weeks, where the patients in quintile 5 increased their fruit and vegetable 
consumption the most, the partners’ fruit and vegetable consumption was increased by an 
average of 345g (95% CI 273, 417) representing the largest  improvement made by 
partners. This was also true at one year with the partners making the largest improvement 
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QUINTILES OF PATIENTS 
Component of 
diet 
BL - 16 weeks BL – 1 year 
n Correlation p-value n Correlation p-value 
Saturated fat (% 
of total energy) 
61 0.42 0.0009 68 0.43 0.0002 
Fruit and 
vegetables(g/day) 
431 0.65 <0.0001 423 0.61 <0.0001 
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(average of 296g increase) being associated with patients in quintile 5. At the other end of 
the spectrum, at 16 weeks, patients in quintile 1, who reported the least success with either 
no improvement or reductions in their fruit and vegetable consumption, had partners who 
reduced their consumption by an average of 43g (95% CI - 84, - 2) representing the 
smallest change made by partners. This was also true at one year with the partners making 
the smallest change (average of 196g reduction in consumption), being associated with 
patients in quintile 1. 
Figure 63:  Mean changes (with 95% CI) in partners for fruit and vegetable consumption grouped 
according to the extent of change in the corresponding patients (BL to 1 year). 
 
At 16 weeks, where the patients in quintile 1 reduced their saturated fat consumption the 
most, the partners’ saturated fat consumption was reduced by an average of 2.7% (95% CI 
- 4.6, - 0.8) total energy representing the largest improvement made by partners. This was 
also true at one year with the partners making the largest improvement (average of 2.6%) 
being associated with patients in quintile 1. At the other end of the spectrum, at 16 weeks, 
patients in quintile 5, who reported the least success with either no improvement or 
increases in their saturated fat consumption, had partners who increased their saturated fat 
consumption by an average of 1.5%(- 1.1, 4.2) representing the smallest change made by 
partners. This was also true at one year with the partners making the smallest change 
(average of 2.3% increase in consumption), being associated with patients in quintile 1. 
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Figure 64:  Mean changes (with 95% CI) in partners for saturated fat consumption grouped 
according to the extent of change in the corresponding patients (BL to 16 weeks). 
 
Figure 65:  Mean changes (with 95% CI) in partners for saturated fat consumption grouped 
according to the extent of change in the corresponding patients (BL to 1 year). 
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2.4.1.3. Physical activity 
At 16 weeks, out of the 645 couples who attended the baseline assessment, data are 
available for 547 patients and 428 partners from the 7-D PAR, and at one year, for 502 
patients and 373 partners. Patients reported an increase of 1.9 kcals/day of moderate 
intensity physical activity from the baseline to a median of 3.5 kcals/day (Q1 1.8, Q3 6.3) 
which was sustained at 1 year. Partners reported a smaller increase of 0.9 kcals/day to a 
median of 2.9 kcals/day (Q1 1.1, Q3 5.5) which was also sustained at 1 year (See Table 33 
and Figure 39). These increases were reflected in proportions of patients and partners 
achieving the European goal for physical activity (See Table 23) which increased from 25% 
at baseline for patients to 68% at 16 weeks and 59% at one year. In partners 30% were 
achieving the goal and baseline and this increased to 53% at 16 weeks and 48% one year. 
Table 33: Physical activity habits in patients and partners at baseline, 16 weeks and one 
year 
Measure 
of 
Physical 
activity 
Patient (n=645) Partners (n=645) 
 
Self reported moderate intensity physical activity from 7DAR (kcal/day) 
 Kcals/day 
(median) 
IQR n Kcals/day 
(median) 
IQR n 
Baseline 1.6 0,5.0 636 2.0 0.3,5.2 608 
16-weeks 3.5 1.8,6.3 547 2.9 1.1,5.5 428 
1-year 3.5 1.9,6.2 502 2.8 1.3,5.7 373 
Steps per day from pedometer 
Baseline 5948 3837,9013 560 7074 4599,9842 476 
16-weeks 7802 5086,10501) 487 8008 5185,11059 358 
1-year 8337 5614,11214 470 8424 5776,11139 330 
 
In 487 patients wearing a pedometer at 16 weeks, the recorded number of steps/day had 
increased from baseline by 1854 to a median of 7802 steps/day (Q1 5086, Q3 10501). In 
358 partners this increase was by 934 to a median of 8008 steps/day (Q1 5185, Q3 11059) 
(See Table 33 and Figure 39). At 1 year the increases in steps per day were even greater. 
470 patients recorded an increase from the baseline of 2389 to a median 8337 steps/day 
(Q1 5614, Q3 11214). In 330 partners an increase of 1350 from the baseline was recorded 
to a median of 8424 steps/day (Q1 5776, Q3 11139). 
Concordance for change between baseline and 16 weeks and baseline and one year for 
physical activity measures can be seen in Table 34. In 409 couples, the correlation 
coefficient for change in reported moderate intensity physical activity (kcals/day) between 
baseline and 16 weeks was positive (r = 0.20) and significant. This concordance for 
change was stronger at one year (r = 0.40) in 342 couples. In 315 couples wearing a 
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pedometer, the correlation coefficient for change in recorded number of steps per day was 
positive (r = 0.34) and significant at 16 weeks, and at one year it was r = 0.29 in 285 
couples. 
Table 34: Concordance between patients and partners for change in physical activity habits from 
baseline to 16-weeks and baseline to 1 year 
Measure of physical 
activity 
BL-16 weeks BL–1 year 
 n Correlation p n Correlation p 
Moderate intensity 
physical activity 
(kcal/day) 
409 0.20 0.0001 342 0.40 <0.0001 
Steps per day 315 0.34 <0.0001 285 0.29 <0.0001 
 
In the same way as for dietary factors, mean changes in physical activity factors in partners 
were examined in relation to quintiles of change in patients (See Figures 66-69).  At 16 
weeks, where the patients in quintile 5 increased their moderate intensity physical activity 
the most, as reported in kcals expended per day, the partners’ kcals/day expenditure 
increased by an average of 1.1 (95% CI 0.0, 2.1) representing the largest improvement 
made by partners. This was also true at one year with the partners making the largest 
improvement (average of 2.5 kcals/day) being associated with patients in quintile 5. At the 
other end of the spectrum, at 16 weeks, patients in quintile 1, who reported the least 
improvement or a reduction in activity levels, had partners who reduced their activity levels 
by an average of 0.9 kcal/day 95% CI - 2.7, 0.8) representing the smallest change made by 
partners. This was also true at one year with the partners making the smallest change 
(average of 2.9 kcal/day reduction in activity), being associated with patients in quintile 1. 
At 16 weeks, where the patients in quintile 5 increased their recorded steps per day the 
most, the partners’ steps per day were increased by an average of 6000 representing the 
largest improvements made by partners. This was also true at one year with the partners 
making the largest improvements (average of 4000 steps/day) being associated with 
patients in quintile 5. At the other end of the spectrum, at 16 weeks, patients in quintile 1, 
who reported the least success with either no improvement or reductions their steps per 
day, had partners who reduced their recorded steps per day by an average of 2000. This 
was also true at one year with the partners making the smallest change (average of 2000 
steps/day reduction) being associated with patients in quintile 1. 
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Figure 66:  Mean changes (with 95% CI) in partners for moderate intensity physical activity (7DAR) 
grouped according to the extent of change in the corresponding patients (BL to 16 weeks) 
 
Figure 67:  Mean changes (with 95% CI) in partners for moderate intensity physical activity (7DAR) 
grouped according to the extent of change in the corresponding patients (BL to 1 year). 
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Figure 68:  Mean changes (with 95% CI) in partners steps taken per day (pedometer) grouped 
according to the extent of change in the corresponding patients (BL to 16 weeks). 
 
Figure 69:  Mean changes (with 95% CI) in partners steps taken per day (pedometer) grouped 
according to the extent of change in the corresponding patients (BL to 1 year). 
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2.5. Concordance for change in cardiovascular risk factors at 16 weeks and one 
year  
Among 645 patients and partners attending the baseline assessment, 552 patients and 427 
partners at 16 weeks, and 567 patients and 408 partners at one year had a BMI recorded 
(See Table 35). In patients, mean BMI had reduced -0.4 from the baseline to 27.9 kg/m2 
(SD 3.8), and in partners -0.6 to 26.9 kg/m2 (SD 4.6). At 1 year it had reduced from the 
baseline in patients - 0.2 to 28.1 kg/m2 (SD 4.3), and in partners it had reduced – 0.4 to 
27.1 kg/m2 (SD 4.8). These modest improvements were reflected in proportions of patients 
and partners achieving the European goal for BMI (See Table 23) which increased from 
21% at baseline for patients to 24% at 16 weeks and 25% at one year. In partners 34% 
were achieving the goal and baseline and this increased to 37% at 16 weeks and one year. 
Among 517 male patients and their female partners attending the baseline assessment, 
444 patients and 350 partners at 16 weeks, and 451 patients and 323 partners at one year 
had a waist circumference recorded (See Table 35). In the male patients, mean waist 
circumference had reduced – 1.4 from the baseline to 96.5 cm (SD 9.7), and in their 
partners – 0.6 to 85.8 cm (SD 11.5). At 1 year it had reduced from the baseline in patients - 
1 to 96.9 cm (SD 10.2), and in their partners there was no change from the baseline. 
Among 128 female patients and their 126 male partners attending the baseline 
assessment, 109 patients and 76 partners at 16 weeks, and 116 patients and 85 partners 
at one year had a waist circumference recorded (See Table 35). In the female patients, 
mean waist circumference had reduced – 0.6  from the baseline to 90.6 cm (SD 12.2), and 
in their partners – 1.8 to 95.2 cm (SD 8.2). At 1 year it had increased in patients + 0.5  to 
91.1 cm (SD 12.9), and in their partners it had reduced – 1.8 to 95.2 cm (SD 9). 
These modest improvements were reflected in proportions of patients and partners 
achieving the European goal for waist circumference (See Table 23) which increased from 
31% at baseline for patients to 38% at 16 weeks and 36% at one year. In partners 33% 
were achieving the goal at baseline and this did not change during the programme (33%) 
or at one year (31%). 
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Table 35: Mean measurements of BMI, waist circumference (WC), systolic blood pressure 
(SBP), total cholesterol (TC), LDL cholesterol (LDL-C) and blood glucose in patients and 
partners at baseline, 16 weeks and one year 
BMI Patient (n=645) Partners (n=645) 
kg/m2 m SD N m SD n 
Baseline 28.3 4.2 644 27.5 5.0 636 
16-weeks 27.9 3.8 552 26.9 4.6 427 
1-year 28.1 4.3 567 27.1 4.8 408 
WC Patient (n=645) Partners (n=645) 
cm m SD n m SD n 
 M F M F M F M F M F M F 
Baseline 97.9 91.2 10.3 12.9 515 128 97.0 86.4 9.4 12.6 126 508 
16-weeks 96.5 90.6 9.7 12.2 444 109 95.2 85.8 8.2 11.5 76 350 
1-year 96.9 91.1 10.2 12.9 451 116 95.2 86.4 9.0 11.6 85 323 
SBP Patient (n=645) Partners (n=645) 
mm Hg m SD n m SD N 
Baseline 127.0 20.4 645 135.8 22.3 645 
16-weeks 126.0 17.7 553 128.5 18.9 440 
1-year 128.7 18.1 563 130.2 18.9 414 
TC Patient (n=645) Partners (n=645) 
mmol/l m SD n m SD n 
Baseline 4.39 1.08 607 5.68 1.06 515 
16-weeks 4.37 1.02 532 5.57 0.99 405 
1-year 4.36 0.95 547 5.51 1.06 394 
LDL-C Patient (n=645) Partners (n=645) 
mmol/l m SD n m SD n 
Baseline 2.62 0.94 600 3.62 0.94 508 
16-weeks 2.48 0.84 524 3.48 0.89 402 
1-year 2.52 0.83 536 3.47 0.98 392 
Blood glucose Patient (n=645) Partners (n=645) 
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Among 645 patients and partners attending the baseline assessment, 553 patients and 440 
partners at 16 weeks and 563 patients and 414 partners at one year had a blood pressure 
reading (See Table 35). In patients, mean systolic blood pressure (SBP) had reduced by         
-1 mmHg from the baseline to 126 mmHg (SD 17.7), and in partners by -7.3 mmHg to 
128.5 mmHg (SD 18.9). At 1 year it had increased from the baseline in patients by +1.7 
mmHg to 128.7 mmHg (SD 18.1), and in partners it had reduced by -5.6 mmHg to 130.2 
mmHg (SD 18.9). The proportion of patients achieving the European goal for blood 
pressure at 16 weeks (Table 23) increased from 63% at baseline to 67% but this dropped 
back to 63% at one year. In partners 51% were achieving the blood pressure goal at 
baseline and this increased to 63% at 16 weeks and 62% at one year. 
Among 645 patients and partners attending the baseline assessment, 532 patients and 405 
partners at 16 weeks and 547 patients and 394 partners at one year had a total cholesterol 
reading (See Table 35). In patients, mean total cholesterol had reduced – 0.02  from the 
baseline to 4.37 mmol/l (SD 1.02), and in partners  - 0.11 to 5.57 mmol/l (SD 0.99). At 1 
year it had reduced  from the baseline in patients – 0.03 to 4.36 mmol/l (SD 0.95), and in 
partners it had reduced – 0.17 to 5.51 mmol/l (SD 1.06). The proportion of patients 
achieving the European goal for total cholesterol at 16 weeks and one year (Table 23) did 
not change from baseline. In partners there was a small increase of 3% in proportions 
achieving the European goal for total cholesterol between baseline (13.2%) and one year 
(16.2%). Changes in LDL-C were more marked with patients reducing their LDL-C by - 
0.14 to 2.48 mmol/l (SD 0.84) at 16 weeks. Between baseline and one year the reduction 
was – 0.10 to 2.52 mmol/l (SD 0.83). In partners LDL-C reduced by – 0.14 to 3.48 mmol/l 
(0.89), and at one year it had reduced from the baseline – 0.15 to 3.47 mmol/l (SD 0.98). 
Proportions achieving the European goal at one year increased in patients by 4% to 53.4% 
and in partners by 5% to 16.6%. There were only minor changes in blood glucose. 
2.5.1. Concordance for cardiovascular risk factors at 16 weeks and 1 year  
Pearson correlation coefficients were calculated at 16 weeks and 1 year in all attending 
couples with anthropometric and blood pressure measurements, (See Table 36). In 426 
couples at 16 weeks and in 408 couples at one year, the correlations were positive and 
significant for both waist circumference: r=0.10 and 0.16 respectively and BMI: r=0.22 and 
mmol/l m SD n m SD n 
Baseline 5.9 1.9 605 5.4 1.3 513 
16-weeks 5.8 1.4 530 5.4 1.2 400 
1-year 5.9 1.8 547 5.3 1.1 392 
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0.33 respectively.  The same was true for blood pressure measured in 440 couples at 16 
weeks (SBP r=0.24; DBP r=0.18) and at one year in 413 couples (SBP r=0.16; DBP 
r=0.16). 
Table 36. Concordance between patients and partners for CVD risk factors at baseline, 16 weeks 
and 1 year. 
Waist 
Circumference 
n r p 
BL 634 0.12 0.004 
16 weeks 426 0.10 0.03 
1 year 408 0.16 0.002 
    
BMI    
BL 636 0.22 <0.0001 
16 weeks 427 0.22 <0.0001 
1 year 408 0.33 <0.0001 
    
Total 
Cholesterol 
   
BL 514 0.07 0.09 
16 weeks 403 0.11 0.03 
1 year 390 0.10 0.04 
    
LDL-C    
BL 502 0.13 0.004 
16 weeks 393 0.24 <0.0001 
1 year 380 0.28 <0.0001 
    
HDL    
BL 510 0.27 <0.0001 
16 weeks 402 0.31 <0.0001 
1 year 388 0.20 <0.0001 
    
GLUCOSE    
BL 510 0.20 <0.0001 
16 weeks 397 0.42 <0.0001 
1 year 389 0.28 <0.0001 
    
SBP    
BL 645 0.20 <0.0001 
16 weeks 440 0.24 <0.0001 
1 year 413 0.16 0.001 
    
DBP    
BL 645 0.18 <0.0001 
16 weeks 440 0.18 <0.0001 
1 year 413 0.16 0.001 
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Concordance for lipids and glucose were as follows: for total cholesterol measured in 403 
couples at 16 weeks and in 390 couples at one year, and LDL-C measured in 393 couples 
at 16 weeks and 380 couples at one year, the correlations were positive and significant 
(total cholesterol r=0.11 and r=0.10 respectively; LDL-C r=0.24 and r=0.28 respectively). 
For HDL-C, measured in 402 couples  at 16 weeks and in 388 couples at one year, there 
were significant and positive correlations (r=0.31 and r=0.20). For blood glucose measured 
in 397 couples at 16 weeks and 389 couples at one year, the correlations were positive 
(r=0.42 and r=0.28 respectively) and statistically significant. 
2.5.2. Concordance for change in cardiovascular risk factors 
Concordance for change between baseline and 16 weeks and baseline and 1 year in 
cardiovascular risk factors can be seen in Table 37. In 425 couples at 16 weeks, patients 
had lost an average of 1.56cm (SD 4.1) from their waist circumference and partners an 
average of 0.78cm (SD 3.7), and at one year in 407 couples, patients had reduced their 
waist circumference by 0.78cm and partners by 0.53cm. The correlations for these 
changes in the couples were positive both at 16 weeks: r=0.19; and 1 year: r= 0.22, and 
statistically significant. In 426 couples at 16 weeks the average BMI reduction was -0.33 
kg/m2 (SD 1.2) in patients and 0.36 kg/m2 (SD 1.1) in partners. At one year in 408 couples, 
there was an average BMI reduction of -0.06 kg/m2 (SD 1.5) in patients and -0.22  kg/m2 
(SD 1.4) in partners. The correlations for change were positive (16 weeks: r=0.26; 1 year : 
r=0.21) and statistically significant. 
Table 37: Concordance for change between  patients (pat) and partners (pr)  in cardiovascular risk 
factors from baseline (BL) to 16 weeks and baseline (BL) to one year 
Cardio-
vascular 
risk factor 
BL-16 weeks BL-1 Year 
 n=425 cm SD r p n=407 cm SD r p 
Waist 
Circum-
ference 
pat -1.56 4.1 0.19 0.0001 pat -0.78 5.2 0.22 <0.0001 
pr -0.78 3.7 pr -0.53 4.8 
           
BMI n=426 kg/m2    n=408 kg/m2    
pat -0.33 1.2 0.26 < 
0.0001 
pat -0.06 1.5 0.21 <0.0001 
pr -0.36 1.1   pr -0.22 1.4 
           
Total 
cholesterol 
n=388 mmol/
L 
   n=364 mmol/
L 
   
pat -0.09 1.10 0.26 < 
0.0001 
pat -0.11 1.13 0.29 <0.0001 
par -0.20 0.91 pr -0.21 0.96 
           
LDL-C n=377     n=348     
pat -0.18 0.93 0.13 0.01 pat -0.19 0.94 0.27 <0.0001 
pr -0.25 0.82   pr -0.22 0.91 
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HDL-C n=388     n=361     
pat 0.14 0.38 0.42 < 
0.0001 
pat 0.17 0.33 0.34 <0.0001 
pr 0.08 0.44 pr 0.12 0.33 
           
Glucose n=379     n=361     
pat -0.09 1.34 0.19 < 
0.0001 
pat 0.05 1.46 0.09 0.08 
pr 0.02 0.77 pr 0.03 0.85 
           
SBP n=440 mmH
g 
   n=413 mmHg    
pat -2.0 16.6 0.21 < 
0.0001 
pat 1.2 19.2 0.13 0.008 
pr -7.7 16.1 pr -6.0 16.0 
           
DBP n=440     n=413     
pat -1.4 9.2 0.19 0.0001 pat -0.6 10.1 0.15 0.002 
pr -4.0 8.8 pr -3.0 8.9 
           
 
For change in blood pressure, measured in 440 couples at 16 weeks, SBP was reduced by 
an average of 2mmHg (SD 16.6) in patients and 7.7mmHg (SD 16.1) in partners, and at 
one year measured in 413 couples, SBP was reduced by SBP was reduced by -1.2mmHg 
(SD 19.2) in patients and -6mmHg (SD 16.0) in partners. The correlations for change were 
positive (16 weeks: r=0.21; 1 year: r=0.13) and statistically significant. There were 
corresponding reductions and similar correlations in DBP both at 16 weeks and at one 
year. 
At 16 weeks, in 388 couples, patients had reduced their total cholesterol by an average of 
0.09 mmol/l (SD 1.10) and partners by 0.20 (SD 0.91). At one year, in 364 couples, the 
reduction in the patients’ total cholesterol was 0.11 mmol/l (SD 1.13) and in partners it was 
an average of 0.21 (SD 0.96). The correlations for these changes were positive both at 16 
weeks (r=0.26) and 1 year (r=0.29) and statistically significant. For LDL-C measured in 377 
couples at 16 weeks patients had a reduction of 0.18 mmol/l (SD 0.93) and partners of 0.25 
mmol/l (SD 0.82), and at one year in 348 couples the LDL-C reduction 0.19mmol/l (SD 
0.94) in patients and 0.22 mmol/l (SD 0.91) in partners. The correlations for these changes 
were positive at both 16 weeks and 1 year (r=0.13 and r=0.27 respectively), and 
statistically  significant. There were increases in HDL-C in patients at 16 weeks (0.14) and 
1 year (0.17), and in partners at 16 weeks (0.08) and at 1 year (0.12). The correlations for 
change were 0.42 at 16 weeks and 0.34 at one year and statistically significant. 
At 16 weeks, in 379 couples, reduction of glucose in patients was on average 0.09 mmol/l 
(SD 1.34), and in partners 0.02 mmol/l (SD 0.77), and at one year in 361 couples, there 
was an average reduction in patients was 0.05 mmol/l (SD 1.46) and in partners an 
increase of 0.03 mmol/l (SD 0.85). The correlations for these changes were positive and 
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significant at 16 weeks (r=0.19) but weak at one year (r=0.09) and not statistically 
significant. 
Mean changes in risk factor measurements in partners examined in relation to quintiles of 
change in patients are shown in Figures 70-83. At 16 weeks, where the patients in quintile 
1 reduced their waist circumference the most, the partners reduced their waist 
circumference by an average of 1.9 cm (95% CI -2.7, -1.1) representing the largest 
improvements made by partners. This was also true at one year with the partners making 
the largest improvements (average of – 2.3 95% CI -3.4 to -1.3) being associated with 
patients in quintile 1. At the other end of the spectrum, at 16 weeks, patients in quintile 5, 
who reported the least success with either no improvement or increases in their waist 
circumference, had partners who increased their waist circumference by an average of 0.3 
cm (95% CI -0.6, 1.1). This was also true at one year with the partners making the smallest 
change (average of + 1.2 cm (95% CI 0.0 to + 2.3 increase) being associated with patients 
in quintile 5. 
Figure 70:  Mean changes (with 95% CI) in partners for waist circumference grouped according to 
the extent of change in the corresponding patients (BL to 16 weeks). 
 
At 16 weeks, where the patients in quintile 1 reduced their BMI the most, the partners 
reduced their BMI by an average of 0.7 kg/m2 (95% CI -1.0, -0.5) representing the largest 
improvements made by partners. This was also true at one year with the partners making 
the largest improvements (average of – 0.5 95% CI -0.9 to -0.2) being associated with 
patients in quintile 1. At the other end of the spectrum, at 16 weeks, patients in quintile 5, 
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who reported the least success with either no improvement or increases in their BMI, had 
partners who increased their BMI by an average of 0.1 kg/m2 (95% CI -0.1, 0.2). This was 
also true at one year with the partners making the smallest change (average of +0.2 kg/m2 
(95% CI -0.1 to +0.5 increase) being associated with patients in quintile 5. 
Figure 71:  Mean changes (with 95% CI) in partners for waist circumference grouped according to 
the extent of change in the corresponding patients (BL to 1 year). 
 
Figure 72:  Mean changes (with 95% CI) in partners for body mass index (BMI) grouped according 
to the extent of change in the corresponding patients (BL to 16 weeks). 
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Figure 73:  Mean changes (with 95% CI) in partners for body mass index (BMI) grouped according 
to the extent of change in the corresponding patients (BL to 1 year). 
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making the smallest change (average of 0.3 mmol/l (95% CI 0.1, 0.5) being associated with 
patients in quintile 5. 
Figure 74:  Mean changes (with 95% CI) in partners for systolic blood  pressure (SBP) grouped 
according to the extent of change in the corresponding patients (BL to 16 weeks). 
 
Figure 75:  Mean changes (with 95% CI) in partners for systolic blood  pressure (SBP) grouped 
according to the extent of change in the corresponding patients (BL to 1 year). 
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making the largest improvements (average of -0.7 mmol/l 95% CI -0.9, -0.5) being 
associated with patients in quintile 1. At the other end of the spectrum, at 16 weeks, 
patients in quintile 5, who reported the least success with either no improvement or 
increases in their LDL-C, had partners who, on average saw a change in their LDL-C of 0.1 
mmol/l (95% CI -0.1, 0.3). This was also true at one year with the partners making the 
smallest change (average of 0.1 mmol/l (95% CI -0.1, 0.3) being associated with patients in 
quintile 5. 
 
Figure 76:  Mean changes (with 95% CI) in partners for total cholesterol (TC) grouped according to 
the extent of change in the corresponding patients (BL to 16 weeks). 
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Figure 77:  Mean changes (with 95% CI) in partners for total cholesterol (TC) grouped according to 
the extent of change in the corresponding patients (BL to 1 year). 
 
Figure 78:  Mean changes (with 95% CI) in partners for LDL cholesterol (LDL-C) grouped according 
to the extent of change in the corresponding patients (BL to 16 weeks). 
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Figure 79:  Mean changes (with 95% CI) in partners for LDL cholesterol (LDL-C) grouped according 
to the extent of change in the corresponding patients (BL to 1 year). 
 
At 16 weeks, where the patients in quintile 5 increased their HDL-C the most, the partners 
increased their HDL-C by an average of 0.27 mmol/l (95% CI 0.10, 0.43) representing the 
largest improvements made by partners. This was also true at one year with the partners 
making the largest improvements (average of 0.23 mmol/l 95% CI 0.13, 0.34) being 
associated with patients in quintile 5. At the other end of the spectrum, at 16 weeks, 
patients in quintile 1, who reported the least success with either no improvement or 
reductions in their HDL-C, had partners who, on average saw a change in their HDL-C of -
0.01 mmol/l (95% CI -0.05, 0.03). This was also true at one year with the partners making 
the smallest change (average of -0.02 mmol/l (95% CI -0.04, 0.07) being associated with 
patients in quintile 1. 
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Figure 80:  Mean changes (with 95% CI) in partners for HDL cholesterol (HDL-C) grouped according 
to the extent of change in the corresponding patients (BL to 16 weeks). 
 
 
Figure 81:  Mean changes (with 95% CI) in partners for HDL cholesterol (HDL-C) grouped according 
to the extent of change in the corresponding patients (BL to 1 year). 
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Figure 82:  Mean changes (with 95% CI) in partners for fasting blood glucose (FBG) grouped 
according to the extent of change in the corresponding patients (BL to 16 weeks). 
 
Figure 83:  Mean changes (with 95% CI) in partners for fasting blood glucose (FBG) grouped 
according to the extent of change in the corresponding patients (BL to 1 year). 
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who reported the least success with either no improvement or increases in their FBG, had 
partners who, saw an increase in their FBG by an average of 0.4 mmol/l (95% CI 0.2, 0.6). 
This was also true at one year with the partners making the smallest change (average of 
0.5 mmol/l (95% CI 0.3, 0.6) being associated with patients in quintile 5. 
 
2.6. Concordance for change in HRQoL and illness perception at 16 weeks and 1 
year 
At 16 weeks, out of the 645 couples who attended the baseline assessment, data are 
available for 519 patients and 414 partners for the IPQ-R, and at one year, for 541 patients 
and 401 partners (See Table 38 and Figures 42-46). 
Table 38: Measures of health related quality of life (HRQoL) and illness perception (IPQ-R)  in 
patients and partners at baseline, 16 weeks and one year 
Measures Patient (n=645) Partners (n=645) 
 median IQR n median IQR n 
IPQ-R score (score: 0-28)  
Baseline 15 14,17 629 15 13,17 590 
16-weeks 16 14,18 519 16 14,17 414 
1-year 16 14,17 541 16 14,17 401 
EQ-VAS (score: 0-100) 
Baseline 70 55,80 576 80 70,90 549 
16-weeks 76 65,85 496 80 70,90 398 
1-year 80 70,88 527 80 70,90 391 
Global mood score (score: 0-40) 
Baseline 20 15,26 600 21 17,26.5 572 
16-weeks 23 18,27 518 23 19,27 411 
1-year 23 18,27 537 23 19,27 395 
HADS-A (score: 0-21)  
Baseline 5 3,8 593 6 4,9 569 
16-weeks 5 3,8 509 6 3,8 399 
1-year 5 3,8 527 6 3,8 393 
HADS-D (score: 0-21)  
Baseline 4 2,7 598 4 2,7 559 
16-weeks 4 2,7 509 4 2,6 397 
1-year 3 1,6 536 4 1,6 388 
 
At 16 weeks, there was an increase in the score of 1 point from the baseline to a median of 
16 (Q1 14, Q3 18) for patients and the same for partners (Q1 14, Q3 17) which was 
sustained in both at 1 year.  At 16 weeks, data are available for 496 patients and 398 
partners for the EQ-VAS, and at one year, for 527 patients and 391 partners. At 16 weeks, 
there was an increase in the patients’ score of 6 points from the baseline to a median of 76 
(Q1 65, Q3 85). Between baseline and 1 year the score increased by 10 points to a median 
of 80 (Q1 70, Q3 88). There was no change in the score for partners whose median score 
of 80 remained the same throughout the study follow-up period (Q1 70, Q3 90). At 16 
weeks, data were available for 518 patients and 411 partners for the GMS, and at one 
year, for 537 patients and 395 partners. At 16 weeks, there was an increase in the patients’ 
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score of 3 points from the baseline to a median of 23 (Q1 18, Q3 27) and an increase in the 
partners’ score of 2 points to a median of 23 (Q1 19, Q3 27). In both patients and partners 
the 16 week score was sustained at 1 year. At 16 weeks, data are available for 509 
patients and 399 partners (2 HADS-D missing for partners) for the HADS, and at one year, 
for 536 patients (9 HADS-A missing) and 393 partners (5 HADS-D missing). The anxiety 
score did not change in either patients or partners during the course of the study remaining 
at a median of 5 for patients and 6 for partners. However for partners, the IQR at baseline 
(Q1 4, Q3 9) indicated a possible higher level of anxiety at this time point compared to 16 
weeks and 1 year when this range was (Q1 3, Q3 8). At 16 weeks, the median depression 
score for patients had not changed from 4, and this was the same for partners, although 
the IQR changed from (Q1 2, Q3 7) at baseline to (Q1 2, Q3 6) at 16 weeks. At 1 year, the 
median depression score for patients reduced by 1 point to 3, but stayed at 4 for partners. 
The IQR for both was (Q1 1, Q3 6). 
Table 39: Concordance for change in HRQoL and IPQ-R between patients and partners from 
baseline to 16 weeks and baseline to one year 
 BL to 16 weeks BL to 1 year 
 n Correlation* p-value n Correlation* p-value 
IPQ-R 407 0.12 0.02 388 0.14 0.005 
EQ-VAS 386 0.25 <0.0001 363 0.23 <0.0001 
Global Mood 
Score 
398 0.19 0.0002 374 0.24 <0.0001 
HADS-A 375 0.08 0.14 359 0.18 0.0005 
HADS-D 371 0.16 0.003 358 0.15 0.006 
 
Spearman rank correlation coefficients for change between baseline and 16 weeks and 
baseline and one year for psycho-social measures in couples can be seen in Table 39. All 
correlations at 16 weeks and 1 year were positive and statistically significant with the 
exception of the anxiety score at 16 weeks which showed a weak positive (r=0.08) and not 
statistically significant correlation. For IPQ-R in 407 couples at 16 weeks, the correlation 
coefficient for change in the score r=0.12, and in 388 couples at 1 year, it was r=0.14. For 
EQ-VAS in 386 couples at 16 weeks, the correlation for change was r=0.25, and in 363 
couples at 1 year it was r=0.23. For GMS in 375 couples at 16 weeks, the correlation was 
r=0.19, and in 374 couples at 1 year it was r=0.24. For HADS-A in 375 couples at 16 
weeks it was r=0.08 and in 359 couples at 1 year it was r=0.18. For HADS-D in 371 
couples at 16 weeks, the correlation was r=0.16 and in 358 couples at 1 year it was r=0.15. 
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Figure 84:  Mean changes (with 95% CI) in partners for illness perception (IPQ-R) grouped 
according to the extent of change in the corresponding patients (BL to16 weeks). 
 
Figure 85:  Mean changes (with 95% CI) in partners for illness perception (IPQ-R) grouped 
according to the extent of change in the corresponding patients (BL to1 year). 
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Mean changes in psycho-social measurements in partners examined in relation to quintiles 
of change in patients are shown in Figures 84-93. At 16 weeks, where patients’ perception 
of their HRQoL improved the most (quintile 5 for EQ-VAS and GMS and quintile 1 for 
HADS A&D), the partners had also made the most encouraging changes (average of: 
HADS-A -1.2 (95% CI -2.0, -0.3); HADS-D -1.4 (95% CI -2.3, -0.6); EQ-VAS 6 (95% CI 3, 
9); GMS 2.8 (95% CI 1.2, 4.5). This was also true at 1 year with the partners making the 
greatest improvements (average of: HADS-A -1.3; HADS-D  -1.3; EQ-VAS +7; GMS +3.5 ) 
being associated with patients in quintile 5 for EQ-VAS and GMS, and in quintile 1 for 
HADS A&D. At the other end of the spectrum, at 16 weeks, patients in the quintiles 
reporting the least success with either no improvement or a worsening of anxiety, 
depression, mood or health state, had partners who were also likely to report the same 
(average of: HADS-A 0.0 (95% CI -0.8, 0.8); HADS-D 0.5 (95% CI -0.5, 1.4); EQ-VAS -2 
(95% CI -6, 1); GMS -0.4 (95% CI -1.8, 1.0). This was also true at 1 year with the partners 
making the least change (average of: HADS-A -+0.5; HADS-D -0.3; EQ-VAS -2; GMS -1.2 
being associated with patients in the worst quintiles. 
Figure 86:  Mean changes (with 95% CI) in partners for anxiety (HADS) grouped according to the 
extent of change in the corresponding patients (BL to 16 weeks). 
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Figure 87:  Mean changes (with 95% CI) in partners for anxiety (HADS) grouped according to the 
extent of change in the corresponding patients (BL to 1 year). 
 
Figure 88:  Mean changes (with 95% CI) in partners for depression (HADS) grouped according to 
the extent of change in the corresponding patients (BL to 16 weeks). 
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For IPQ-R at 16 weeks, patients in quintile 1 reported the most threatening view of their 
illness and they were associated with partners who did the same (average of -0.4). Patients 
in quintile 5 are associated with partners who reported the most improvement in their 
illness perception (average of +0.8). At one year where patients’ perception of their illness 
perception improved the most (quintile 5), the partners had also made the most 
encouraging changes (average of: IPQ-R +0.8). At the other end of the spectrum, patients 
who reported the worst change in illness perception (quintile 1) had partners who were also 
likely to report the same (-0.1). 
Figure 89:  Mean changes (with 95% CI) in partners for depression (HADS) grouped according to 
the extent of change in the corresponding patients (BL to 1 year). 
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Figure 90:  Mean changes (with 95% CI) in partners for HRQoL (EQ-VAS) grouped according to the 
extent of change in the corresponding patients (BL to 16 weeks). 
 
Figure 91:  Mean changes (with 95% CI) in partners for HRQoL (EQ-VAS) grouped according to the 
extent of change in the corresponding patients (BL to 1 year). 
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Figure 92:  Mean changes (with 95% CI) in partners for mood (GMS) grouped according to the 
extent of change in the corresponding patients (BL to 16 weeks). 
 
Figure 93:  Mean changes (with 95% CI) in partners for mood (GMS) grouped according to the 
extent of change in the corresponding patients (BL to 1 year). 
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Summary 
The results of my literature review of concordance for lifestyle habits and concordance for 
change were summarised in tables at the start of this chapter showing consistently 
concordance for lifestyle behaviours in couples often due to assortative mating. The results 
of my observational study of couples were also presented showing a high prevalence of 
adverse lifestyle behaviours and concordance for these factors at the time of the coronary 
event of the patient. In addition, improvements in risk factor profiles were seen in both 
patients and partners during the course of the programme and in the longer term and 
concordance in the couples for change in smoking, dietary and physical activity behaviours 
was demonstrated.  
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CHAPTER 4. DISCUSSION 
In this final chapter of my thesis, the results of my observational study of concordance for 
concordance in couples where one partner has presented with incident coronary disease 
will be discussed in the light of my systematic review of the literature on concordance for 
lifestyle and concordance for change. As a starting point the principal results of the 
EUROACTION cluster randomised controlled trial will be briefly summarised and a 
comparison made with other studies examining concordance for change during a family 
centred programme. Subsequently, the discussion will focus on firstly smoking, then diet 
and then physical activity all of which impact on cardiovascular risk factors.  
1. Summary of the EUROACTION Trial 
In discussing the results on concordance for lifestyle and associated risk factors, and 
concordance for change over one year, it is important to view them in the context of the 
EUROACTION study as a whole. The EUROACTION cluster randomised controlled trial 
was launched in 2003 in response to the disappointing findings of the EUROASPIRE 
surveys conducted in Europe (EUROASPIRE, 1997, EUROASPIRE, 2001a, 
EUROASPIRE, 2001b), which showed that preventive care in coronary patients following 
an acute event was sub-optimal despite the existence of European evidence based 
guidelines since 1994 (Pyorala et al., 1994, Wood et al., 1998, De Backer et al., 2003, 
Graham et al., 2007, Perk et al., 2012) . The objective of EURACTION was to demonstrate 
that a nurse-led multidisciplinary model of care could facilitate the implementation of these 
evidence based guidelines and achieve outcomes at the end of the 16 weeks programme 
and sustain them to one year. Most importantly, it targeted not only patients who were 
diagnosed for the first time with coronary heart disease, but also their spouses, in the 
expectation that a family centred intervention would be more effective in achieving lifestyle 
changes which would impact favourably on cardiovascular risk than treating patients in 
isolation. The hospital trial conducted in 6 countries and 12 hospital centres, one pair of 
hospitals in each country was randomised within pairs to either the EUROACTION 
programme or usual care. 
 
The hospital preventive cardiology programme managed to recruit two thirds of all eligible 
patients who were consecutively identified in each intervention hospital. Just over three 
quarters reported living with a spouse and nearly 80% came to the programme with the 
patients. Once recruited, adherence to the 16 weeks programme was 81% in patients and 
63% in partners. Achievement of the principal dietary and physical activity outcomes as 
measured at one year after recruitment were significantly better in patients attending the 
programme compared to those being monitored in the usual care hospital centres. Three 
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quarters were achieving the goal for fruit and vegetable consumption in intervention 
compared to only one third in usual care, more than one half were achieving the goal for 
saturated fat consumption in intervention compared to usual care, and 16% the goal for oily 
fish compared to 8% in usual care. More than one half of patients were achieving the 
physical activity goal in the intervention arm compared to a fifth in usual care. The partners 
also made changes in the same direction, although these changes were only statistically 
significant for fruits and vegetable consumption. Whilst nearly 60% of patients stopped 
smoking in intervention compared to 47% in usual care, this difference was not statistically 
significant (p=0.06). These lifestyle changes made by patients and partners in the 
intervention hospitals impacted favourably on their cardiovascular risk profiles. A greater 
proportion of overweight and obese patients lost > 5% of their body weight in intervention 
(19%) compared to usual care (13%). Whilst this difference was not statistically significant, 
the odds ratio for the difference in distributions of waist circumferences between the two 
arms was 0.61 and statistically significant in favour of intervention. There were significant 
differences in favour of the intervention arm regarding proportions of patients achieving the 
blood pressure goal (65% in intervention v. 55% in usual care) and this was despite there 
being no difference in the prescribing of antihypertensive medications. A high proportion of 
patients achieved the lipid goals in both intervention and usual care. 
 
2. How does EUROACTION compare with other observational studies of 
concordance? 
My study of concordance included a larger number of couples with coronary disease who 
attended the EUROACTION preventive cardiology hospital programme, two thirds of whom 
adhered to the programme together, and for whom two thirds had one year outcomes 
measured. 
 
Whilst there is a large literature investigating concordance for lifestyle habits and the 
dynamics between married partners for changes in their habits throughout marriage, there 
are only two other studies apart from EUROACTION, both using observational data from 
RCTs (Nader et al., 1989, Wood et al., 1994), to evaluate concordance for change in 
lifestyle and cardiovascular risk factors during the course of a multifactorial primary 
prevention programme. In the San Diego Family Health Project, 206 Anglo and Mexican 
American families with at least one adult and one child were recruited along with their 
children identified via elementary schools to the study and randomised to join the 
intervention programme or to control with no treatment. Adults with pre-existing 
cardiovascular disease or with abnormal risk factor levels were excluded. The 12 week 
programme was multidisciplinary, structured and included education, behavioural support 
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with goal setting and review and a supervised exercise programme.  After completion of 
the initial intensive 12 week course, there were 6 maintenance sessions or 9 months. Data 
were collected at baseline and one year. Dietary assessment tools included 24 hour dietary 
recall, 3 day food diary, and a food frequency questionnaire. Moderate and vigorous 
physical activity were recorded using the 7 day physical activity recall tool used in the 
EUROACTION study. The concordance study (Patterson et al., 1989) measured 
correlations for change between baseline and one year in families participating in the 
intervention programme and compared change in families with randomly assigned families. 
Examples of significant aggregations of change in couples include 3 day fat scores (0.51) 
and kilocalories of energy expended (0.43). In the British Family Heart Study, 13 pairs of 
comparable general practices were identified in 13 towns in the UK. 12,472 men and their 
partners were recruited and either randomised to an external comparison group in one of 
the 13 general practices not receiving the intervention, or to an internal comparison group 
within the practices receiving the intervention. The remaining men (2246) and women 
(1604) were randomised to receive the nurse-led family centred lifestyle programme which 
focussed smoking, diet, exercise, and alcohol intake. The intensity of the intervention was 
determined by a coronary risk score which identified those at the highest risk. The primary 
outcome was the Dundee risk score which provides an overall measure of coronary risk 
over 5 years. The concordance analyses (Pyke et al., 1997), were based on the 1477 
couples who were recruited to the intervention programme and on the 1204 who returned 
at one year. Concordance for the initial total coronary risk score was 0.27, and for change 
in the score over one year, it was 0.20, both statistically significant. 
 
3. A discussion of the results of the EUROACTION observational study of 
concordance in the context of my systematic review. 
The results of the EUROACTION analyses of concordance and concordance for change in 
coronary patients and their partners participating in a preventive cardiology programme are 
interpreted in the context of the results from my systematic review of the scientific literature 
on concordance for smoking, diet and physical activity and patterns of change in lifestyle 
between couples during marriage. 
For the patients in EUROACTION this was their first cardiac event, and a retrospective 
assessment of habits prior to their diagnosis with coronary artery disease revealed adverse 
lifestyles which will have contributed to their increased cardiovascular risk. One third were 
smoking cigarettes, only about half were meeting dietary goals for saturated fat and fruit 
and vegetable consumption, and only one quarter were meeting the physical activity goal. 
This lifestyle profile was similar in the partners of these patients, although smoking 
prevalence was lower. 
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3.1. Concordance for smoking 
Concordance for smoking was found in the couples participating in the EUROACTION 
preventive cardiology programme. This was quantified as the observed over expected 
ratios for both partners having the same smoking status (current smokers or ex-smokers or 
non-smokers) and if they were discordant, the ratio would have been one. In fact, for both 
partners being current smokers, the ratio was 1.76, and for both being ex-smokers, the 
ratio was 1.18, and for both being never smokers, it was 1.14). In other word, these ratios 
were always higher than for those who were discordant in their smoking habits. 
These findings accord with my systematic review, which shows remarkably consistent 
results in all but one (Kolonel and Lee, 1981) of the studies included on smoking 
concordance (Sackett et al., 1975, Sutton, 1980, Kolonel and Lee, 1981, Barrett-Connor et 
al., 1982, Haynes et al., 1983, Venters et al., 1984, Speers et al., 1986, Perusse et al., 
1988, Hunt et al., 1989, Tambs Kristian, 1992, Brenn, 1997, Pyke et al., 1997, Macken et 
al., 2000, Hippisley-Cox et al., 2002, Bloch et al., 2003, Izumi et al., 2004, Jurj et al., 2006, 
Stimpson et al., 2006, Di Castelnuovo et al., 2007, Kuo, 2007, Ask et al., 2012).This 
consistency in the results for smoking habit is evident despite the wide variety of study 
populations coming from different countries and cultures such as China, Japan, Brazil, the 
United Sates of America including Mexican and Korean Americans, Hawaiii, Australia, and 
countries from both Northern and Southern Europe where smoking prevalence varies 
according to gender and generation. Results are also consistent whichever statistical 
method of measuring concordance was used: correlation coefficients, odds ratios or 
percentage agreement. 
They also accord with the findings from two other published systematic reviews of 
concordance in couples. The first (Meyler et al., 2007) review was of concordance for 
health and health behaviours,  and the second review (Di Castelnuovo et al., 2009) of 
concordance for major coronary risk factors. Both included concordance for smoking. The 
review by Di Castelnuovo identified sixteen of the forty-two studies included in my 
systematic review and conducted two meta-analyses, the first was based on 4,763 pairs 
from seven studies (Hunt et al., 1989, Kolonel and Lee, 1981, Speers et al., 1986, Sutton, 
1980, Di Castelnuovo et al., 2007, Barrett-Connor et al., 1982, Macken et al., 2000) where 
concordance was measured with a correlation coefficient, and found an overall result for 
smoking of 0.23 (95%CI 0.12 to 0.36). The second was based on 74,881 pairs from three 
studies (Hippisley-Cox et al., 2002, Bloch et al., 2003, Jurj et al., 2006) where concordance 
was measured using odds ratios, and found an overall result of 3.25 (95% CI 2.94 to 3.59). 
The remaining six studies (Brenn, 1997, Izumi et al., 2004, Kuo, 2007, Pyke et al., 1997, 
Sackett et al., 1975, Venters et al., 1984) were deemed unsuitable for meta-analyses 
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because the intra-pairs correlations were assessed using other measures, i.e. percentage 
of concordance and observed over expected ratios. 
 
In Meyler’s review, only six studies were included. This review concluded that there was 
general agreement in all but one of these studies (Kolonel and Lee, 1981) and that there is 
concordance for smoking habit in couples. Their main criticism of concordance research is 
that it has not applied theories of concordance to explain its existence, and therefore no 
conclusions are drawn as to whether concordance is due to shared lifestyle or assortative 
mating with regard to smoking behaviour in couples. 
 
In addition to finding smoking to be the risk factor with the strongest correlation in couples, 
one systematic review (Di Castelnuovo et al., 2009) also suggested that assortative mating 
is primarily responsible for smoking concordance in couples as the studies that 
investigated concordance at different time-points in marriage found either greater 
concordance at the start of marriage, or at the point where couples get engaged to be 
married, and no increase in concordance with marriage duration. 
 
In addition to the studies identified by Di Castelnuovo and Meyler, my systematic review 
identified a further twenty-six studies. This included two Norwegian studies that drew on 
data from the same on-going cohort study (Tambs Kristian, 1992, Ask et al., 2012). One of 
these had not been published at the time of the previous systematic reviews. Another study 
(Haynes et al., 1983) was excluded from Di Castelnuovo’s review because it drew on the 
same cohort as another one of the included studies (Sackett et al., 1975)). A study of 
lifestyle concordance in Mexican Americans (Stimpson et al., 2006) was included in 
Meyler’s review but not in Di Castelnuovo’s. Two studies that did not measure concordance 
with correlation, odds ratios or percentage agreement, but compared prevalence of 
smoking in patients with coronary disease with their spouses and close relatives and also 
with the general population (Goble et al., 1997, Wood et al., 1997) and both were included 
in my review but in neither of the others. 
 
The remit of my systematic review was broader than the reviews by Meyler and Di 
Castelnuovo as it not only looked at concordance for smoking habit but also included 
studies that (i) evaluated patterns of change in smoking behaviour in couples during 
marriage (Hanson, 1990, Falba and Sindelar, 2007, Christakis and Fowler, 2008), (ii) the 
importance of partners’ smoking status when the other partner is trying to quit and finally 
(iii) the value of partner support in smoking cessation (Mermelstein et al., 1986, Ginsberg 
et al., 1992, Gruder et al., 1993, Roski et al., 1996, McBride et al., 1998, Park EW, 2004, 
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Manchon Walsh, 2007, Thomas et al., 2009, Vilchinsky et al., 2011, Park et al., 2012, 
Rohrbaugh, 2012). Two RCTs which evaluated the effectiveness of programmes to 
manage lifestyle (including smoking) and cardiovascular risk factors were also included in 
my review (Dracup et al., 1984, Sexton et al., 1987). 
 
In my review of those studies using correlation there was a broad range of coefficients from 
0.07 to 0.61, although the study with the smallest correlation coefficient comes from the 
only study not to demonstrate a significant positive relationship. This is an outlier compared 
to the other results. Otherwise the range is from 0.18 to 0.61, all positive and statistically 
significant, but nevertheless representing heterogeneity in the strength of the association. 
In studies applying an overall odds ratio, the range was between 2.4 and 4.44 and all 
statistically significant. 
 
Whatever measure of concordance was used, the strongest effect sizes were seen in the 
studies from Canada (Perusse et al., 1988) with a contingency coefficient of 0.61; Norway 
(Ask et al., 2012) with a polychoric correlation coefficient of 0.48; United Kingdom 
(Hippisley-Cox et al., 2002) with an OR of 4.44; and Brazil (Bloch et al., 2003) with an OR 
of 3.26. 
 
More moderate effect sizes were seen in three studies from the United States of America 
(Barrett-Connor et al., 1982, Haynes et al., 1983, Speers et al., 1986) with a Tau B 
correlation coefficient of 0.18 in the first, a Pearson correlation coefficient of 0.21 in the 
second and a PHI correlation coefficient of 0.24 in the third.  A European study 
(Di Castelnuovo et al., 2007) found a Pearson correlation coefficient of 0.26. 
 
Some of the variation in smoking concordance may be explained by the wide range of 
countries and cultures included in the studies, conducted in a number of different countries 
and thus reflecting different attitudes and norms regarding smoking behaviour and gender. 
Given that the studies have also been conducted over a timespan of more than 30 years, 
many changes have occurred in smoking trends during this time. In Northern Europe, the 
United States and Australia, there has been a reduction in smoking prevalence, particularly 
in men, and a concurrent rise in women. As a consequence this gap in smoking prevalence 
between men and women is now closing in these countries. This is not the case in China, 
Japan, South America and to some extent Eastern and Southern Europe, where female 
smoking prevalence remains much lower than in men, and male smoking prevalence is 
either substantially higher or still rising (Lopez et al., 1994). 
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In the UK, observational data from the British Family Heart Study (Pyke et al., 1997) RCT 
used the same statistical methods as I have used for the analyses of the EUROACTION 
study to measure concordance and found a similar result (Table 40). The ORs for partners 
to share the same smoking status were 2.3 for current smokers to be married to another 
current smoke, 1.53 for ex-smokers to be married to another ex-smoker and 1.31 for a 
never-smoker to be married to another never smoker compared to what would be expected 
if there were no relationship between married partners for smoking. As in the 
EUROACTION study, these ORs for couples sharing the same smoking status were all 
stronger than those for discordance. 
Table 40. Concordance for smoking behaviour at baseline in couples attending the BFHS 
and EURACTION programmes 
PARTNERS 
 Current Ex Never 
 BFHS EUROACTION BFHS EUROACTION BFHS EUROACTION 
PATIENTS O/E O/E O/E O/E O/E O/E 
Current 2.27 1.76 0.56 0.67 0.69 0.85 
Ex 0.68 0.79 1.53 1.18 0.90 1.00 
Never 0.57 0.55 0.67 1.06 1.31 1.14 
 
A Chinese study (Jurj et al., 2006) found similar odds for a current smoker to be married to 
another current smoker (2.4) compared to the reference group of being married to a never 
smoker. An American study of older Mexican Americans (Stimpson et al., 2006) calculated 
a risk ratio (RR) instead of an OR and found a RR of 2.15 for wives to be smokers if their 
husbands had ever smoked (current or ex). These data demonstrate similar effect sizes 
across different cultures and geographic areas. 
There was only one study (Macken et al., 2000) that formally evaluated concordance in 
couples where one partner had coronary disease.  In this study from Nebraska, 177 male 
patients in a non-probability sample and their wives were interviewed at home 8 –10 weeks 
post discharge from an admission for an acute myocardial infarction or revascularistion. 
The Behavioral Risk Factor Surveillance System from the Center for Disease Control and 
Prevention was used to collect data with some modifications. Smoking status following the 
cardiac event of the patient was used to calculate concordance (current smoker yes/no; 
history of smoking yes/no) and the PHI correlation coefficient for categorical variables was 
used. 76% of the couples were concordant for smoking status and the PHI correlation 
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coefficient was 0.39 and highly statistically significant. In couples with discordance (25 
couples), it was usually the female partner who continued to smoke. There were only four 
couples where the patient continued to smoke and the partner was not smoking. However, 
male patients were more likely to have a history of smoking. 
 
Differences in smoking prevalence according to gender and culture 
Differences in smoking prevalence at the time of the event were apparent between patients 
and partners in the EUROACTION study with a greater proportion of patients smoking than 
partners. These differences are probably explained largely by gender (80% patients male 
and 80% partners female) and cultural differences across 6 European countries, which are 
in different stages of the smoking epidemic (Lopez et al., 1994). Women are less likely to 
be smokers, for example, in Poland and Spain (Eastern and Southern Europe) compared 
to the UK and Sweden (Northern Europe), and particularly in the generation that were 
participating in this study (mean age range from 57 years in female partners to 64 years in 
male partners). Smoking prevalence was highest in the male coronary patients and lowest 
in the female coronary patients. Whilst concordance for smoking was found overall, despite 
these differences in prevalence, there was some heterogeneity. The lowest observed over 
expected ratio (0.57) was for current smoking partners (mostly women) to be married to 
never smoking patients (mostly men), whereas it was higher (0.85) the other way around. 
This result may be attributed to the fact that in older generations and in cultures where 
smoking is less common in women and still much more common in men, men are less 
likely to be influenced by their wives’ smoking status than the other way round. An 
American study which investigated health behaviours in married individuals (Falba and 
Sindelar, 2007), found that in male smokers 35% of the wives were reported as having 
never smoked. This was in contrast to only 12% of husbands who had never smoked being 
married to female smokers. 
 
Whilst concordance for smoking was found (0.26) for smoking in a European study (Di 
Castelnuovo et al., 2007) of concordance for cardiovascular risk in couples from high (UK), 
medium (Belgium) and low (Italy) cardiovascular risk countries, there was heterogeneity 
between the three centres, although exact differences are not stated in the paper. This was 
attributed to cultural disparities between these countries. Male smoking prevalence is 
higher in southern Europe, but female smoking prevalence remains lower in southern 
compared to northern European countries. In the study from China (Jurj et al., 2006) and 
Japan (Izumi et al., 2004), large differences were seen between men and women in 
smoking prevalence, although a significant and positive relationship is nevertheless 
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demonstrated in smoking behaviour amongst the couples, albeit small in the case of the 
Japanese study where there was 22% observed agreement in smoking status in couples 
compared to 20% expected. 
 
 
 
Assortative marriage and smoking 
When couples’ smoking behaviour was investigated at different time points in a marriage, 
the strength of concordance was seen to vary. In the couples from the Framingham cohort 
(Haynes et al., 1983) at the eighth and ninth examinations (1965 – 1967), whilst the overall 
Pearson correlation coefficient was 0.21 for number of cigarettes smoked per day, it varied 
from 0.26 for those married for 20 years or less, to 0.42 for those married for between 21 
and 25 years to 0.12 for those married for 26 years or more. 90% of the couples had been 
married for more than 20 years. Concordance dropped in the later years of marriage rather 
than increased. Data from a Norwegian health study (Tambs Kristian, 1992) conducted in 
Oslo between 1984 and 1986 classified marriage duration into 9 periods ranging from < 1 
year to > 20 years. They showed concordance reducing over the 9 classifications with 
correlations for number of cigarettes smoked per day ranging from 0.34 to 0.29. These do 
not support the premise that spouses may become more alike over a lifetime together, and 
in particular, in relation to smoking behaviour. The explanation for this difference may be 
that concordance was stronger earlier in the marriage (and perhaps at the time couples 
meet and become engaged to be married) but reduces over marriage duration because 
one partner quits before the other for health reasons. Alternatively, concordance may be 
weaker in the couples married for longer because of gender differences in smoking 
prevalence at the time (smoking was not as socially acceptable in women at the time when 
the older couples married). 
 
In the Scottish study of 403 couples (Sutton, 1980) which recruited engaged couples, 
newly wedded couples and those married for 6 years or more, concordance was strongest 
in engaged couples with a Pearson correlation coefficient of 0.42 compared to the overall 
correlation of 0.33, suggesting that the smoking phenotype may be important when 
selecting a marital partner. In 2012, a new analysis of the Norwegian data (Ask et al., 
2012) has contributed significantly to evidence that smoking concordance is indeed due to 
assortative mating. Using cross-sectional data from the study conducted between 1984 
and 1986, combined with longitudinal data from the Norwegian registry of marriages, from 
19,599 couples, the researchers investigated 1,551 ‘future’ couples identified 14 to 16 
years prior to their marriages. This time the variable for smoking was different, based on a 
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response of yes or no to current daily smoking. The predicted similarity in partners’ 
smoking habits 12 years prior to entering into marriage was 0.38 (polychoric correlation). At 
the time of entry into marriage, this correlation was 0.55. After 39 years of marriage 
duration, it was 0.39. The strong correlation at 12 years prior to marriage, when it is 
unlikely the partners had yet met, supports the theory that smoking concordance is due to 
assortative mating. 
 
This divergence rather than convergence of smoking concordance over marriage duration 
described above suggests that, in the EUROACTION couples, where the mean age ranged 
from 57 to 64 years, and couples had probably been married for many years, the true level 
of concordance over the whole marriage duration may have been somewhat 
underestimated. 
 
Exposure to tobacco 
Lifetime exposure to tobacco was high in the coronary patients and their partners 
participating in the EUROACTION programme with over two thirds of the patients (mainly 
men) reporting that they had ever smoked, and almost one half of the partners (mainly 
women) who had ever smoked. In more than one third of the couples, at least one of the 
partners was smoking at the time of the cardiac event. In an Australian study (Goble et al., 
1997), the risk factor profile of family members of patients with an acute cardiac event was 
investigated and found to be worse than the general population, as represented by data 
from the National Heart Foundation Risk Factor Prevalence Study (NHF RFPS) conducted 
in 1989. Patients and families attended a risk factor screening clinic 3 to 4 months after the 
cardiac event of the index patient. From 895 patients post acute cardiac event, 628 were 
screened and 2835 family members identified with1723 being screened. Measurements 
were made using the same methods as those from the NHF RFP Risk so that comparisons 
could be made between the two study populations in terms of risk factor prevalence. 
Tobacco exposure was similar to that found in EUROACTION in the male and female 
patients (includes both ex and current smokers). It was 79% for male patients and 37% for 
their wives, and 54% for female patients and 60% for their husbands. The comparison with 
the NHF RFP study was made between all relatives in each group and not just spouses. 
31.6% of FARIS male relatives were found to be smokers compared to 27% of the male 
NHF RFPS participants and 25% of FARIS female relatives were smokers compared to 
21% of the female NHF RFPS participants. 
 
In the study of male coronary patients and their partners from Nebraska (Macken et al., 
2000), exposure to tobacco was again similar with 73% of the patients and 45% of the 
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partners reporting a history of smoking. A case control study from Southampton (Wood et 
al., 1997) compared the risk profile in the wives of men under the age of 65 with an acute 
myocardial infarction and healthy female controls matched for age and marital status. A 
number of risk factors were measured which included smoking. The wives and healthy 
controls were divided into younger (25-44 years) and older (≥ 45 years) age groups. 
Tobacco exposure in the older wives (42% either current or former smokers) was 
comparable with exposure in the EUROACTION partners (mostly female). Interestingly, 
exposure to tobacco was greater in the older female controls (56%) from the Southampton 
study. However, this may reflect limitations of the study pointed out by the authors which 
included possible poorer response rates in those with an unhealthy risk profile and non-
inclusion of wives of men who died from their cardiac event in the community. 
 
Changes in smoking prevalence relative to a cardiac event 
Whilst a third of EUROACTION patients were current cigarette smokers at the time of their 
event, many had quit before they came to the initial assessment (conducted on average 
around three weeks after the event), almost certainly as a result of their acute cardiac 
event. Three other studies have found a similarly low prevalence of smoking in patients 
following a cardiac event. The FARIS study from Australia (Goble et al., 1997) reported a 
smoking prevalence of 6% in male patients and 5% in female patients 3-4 months post 
event. In fact just over a quarter of the male patients and just under a fifth of the female 
patients had given up less than 12 months prior to the screening, suggesting that they may 
have quit smoking at the time of their acute cardiac event. A small RCT (Dracup et al., 
1984) randomised fifty-eight men post myocardial infarction or revascularisation and their 
wives to one of three arms: behavioural councelling for both patients and partners, 
behavioural counselling for patient only, or behavioural counselling for neither patients or 
partners. Only two smokers were entered into the trial and both remained smokers at exit. 
However, 36 reported a <12 months history of smoking suggesting that they had stopped 
smoking at the time of their event. The authors do not indicate to which arm of the trial 
these smokers were randomised. In the study from Nebraska (Macken et al., 2000) of male 
coronary patients and their wives 8–10 weeks after an acute myocardial infarction or 
revascularisation procedure, there was also a low prevalence (10%) of smoking in the 
patient population. Interestingly, the prevalence of smoking in the patients was lower than 
in the wives (21%). This was also true in the EURACTION couples, with a similar 
proportion of partners (18%) smoking after their partner’s cardiac event. In fact, relatively 
few of these partners had quit since the event in their spouse. Whilst patients experiencing 
an acute event are triggered to quit spontaneously and undoubtedly prompted by strong 
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advice from their cardiologist, partners of these patients may not be similarly advised and 
therefore do not necessarily quit. 
 
The real challenge for the nurses in the multidisciplinary teams was to prevent relapse to 
smoking in those patients who had quit spontaneously as a result of their cardiac event. To 
some extent they succeeded with a quit rate of 70% in all those returning at 16 weeks and 
68% at one year. However, just under half of those patients who had reported smoking at 
the time of their event did not return at 16 weeks and just over a half did not return at one 
year. If all of those who did not return at one year had continued to smoke, the quit rate 
would be 40% at 16 weeks and 38% at one year. Whilst this result is less encouraging, it 
can be seen in a different light in the context of the principal results for smoking in the 
EUROACTION trial. Between the intervention and usual care arms of the trial, there was a 
10% (-0.3% to +21%) absolute difference in the proportion of patients smoking at the time 
of their event who were abstinent at one year in favour of the intervention arm, although 
this was of borderline statistical significance (p=0.06). 
 
If the same analyses are applied to the partners, the quit rates appear even lower (12% at 
16 weeks and 17% at one year). However, it is possible that there were more non-returning 
partners who had quit smoking, but did not return because their spouse, the patient, had 
not quit. Data were not collected on partners in the absence of the patients. 
 
Quitting and social support from a partner 
Interestingly, the quit rate was higher in patients whose partner was not smoking at 
baseline compared to the quit rate in those whose partner was smoking. More than one 
study corroborates these results. The British Family Heart Study (Pyke et al., 1997) 
showed a higher quit rate at one year in partners where one was not smoking at baseline 
(19%) compared to if they both were both smoking (12%). However the response rate in 
smokers compared to non-smokers at the one year follow-up was lower (76% v. 88% men 
and 74% v. 89% women) so creating a potential bias. Nevertheless, when Pyke corrected 
the analyses assuming that in those who did not attend the one year follow up the smoking 
habits were unchanged, the quit rate was corrected to 14% in men and women with 
partners who did not smoke at baseline and 6% in those whose partners did. The result 
remained statistically significant. The quit rates were much lower than in the 
EUROACTION study and this is because the patients in this study had not experienced a 
first cardiac event. 
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There are several studies investigating patterns of smoking behaviour change during 
marriage using cross-sectional and longitudinal data with similar results supporting the 
observation that greater smoking cessation occurs when the partner of a smoker is a non-
smoker. A Swedish cohort study (Hanson et al., 1990) investigated the relationship of 
social support to quitting smoking and identified these spousal influences. Male smokers 
married to non-smoking women were significantly more likely to have quit smoking (64%) 
than those living alone (48%) or with smoking women (37%). In a longitudinal study of 
spousal concordance for health behaviours from the US (Falba and Sindelar, 2007), the 
same phenomenon was reported when smoking status was compared in married 
individuals at two time points, 1992 and 1996 using data from the Michigan Health and 
Retirement Study. In husbands who had stopped smoking (29%) between 1992 and 1996, 
their wives were more likely to be reported as former smokers or never smokers (61%) 
than current smokers (20%) or to have stopped smoking as well (19%). In wives who quit 
(22%), whilst nearly half (45%) of husbands were either former or never smokers, a larger 
proportion continued to smoke (29%) compared to the wives of male quitters, but equally a 
larger proportion quit (27%). In both men (71%) and women (78%) who did not quit, the 
quit rate in the spouse was very low (both 7%). A second longitudinal study from the US 
(Franks et al., 2002) investigated middle-aged couples at two time-points (1992 and 1994). 
In the 150 men who quit, they were more likely to be married to non-smokers 62% than 
smokers 23%. In the 95 women who quit, 49% husbands were non-smokers. Men were 
more likely to quit if married to a female never smoker (OR 2.2). Whilst the same can be 
said of women’s likelihood to quit if married to a male never smoker, the odds ratio was not 
as strong (1.1). In those men and women continuing to smoke only 5% of wives and 4% of 
husbands managed to quit. 
 
Marriage also appears to have a protective effect, or alternatively discordant marriages are 
more likely to be dissolved. Both married men and women are more likely to have never 
smoked or to have stopped smoking compared to those who live alone, and in particular 
those who are divorced or separated. In two studies from the US (Venters et al., 1984, 
Franks et al., 2002), a comparison was made between married and non-married individuals 
and showed similar results.  In Venters’ study, 50% of separated females were found to be 
smokers compared to 23% of those who were married. Similarly in Franks’ study of middle-
aged individuals 24% of married individuals were smokers compared to 40% of those who 
were divorced. 
A Spanish prospective cohort study (Manchon Walsh, 2007) investigated the effect of 
partners’ smoking status on quitting. At 12 month follow up, 28% were abstinent in people 
with a smoking partner compared to 47% in those with a non-smoking partner. This 
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difference was statistically significant. In the Cochrane systematic review of RCTs of 
smoking cessation interventions with enhanced partner support (Park et al., 2012), 13 trials 
were included in the meta-analysis of abstinence at different time points. This showed no 
overall effect of partner support in either the meta-analysis at 6-9 months or at 12+ months. 
However, the study (Gruder et al., 1993) with the greatest effect size (RR 3.07) was the 
only one in which 100% of partners were non-smokers. In this study, an effect was still 
present at twelve months (RR 1.44). Interestingly, the only studies showing any effect, 
were those which only included spouses as partners as opposed to mixed partner types 
(buddy, work colleague etc). Park had led the previous systematic review on the same 
topic (Park EW, 2004), which also showed no overall effect (Peto OR 1.08 6-9 months; 
1.00 12+ months) but was able to show in a sensitivity analysis, that that live in partners 
may be more effective than others. 
 
The kind of support that is provided by the spouse is important. In one of the trials (McBride 
et al., 1998) included in Park’s 2012 systematic review, there was an indication of how 
partner support can vary in its effectiveness. In this small trial of pregnant women and their 
partners, which provided support materials to the women, a guidance booklet for the 
partners and counselling calls for both, positive support was reported to decline and 
negative support to increase in a U shape after the intervention. In a non-randomised study 
of smokers with spouse, versus those without a spouse, all recruited to a cessation 
programme, high levels of spouse support proved effective in the short term only 
(Mermelstein et al., 1986), although they do not define the nature of the support provided. 
An RCT (Roski et al., 1996) showed that a lower frequency of negative support was 
associated with a greater likelihood of success. Negative support is defined as nagging and 
policing. Further investigation into the kind of support that is effective has come from two 
more studies (Vilchinsky et al., 2011, Rohrbaugh, 2012). In Vilchinsky’s study from Israel in 
men following a first myocardial infarction, the interaction of men’s perceptions of smoking 
cessation support from their wives and the actual support received was evaluated. Patients 
and wives were interviewed at baseline, at 1 month and at 6 months. At 6 months, 65% of 
the patients had quit smoking, although the response rate in the study was poor so this 
may be an over-estimation of the result. Support was assessed with the ‘Ways of helping 
questionnaire’ which is defined as follows: active engagement (discussing problems and 
finding solutions together); buffering (denying and hiding concerns); and over-
protectiveness. Smoking cessation was significantly predicted by the interaction of the 
wives’ active engagement and the patients’ perception of this engagement (OR 42.5). 
Active engagement was more successful in predicting smoking cessation than over 
protectiveness and buffering. This may be because this kind of support is more likely to 
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increase self-efficacy. Rohrbaugh conducted an interesting study of couple coping 
mechanisms in 20 couples during smoking cessation where one partner had a health 
problem. The aim of the intervention was to promote definition of smoking as ‘our problem’ 
rather than ‘your problem’ or ‘my problem’ by encouraging the use of the personal pronoun 
during the smoking cessation programme. The use of the personal pronoun, ‘we talk’ as it 
was coined, was assessed from transcripts of conversation between the partners in a pre-
treatment interaction. When correlated with 30 day point prevalence of abstinence at 12 
months in the patient, it was 0.44 in partners and statistically significant, but not in patients. 
However, when change in the use of ‘we talk’ during the intervention was correlated with 
outcome, there was a significant correlation in both patients (0.51) and partners (0.51). In 
addition, this association was stronger when both partners were smokers at the start of the 
intervention. 
 
At the Mayo clinic in the US (Thomas et al., 2009) an intervention study of couples where 
one was trying to quit smoking, surveyed the partner’s attitude to the quit attempt of their 
spouse. 84% claimed they were very or extremely interested in helping their spouse to quit 
and 90% claimed they were either very or extremely interested in learning how to do it. 
 
Quitting together 
In the EUROACTION couples, where both partners were smoking at baseline, the quit rate 
was higher in both patients and partners if the other quit too. Whilst this result has to be 
qualified by a poor response rate in smokers at both 16 weeks and one year, it 
nevertheless shows that patients and partners who supported each other by stopping 
smoking together were more successful. 
 
Pyke (1997) demonstrated higher quit rates in male and female smokers when the spouse 
quit too. At one year the quit rate in men was 63% if their wife also quit but only 11% if she 
did not. It was 31% in women if their husband quit but only 3% if he did not. These results 
should also be seen in the context of a lower response rate to the one year follow-up in 
smokers compared to non-smokers. Cross-sectional and longitudinal data also support 
these findings. In their analyses of ex-smokers, Venters (1984) found that the year of quit 
date for both partners was more likely to be within 3 years in married couples compared to 
surrogate pairs. Falba (2007) found an OR of 7.53 for men to quit if their wives quit too and 
8.52 for women to quit if their husbands quit too, both highly statistically significant. In 150 
male quitters, Franks (2002) found that 13% of wives also quit, and in 95 female quitters, 
12% of husbands quit. A limitation of these cross-sectional and longitudinal data is the 
inability to ascertain whether or not these quits were simultaneous in partners. 
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Sexton (1987) conducted a secondary analysis of the Multiple Risk Factor Intervention Trial 
(MRFIT), and compared the wives of men attending the intervention programme, who were 
encouraged to become involved in the programme activities, with the wives of men 
randomised to usual care. The prevalence of smoking was lower (25%) in the wives of men 
randomised to intervention compared to the wives of men randomised to usual care (31%). 
Baseline smoking data on these women were also reported by their husbands thus 
allowing change over time to be analysed. In those who had been smoking at baseline, the 
mean reduction in cigarettes per day was 12.4 in the intervention wives compared to 1.7 in 
usual care. All of these results were statistically significant. 
Conclusions on smoking 
Concordance for smoking was found in the EUROACTION couples with coronary disease 
in whom exposure to tobacco was high. This supports previous findings of increased 
exposure to tobacco in coronary families compared to the general population. 
Concordance was found despite gender differences in smoking prevalence in this mixed 
European population. The broad range in findings from the studies included in my review is 
undoubtedly explained by a number of factors: the variation in study populations and 
cultures, the period of data collection, the criteria for assessing smoking status and the 
statistical methods for assessing concordance. In addition, not all of the studies use formal 
statistical methods to quantify concordance and some do not come to conclusions based 
on recognised theories of concordance. Despite these factors the findings are consistent 
with most studies showing concordance for smoking among couples. 
 
Comparison of effect sizes is problematic because concordance was measured in many 
different ways. However, the most important conclusion is that in all but one study of 
concordance for smoking, a positive relationship was found in smoking behaviour amongst 
married and cohabiting partners. In addition, studies examining concordance at different 
time points during a marriage relationship, concluded that smoking concordance is largely 
due to assortative mating, i.e. people who smoke, or do not smoke, are more likely to seek 
out a partner with the same smoking status as themselves. Concordance does not 
increase over marriage duration, if anything, it reduces. This is probably because one 
partner decides to quit, maybe for health reasons. 
 
Quitting patterns seen in the EUROACTION couples were similar to those reported in other 
studies with many patients spontaneously quitting at the time of their cardiac event. But 
those with a non-smoking partner found it easier to quit than those with a partner who also 
smoked. However, this was dependent on whether the partner decided to try to quit as 
well, in which case greater success was evident. 
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Whilst the results from the EUROACTION study do not allow for identification of the 
determinants of helpful partner support, in order to maximise the potential for partner 
support for smokers trying to quit, it is important to identify the kind of support that works 
best, and especially for those whose smoking is compromising their health. The principles 
of helpful support can be determined from the results of studies included in my systematic 
review. Live in partners and spouses provide the best opportunity for support, so long as 
they use the right skills. Partners who actively engage with the problem of smoking in 
relation to the health of their spouse and view it as a shared problem to manage together, 
rather than nagging, policing and viewing it as a problem that was the other’s fault, are 
going to be the most successful. Although the evidence supports more effective cessation 
when the partner is a non-smoker, there is also evidence which suggests that couples 
where both partners smoke, and one has a health problem, they can support each other to 
quit together. The mechanism for this is most likely a problem sharing and solving 
approach. 
 
These findings have important implications for clinical practice. For patients making a quit 
attempt, it is essential to engage the spouse and empower them with the right skills to help 
their partner to quit successfully. 
3.2. Concordance for dietary habits in couples 
Concordance for diet was found in the couples participating in the in the EUROACTION 
programme and this was evident in over-consumption of saturated fat by nearly two thirds 
and under-consumption of fruit and vegetables by more than half for both patients and 
partners. The correlations between patients and partners for dietary intake were stronger 
than for any other factors where correlation was measured. In particular, the correlation for 
fruit and vegetables was the strongest. Concordance was evaluated for saturated fat and 
fruit and vegetable intake, which were amongst the most important key messages 
delivered by the dietitians from the EUROACTION teams. 
Total and saturated fat 
The correlation coefficient for saturated fat intake (0.43) is consistent with those found in 
the only two studies from my review using correlation to measure concordance for 
saturated fat intake in couples. Lyu’s cross-sectional study (Lyu et al., 2004) which 
recruited outpatients and their spouses in urban Taipei in Taiwan analysed data from a 473 
item food frequency questionnaire and found a Pearson inter-class correlation coefficient of 
0.41 for saturated fat. This study also reported on MUFAs and PUFAs and found similar 
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correlations to those for saturated fat (MUFA 0.43; PUFA 0.39). In Lee’s cross-sectional 
study from Hawaii (1982) of Japanese, Hawaiian, Chinese, Filipino and Caucasian 
couples, both the intra-class (ICC) and Spearman’s rank (SR) correlation coefficient were 
used. A difference was found between the two (ICC0.43. SR0.57) for absolute intake of 
saturated fat which disappeared when the analysis was conducted on intake per kg of 
bodyweight (ICC 0.49, SR 0.52). 
Most of the studies evaluating concordance for fat looked at total fat rather than focussing 
on saturated fat (Nelson et al., 1980, Eastwood et al., 1982, Macken et al., 2000, Di 
Castelnuovo et al., 2007). In all of these studies, the correlation coefficients were moderate 
but positive and either equal to or stronger than those seen for smoking. They ranged 
between 0.38 from an Nelson’s unpublished study from Cambridge to 0.58 in the study 
from Hawaii (Lee and Kolonel, 1981). In Nelson’s study, this compared with a correlation of 
0.58 for fibre, the only other nutrient on which they reported. In the Hawaiian study (Lee 
and Kolonel, 1981) correlations for fat were amongst the strongest that they measured 
(calories, fat, protein, carbohydrates, vitamins), the lowest being for absolute calorie intake 
(ICC 0.35) and the highest for per/kg bodyweight of vitamin A (SR 0.76), but the latter was 
an outlier. In the small cross-sectional study from Edinburgh of couples married between 
20-50 years in their first marriages (Eastwood et al., 1982), after dietary analysis of a seven 
day food diary, the correlation for fat intake was 0.53 and this was in the context of a range 
of correlation coefficients from 0.16-0.64 for other nutrients. This study also reported on 
dietary analysis on faecal constituents. The correlation for fat was 0.49, the only 
significantly positive result for the faecal analyses. 
In the study from Iowa in the US (Schafer et al., 1995), which investigated the effect of 
women’s low fat diets on their husbands’ eating habits, dietary analysis of food frequency 
data found that 39% of calories came from fat in the husbands’ diets compared to 37% in 
wives. Although no formal concordance measure was used, these results in husbands and 
wives are almost identical. In another American study from Seattle (Hannon et al., 2003), 
baseline cross-sectional data from both arms of an RCT testing an initiative to increase fruit 
and vegetable consumption and reduce fat consumption among religious organisations by 
targeting the Family Food Preparer (FFP), to look at the association of family food habits. 
Fat intake was reported for both partners by the FFP on a 4-point Likert scale which ranged 
from 1 = very little of the time to 4 = all of the time.  Where FFPs reported a low intake of 
fat for themselves, it was associated with a low intake in spouses as well (mean 1.72 likert 
scale response), whereas, when FFPs reported a high intake for fat, the response for 
spouses was also high (mean Likert scale response 3.75). Whilst reporting of the FFP on 
behalf of the spouse may be seen as a limitation, previous studies have shown that report 
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by female spouses on food intake is reliable (Marshall et al., 1980, Kolonel and Lee, 1981, 
Lee and Kolonel, 1981). 84% of the FFPs in this study were female. 
Three studies (Kolonel and Lee, 1981, Eastwood et al., 1982, Izumi et al., 2004) reported 
on intake of dairy produce which contains saturated fat. The Edinburgh study (Eastwood et 
al., 1982) found a correlation of 0.44 for dairy intake although this included eggs. When 
milk intake was analysed on its own, the correlation was much lower (0.10) and not 
statistically significant. In the smaller pilot study from Hawaii (Kolonel and Lee, 1981), 
intake was measured for 11 food items. The correlation for milk intake was higher at 0.32, 
by comparison with Eastwood, but the lowest correlation for any food item within the study. 
In a Japanese study (Izumi et al., 2004), food intake was measured using a 9 item food 
frequency questionnaire. Concordance was evaluated using observed compared to 
expected percentage agreement which was 49% observed for dairy intake compared to 
34% expected by chance. Whilst this finding was statistically significant, it was the weakest 
of all foods measured in this study, which included fish, meat, fruits, soy, eggs, dairy and 
vegetables. 
One American study from Nebraska evaluated concordance for fat intake in couples where 
the male partner had coronary disease (Macken et al., 2000). Eight – ten weeks after an 
acute event or revascularisation procedure, couples reported on the amount of fat in their 
diet using a 100 mm visual analogue scale. Mean values were higher in the patients (27) 
compared to the wives (17) but the Pearson inter-class correlation coefficient was 0.44 and 
highly statistically significant. 
Fruit and vegetables 
Concordance for consumption of fruit and vegetables in the EUROACTION couples was 
strong (0.67). Two of the studies (Kolonel and Lee, 1981, Eastwood et al., 1982) from my 
systematic review evaluated concordance for fruit and vegetable consumption using 
correlation. In the Hawaiiian study (Kolonel and Lee, 1981) the correlation coefficients were 
moderate and similar for both fruit (0.39) and raw vegetables (0.35) and not as strong as 
those found in the EUROACTION study. However, in EUROACTION all vegetables were 
measured, not just those that were raw. The range of correlations for all food items in this 
study was 0.33-0.55. In the Scottish study (Eastwood et al., 1982), the correlations were 
stronger, 0.45 for fruit and 0.66 for vegetables with a range for all food items between 0.10 
to 0.88. Notably, the reported daily consumption for fruit and vegetables was very low for 
both husbands and wives in this study (medians of 60g husbands, 75g wives for fruit; and 
72g husbands and 76g wives for vegetables). This is much lower than the median daily 
reported consumption of fruit and vegetables in the EUROACTION couples, which was 
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already inadequate. The Japanese study (Izumi et al., 2004) evaluated concordance for 
fruit and vegetable consumption with percentage agreement which was 56% observed over 
an expected 38% for fruit, and 59% observed over an expected 44% for vegetables. When 
green and yellow vegetables were analysed separately, the agreements for both were 
stronger with an observed 60% observed over an expected 41% for greens and an 
observed 61% over an expected 43% for yellow vegetables. Percentage agreements for 
green and yellow vegetables and fruit were the strongest in the study. Mean consumption 
was not reported in the study. 
The study from Massachusets in the US (Macario and Sorensen, 1998) investigated fruit 
and vegetable consumption in health centre employees and their spouses using 
percentage agreement and the kappa statistic to take account of chance. The percentage 
agreement between the partners for consumption of fruit was 67% with a kappa of 0.30, 
and for vegetables it was 69% with a kappa of 0.34. 75% of the couples were within one 
serving response category of each other. Reported consumption of both fruit and 
vegetables was low in couples with employees reporting a mean 4.68 servings per day 
compared to a reported 4.30 in spouses and only one half of employees and 43% of 
spouses meeting the recommended intake of five or more servings per day, similar to the 
EUROACTION couples. The number of meals that the couples ate together per week 
significantly correlated with fruit (0.22) and vegetable (0.20) consumption, indicating that 
when couples ate together, they were more likely to eat fruit and vegetables. 83% of the 
employees were women and 73% of these female employees carried a greater 
responsibility for food purchase and preparation than their husbands. Interestingly this was 
less true of female spouses of male health centre employees (59%). In the study from 
Seattle (Hannon et al., 2003), a low intake of fruit and vegetables in the FFP was 
associated with the same in the spouse (mean of 1.42 servings/day), and a high intake by 
the FFP was associated with the same in the spouse (mean 4.68 servings/day). 
Meyler’s (2007) systematic review of health concordance and health behaviours identified 
10 studies for concordance regarding dietary intake, five of which are included in my review 
and five investigating body mass index (BMI) and quantifying the resemblance in couples 
as a surrogate for diet. Concordance for BMI is complex, as it is a function of both diet and 
physical activity both of which are associated with a shared living environment and 
assortative mating and this latter subject is outside the remit of my literature review. 
Otherwise Meyler’s review accords with the findings of my review. 
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Changing diet together 
By the end of the 16 weeks preventive cardiology programme, with the intensive support 
from the dietitians on the teams, both patients and partners had made impressive changes 
to their diets with a much higher proportion reaching the goals for saturated fat and fruit 
and vegetable consumption, and these changes were sustained at one year. There was 
also concordance for these changes in the couples. Moreover, those patients who made 
the most impressive changes were associated with the partners who did the same. Equally, 
those patients who had not responded to the programme by making fewer healthy changes 
were associated with partners who did the same. 
Only one American study (Patterson et al., 1989) from San Diego in California, which used 
data from a RCT of a family centred prevention programme, included in my review, 
measured concordance for change in dietary factors. Families were recruited via their 
children from schools. All those with symptomatic disease or with treated risk factors were 
excluded.  Subsequently, they attended a structured 12 week programme addressing diet, 
physical activity and CVD risk factors which was followed by 6 maintenance sessions over 
5 months.. Concordance for change in couples for fat intake (3 day fat scores), where 
intake was measured using dietary analysis of a three day food diary was 0.51 which is 
somewhat higher than the result in the EUROACTION couples (0.42), although, the 
EUROACTION result was based on saturated and not total fat. In addition, the 
EUROACTION programme ended at 16 weeks with no maintenance sessions. 
 
The literature on dietary behaviour in couples during marriage suggests that the influence 
of the female partner is more important than that of the male partner. In several studies, 
women reported themselves as being the person in the household responsible for buying 
and preparing food. This was reported in two of the studies of dietary concordance 
reviewed above (Macario and Sorensen, 1998, Hannon et al., 2003), and also in two 
additional studies (Shattuck et al., 1992, Bove et al., 2003). In a small study of newly 
married couples, Bove revealed from in depth semi-structured personal interviews that one 
partner, more often the wife, takes on a ‘Food Director’ role which has the objective of 
changing the other’s food preferences – usually for health reasons. The Food Director 
exercises their role by serving particular foods at the table when the couple eat together 
and by putting healthy options in the fridge or in lunch boxes. Shattuck’s RCT from the US 
randomised women to either a fat reduction programme or usual care and followed up a 
sample of husbands at 12 months in both arms in order to investigate the effect that wives’ 
low fat diets had on their husbands. There was an absolute significant difference of 4% 
points in percentage energy from fat found between intervention husbands (33%) and 
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control husbands (37%), even though the intervention husbands were not included in the 
programme sessions. The change in the husbands’ diets was due to a passive acceptance 
of their wives choices rather than an active attempt to eat less fat themselves. More than 
70% of women in both arms of the trial said they had at least 90% responsibility for food 
purchase and preparation. Interestingly the fat intake was significantly higher by 3.6% 
points in husbands of wives participating in the intervention arm where the wives prepared 
separate meals for themselves compared to wives of husbands who did not. 
 
In a secondary analysis of the MRFITT trial, Sexton (1987) investigated the cardiovascular 
risk profiles of wives of men randomised to receive the risk reduction programme and 
compared them with the wives of men randomised to usual care. Regarding dietary intake, 
the intervention wives had significantly superior food rating scores (13.1) calculated from a 
3 day record, compared to wives of men randomised to usual care (16.8). Dietary 
knowledge, assessed with an 11 item questionnaire, was also superior in intervention 
(30.2) compared to usual care (27). This may have impacted on their lipid profiles which 
were significantly better in the intervention wives (TC 204 mg/dl; LDL-C 127 mg/dl) 
compared to usual care (TC 223 mg/dl; LDL-C 142 mg/dl), and also on the lipid profiles of 
the husbands which improved in the men participating in the intervention arm. 
 
However, there is also evidence that both partners influence each other equally. Homish 
(2008) conducted a longitudinal study of couples’ lifestyle habits in the early years just prior 
to marriage, and at 1, 2 and 4 years after marriage. They showed, using risk ratios, that 
wives’ pre-marital dietary habits had a significant prospective association with their 
husbands’ healthy eating habits (RR 1.12) and conversely their unhealthy eating habits 
(RR 1.11). Equally, husbands’ premarital dietary habits had a significant prospective 
association with wives’ healthy eating (RR 1.12) and unhealthy eating habits (RR 1.12). 
The mean age of the couples was 29 years for men and 27 years for women. In older 
couples the authors point out that, women may be more likely to take on a ‘monitor’ role, 
especially where illness is apparent.  (Franks et al., 2012) conducted a study investigating 
concordance for eating a healthier diet and for readiness and motivation for dietary change 
in couples who were participating in an on going health screening programme. Participants 
were assessed on the number of servings per day of 3 food items and asked about 
whether they avoided unhealthy foods like fried and high fat foods and snacks. Stage of 
change was assessed and categorised according to the following responses: ‘no plans to 
make this change’ = pre-contemplation, ‘plan to start in next 6 months’ = contemplation, 
‘pan to start in next 30 days’ = preparation, ‘started doing it in last 6 month’ = action or 
‘made this change over 6 months ago’ = maintenance. The Intra-class correlation 
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coefficient for eating a healthier diet was 0.29 and statistically significant. 40% of couples 
were at the same stage of change for adopting a healthier diet. 
After a cardiac event 
Bramwell (1986) investigated the experience of wives in their support role following their 
husbands’ first myocardial infarction (MI) using semi-structured interviews 2-3 weeks after 
the event. A large majority (82%) reported little or no difficulty with dietary management of 
their husbands. The difficulties they encountered in their support role were more related to 
the lack of communication from the husband and worries over him making a good 
recovery. A case control study (Russell et al., 1994) investigated the extent to which wives 
and offspring of men who have experienced a premature MI follow dietary 
recommendations after the event. In the MI group a median of 2.2 years had passed since 
the husband’s event. Significant differences were seen in all elements of the men’s diets 
compared to controls. The men in the MI group were consuming 33% of fat from total 
energy compared to 37% in controls. In the wives, significant differences were seen for 
energy, carbohydrates, fat and saturated fat. When these cross-sectional data from the MI 
families were divided into time points post MI (≤ 1 year to > 5 years), the results showed 
that whilst the husbands sustain the dietary changes they made following their event in the 
long-term, wives do not. For example, in husbands, saturated fat intake was at 10.1% of 
total energy at ≤ 1 year compared to 10.7% total energy at > 5 years (p=0.3939), whereas 
in the wives it was 11.1% of total energy at ≤ 1 year compared to 12.1% of total energy at > 
5 years (p=0.0409). Nevertheless, in comparing the changes in saturated fat intake 
between husbands and wives in the MI group and controls, there were significant 
differences for both husbands and wives in favour of reduced saturated fat intake for the MI 
group. 46% of men in the MI group were consuming < 10% of energy as saturated fat 
compared to 11% in control group. For wives, it was 24% consuming < 10% of energy as 
saturated fat compared to 13% in controls. Both of these results were highly statistically 
significant suggesting that this important key message regarding saturated fat was taken 
seriously in the MI group. 
Conclusions on diet 
Concordance for intake of food items which are strongly associated with cardiovascular 
health (increased fruit and vegetables and reduced saturated fat) was found in the 
EUROACTION couples, of whom less than half were not meeting guidelines for intake of 
these foods at the start of the study. Findings from my systematic review support these 
results with one study (Macken et al., 2000) investigating concordance for fat intake in 
couples where one had suffered a cardiac event, and found an almost identical correlation, 
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although the method of assessing fat intake was more robust in the EUROACTION study. 
Like the review of studies investigating concordance for smoking in couples, the studies 
reviewed here for dietary concordance have been conducted over a long period and in a 
variety of different countries and cultures. However, there is consistent evidence from the 
studies reviewed for concordance among couples for dietary habits with significant and 
positive relationships for most food items and nutrients. There are some inconsistencies, 
for example, in milk consumption. However, concordance for the consumption of fruits and 
vegetables and fat is clearly evident. In the studies using the more robust methodologies 
applying dietary analysis to food frequency data in order to estimate percentage of fat in 
the diet, the results are consistent and support concordance. This is still evident when fat 
consumption is broken down into types of fat – saturated, monounsaturated and 
polyunsaturated - and when different correlation methods are compared within the same 
study. Agreement for consumption of vegetables is amongst the strongest in the studies 
reviewed whatever statistical methodology was used. In addition, two of the studies found a 
low consumption of fruit and vegetables in both partners, well below the recommended 
level of 5 portions per day which accords with the findings at baseline in the EUROACTION 
study.  Two American studies identified that the female partner is usually the person 
responsible for food purchasing and preparation, although that does not necessarily 
indicate that the food choices of others in the family have not been taken into account. 
However, it does indicate that this person should always be included in dietary 
interventions to change food consumption in patients. 
The EUROACTION couples made healthy dietary changes together reducing saturated fat 
intake and increasing fruit and vegetable consumption in response to intensive support 
from dietitians in the multidisciplinary teams. There was concordance between couples for 
these changes. Only one other programme measured concordance for change and 
showed a similar but stronger effect in healthy couples. 
In several studies included n my review, the role of women was identified as being 
important in shaping family diets, and in particular in response to an illness developing in 
one spouse. Given that most of the EUROACTION partners were female, it is probable that 
they played an important role in improving the diets of both themselves and their husbands 
during the programme and in sustaining the changes one year after their partners’ acute 
cardiac event. 
However, whilst wives of men who had a myocardial infarction reported little difficulty in 
managing their husbands’ diets after an event in one study, they were shown to not 
necessarily sustain their own dietary changes as well as their husbands’ in the long-term in 
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another study. Nevertheless, they adhered to key messages, such as that given for 
saturated fat. 
3.3. Concordance for physical activity habits in couples 
Concordance was found for self reported habitual physical activity in the EUROACTION 
couples and this reflected typical activity undertaken in the year prior to the patients’ 
cardiac event. Concordance was also found in the number of steps recorded per day at the 
time of the initial assessment. This concordance should be seen in the context of a 
sedentary population with only a quarter of patients and partners meeting the European 
goal for physical activity at baseline. Although the number of steps recorded per day placed 
both partners in Tudor-Locke’s (Tudor-Locke and Bassett, 2004) ‘low active’ category, 
partners recorded a higher number and this is probably because, at the time of the first 
assessment, two thirds of the patients were still in the recovery period following their acute 
cardiac event. 
These results accord with the results of my systematic review of concordance for physical 
activity and exercise in couples where, in nearly all cases, there is a positive relationship 
demonstrated for physical activity behaviour in couples, and in most cases this is 
statistically significant. However, in the studies using correlation, effect sizes ranged from 
as low as 0.16 to as high as 0.60. This apparent heterogeneity in results is partly explained 
by the differences in how physical activity is measured, and in whom, and how 
concordance is evaluated in the studies. 
The lowest correlation coefficient reported was 0.16 for exercise participation in a small 
study from Quebec in Canada (Perusse et al., 1989). In the same study, the correlation for 
habitual physical activity was similar at 0.18 where physical activity was measured using 
the same methodology as the EUROACTION study with a 3 day activity record which 
included one weekend day. In a study conducted by the same researcher a year earlier 
(Perusse et al., 1988), the correlations were stronger, but this time, the population was a 
representative sample from the whole of Canada and leisure energy expenditure was being 
measured. The strongest correlation in this study was for activity level (0.60), which was 
derived from the total time spent on an activity and the total number of months for all 
reported activities, which was then classified into three groups: sedentary, moderate or 
active. 
Three studies measured concordance for leisure time physical activity (LTPA) only (Godin 
and Shephard, 1985, Aarnio et al., 1997, De Moor et al., 2011). In Canada, Godin 
investigated spousal influences regarding exercise looking at both intention to exercise and 
current physical activity levels. Using Godin’s current physical activity habits questionnaire, 
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they found a correlation coefficient of 0.24, almost identical to the result found in the 
EUROACTION couples, and 0.29 for intention. In Finland, Aarnio found a correlation 
coefficient of 0.19 using data from a central population registry to evaluate aggregation of 
activity in twins and their parents. Activity was assessed with two separate questionnaires, 
one validating the other. The assessment was robust and took frequency, intensity and 
duration into account and METs were assigned. In another study using data from the 
voluntary Netherlands Twins Registry, which included parents and their twins, and also 
assessed the twins as adults together with their spouses, De Moor measured leisure time 
physical activity (LTPA) with a ‘yes’ or ‘no’ to participation in exercise at 4 METs for one 
hour per week for at least 10 months. Type, frequency and duration were measured. The 
correlation coefficients were similar for both the parents of the twins 0.41and later for the 
twins as adults and their spouses 0.44. 
In the Portuguese study (Seabra et al., 2008), they measured occupational as well as 
LTPA and the overall correlation was 0.21, similar to my finding in the EUROACTION 
couples. This compared to a correlation of 0.29 for LTPA alone. 
Macken’s study from Nebraska (2000) was the only study to investigate concordance in a 
similar study population, namely male coronary patients and their partners. They asked for 
a yes or no answer to regular participation in exercise. They found a correlation coefficient 
of 0.20, close to that found in the EUROACTION couples, although the measurement of 
physical activity was more robust in the EUROACTION study. 
Two studies used odds ratios to measure concordance for physical activity reported 
positive results (Santariano 2002, Jurj 2006). In the study from Shanghai of women and 
their husbands (Jurj 2006) concordance for participation in sports or exercise was 
measured with a ‘yes’ or ‘no’ response to regular participation over the past five years. The 
study found an OR of 2.0 for husbands currently participating in exercise being associated 
with wives doing the same. In the study from California (Satariano et al., 2002), the 
population was older and so more like the EUROACTION couples. It used cross-sectional 
data from a longitudinal study, to ascertain determinants of physical activity in older adults 
and to establish whether LTPA in one partner predicted the same in the other. Significant 
associations were found, particularly in relation to vigorous physical activity, women being 
more likely to participate in moderately vigorous physical activity (OR 3.94) or highly 
vigorous physical activity (OR 6.5) if their husband did too. The odds were similar for men. 
Two studies evaluated physical activity using percentage agreement (Venters et al., 1984, 
Ju et al., 2011). In Venters’ study from Minnesota, the measure was daily sedentary 
behaviour (or no regular participation in work or leisure time physical activity). There was 
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60% agreement amongst the couples which was compared with 49% expected by chance. 
Ju’s study of Korean American dry cleaners from Chicago and their spouses measured 
work, leisure time and house related physical activity. The strongest percentage agreement 
was for leisure time activity (61%) which was not compared to expected values. However, 
pedometer data were collected which correlated with the self-reported data. 
Concordance for fitness 
Two of the studies from Canada (Perusse et al., 1987, Katzmarzyk et al., 2000) 
investigated concordance for fitness in families. These two studies were conducted by the 
same research group. The first study was from Quebec (Perusse et al 1987) and measured 
concordance for physical fitness indicators in couples.  It found positive and statistically 
significant intra-class correlation coefficients (ICC) and Pearson inter-class correlation 
coefficients (Pearson) for submaximal power output (ICC 0.25, Pearson 0.21), muscular 
strength (ICC 0.27, Pearson 0.22) and endurance (ICC 0.27, Pearson 0.30) in couples. 
The second study (Katzmarzyk 2000) used data from the Canada Fitness Survey to 
generate standardised risk ratios (SSR) in order to establish whether fitness in one partner 
predicts fitness in the other. Work capacity, strength, endurance and trunk flexibility were 
measured. The SRRs in spouses were statistically significant and greatest at the extremes 
of the probands’ (the referent family member for the survey) percentiles for all fitness 
measures (work capacity, strength and trunk flexibility). For example, for work capacity, the 
SRR for being fit in spouses was 1.63 married to fit probands (≥ 95th percentile) and 1.54 
for being unfit in spouses married to unfit probands (≤ 5th percentile). The SRRs in between 
these extremes were always lower. 
Assortative mating as a reason for concordance 
Researchers from Norway and the Netherlands (Tambs Kristian, 1992, Ask et al., 2012, De 
Moor et al., 2011) were interested in the extent to which assortative mating was 
responsible for concordance for physical activity in couples. The findings were not entirely 
consistent although there were some similarities. All three studies found positive significant 
correlations at the beginning of marriage, although this was defined at different time-points 
for each study. In two studies the correlation coefficient was at 0.61 at < 5 years (De Moor 
et al., 2011) and 0.29 < 1 year (Tambs Kristian, 1992). In the third study (Ask et al., 2012), 
the researchers were able to identify ‘future’ couples 12 years before they had entered into 
marriage or cohabitation and found a correlation coefficient of 0.22. Concordance 
increased over marriage duration in the two Norwegian studies, increasing from 0.29 to 
0.38 over 9 classifications of marriage duration ranging from < one year to > 20 years 
(Tambs Kristian, 1992): and from 0.30 (entry into relationship) to 0.41 (≥ 39 years of 
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marriage/cohabitation) (Ask et al., 2012). This was not the case in the Dutch study (De 
Moor et al., 2011) where the correlation was very strong at the beginning of the marriage 
(0.61) and reduced at 15 years or more of marriage to 0.47, which was still moderately 
strong. These results suggest that, whilst couples may choose each other based on the 
exercise or leisure activity phenotype, they may also become more concordant over the 
years. This is not necessarily because they become more inactive together, as shown by 
the findings of the study of older couples from California described above (Satariano et al., 
2002). Couples may choose to take on more active pursuits together in retirement, or one 
partner may actively support the other by joining them in walking or exercise, which has 
been prescribed for health reasons. 
Patterns of physical activity during marriage 
Cross-sectional and longitudinal data have shown that patterns of physical activity in 
couples during marriage appear to show an equal influence from each partner (Falba and 
Sindelar, 2007, Homish and Leonard, 2008, Franks et al., 2012). Falba calculated ORs for 
starting to participate in exercise for each partner where the other partner also started, was 
already a regular exerciser or never exercised. For husbands they were 1.5 for starting to 
exercise if the wife started to exercise, 1.6 if she exercised regularly and 0.8 if she never 
exercised. For wives the ORs were similar at 1.58, 1.93 and 0.71. The authors point out 
that a limitation of these analyses, drawing on data from two time points, is that it is not 
possible to see when changes were made or who initiated them. In addition, it does not 
include data from divorced or separated couples who are more likely be discordant. In their 
longitudinal study of couples in the first four years of marriage, Homish calculated ORs 
which show a significant prospective association between the premarital exercise habits of 
each partner and the other’s exercise habits. The wives were more or less likely to be 
exercising regularly  depending on whether or not husbands exercised before the marriage 
(OR 2.16). Equally husbands were more or less likely to be exercising regularly depending 
on whether or not wives exercised before the marriage (OR 2.10).  In the cross-sectional 
study of lifestyle in employees and retirees participating in an ongoing health screening 
programme (Franks et al., 2012), concordance for getting more exercise was lower than for 
eating a healthier diet (0.15) but still statistically significant. Just over one third of the 
couples were in the same stage of change for getting more exercise, and this was 
associated with self-efficacy for getting more exercise in women. 
 
A small experimental but non-randomised study by Wallace (1995) used a design to 
evaluate adherence to an exercise programme by comparing those attending a fitness 
programme as married pairs with married individuals attending alone. Married pairs were 
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significantly more likely to adhere, as measured by their average monthly attendance (54% 
married pairs v. 40% singles). The dropout in the married pairs was significantly lower (6% 
v. 43%) compared to those attending alone. Whilst there were no differences identified in 
motivation, in the singles 50% of those who dropped out said they did so for family 
reasons. Average attendance over each month was significantly correlated in the married 
pairs. 
 
Changing physical activity together 
By the end of the 16 weeks EUROACTION programme, with intensive support from the 
physical activity specialists to increase activity in daily life, and also experiencing a 
supervised exercise programme, both patients and partners had made impressive changes 
with more than half reaching the physical activity goals defined in the guidelines at the end 
of the programme, and sustaining these changes at one year. Pedometer data also 
showed increases in steps per day at both 16 weeks and one year shifting the couples up 
into the ‘somewhat active’ category as described by Tudor-Locke (2004). There was also 
concordance for these changes in the couples as those patients who made the most 
impressive changes were associated with partners who did the same. Equally, those 
patients who had not responded to the programme by making changes to their physical 
activity levels were associated with partners who did the same. 
The American study (Patterson et al., 1989) from San Diego in California, which used data 
from families participating in the intervention arm of a RCT of a family centred prevention 
programme, included in my systematic review, measured concordance for change in 
physical activity using the same tool (7 day PAR) as used in the EUROACTION study. 
Concordance for change in couples for energy expenditure (0.43) was almost identical to 
the result in the EUROACTION couples (0.40). 
After a coronary event 
Several studies have investigated the dynamics in couples with regard to physical activity 
and exercise after a coronary event in one partner, usually the husband. In many cases, 
spousal support is shown to be important. In an early study conducted Heinzelmann and 
Bagley (1970) of exercise participation in men, 80% exhibited good to excellent attendance 
in contrast to 40% where wives were neutral. In two studies of male cardiac patients post 
cardiac event or revascularisation procedure (Dracup et al., 1984, Macken et al., 2000), 
enthusiastic support from female spouses for exercise in their husbands was evident and 
accompanied by active participation in exercise themselves. 
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In Dracup’s study, a small RCT, where male coronary patients were randomised to either 
receive behavioural counselling with (Group 1) or without their wives (Group 2) or not at all 
(Group 3), the objective was to evaluate adherence to behavioural interventions, including 
weekly exercise (amount of time spent exercising at a prescribed target heart rate), and to 
establish the importance of spouses in improving adherence. Measurements were taken at 
baseline, 10 weeks and 6 months, thus allowing evaluation of adherence in both the 
shorter and longer term. Counselling was shown to have a positive effect in both Groups 1 
and 2 compared to a negative effect in Group 3.  In Group 1, the percentage change in the 
reported number of hours of exercise per week according to recommendations increased 
by +1.45 between baseline and 10 weeks and by +2.32 between baseline and 6 months. In 
spouses, these increases were +11.28 at baseline to 10 weeks although this was not 
sustained at 6 months (-0.51). In Group 2, the increase in exercising between baseline and 
10 weeks in patients was even better (+4.95) but not sustained at 6 months (-3.85) with a 
similar picture for spouses but more pronounced. It is possible that longer term 
maintenance of these changes in patients’ adherence to their exercise was facilitated by 
spousal support in Group 1. Lack of longer term maintenance in the spouses in both 
groups may have been the result of spouses seeing exercise as a priority for their 
husbands who were in need of physical rehabilitation, but not for themselves, although 
their initial enthusiasm for exercising was evident in the large changes between BL and 10 
weeks for spouses in both Groups 1 and 2. 
In Macken’s study of male coronary patients and their wives from Nebraska, 74% of the 
couples, where the husband had experienced a coronary event 8-10 weeks previously, 
were concordant in reporting their exercise behaviour with 118 concordant couples saying 
they both exercised regularly and only 9 saying they did not. In the discordant couples, it 
was more commonly the patient who reported exercising and the wives reporting that they 
did not. Overall, 87% of the patients reported exercising regularly, which is extraordinarily 
high, and probably related to their recent cardiac event or revascularisation procedure. The 
couples were recruited from multiple sites including an outpatient cardiac rehabilitation 
programme, which may account for this high prevalence of exercising. Participation in 
exercise was based on self-report with all of its limitations, although the validated 
Behavioral Risk Factor Surveillance System (BRFSS), from the Centers for Disease 
Control and Prevention in the US, was used. Of these 154 patients exercising regularly, 
118 of their wives reported exercising too, thus providing them with an important source of 
encouragement and support. In those couples who were exercising there were positive 
correlations for miles per session (r=0.33), times per week (r=0.30) and minutes per week 
(r=0.20), all statistically significant except for minutes per week. Missing from this study is 
! !
! 221!
information on the extent to which the couples were concordant for physical activity prior to 
the occurrence of the husbands’ cardiac event, and to what extent they sustained the high 
activity levels in the longer term, either alone or together. 
In Bramwell’s Canadian study (1986) of wives experiences in the support role after their 
husband’s myocardial infarction, one third of wives reported that their husbands carried out 
their exercise routines independently, and one quarter said that they encouraged exercise 
in their husbands by going out for walks with them. Whilst one quarter said that they had to 
actively encourage their husbands to rest, a third said that their husbands decided 
themselves when to rest.  Another cross-sectional study (Hong et al., 2005) investigating 
similarity of exercise behaviour in couples and spousal support during cardiac 
rehabilitation, couples were interviewed separately. Out of 99 couples, 49 couples had 
similar exercise habits. Among these 49 couples, 84% of the patients and spouses were 
both either making or maintaining changes. In this group there was a positive relationship 
between provision and receipt of support (beta coefficient of 0.52) indicating that when 
support for exercise was given it was recognised by the other. In the remaining 50 couples, 
exercise habits were different with 72% of the patients either making or maintaining 
changes and the spouses either not ready or ambivalent to change. There was no 
significant effect from partners in this group (beta 0.08). 
 
In the US, Dishman (1985) conducted a review of 9 studies to investigate the determinants 
of physical activity and exercise and found a positive association between spouse support 
and physical activity and exercise. No studies were found showing a negative or no 
association. The association was particularly strong for supervised exercise programmes. 
Conclusions on physical activity 
In this sedentary population of older coronary couples there was concordance for physical 
activity and an even stronger concordance for change at one year. The studies included in 
my systematic review support this finding, although many of them investigated 
concordance for leisure time activity and exercise as opposed to habitual physical activity. 
This may explain some of the stronger effect sizes for these measures as these are active 
pursuits which couples may chose to take on together. Explanation for concordance is 
inconclusive as concordance has been shown to vary over marriage duration but is higher 
at the beginning and later on in couples who have been married for decades. Older 
couples may be concordant for vigorous activity. 
Targeting female spouses is important because their attitude has been shown to be 
important in encouraging participation in exercise. They may also worry unnecessarily and 
! !
! 222!
have an adverse effect on their husband’s participation. At best they are probably effective 
in sustaining activity in the long-term although, not necessarily for themselves. 
When selecting a marriage partner, people seek others who share the same exercise 
habits or leisure pursuits and concordance increases in the later years of marriage 
duration. In addition, in men who experienced a cardiac event or revascularisation 
procedure, wives were, for the most part, supportive in joining their husbands in their 
exercise, which may have been medically prescribed. 
3.4. Impact on CVD Risk Factors 
During the course of the EUROACTION programme, these important lifestyle changes in 
diet and physical activity impacted on overweight, central obesity, blood pressure and lipids 
in the couples, and to a large extent these favourable changes were sustained at one year. 
In addition, concordance was found for these changes in risk factors in the couples where 
patients made the most impressive changes in association with partners who did the same. 
These improvements to the cardiovascular risk profile are mainly attributable to dietary and 
physical activity changes made by the couples rather than to an increase in prescribing. As 
expected, the prevalence of prescribing of cardio-protective blood pressure and lipid 
modifying medications in the coronary patient population was high. However, the same 
was not true for the partners. 
The benefits of healthy lifestyle changes on blood pressure lowering and lipid modification 
have been well documented. The European Guidelines on Cardiovascular Disease 
Prevention in Clinical Practice strongly recommend lowering blood pressure and lipid 
modification through weight control, increasing physical activity, and dietary measures 
(reducing saturated fat, moderating alcohol and sodium intake, increasing consumption of 
fruit, vegetables, fibre and whole-grains, consuming low fat dairy products and including 
fish). 
Weight Reduction 
A meta-analysis of twenty-five RCTs (Neter et al., 2003) was conducted to investigate the 
effect of weight reduction on blood pressure. A net 5.1 kg of weight loss (95% CI -6.03 to -
4.25) induced by either energy restriction or increased physical activity or both, reduced 
systolic blood pressure by -4.44 mm Hg (95% CI -5.93 to 2.95) and diastolic blood 
pressure by -3.57 mm Hg (95% CI, -4.88 to -2.25). 
A study (Stefanick et al., 1998) of post-menopausal women and men aged 30 – 65 years 
with low HDL-C and moderately elevated LDL-C randomised to either aerobic exercise or 
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the American National Cholesterol Education Programme Step 2 diet, or a combination of 
the two, or to a control group showed that combined diet and exercise is the most effective 
way to reduce LDL-C (-14.5±22.2 mg/dl p<0.05 in women and -20.0±17.3 mg/dl p<0.001 in 
men). This reduction was associated with weight loss (-3.1±3.7 kg p<0.001) which was 
achieved to the greatest extent in the combined exercise and diet group. In contrast, 
neither exercise alone, nor diet alone, compared to control had a significant LDL-C 
lowering effect. 
 
Blood pressure 
A diet high in fruit and vegetables, low fat dairy products and low in saturated and total fat 
was shown in the Dietary Approaches to Stop Hypertension (DASH) RCT (Appel et al., 
1997) to substantially reduce blood pressure. After consuming a control diet (in line with a 
typical American diet) for 3 weeks, 459 adults with systolic blood pressures of less than 
160 mm Hg were randomised to either stay on the control diet, or a diet high in fruit and 
vegetables, or a ‘combination’ diet which was high in fruit and vegetables, low fat dairy and 
low in saturated and total fat. During this time sodium intake and weight were maintained at 
the same level. The combination diet reduced blood pressure the most, 5.5 mm Hg and 3.0 
mm Hg reductions in systolic and diastolic respectively compared to the control diet 
(p<0.001). The diet high in fruit and vegetables only was also better than the control diet 
reducing systolic by 2.8 mm Hg and diastolic by 1.1 mm Hg compared to the control diet 
(p=0.07). Among those with a blood pressure ≥ 140 mm Hg systolic, the combination diet 
was even more successful reducing systolic by 11.4 mm Hg and diastolic by 5.5 mm Hg 
compared to the control diet (p<0.001). These differences were also significant for men 
and women, minority and non-minority groups alike. 
In fact, fruit and vegetable consumption is associated with a reduction in risk from coronary 
heart disease. A meta-analysis of six cohort studies from 2006, (Dauchet et al., 2006) 
showed that for every 80g increment per day of fruit and vegetables, there was a relative 
risk reduction from CHD of 4%. The pooled risk ratio was 0.96 (95% CI 0.93-0.99). 
In two systematic reviews, the first (Whelton et al., 2002) included a meta-analysis of 54 
RCTs, investigating the effect of aerobic exercise on blood pressure. There was a 
significant effect on blood pressure lowering in both those with raised and normal blood 
pressures (SBP -3.84 mm Hg [95% CI, -4.97 to -2.72 mm Hg] and DBP -2.58 mm Hg [CI, -
3.35 to -1.81 mm Hg]). The second review (Cornelissen et al., 2011) included a meta-
analysis of 28 RCTs to investigate the impact of resistance training on blood pressure. 
Whilst there was a significant effect in those with systolic blood pressures under 140 mm 
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Hg (SBP-3.9 [95% CI -6.4 to -1.2] mm Hg and DBP -3.9 [-5.6 to -2.2] mm Hg), individuals 
with systolic blood pressures of 140mm Hg or more, responded better to isometric 
handgrip training (SBP -13.5 [-16.5 to -10.5] mm Hg and DBP -6.1[-8.3 to -3.9] mm Hg), 
although this finding was based on relatively few studies of this mode of training. 
 
Lipids 
As summarised in a recent expert panel review (Astrup et al., 2011) coronary risk is 
reduced by 2-3% when 1% of energy intake from saturated fatty acids is replaced with 
polyunsaturated fat. Current advice is to lower saturated fat to less than 10% total energy 
and replace with unsaturated fats. 
However, eating a diet composed of various protective foods rather than just focussing on 
changing single nutrients is important in terms of reducing total cardiovascular risk (Perk et 
al., 2012). A twenty-five year follow up (Verschuren et al., 1995) of The Seven Countries 
Study started by Ancel Keys in 1958, demonstrated how differences between eating 
patterns, for example between northern and southern Europe, impacted on cardiovascular 
risk. The traditional Mediterranean diet from Southern Europe and Eastern European 
countries on the Mediterranean, with a high intake of fruits, vegetables, legumes, 
wholegrain products, fish and unsaturated fatty acids, especially olive oil, wine with meals, 
low consumption of red meat, low fat dairy and low saturated fat, was shown to be 
protective. A recent meta-analysis (Sofi et al., 2010) of published prospective cohort 
studies that used a score to assess adherence to the Mediterranean diet on health status 
and demonstrated that an increase of 2 points is associated with a10% reduction in 
incidence of CVD or mortality (pooled RR 0.90 95% CI 0.87 to 0.93) and also with an 8% 
reduction in all cause mortality (pooled RR 0.92, 95% CI 0.90 to 0.94). 
 
There is some evidence to suggest that exercise has a tangible impact on the lipid profile. 
Using data from 200 healthy, sedentary white fathers and sons recruited to the HERITAGE 
(Health, Risk Factors, Exercise Training and Genetics) Family Study, (Couillard et al., 
2001) divided the study population into four groups: those with normal lipid levels, those 
with isolated low HDL cholesterol, those with isolated high triglycerides and those with a 
combination of the two. The study showed that an intensive endurance exercise 
programme induced the greatest HDL rise (4.9% p<0.05) and in particular in HDL2 in the 
group with a combination of high triglycerides and low HDL, which was the group with the 
most to gain, being the most overweight and most centrally obese. In fact, this group lost 
the most weight and the most abdominal visceral (-10.8 ± 21.1 cm2 p<0.01) and 
subcutaneous fat (-12.7 ± 22.9 cm2 p<0.01). The HDL raising effect in this combination 
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group was shown in multiple regression analyses to be independently and significantly 
associated with a change in abdominal subcutaneous adipose tissue (10.6% p<0.01). 
 
Conclusion on risk factors 
The lifestyle changes that the couples made in the EUROACTION programme together 
were reflected in an improved risk factor profile. A programme that addresses lifestyle with 
an intensive multi-disciplinary family centred approach can reduce cardiovascular risk in 
both coronary patients and their partners. 
 
3.5. Psycho-social factors 
Although psycho-social factors were not within the scope of my thesis on lifestyle 
concordance the psychosocial measures of health related quality of life (HRQoL), I 
analysed emotions and perceptions of illness and I decided to report these results in my 
thesis out of interest. However, I have not explored the scientific literature on this topic in 
order to provide an informed discussion. Given the depth and complexity of the lifestyle 
results, and their interpretation in the context of my systematic review, the topic of psycho-
social health and its impact on concordance for my study population, is an area of future 
research. 
 
4. Strengths and limitations  
 
My thesis on concordance is based on the largest multi-national study of couples and their 
lifestyle, and the lifestyle changes these couples make when participating in a preventive 
cardiology programme. It is the only study, to my knowledge, to investigate concordance 
for change in coronary patients and their partners as all other studies have been in couples 
free of disease. Whilst it is an observational study, with the potential for both confounding 
and bias, it is the only way in which concordance for lifestyle between married partners can 
be assessed. However, concordance for lifestyle change could be measured in a 
randomised controlled trial and the design of such a trial is proposed under future research.  
 
This observational study benefitted from patients being identified consecutively with a high 
couple recruitment rate (78%) together with a good couple response rate at both 16 weeks 
(68%) and one year (65%) follow ups. In contrast, data from the EUROASPIRE survey 
reported that only 36.5% of patients eligible for cardiac rehabilitation attend such 
programmes. So the EUROACTION programme achieved a much higher participation rate 
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of both patients with their partners, thus making the concordance results generalisable to 
coronary patients and partners. Although the 1-year response rate was good, it was not 
optimal, which raises the potential for bias as those patients and partners who did not 
return may be different from those who did. As a consequence concordance may have 
been either overestimated (in the extreme case where all those not returning for follow-up 
were discordant couples) or underestimated (in the extreme case where all those not 
returning for follow-up were concordant couples) and the direction of this potential bias is 
not known. A future task is to compare the baseline characteristics of those couples who 
attended the follow-ups with those who did not, and to adjust the concordance analyses for 
any such differences to get a truer picture of concordance. For example, those who 
relapsed to smoking in the follow-up period may have been less likely to return at one year 
which may have exaggerated the one year quit rate if those not returning are not taken into 
account in the statistical analyses.  
 
The methodology for assessing lifestyle was objective in that it used trained nurses, 
dieticians and physiotherapists. Whilst assessment of lifestyle habits relied on self-report 
measures, which are less reliable than direct measurements, the assessment methods 
were nonetheless detailed and validated. For example, self reported smoking status was 
validated by the nurses with a breath carbon-monoxide measurement. Although blood 
cotinine would have provided a more sensitive validation of smoking habit this could not be 
measured because of cost. Dietary assessment relied entirely on self-reported habits using 
no direct measures of intake but was undertaken by qualified dieticians. The dieticians from 
all countries were all centrally trained by our Chief Dietician to use a standardised 
approach to probe for information from patients and partners in order to clarify food 
consumption. In addition multiple methodologies (diet history, 24 hour recall and food 
frequency questionnaire) were employed in order to increase the validity of the dietary 
assessment. In the same way qualified physiotherapists were used to measure physical 
activity and they were also centrally trained by our Superintendent Physiotherapist. The 
physical activity assessment based on self reports was strengthened with two direct 
measures; the pedometer recordings and the Incremental Shuttle Walk Test (to assess 
functional capacity). However, it was not possible to use the walk test data for my 
concordance analyses because the test was not conducted in partners. Data from the walk 
test would have enhanced the validity of the self reported habitual activity, more than 
pedometer data, because it could have shown an increase in fitness as a result of 
increased physical activity. Unfortunately pedometer recordings were missing in a large 
number of partners (couples held on to the pedometers) and these data could not be used 
with any confidence.  
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Although EUROACTION was a multi-national study it has not been possible to investigate 
concordance for lifestyle, and lifestyle change within countries, due to insufficient statistical 
power at a country level. Consequently, we do not know, for example, whether the same 
couple relationships for lifestyle hold true in Spain compared with Poland. Given the large 
cultural differences between countries in Europe in the construct, values and behaviour of 
families it would be particularly interesting to compare concordance for lifestyle, and 
concordance for change, between families from different countries. 
 
There are examples in the data set where values are missing, in particular for blood test 
results, and there has been no adjustment for such missing data in the statistical analyses.  
 
The concordance analyses are based on all couples taken together but, in fact, there are 
two types of couples: a male coronary patient with a female partner, and a female coronary 
patient with a male partner. My analyses are based on the assumption that concordance 
for lifestyle, and concordance for change, are the same for both types of couples but this 
may not be the case. There was a difference in both patient and partner response rates. 
Out of all those eligible for the EUROACTION programme male patients (69%) were more 
likely to attend than female patients (62%) and this gender difference has already been 
extensively reported by cardiac rehabilitation programmes. In addition in this study the 
female partners of male patients were more likely to attend with their husbands than the 
male partners of female patients. This heterogeneity in the types of couples participating 
raises the possibility that concordance for lifestyle, and concordance for change, may not 
necessarily be the same for each type of couple. My sample of couples was not large 
enough to analyse these two types of couples separately – the number of female patients 
and their male partners was too small - but it is a subject worthy of further investigation. A 
possible explanation of these observations is that whilst women are less likely to attend a 
programme of preventive care for themselves, they are more likely to attend in support of 
their husbands. In addition to improving preventive care for male patients, it also presents 
an important opportunity for providing preventive care for women in a family based 
programme. It would be worthwhile investigating the determinants of partner involvement in 
a lifestyle programme, both female partners of male patients and male partners of female 
patients.  
 
Given the evidence from my thesis and other observational studies on concordance for 
lifestyle, and concordance for change, should partners of patients with coronary disease be 
included in a preventive cardiology programme? In EUROACTION both patients and 
! !
! 228!
partners had a comprehensive lifestyle assessment and the partners participated in the 
programme in the same way as the patients. This increases the complexity and cost of the 
intervention which could only be justified if involvement of the partner made a real 
difference to the lifestyle changes made by patients. Therefore, a randomised controlled 
trial is required to evaluate the independent effect of including a partner in a prevention 
programme and its cost effectiveness. Patients with partners would be randomised to a 
programme with partners included, or an identical programme but without partners. For the 
latter partners would still be allowed to attend but they would not have a lifestyle 
assessment and nor would they be managed individually. In this way the independent 
contribution of partner involvement on the patients lifestyle changes could be measured, 
together with lifestyle changes in the partners themselves, by comparison with usual care. 
 
5. Implications for practice.  
Consistent with the findings from my systematic review of the scientific literature on 
concordance, there was concordance in couples in my study for all of the lifestyle habits 
investigated: smoking, diet and physical activity. Importantly, concordance was also 
demonstrated for change in these habits over one year; stopping smoking, eating less 
saturated fat, more fruit and vegetables and becoming more physically active. Patients 
changed in the same direction together, and this was usually for the better rather than the 
worse. Several factors for achieving healthy lifestyle changes in couples can be identified 
from this observational study. 
 
i. Spouses have the potential to be the best support for smokers trying to quit 
whether or not they are smoking themselves, but as shown in this study the 
best chances of a patient quitting are when they have a partner who does 
not smoke. A patient is also more likely to quit if the partner who smokes 
also quits smoking. So the smoking intervention should always include the 
partner with the object of achieving a non-smoking household.  
ii. Women play an important role in shaping family dietary patterns because 
they are usually responsible for the shopping and cooking. Therefore, the 
female partner of a male patient should always be included in the dietary 
intervention, rather than the patient in isolation, in order to change the 
dietary habits of the family as a whole. The concordance for lifestyle 
between married partners at the initial assessment and concordance for 
healthy dietary changes over one year, through reducing saturated fat and 
increasing fruit and vegetable consumption as shown in this study, strongly 
reinforce the value of involving the female partner of a coronary patient. 
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Whether the same applies to involving the male partner of a female patient 
remains an open question. Although a woman may be in control of dietary 
habits through shopping and cooking the male partner may be less willing to 
make healthy changes, thus limiting the changes the female patient can 
make. It is not possible from my study to analyse this question further as 
there were too few female patients attending as couples. Until further 
evidence becomes available the male partner of a female patient should still 
be included in the dietary intervention as education of the man may facilitate 
adoption of healthier eating habits. 
iii. For physical activity there was also concordance for change with patients 
and partners in this study becoming more physically active over one year. 
The involvement of the partner in this context, whether male or female, may 
be particularly important because the natural inclination of the partner is to 
limit the amount of physical activity undertaken by the patient in order to 
‘protect’ them. By educating the partner about physical activity and including 
them in the supervised exercise sessions will give them the knowledge, the 
practical and the confidence to support the patient to achieve and adhere to 
the exercise prescription. The opportunities for starting up active leisure 
pursuits together as a family are substantial. 
 
Important opportunities for lifestyle change present themselves when one partner in a 
couple falls ill. In this study population of coronary couples, exposure to tobacco was high, 
dietary habits were poor and they were physically inactive at the time coronary disease 
was diagnosed. The event in the patient spontaneously prompted changes like stopping 
smoking in some but these changes may not have been sustained without the support of 
the family and the multi-disciplinary team in the prevention programme. 
 
One reason for concordance for change being strongly evident was because the partners’ 
lifestyle and risk factors were assessed initially, just like the patients, and then they actively 
participated in the programme.  This would have increased the chances of both partners 
changing together.  
 
Observational analyses in the context of the EUROACTION trial provide strong 
observational data to support the involvement of partners of patients with coronary disease 
and my systematic review extends this observation to other populations of couples without 
coronary disease. 
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6. Implications for research 
The most important implication from this research based on observational data is to 
conduct a randomised controlled trial to evaluate the independent contribution of partner 
involvement in a preventive cardiology programme to patient lifestyle outcomes. This would 
involve comparing an intervention for coronary patients  which involved their partner, with 
one that did not, in order to quantify the contribution that partners make to changes in 
patients’ lifestyle and associated cardiovascular risk factors. The proposed design of the 
trial would be a randomised parallel group trial where patients would be randomised to a 
programme for patients alone with no involvement of partners other than is common 
practice in usual care. The programmes would run in parallel and the primary endpoint 
would be lifestyle and risk factor targets achieved, as defined in the guidelines, at one year 
in intervention compared to usual care.  
 
The EUROACTION programme aimed to reduce total cardiovascular risk through lifestyle 
change and management of associated cardiovascular risk factors but outcomes were 
reported for each aspect of lifestyle, and for each risk factor, separately because there is 
no score which incorporates smoking, diet and physical activity as well as other risk 
factors. A total risk score is available to estimate 10 year risk in individuals who have not 
yet developed disease (SCORE), but this score cannot be used to measure total risk 
following the development of disease. A second implication for research, therefore, is the 
development of a global EUROACTION healthy score which is able to measure overall 
achievement of a healthy lifestyle in a comprehensive multifactorial programme and also to 
measure concordance for healthy lifestyles in couples.  
Some lifestyle scores have already been developed but these are all in the context of 
primary prevention. In 2006 researchers from Harvard School of Public Health (Chiuve et 
al., 2006) created a healthy lifestyle score in order to assess benefits of adopting healthy 
lifestyles for the primary prevention of coronary disease in men, whether or not they were 
taking lipid lowering and blood pressure lowering medications. Two years later they 
reported on the application of the same healthy lifestyle score in relation to the primary 
prevention of stroke (Chiuve et al., 2008). Researchers from the EPIC Norfolk prospective 
population study (Khaw et al., 2008) developed a lifestyle score to investigate the 
combined impact of health behaviours and mortality in the general population.   Finally, two 
studies from Australia also presented lifestyle scores. The first was reported in 2005 
(Spencer et al., 2005) and was designed to show whether a healthy lifestyle score predicts 
survival in health elderly men, and the second in 2010 (Gall et al., 2010), in which 
researchers examined the relationship between current education, parental education or 
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educational mobility between generations and a healthy lifestyle in young Australian adults.  
 
Development of a lifestyle score based on the EUROACTION study, which will take 
account of smoking, diet and physical activity, needs to be derived from several elements 
of the EUROACTION assessment with appropriate weightings given to each variable. The 
proposed scoring system ranges from 0 to 4 for each item with a higher value indicating a 
healthier score. Smoking is given a score of either 0 for ‘YES’ to current smoking or 4 for 
‘NO’. The weighting for smoking widens the range of the score from 0 to 4 so as to reflect 
its importance in contributing to cardiovascular risk. The dietary part of the score could be 
based on consumption of saturated fat and fruit and vegetables. As dietary analysis of 
saturated fat consumption was based on a small sub-sample of patients and partners it has 
insufficient discriminatory power for the score, and therefore ascertainment of saturated fat 
consumption could be based on questions from the Food Habit Questionnaire instead. The 
first question is on the use of saturated fat for frying and roasting. This is scored as 0 for 
‘YES’ – uses saturated fat for frying and roasting and 2 for not using it. The second 
question to capture saturated fat consumption for the score could also be taken from the 
Food Habit Questionnaire and picks up the number of full fat options selected amongst 
dairy, sausages and burgers. This part of the score ranges from 0 (4 or more full fat options 
selected in addition to any other options) to 2 (1 or less full fat options selected with any 
low fat options as well). A score of 1 for this part included anything in between. The cut-offs 
of 3 full fat options accompanied by 2 low fat options or none eaten, to 3 none eaten 
options accompanied by 2 full fat, were chosen in order to maximise the sensitivity of the 
score to pick up changes made in saturated fat consumption. The fruit and vegetable score 
ranges from 0 to 2 with 2 indicating an achievement of the European recommendation, i.e. 
more than 400g per day and 0 representing an intake of less than half of this 
recommendation. 
The physical activity part of the score could incorporate habitual physical activity and 
fitness which are both derived from the 7-day physical activity (7D-PAR) recall data. 
Ideally, the data collected from more objective measures could be used, i.e. the pedometer 
and 10-metre incremental shuttle walk test (10M-ISWT) data. However this was not 
possible for the following reasons. Data collected from the pedometers at baseline are 
unsuitable because the motivational effect of wearing a pedometer for the first time may 
not be truly reflective of usual physical activity levels at that time. No 10M-ISWT data were 
available on partners as they did not perform this test. 
The data from the 7D-PAR assesses whether or not the patient/partner was achieving the 
European recommendation for physical activity: 30 minutes of moderate intensity activity 
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on 5 or more days of the week. The Caspersen and Powell classification as applied to the 
7D-PAR data allocates the responder to one of four activity categories. The highest: 
‘regularly active intensive’ could be applied to the score because this category would reflect 
a degree of fitness. A physical activity score of 2, therefore, would be equal to achieving 
the guidelines for physical activity in addition to meeting the requirements for category 4 on 
the Caspersen and Powell classification, whereas a score of zero equates to the opposite. 
In summary, the score (See Table 41) would range from 0-12 with a higher score 
representing the healthiest achievement on the programme. The score generates a 
continuous variable which can then be subject to analysis of concordance using a 
correlation coefficient. Mean changes in partners could be grouped according to quintiles of 
change in patients, similar to the analyses conducted for the dietary and physical activity 
variables in my study. In addition, analysis of linear regression could be conducted to 
analyse the association between changes in the score in one partner, and the other 
partner’s baseline measurement, in order to establish to what extent either partner group 
was dependent on the other for change.  
 
Table 41. EUROACTION Lifestyle Score *  
 0 1 2 3 4 
Smoking†  Yes - - - No 
Fruit and vegetables < 200g/day 200– 400g/day >400g/day - - 
Saturated fat used 
for frying and 
roasting 
Yes - No - - 
Low fat or high fat 
options (dairy, 
sausages and 
burgers) 
4 or more full 
fat options 
selected with 
any other 
options 
Anything in 
between which 
may be anything 
from: 
 
3 full fat choices 
selected 
accompanied by 2 
low fat or not 
eaten choices  
to 
3 not eaten 
options selected 
accompanied by 2 
high fat choices 
1 or less full fat 
option allowed 
with the rest 
being not eaten or 
low fat options. 
 
- - 
Physical activity‡ Not achieving 
guidelines and 
not category 4 
on C&P 
Achieving 
guidelines but not 
category 4 C&P 
Achieving 
guidelines and 
category 4 C&P 
- - 
 
Maximum score = 12 
Minimum Score = 0 
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*For the lifestyle score the baseline measurement for all factors (smoking, fruit, vegetable 
and saturated fat consumption, achieving physical activity guideline and a measure of 
fitness) is defined as what the patient and partner were doing in the month prior to the 
patient’s cardiac event.  
† Self reported not smoking at 16 weeks and 1 year is validated with a breath CO of ≤ 6 
ppm.  
‡Category 4 C&P is the most active category on the Caspersen and Powell Activity 
Classification and gives some indication of fitness – regularly active intensive  
 
A third implication for research from my study is to further investigate the potential gender 
differences given the two types of couples: a male coronary patient with a female partner, 
and a female coronary patient with a male partner. My study has shown heterogeneity in 
the types of couples participating which raises the possibility that concordance for lifestyle, 
and concordance for change, may not necessarily be the same for each type of couple. 
This interesting question could be addressed in a larger observational study than mine with 
a sufficiently large sample size of both female partners of male patients and male partners 
of female patients to permit a comparison of concordance for lifestyle and concordance for 
change. My hypothesis would be that concordance for lifestyle was the same regardless of 
the gender of the partner, but concordance for lifestyle change would be less in male 
partners of female patients compared to female partners of male patients.  
7. Conclusions of my thesis  
The EUROACTION study set out to demonstrate that a nurse-led family centred multi-
disciplinary approach to preventive care could contribute to a significant reduction in 
cardiovascular risk in priority groups identified in the European Guidelines on 
cardiovascular disease prevention in clinical practice. A key element to this approach is the 
involvement of the married partner because it was expected that partners can provide 
valuable support to patients who have experienced a coronary event and who need to 
make essential changes to their lifestyle in order to reduce the risk of disease recurrence. 
My study confirmed that couples are concordant, for whatever reason, for all of the lifestyle 
behaviours investigated and, importantly, couples are concordant for change out to one 
year. This concordance for change is especially strong in this population of couples where, 
most commonly, the patient is male and the partner female, and the partner shows support 
in helping with smoking cessation, dietary modification and adherence to exercise 
prescription. Whilst the evidence from my systematic review strongly reinforced my 
observations of couples having a concordant lifestyle, this is the first study, to my 
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knowledge, to show with longitudinal data that there is also strong observational evidence 
for concordance for change. 
 
This concordance for change was observed for quitting smoking, eating more healthily and 
becoming more physically active together. This benefits the patients by reducing their risk 
of recurrent disease but it also benefits the partners, most of whom are free of disease, by 
reducing their risk of developing CVD. If the adults in the household adopt a healthier 
lifestyle this might also impact on the offspring of such families as well. 
 
This observational evidence of concordance for change is sufficiently strong to justify a 
randomised controlled trial to evaluate the independent contribution of partners to patients 
achieving a healthier lifestyle, and the extent to which partners also benefit themselves. 
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9. APPENDICES 
APPENDIX I. NURSE ASSESSMENT DOCUMENT 
In the interest of paper saving, only the baseline nurse assessment document for patients 
is included in the appendices. Similar questions were asked of partners. In addition, at 16 
weeks and one year, hospitalisations, events, participation in the programme and elements 
of the programme received such as lifestyle counselling and additions to medications were 
assessed.  
 
!
!
Nurse Assessment Document 
For patients with coronary heart disease 
BASE LINE!
!
!
 
NAME:______________________________ 
!
 
UNIQUE ID           
 
!
Date of Recruitment:______________________ 
 
!
Current Recruiting Diagnosis:______________________ 
!
!
!
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!
I. Baseline information from medical notes (prior to the interview with the 
patient) 
 
Personal Details 
 
Title: Mr/Miss/Ms/Mrs 
Forename(s): 
Surname: 
Address: 
 
Post Code 
Telephone Number:             
 
National hospital number:         
 
GP (Family Doctor) contact details 
Name: 
Address: 
 
Telephone Numbers:             
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Q1. Date of birth of patient:       
 
Age____________________________ 
 
Q2. Sex M   =1  
 F   =2 
 
Recruitment Details and Entry Criteria 
3a. Where was the patient recruited from? 
 
! Inpatient 
! Outpatients 
! Specialist chest pain clinic 
! Community clinic 
! Other centre   (please specify) 
 
 
 
Name of recruitment centre/doctor 
 
 
Include any letters of referral to the CVPR Programme in the Family Medical Record 
 
Current Recruiting Diagnosis 
Q3b. If inpatient, what is the patient’s CURRENT recruiting diagnosis? 
Yes=1 No=2         Date of admission            Date of discharge    
                 Unknown=3 
(i) Acute myocardial infarction                
    
(ii) Unstable angina                
    
(iii) Stable angina pectoris                
! !
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(iv) Elective Revascularisation                
 a) PTCA                
    
 b) CABG                
 
Q3c. If outpatient, what is the patient’s CURRENT recruiting diagnosis? 
 
Yes=1 No=2               Date of appointment                         
Unknown=3 
(i) Acute myocardial infarction         
    
(ii) Unstable angina         
    
(iii) Stable angina pectoris         
    
(iv) Elective Revascularisation   
 a) PTCA         
    
 b) CABG         
 
Yes=1 No=2 Unsure=3 
Q4a. Is the patient eligible for Cardiovascular Prevention and Rehabilitation 
Programme (CVPR)? 
 
 
Q4b. If No please specify why 
! Severe heart failure 
! Impaired cognitive function 
! Severe physical disability 
! Other medical reason 
(please specify) 
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Yes=1 No=2 Unsure=3 
Q5a. Has the patient agreed to participate in the programme?  
 
Q5b. If NO, why not (please select one main reason) 
 
! No time =  1  
! Does not believe the programme is appropriate for him her = 2  
! Does not believe the programme is useful  =  3  
! Living too far away  =  4  
! Other (please specify)  =  5 
!
!
 
Yes=1 No=2 Unsure=3 
Q6a. Has the patient agreed to participate in the study?  
 
Q6b. If NO for Q5a and Q6a – end of questionnaire 
 
Q6c. If YES for Q5a and/or Q6a – continue with questionnaire 
 
Yes=1 No=2 Unsure=3 
Q7. Is this the patient’s first presentation?  
 
Q8. What cardiac investigations supported the diagnosis of Coronary Heart Disease? (tick 
as applicable) 
! History 
! Myocardial damage blood marker 
! Exercise Tolerance Test 
! Stress Echo 
! Angiogram 
! Myocardial perfusion scan 
 
Past Medical History as recorded in the Medical notes. 
! !
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Other current medical problems or diagnoses recorded in the medical notes or referral 
letter? 
 
 
 
 
 
 
 
 
 
 
Special note for patients recruited with myocardial infarction or unstable angina 
 
• In the local blood analysis section on the database, record the first blood cholesterol 
result immediately following admission or diagnosis of coronary disease. 
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Medication as recorded in the medical notes 
 
Yes=1 No=2 
Medication Not recorded = 3 
Q9a. Is the patient CURRENTLY taking any of the following medication?  
 
Q9b.  If YES, please list these drugs on the following pages.  
If NO, or Not Recorded, proceed to next question.  
 
 
Drug Type Yes/No/ 
Not 
recorded 
Generic Name Total 
Daily 
Dose 
Comments 
 
Aspirin or other anti-platelet 
drugs? 
    
Aspirin or other anti-platelet 
drugs? 
    
Beta blockers?     
ACE inhibitors?     
Antiotensin II receptor 
antagonists? 
    
Calcium antagonists?     
Potassium channel openers?     
Metabolic agents     
Nitrates?     
Diuretics?     
Diuretics?     
Other anti-hypertensive drugs?     
Digitalis glycosides?     
Antiarrhythmics?     
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Lipid lowering drugs: Statins     
Lipid lowering drugs: Fibrates     
Lipid lowering drugs: Resins     
Lipid lowering drugs: Other     
Anti-diabetic drugs: Insulin?     
Anti-diabetic drugs: Insulin?     
Anti-diabetic drugs: oral?     
Anti-diabetic drugs: oral?     
Anti-coagulants?     
Oral contraceptive pill?     
Hormone replacement therapy:     
Appetite suppressants/other 
antiobesity? 
    
Nicotine replacement therapy?     
Chewing Gum     
Nasal spray     
     
Inhalator     
Patches     
Losenges     
Buproprion     
 
II. Information and Consent 
 
1. Has the patient signed the consent? 
 
2. Does he have a First Assessment appointment? (Remind to fast beforehand and to bring 
food and drink unless you can provide.) 
 
3. Have you invited the partner to this appointment? 
 
4. If the patient is a premature presentation of CHD, does he/she have any siblings or offspring 
over the age of 18 living in the same household? 
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5. If YES give a letter to explain the EuroAction programme to the relative and partner (see 
Health Professional Manual for the template). 
 
III. Baseline Interview and Assessment with Patient 
 
If the patient arrives at the clinic after an overnight fast, take blood immediately and 
provide drink and breakfast if possible, or advise him/her to bring some food to the 
clinic. 
 
Random sample for GTT:        YES  NO 
 
Give the patient the ‘Beliefs and Experiences’ questionnaire pack, and the Euroqol 
questionnaire to complete. 
 
! Check the first part of the assessment form (Baseline information from medical notes) to 
ensure that you have completed as much of it as possible. Ensure that current recruiting 
diagnosis and the date of recruitment are recorded on the front of the assessment form. 
The date of recruitment is the same as the date of this first assessment. 
 
! Ask how he/she has been since discharge 
o Note history of presenting condition 
 
 
o Has the patient been revascularised since the recruiting coronary event? 
 
 
o PTCA or CABG? 
 
o Comments regarding recovery and symptoms 
 
 
 
Concurrent Medical Problems 
! Asthma 
! Arthritis 
! Other (specify) 
 
 
Yes =1 No=2 
N1a. Did the patient attend the baseline assessment?  
 
N1b. If YES, date of assessment ! ! ! ! ! !
!
!
!
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!
!
N1c. If NO, why not? 
o Patient died (Go to N1d) 
o Refused to attend 
o Change in health status 
o No time 
o Moved away 
o Personal reasons 
o Other (please specify) ----------------------------------------------------------------------------
----- 
 
 
N1d. Date of death ! ! ! ! ! !
 
N2a. Does the patient have a previous history of CHD? (DO NOT record the recruiting 
coronary event) 
Yes=1 No=2 
Unknown=3 
(i) Acute myocardial infarction  
   
(ii) Unstable angina  
   
(iii) Stable angina pectoris  
   
(iv) PTCA  
   
(v) CABG  
 
N2b. If YES, how old was the patient when he/she was first diagnosed with 
coronary 
 
disease?                  
(00=Unknown) 
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N3. If YES, in the last 6 months PRIOR to the recruiting coronary event, has the patient 
been seen by any of the following for his/her coronary condition 
 
! Cardiologist 
! Physician 
! General practitioner 
! Cardiac specialist nurse 
! Other   (please specify) 
 
 
! No one 
! Does not remember 
 
!
Cardiovascular Risk Factors 
!
SMOKING 
Yes=1 No=2 
Unsure=3 
N4a. Has the patient ever smoked?  
 
If NO, proceed to question N7 
 
N4b. If YES, for how many years in total has the patient smoked? (years)   
(00 = Unknown)   
 
N4c. In general how many did he/she smoke in the year PRIOR to the recruiting coronary 
event? 
Cigarettes No./day  
Pipe gs/wk  
Cigars No/day  
 
 
 
Yes=1 No=2 
Unsure=3 
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N4d. Was the patient smoking in the month PRIOR to the recruiting coronary event  
 
Yes=1 No=2 
Unsure=3 
N4e. Does the patient smoke now?  
 
N4f. If not smoking now how long ago did the patient stop? (months):  
 
N4g. If smoking now, how many does he/she smoke? 
Cigarettes No./day  
Pipe g./wk  
Cigars No./day  
 
N5a. Was the patient offered any personal advice (in the last year PRIOR to the recruiting 
coronary event) about stopping smoking by: 
! doctor 
! nurse 
! Other health worker 
(please specify) 
 
 
 
N5b. If YES, please specify how: 
! Verbal 
! Written materials 
! Smoking cessation clinic 
! Nicotine replacement therapy 
! Buproprion 
! Other   (please specify) 
 
 
 
Yes=1 No=2 
Unsure=3 
N5c. Has the patient attempted to stop smoking in the last year PRIOR to the 
recruiting coronary event? 
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N5d. If YES, please specify how: 
! Abstinence 
! Reduction 
! Nicotine replacement therapy 
! Buproprion 
! Smoking cessation clinic 
! Other   (please specify) 
 
 
 
N6a. Was the patient offered any personal advice (SINCE the recruiting coronary event) 
about stopping smoking by: 
! doctor 
! nurse 
! Other health worker 
(please specify) 
 
 
N6b. If YES, please specify how: 
! Verbal 
! Written materials 
! Smoking cessation clinic 
! Nicotine replacement therapy 
! Buproprion 
! Other   (please specify)  
 
Yes=1 No=2 
Unsure=3 
N6c. Has the patient attempted to stop smoking SINCE the recruiting coronary 
event? 
 
 
N6d. If YES, please specify how: 
! Abstinence 
! Reduction 
! Nicotine replacement therapy 
! Buproprion 
! Smoking cessation clinic 
! Other   (please specify) 
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N7. Carbon monoxide in breath (ppm):  
 
Assessment of Need for Referral to Smoking Cessation Service 
1. Is the patient nicotine dependent? 
!
!
!
Fagerstrom score: /10 
o 1-4    Low dependence 
o 5-6    Moderate 
o >7!!!!!High 
 
Fagerstrom Test for Nicotine Dependence 
1. How soon after you wake up do you 
smoke your first cigarette? 
o Within 5 minutes 
o 6-30 minutes 
o 31-60 minutes 
o After 60 minutes 
 
3 
2 
1 
0 
2. Do you find it difficult to refrain from 
smoking in places where it is forbidden? 
!
o Yes 
o No 
1 
0!
3. Which cigarette would you hate to give up 
most? 
!
o The first one in the morning 
o All others 
1 
0!
4. How many cigarettes per day do you 
smoke? 
!
o 10 or less 
o 11-20 
o 21-30 
o 31 or more 
0 
1!
2!
3!
5. Do you smoke more frequently during the 
first hours after waking than during the rest 
of the day? 
!
o Yes 
o No 
1 
0!
6. Do you smoke if you are so ill that you 
are in bed most of the day? 
!
o Yes 
o No 
1 
0!
 TOTAL  
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2. Is the patient ready to quit 
smoking? 
 
Stage of Change 
 
 Non smoker  
! Pre-contemplation Ask about smoking status on 
ongoing basis 
! Contemplation 
! Preparation 
 
 
Arrange follow up 
! Action 
! Maintenance 
 
Question Answer Stage 
 
 
Have you ever smoked? 
I. No 
II. Quit 
III. Now 
I. Non smoker 
II. Go to last question 
III. Go to next section 
Do you intend to quit in six 
months and have you tried to 
quit for at least 24 hours in the 
last year? 
I. No 
II. Yes 
I. Precontemplation 
II. Go to next question 
If YES, are you ready to quit 
within one month? 
I. Yes 
II. No 
I. Preparation 
II. Contemplation 
If you quit, did you quit within 
the last six months? 
I. Yes 
II. No 
I. Action 
II. Maintenance 
 
Date arranged for follow up in smoking cessation______________________________ 
 
Refer the patient to information regarding smoking in Family Support Pack 
 
BLOOD PRESSURE 
Yes=1 No=2                                                                               Unsure=3 
N8a. Has the patient been told (in the last year PRIOR to the recruiting 
coronary 
 
event) by a doctor (or other health worker) that he/she has high blood pressure?  
 
N8b, If NO, go to N10a 
Yes=1 No=2 
Unsure=3 
N8c. If Yes, was the patient offered any personal advice (in the last year  
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PRIOR to 
the recruiting coronary event) by a doctor (or other health worker) about 
blood 
 
pressure lowering?  
 
N8d. If YES, please specify how: 
! Verbal 
! Written materials 
! Blood pressure clinic 
! Other   (please specify) 
 
 
 
Yes=1 No=2 
Unsure=3 
N9a. Has the patient been (in the last year PRIOR to the recruiting coronary 
event) 
 
on a special diet prescribed by a doctor (or other health worker) about blood  
pressure lowering?  
 
N9b. If YES, please specify how: 
! By reduction of salt intake 
! By reduction of fat intake 
! By reduction of calorie intake 
! By reduction of alcohol 
! Other   (please specify) 
 
 
 
Yes=1 No=2 
Unsure=3 
N9c. Was the patient on regular medication for high blood pressure in the 
last 
 
year PRIOR to the recruiting coronary event?  
 
Yes=1 No=2 
Unsure=3 
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N10a. Has the patient been told (SINCE the recruiting coronary event) by a  
doctor (or other health worker) that he/she has high blood pressure?  
 
N10b, If NO, go to N12a 
Yes=1 No=2 
Unsure=3 
N10c. If Yes, was the patient offered any personal advice (SINCE the 
recruiting coronary event by a doctor (or other health worker) about blood 
pressure lowering? 
 
  
 
 
N10d. If YES, please specify how: 
! Verbal 
! Written materials 
! Blood pressure clinic 
! Other   (please specify) 
 
 
 
Yes=1 No=2 
Unsure=3 
N11a. Has the patient been (SINCE the recruiting coronary event) on a 
special diet 
 
prescribed by a doctor (or other health worker) about blood pressure 
lowering? 
 
 
N11b. If YES, please specify how: 
! By reduction of salt intake 
! By reduction of fat intake 
! By reduction of calorie intake 
! By reduction of alcohol 
! Other   (please specify) 
 
 
 
Yes=1 No=2 
Unsure=3 
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N11c. Is the patient CURRENTLY on regular medication for high blood 
pressure? 
 
 
N11d. If Yes, then select drug categories: 
 
! Beta-blockers 
! ACE inhibitors 
! Calcium Antagonists 
! Diuretics 
! Angiotensin II receptor antagonist 
! Other anti-hypertensive drug 
Yes=1 No=2 
Unsure=3 
N12a. In the 6 months PRIOR to the recruiting coronary event was the 
patient’s 
 
blood pressure measured?  
 
N12b. If YES, does the patient remember the level of his/her last blood pressure 
measurement? 
 
Yes = 1  
Told, doesn’t remember = 2  
Not told = 3  
 
N12c. If YES, what was the value 
 Value 
 
!N13.!Measurements!
  Reading 1  Reading 2 
Systolic BP (mm 
Hg): 
    
Diastolic BP (mm 
Hg): 
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Heart Rate     
 
Summary 
BP at recommended level                                   YES/NO 
Review of medication needed                             YES/NO 
Refer the patient to information regarding blood pressure in Family Support Pack 
 
CHOLESTEROL 
 
Yes =1 No =2 
Unsure =3 
N14a. Has the patient been told (in the last year PRIOR to the recruiting 
coronary 
 
event) by a doctor (or other health worker) that he/she has high blood cholesterol?  
 
N14b, If NO, go to N16a 
Yes=1 No=2 
Unsure=3 
N14c. If Yes, was the patient offered any personal advice (in the last year 
PRIOR to 
 
the recruiting coronary event) by a doctor (or other health worker) about 
cholesterol 
 
lowering?  
 
N14d. If YES, please specify how: 
! Verbal 
! Written materials 
! Lipid clinic 
! Other   (please specify) 
 
 
 
Yes=1 No=2 
Unsure=3 
N15a. Has the patient been (in the last year PRIOR to the recruiting coronary 
event) 
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on a special diet prescribed by a doctor (or other health worker) to lower 
his/her 
 
blood cholesterol level?  
 
N15b. If YES, please specify type of diet: 
 
! Reducing fat intake 
! Changing type of fat 
! Eating more oily fish 
! Eating more fruit and vegetables 
! Reducing calorie intake 
! Reducing alcohol 
! Other   (please specify) 
 
 
 
Yes=1 No=2 
Unsure=3 
N15c. Was the patient on regular medication for high cholesterol level in the 
last year 
 
PRIOR to the recruiting coronary event?  
 
Yes=1 No=2 
Unsure=3 
N16a. Has the patient been told (SINCE the recruiting coronary event) by a 
doctor 
 
(or other health worker) that he/she has high blood cholesterol?  
 
N16b, If NO, go to N18a 
Yes=1 No=2 
Unsure=3 
N16c. If Yes, was the patient offered any personal advice (SINCE the 
recruiting 
 
coronary event) by a doctor (or other health worker) about cholesterol 
lowering? 
 
 
N16d. If YES, please specify how: 
! Verbal 
! Written materials 
! Lipid clinic 
! !
! 270!
! Other   (please specify) 
 
 
Yes=1 No=2 Unsure=3 
N17a. Has the patient been (SINCE the recruiting coronary event) on a 
special 
 
diet prescribed by a doctor (or other health worker) to lower his/her blood  
cholesterol level?  
 
N17b. If YES, please specify type of diet: 
 
! Reducing fat intake 
! Changing type of fat 
! Eating more oily fish 
! Eating more fruit and vegetables 
! Reducing calorie intake 
! Reducing alcohol 
! Other   (please specify) 
 
 
 
Yes=1 No=2 Unsure=3 
N18a. In the 6 months PRIOR to the recruiting coronary event was the 
patient’s cholesterol measured? 
 
  
 
N18b. If YES, does the patient remember the level of his/her last blood cholesterol 
measurement? 
 
Yes = 1  
Told, doesn’t remember = 2  
Not told = 3  
 
N18c. If YES, what was the value 
 Value 
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Summary 
Cholesterol at recommended level                                   YES/NO 
Review of medication needed                                           YES/NO 
Refer the patient to information regarding cholesterol in Family Support Pack 
!
DIABETES 
N19a. Has the patient ever been told PRIOR to the recruiting coronary event by a doctor (or other 
health worker) that he/she has 
! Diabetes  
! Impaired glucose tolerance  
! Unsure  
! No  
 
N19b. If NO, go to N21a 
N19c. If YES, how was it being treated PRIOR to the recruiting coronary event? 
! Diet 
! Oral anti-diabetic medicines 
! Insulin 
 
Yes=1 No=2 Unsure=3 
N20a. Has the patient been offered PRIOR to the recruiting coronary event  
personal advice by a doctor (or other health worker) about treating his/her 
diabetes? 
 
N20b. If YES, please specify how: 
! Verbal 
! Written materials 
! Diabetic clinic 
! Other   (please specify) 
 
 
 
Go to N21c. 
 
N21a. Has the patient been told (SINCE the recruiting coronary event) by a doctor (or other health 
worker) that he/she has 
! Diabetes  
! Impaired glucose tolerance  
! Unsure  
! No  
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N21b.  If NO, go to N24a 
If YES, go to N21c 
N21c. How has the patient’s diabetes been treated SINCE the recruiting coronary event? 
! Diet 
! Oral anti-diabetic medicines 
! Insulin 
 
Yes=1 No=2 Unsure=3 
N22a. Has the patient been offered (SINCE the recruiting coronary event)  
personal advice by a doctor (or other health worker) about treating his/her 
diabetes? 
 
N22b. If YES, please specify how: 
! Verbal 
! Written materials 
! Diabetic clinic 
! Other   (please specify) 
 
 
 
N23. How is it CURRENTLY being treated? 
! Diet 
! Oral anti-diabetic medicines 
! Insulin 
 
Yes=1 No=2 Unsure=3 
N24a. In the 6 months PRIOR to the recruiting coronary event was the 
patient’s blood glucose measured? 
 
  
N24b. If YES, does the patient remember the level of his/her last blood glucose 
measurement? 
 
Yes = 1  
Told, doesn’t remember = 2  
Not told = 3  
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N24c. If YES, what was the value 
 Value 
 
 
Summary 
Glucose at recommended level                                   YES/NO 
Review of medication needed                                      YES/NO 
GTT sub-sample                                                              YES/NO 
 
Refer the patient to information regarding diabetes and impaired glucose tolerance in Family 
Support Pack 
MEDICATION 
 
The ‘Baseline information from medical notes’ information may be useful in completing this 
section with the patient 
Yes =1 No =2  
                                                                                                               Unsure =3 
N25a. Has the patient ever taken any of the following medication in the last year  
PRIOR to the recruiting coronary event?  
 
N25b.  If YES, please list these drugs on the following pages.  
If NO, or Not Recorded, proceed to question N26a.  
 
Yes=1 No=2 Unsure=3 
N26a. Is the patient CURRENTLY on any medication?  
 
N26b.  If YES, please list these drugs on the following pages.  
If NO, or Not Recorded, proceed to question N27  
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DRUG LIST 
 
Drug Type 
 
Generic Name Taking 
now 
Taking 
before 
Dose 
now 
Dose 
before 
Aspirin or other anti-platelet 
drugs? 
     
Aspirin or other anti-platelet 
drugs? 
     
Beta blockers?   
 
   
ACE inhibitors?   
 
   
Antiotensin II receptor 
antagonists? 
     
Calcium antagonists?   
 
   
Potassium channel openers?      
Metabolic agents   
 
   
Nitrates?   
 
   
Diuretics?   
 
   
Diuretics?   
 
   
Other anti-hypertensive drugs?      
Digitalis glycosides?   
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Antiarrhythmics?  
 
    
Lipid lowering drugs: Statins   
 
   
Lipid lowering drugs: Fibrates   
 
   
Lipid lowering drugs: Resins      
Anti-diabetic drugs: Insulin?   
 
   
Anti-diabetic drugs: Insulin?      
!
!
Drug Type 
 
Generic Name Taking 
now 
Taking 
before 
Dose 
now 
Dose 
before 
Anti-diabetic drugs: oral?   
 
   
Anti-diabetic drugs: oral?   
 
   
Anti-coagulants?   
 
   
Oral contraceptive pill?   
 
   
Hormone replacement therapy:      
Appetite suppressants/other 
antiobesity? 
     
Nicotine replacement therapy?      
Chewing Gum      
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Nasal spray   
 
   
Inhalator      
Patches      
Losenges      
Buproprion      
 
Does the patient have a GTN spray or tablets?                      Yes/No 
Organise supply if necessary 
Refer the patient to information regarding their cardiac medications in the Family Support Pack 
 
Summary 
Has the patient been prescribed the appropriate prophylactic medications? 
If not why not? 
 
Review of medication needed                                      YES/NO 
 
 
ADHERENCE TO MEDICATIONS 
 
N27a. In the year PRIOR the recruiting coronary event, has the patient missed taking or altered the 
dosage of his/her prescribed medication? 
 Missed  Altered 
Never =1    
Seldom =2    
Often =3    
Always =4    
 
N27b. If Often or Always, please specify why 
 Missed  Altered 
! Ran out of supplies    
! Forgot to take supply with him/her (if away from home)    
! Forgot to take medicine    
! Not convinced medicine was beneficial    
! Not convinced dosage was beneficial (more or less needed)    
! To avoid side effects    
! Cost of medicines    
! Other (please specify)    
 
!
!
!
!
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N28a. SINCE the recruiting coronary event, has the patient missed taking or altered the dosage of 
his/her prescribed medication? 
 Missed  Altered 
Never =1    
Seldom =2    
Often =3    
Always =4    
 
N28b. If Often or Always, please specify why 
 Missed  Altered 
! Ran out of supplies    
! Forgot to take supply with him/her (if away from home)    
! Forgot to take medicine    
! Not convinced medicine was beneficial    
! Not convinced dosage was beneficial (more or less needed)    
! To avoid side effects    
! Cost of medicines    
! Other (please specify)    
!
 
Identify the medications which cause the patient particular problems. Provide education 
and support. Refer to Family Support Pack for information regarding medications. 
 
 
Social History 
Education and Job Status 
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N29. How many years has the patient spent at school or in full time study?  (00 = unknown)  
 
N30. What is the highest level of education the patient has completed? 
 
! University, College or equivalent  =  1  
! Intermediate between Secondary level and University  =  2  
! Secondary School  =  3  
! Primary School only (or less)  =  4  
! Unknown  =  5  
 
N31a. What is the job status of the patient (PRIOR to the recruiting coronary event)? 
 
! Full time employed = 1  
! Part time employed = 2  
! Self employed = 3  
! Unemployed = 4  
! House person = 5  
! Full time education = 6  
! Retired = 7  
 
N31b. If retired 
! Age related=1  
! Heart disease related=2  
! Other illness=3  
! Personal choice=4  
!
SOCIAL CIRCUMSTANCES AND FAMILY HISTORY 
!
N32. How far (in km) does the patient live from the hospital?  
 
N33a. What is the patient’s marital 
status? 
Married/partner = 1  
 Divorced/separated = 2  
 Single = 3  
 Widowed = 4  
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N33b. Who does the patient live with in the same household (tick all that apply) 
 No. of 
persons 
! Lives alone  
! Spouse/Partner  
! Father  
! Mother  
! Brother(s)                how many  
! Sister (s)                 how many  
! Son(s)                how many  
! Daughter(s)               how many  
! Other (please specify number)  
 
Yes=1 No=2 Unsure=3 
N33c. If patient lives with spouse/partner can we contact them?  
N33d. Partners contact details: 
 
Title: Mr/Miss/Ms/Mrs 
 
Forename(s):     Surname: 
Telephone Number:         
GP or relevant contact person's details 
Name: 
Address: 
Telephone Number:         
Family History Of Coronary Heart Disease 
N34. Please complete the following table for the patient: 
ID 
No. 
 
 
1) 
Relationship 
(Father, Mother, 
Brother, Sister, 
Son, Daughter) 
 
 
Father 
Age 
(current age or 
age at death of 
deceased) 
 
 
History 
of CHD 
Age at 
Diagnosis of 
CHD 
(in years) 
 
Died of CHD Were they ever 
Screened for 
CHD 
 
 
2) 
 
Mother 
     
 
3) 
      
 
4) 
      
 
5) 
      
 
6) 
      
 
7) 
      
 
8) 
      
 
21
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!! ! ! !
Yes = 1 No = 2 
Don’t know = 3 
Yes = 1 No = 2 
Don’t know = 3 
Still alive = 4 
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
Yes = 1 No = 2 
Don’t know = 3 
!
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Family Information for Premature CHD Patients 
 
N35a. Patients with premature CHD (i.e. men under 55 years and women under 65 
years). Please complete the following for each of the following living relatives: 
Brother/Sister/Son/Daughter age 18 and above. Use additional sheets if necessary. 
 
(Address and phone number of the members of family remain at centre - not centrally 
stored) 
 
N35b. 
 
Relationship: Brother/Sister/Son/Daughter 
 
Title: Mr/Miss/Ms/Mrs 
 
Forename(s): 
Surname: 
Yes=1 No=2 
Unsure=3 
N35c. Can we contact the relative?  
 
N35d. If NO, why not? (tick all that apply) 
! Relative already being treated for heart disease 
! Relative seriously ill (non-cardiac) 
! No contact address 
! Not appropriate – patient has no contact with relative 
! Relative would not be interested/has no time (try to persuade) 
! Contact would cause distress/worry the relative (try to persuade) 
! Patient does not want the relative to know about patient’s health problems 
! Other   (please specify) 
 
 
 
Yes=1 No=2 
Unsure=3 
N35e. Do they live at the same address as the patient?  
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N35f. If NO, please specify the address: 
 
Address: 
 
Post Code 
Telephone Number:             
GP or relevant contact person's details (if known) 
Name: 
Address: 
 
 
Telephone Number:             
 
Use additional sheets if necessary 
 
HAD SCORE 
N38. 
Anxiety  
  
Depression  
 
GLOBAL MOOD SCORE 
N39. 
G.M.S  
 
EUROQOL SCORE 
N40. 
Euroqol  
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BLOOD SAMPLE FOR CENTRAL LABORATORY 
!
Yes=1 No=2 Unsure=3 
N41a. Has a venous blood sample been taken from the patient?  
N41b. If NO, state why not 
 
 
 
Yes=1 No=2 Unsure=3 
N41c. Was the patient fasting before blood sampling?  
  
N41d. If YES, state duration of fast before blood sampling:               hours  
  
N41e. For patients with Myocardial Infarction how long after the recruiting  
coronary event was blood taken for cholesterol measurement  
hours  
 
LOCAL MEASUREMENTS 
 
Total Cholesterol (mmol/l)   Glucose ToleranceTest:(subsample) 
     
LDL Cholesterol (mmol/l)   Fasting  
     
HDL Cholesterol (mmol/l)   1 hour  
     
Triglycerides (mmol/l)   2 hours  
     
Fasting Glucose (mmol/l)     
     
Random Glucose (mmol/l)     
 
 
For patients with Myocardial Infarction how long after the recruiting  
coronary event was blood taken for cholesterol measurement  ?  
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GOALS 
 
Smoking____________________________________________ 
 
Blood Pressure______________________________________ 
 
Cholesterol__________________________________________ 
 
Diabetes and Impaired Glucose Tolerance_______________________ 
 
 
ACTION POINTS 
 
1. Beliefs and Experiences 
 
i. Health Beliefs_________________________________________ 
 
 
 
ii. Views about Heart Disease. ______________________________ 
(Illness Perception) 
 
iii. HADS 
Anxiety__________________ 
 
 
Depression_______________ 
 
 
 
2. Medical Review Blood pressure              YES/NO 
 
Cholesterol                    YES/NO 
 
 
Diabetes                        YES/NO 
 
 
Cardio-protective medication  YES/NO 
 
 
Symptom management________________________ 
 
 !
3. Smoking________________________________________________________ 
 
 
4. For dietitian_____________________________________________________ 
 
 
5. For Physiotherapist _______________________________________________ 
 
 
6. Family to contact                                          YES/NO 
!
!
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APPENDIX II. SELF ADMINISTERED QUESTIONNAIRES  
These questionnaires were identical for both patients and partners at baseline, 16 
weeks and one year except for the wording in Part 2. Views about heart disease 
questionnaire (Illness Perception Questionnaire). Wording for partners can be seen 
in Figure 13 page 65. 
Heart Disease: Your Beliefs and Experiences 
(For patients with coronary heart disease) 
These questions are about your own beliefs and experiences of heart disease. There 
are no right or wrong answers. We want to know about your views on heart disease. 
They are an important part of this study. We ask that you complete the form and 
return it to the EuroAction nurse as soon as possible. 
Don’t take too long over your replies. Your immediate reaction to each item will 
probably be more accurate than a long thought out response. 
Part 1. Health Beliefs 
Please rate your answers to the following health belief questions by circling the most 
appropriate answer for you. 
N36a. Do you believe that smoking is harmful to your health? 
Not 
harmful 
Somewhat 
harmful 
Quite 
harmful 
Very 
harmful 
Extremely 
harmful 
!
N36b. Do you believe that being overweight (10kgs or more) is harmful to 
your health? 
Not 
harmful 
Somewhat 
harmful 
Quite 
harmful 
Very 
harmful 
Extremely 
harmful 
!
N36c. Do you believe that a high fat diet is harmful to your health? 
Not 
harmful 
Somewhat 
harmful 
Quite 
harmful 
Very 
harmful 
Extremely 
harmful 
!
N36d. Do you believe that drinking heavily is harmful to your health? 
(heavily = more than 5 days a week and more than 3 drinks a day) 
Not 
harmful 
Somewhat 
harmful 
Quite 
harmful 
Very 
harmful 
Extremely 
harmful 
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!
36e. Do you believe that not exercising regularly (at least 3 to 4 times a week) 
is harmful to your health? 
Not 
harmful 
Somewhat 
harmful 
Quite 
harmful 
Very 
harmful 
Extremely 
harmful 
!
N36f. Do you believe that feeling under regular stress (at least twice a week) 
is harmful to your health? 
Not 
harmful 
Somewhat 
harmful 
Quite 
harmful 
Very 
harmful 
Extremely 
harmful 
!
N36g. Do you believe that not taking prescribed medication is harmful to 
his/her health? 
Not 
harmful 
Somewhat 
harmful 
Quite 
harmful 
Very 
harmful 
Extremely 
harmful 
 
Part 2. Views about Heart Disease 
N37a.          My illness will last for a long time 
Strongly 
agree 
Agree Neither agree or 
disagree 
Disagree Strongly 
disagree 
!
N37b.         My symptoms come and go in cycles!
Strongly 
agree 
Agree Neither agree or 
disagree 
Disagree Strongly 
disagree 
!
N37c.        My illness has major consequences on my life!
Strongly 
agree 
Agree Neither agree or 
disagree 
Disagree Strongly 
disagree 
!
N37d.     Nothing I do will affect my illness!
Strongly 
agree 
Agree Neither agree or 
disagree 
Disagree Strongly 
disagree 
!
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N37e.     My treatment can control my illness!
Strongly 
agree 
Agree Neither agree or 
disagree 
Disagree Strongly 
disagree 
!
N37f.      My illness is a mystery to me/I don’t understand my illness!
Strongly 
agree 
Agree Neither agree or 
disagree 
Disagree Strongly 
disagree 
!
N37g.      When I think about my illness I get upset!
Strongly 
agree 
Agree Neither agree or 
disagree 
Disagree Strongly 
disagree 
!
N37h.     Worries or family problems caused my illness!
Strongly 
agree 
Agree Neither agree or 
disagree 
Disagree Strongly 
disagree 
!
N37i.    My illness is hereditary – it runs in my family!
Strongly 
agree 
Agree Neither agree or 
disagree 
Disagree Strongly 
disagree 
!
My illness is because of my diet or eating habits!
Strongly 
agree 
Agree Neither agree or 
disagree 
Disagree Strongly 
disagree 
!
My illness is because of smoking!
Strongly 
agree 
Agree Neither agree or 
disagree 
Disagree Strongly 
disagree 
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My illness is because of drinking alcohol!
Strongly 
agree 
Agree Neither agree or 
disagree 
Disagree Strongly 
disagree 
!
N37j.  My illness is because of a germ or virus!
Strongly 
agree 
Agree Neither agree or 
disagree 
Disagree Strongly 
disagree 
!
N37k.  My illness is because of chance or bad luck!
Strongly 
agree 
Agree Neither agree or 
disagree 
Disagree Strongly 
disagree 
!
Part 3. Hospital Anxiety and Depression Scale 
These questions are designed to help us know how you feel. Read each item and tick the 
reply which comes closest to how you have been feeling in the last week. 
1. I feel tense or wound up: 
 
o Most of the time 
o A lot of the time 
o Time to time, occasionally 
o Not at all 
8. I feel as if I am slowed: 
o Nearly all the time 
o Very often 
o Sometimes 
o Not at all 
 
2. I still enjoy the things I used to enjoy: 
 
 
o Definitely as much 
o Not quite so much 
o Only a little 
o Hardly at all 
 
9. I get a sort of frightened feeling like 
‘butterflies’ in the stomach: 
o Not at all 
o Occasionally 
o Quite often 
o Very often 
 
3. I get a sort of a frightened feeling as if 
something awful is about to happen: 
 
o Very definitely and quite badly 
o A lot of the time 
o Time to time, occasionally 
o Not at all 
 
 
10. I have lost interest in my appearance: 
o Definitely 
o I don’t take so much care as I 
should 
o I may not take quite as much 
care 
o I take just as much care as ever 
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4. I can laugh and see the funny side of 
things: 
 
o As much as I always could 
o Not quite so much now 
o Definitely not so much now 
o Not at all 
 
11. I feel restless as if I have to be on the 
move: 
o Very much indeed 
o Quite a lot 
o Not very much 
o Not at all 
 
5. Worrying thoughts go through my mind: 
 
o A great deal of the time 
o A lot of the time 
o Sometimes, but not too often 
o Only occasionally 
 
12. I look forward with enjoyment to things: 
o As much as I ever did 
o Rather less than I used to 
o Definitely less than I used to 
o Hardly at all 
 
6. I feel cheerful: 
 
o Not at all 
o Not often 
o Sometimes 
o Most of the time 
 
13. I get sudden feelings of panic: 
o Very often indeed 
o Quite often 
o Not very often 
o Not at all 
 
7. I can sit at ease and feel relaxed 
 
 
o Definitely 
o Usually 
o Not often 
o Not at all 
 
14. I can enjoy a good book, radio or TV 
programme: 
o Often 
o Sometimes 
o Not often 
o Seldom 
 
 
Part 4. Global Mood Scale 
Below are a number of words that describe feelings and emotions. Please read each 
item carefully and then mark the appropriate box next to that word. Indicate to what 
extent you have felt this way lately. Please use the following scale to record your 
answers. 
To what extent have 
you felt this way lately 
 
Not at 
all 
A little bit Moderately Quite a 
bit 
Extremely 
Active 
 
     
Dynamic      
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Bright 
 
     
Hard-working 
 
     
Lively 
 
     
Enterprising 
 
     
Relaxed 
 
     
Sociable 
 
     
Cheerful 
 
     
Self-confident 
 
     
 
Please check back that you have answered all the questions from the different forms. 
Thank you for your time. Please return in the envelope provided. 
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Part 5. Euroqol EQ-5D 
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EQ-VAS 
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APPENDIX III. DIETETIC ASSESSMENT DOCUMENT  
In the interest of paper saving, only the baseline dietetic assessment document for 
patients is included in the appendices. Similar questions were asked of partners. In 
addition, at 16 weeks and one year, changes in diet and weight were assessed.  
CORONARY PATIENTS 
Intervention Baseline 
 
 
DIETETIC ASSESSMENT DOCUMENT 
 
 
 
PATIENT NAME: 
 
UNIQUE ID     
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SECTION 1: BACKGROUND DETAILS 
 
HPC: 
 
 
 
 
 
 
 
PMH: 
 
 
 
 
 
 
 
SH: 
 
Occupation? 
 
Plans to return to work? 
 
Other social history 
 
 
 
DOB:  _____________ 
GENDER: M/F 
Have you ever seen a dietitian before?  Y/N 
If Yes what was it for? ________________________________________ 
_____________________________________________________
_________ 
Anthropometric Data 
Height (m)  
Weight (kg)  
BMI (kg/m²)  
Waist (cm)  
Estimated Energy Requirements (kcal)  
EER for Weight Loss (kcal)  
 
DATE OF ASSESSMENT: 
!
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SECTION A: 
 !
D1a. In the past year prior to the coronary event have you Yes  
been told by a doctor (or other health worker) that you are No  
overweight? Unsure  
 
 
D1b. If Yes, were you offered any personal advice prior to the Yes!  
coronary event by a doctor or other health worker about No  
weight loss? Unsure  
 
D1c. If YES, please specify who from: 
! Dietitian 
! Local support group (e.g. slimming club) 
! Fitness Instructor 
! Doctor 
! Nurse 
! Other   (please specify) 
 
 
 
D1d. If Yes, were you provided with written information? Yes!  
 No  
 Unsure  
 
D2a. Since the coronary event have you been told by Yes  
a doctor (or other health worker) that you are overweight? No  
 Unsure  
 
 
D2b. If Yes, were you offered any personal advice since the Yes!  
coronary event by a doctor or other health worker about No  
weight loss? Unsure  
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D2c. If YES, please specify who from: 
! Dietitian 
! Local support group (e.g. slimming club) 
! Fitness Instructor 
! Doctor 
! Nurse 
! Other   (please specify) 
 
 
 
D2d. If Yes, were you provided with written information? Yes!  
 No  
 Unsure  
 
D3a. In the last year prior to the coronary event, have you Yes!  
been on a special diet prescribed by a doctor or other health No  
worker for weight loss? Unsure  
 
D3b. If YES, please specify how: 
! By reduction of fat intake 
! By reduction of calorie intake 
! By reduction of carbohydrate intake 
! By reduction of alcohol intake 
! Other   (please specify) 
 
 
 
D4a. Since the coronary event, have you been on a Yes!  
special diet prescribed by a doctor or other health worker for No  
weight loss? Unsure  
 
D4b. If YES, please specify how: 
! By reduction of fat intake 
! By reduction of calorie intake 
! By reduction of carbohydrate intake 
! By reduction of alcohol intake 
! Other   (please specify) 
 
 
!
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PART B: FOOD HABIT QUESTIONS 
 
D5. In the month PRIOR to the recruiting coronary event did you eat any of the following fish 
dishes? 
 
 
 
 
Never or 
less than 
once per 
month 
1-3 
days 
per 
month 
1-2 
days 
per 
week 
3-4 
days 
per 
week 
5-6 
days 
per 
week 
Every 
day 
Amount PER 
DAY on days 
eaten 
White fish (no batter or coating) 
 
∗ ∗ ∗ ∗ ∗ ∗ 
 
 
 
grams 
Oily fish 
 
∗ ∗ ∗ ∗ ∗ ∗ 
 
 
 
grams 
Shellfish 
 
∗ ∗ ∗ ∗ ∗ ∗ 
 
 
 
grams 
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D6a. In the month PRIOR to the recruiting coronary event, how often did you eat vegetables? 
(DO NOT include potatoes or baked beans. 
DO include ALL fresh, tinned, frozen and dried vegetables and salad vegetables) 
 
Never or less than once 
per month 
1-3 days 
per 
month 
1-2 days 
per 
week 
3-4 days 
per 
week 
5-6 days per 
week Every day 
Amount PER DAY 
on days eaten 
∗ ∗ ∗ ∗ ∗ ∗ 
 
 
 
grams 
 
D6b. PRIOR to the recruiting coronary event, what did you eat in a typical week? 
Select from list below and add any additional vegetables below 
 
Mixed vegetables (cooked) 
 
[  ] Courgettes [  ] 
Mixed vegetables (raw) 
 
[  ] Cucumber [  ] 
Aubergine 
 
[  ] Green beans [  ] 
Asparagus 
 
[  ] Green salad [  ] 
Avocado 
 
[  ] Leeks [  ] 
Beetroot 
 
[  ] Mushrooms [  ] 
Broad beans 
 
[  ] Okra [  ] 
Broccoli 
 
[  ] Onions [  ] 
Brussels sprouts [  ] Peas [  ] 
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Cabbage (all kinds) 
 
[  ] Peppers (green, red, yellow, orange) [  ] 
Carrots 
 
[  ] Spinach [  ] 
Cauliflower 
 
[  ] Sweetcorn [  ] 
Celery 
 
[  ] Tomatoes [  ] 
Coleslaw 
 
[  ] Other 
PLEASE SPECIFY BELOW 
[  ] 
 
 
Please write in on the lines below any other vegetables in the last 7 days 
 
 
 
D7a. In the month PRIOR to the recruiting coronary event, how often did you eat fruit? 
(DO NOT include fruit juices. 
DO include ALL fresh and tinned fruit) 
 
Never or less than 
once per month 
1-3 days per 
month 
1-2 days 
per 
week 
3-4 days 
per 
week 
5-6 days per 
week Every day 
Amount PER DAY 
on days eaten 
∗ ∗ ∗ ∗ ∗ ∗ 
 
 
 
grams 
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D7b. PRIOR to the recruiting coronary event, what did you eat in a typical week? 
Select from list below and add any additional fruits below 
 
Fruit salad (also tinned fruit) 
 
[  ] Orange [  ] 
Apple 
 
[  ] Raspberries [  ] 
Banana 
 
[  ] Redcurrants, blackcurrants [  ] 
Cherries 
 
[  ] Strawberries [  ] 
Clementine 
 
[  ] Peach [  ] 
Grapefruit 
 
[  ] Pear [  ] 
Grapes 
 
[  ] Pineapple [  ] 
Kiwi fruit 
 
[  ] Plum [  ] 
Melon 
 
[  ] Dried fruit (like raisins, dates, figs) [  ] 
Mango 
 
[  ] Pomegranate [  ] 
Nectarine [  ] Other 
PLEASE SPECIFY BELOW 
 
 
Please write in on the lines below any other fruit in the last 7 days 
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D8. In the month PRIOR to the recruiting coronary event, how often did you drink any of the following 
alcoholic drinks? 
 
 
 
 
Never or 
less than 
once per 
month 
1-3 
days 
per 
month 
1-2 
days 
per 
week 
3-4 
days 
per 
week 
5-6 
days 
per 
week 
Every 
day ml/drink 
Low strength beer/lager 
(less than 3% by volume) 
* * * * * * 
 
 
 
ml/drink 
Normal strength 
beer/lager/stout/cider (less than 6% 
by volume) 
∗ ∗ ∗ ∗ ∗ ∗ 
 
 
 
ml/drink 
Strong beer/lager/stout/cider (6% 
and over by volume) 
∗ ∗ ∗ ∗ ∗ ∗ 
 
 
 
ml/drink 
Red/white wine ∗ ∗ ∗ ∗ ∗ ∗ 
 
 
 
ml/drink 
Spirits or liqueurs ∗ ∗ ∗ ∗ ∗ ∗ 
 
 
 
ml/drink 
Strong wines ∗ ∗ ∗ ∗ ∗ ∗ 
 
 
 
ml/drink 
Alcopops ∗ ∗ ∗ ∗ ∗ ∗ 
 
 
 
ml/drink 
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D9. In the month PRIOR to the recruiting coronary event, what milk did you usually 
consume? 
PLEASE SPECIFY BRAND/ MAKE 
! ≥ 4% fat milk =1  
! 2 – 3.9% fat milk =2  
! < 2 % fat milk =3  
! No milk use =4  
! Unknown=5  
 
D10. In the month PRIOR to the recruiting coronary event, what type of fat did you use when preparing 
food? 
 
TICK ONE OR MORE BOXES IN EACH COLUMN 
 None Saturated 
Fats 
Solid Vegetable 
fat/ 
Polyunsaturated 
Margarine 
(PUFA) 
Solid Vegetable 
fat/ 
Monounsaturated 
Margarine 
(MUFA) 
MUFA PUFA Ghee Other Don’t 
know 
Spreading          
Dressing          
On 
Vegetables 
         
Frying or 
Roasting 
         
Baking          
Stew, Soup, 
curry 
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D11. In the month PRIOR to the recruiting coronary event, if you ate meat, did they trim off the fat? 
 
 Tick one box 
Do not eat meat  
Trim most of the fat  
Trim some of the fat  
Do not trim the fat  
 
D12. For each of the foods listed below, please indicate the variety that you most often consumed in the 
month PRIOR to the recruiting coronary event. 
TICK ONE OR MORE BOXES FOR EACH FOOD 
 Do not eat Ordinary Low Fat Low 
Calorie 
Added 
Vitamin C 
Yoghurt, 
Fromage frais 
     
Hard Cheese      
Cream Cheese      
Cheese 
Spread 
     
Crisps      
Mayonnaise, 
salad cream, 
dressings 
     
Sausages, 
Beefburgers 
     
Fizzy drinks      
Squash      
 Type of Food e.g.$ Salmon,$ Beef,$ Peas,$Potato 
State%of%food%e.g. Canned,$Frozen, Fresh 
Cut%of%Food$e.g. Fillet Whole Small$Pieces 
Cooking% method% e.g.$ Fried,$Steamed,$Roasted,$Boiled Amount%Eaten%e.g. Portion$of$Fruit Slices$of$meat Tablespoons Cups 
 
Breakfast 
 
     
 
Mid- 
Morning 
 
     
 
Lunch 
 
     
      
Mid- 
Afternoon 
 
 
Evening 
Meal 
 
     
 
Supper 
 
     
 
Snacks 
 
 
 
     
 Type of Food State%of%food%e.g. Cut%of%Food$e.g. Cooking% method% e.g.$ Fried,$ Amount%Eaten%e.g. 
e.g.$ Salmon,$ Beef,$ Peas,$Potato Canned,$Frozen, Fresh Fillet Whole Small$Pieces 
Steamed,$Roasted,$Boiled Portion$of$Fruit Slices$of$meat Tablespoons Cups 
 
Breakfast 
 
     
 
Mid- 
Morning 
 
     
 
Lunch 
 
     
 
Mid- 
     
Afternoon 
 
 
Evening 
Meal 
 
     
 
Supper 
 
     
 
Snacks 
 
     
$
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Targets: 
Weight!Target:! _____________kg 
Dietary!Targets!Set: 
 
1. ____________________________________________ 
2. ____________________________________________ 
3. ____________________________________________ 
4. ____________________________________________ 
5. ____________________________________________ 
 
Date Comments*
*
*
*
*
*
*
*
*
*
*
*
*
*
 
Signature 
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APPENDIX IV. FOOD PROMPTS 
INTERVIEWER PROMPT/EATING HABITS. 
 
Prompts and probing 
All of the information is collected with a series of neutral prompts to encourage recall.  You should ask 
neutral questions which do not encourage a specific response. 
So, for individual foods, you should not say specifically “was that boiled or fried?” but “how was that 
cooked? For additional foods, you should not presume consumption of foods in specific combinations, 
for example you should say “what else did you have with that?” rather than “did you have butter on your 
potatoes?” 
However, where initial neutral prompts do not lead to further information it may be necessary to list a 
series of specific options eg “was that boiled, fried, roasted, grilled etc?” Always list the options. 
 
In general the following information is required: 
 
• What type of food or drink was it? 
• Did it have a brand or product name? 
• How was it bought?– fresh, canned, frozen, dehydrated etc? 
• Was it homemade – if so – what was in it? 
• How was it cooked – boiled, poached, fried etc? 
• If it was cooked in fat, or fat was used in pastry or cakes or any other dish, what sort of fat or oil was 
used? 
• If it was a dried / dehydrated product eg hot chocolate was it reconstituted using water, milk (specify 
type) or both? etc 
• Was the item coated before cooking?  Eg flour, batter, egg, breadcrumbs 
• Was it unsweetened, sweetened with sugar, or artificially sweetened? 
• Was it low fat / low calorie? 
 
Interviewer prompt/eating habits 
The prompts are arranged according to food type. They are not comprehensive, but offer a guide as to 
the type of information required. See end of this sheet 
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Food Prompter sheets 
 
Food 
group 
Description Portion size 
Bacon Lean or fat, smoked or unsmoked, cut eg back, 
middle, streaky 
Slices small , medium or 
large 
Baked beans Standard, Reduced sugar, Reduced salt. 
 
Size of tin, Spoon, Plateful 
Biscuits Name of biscuit 
Sweet or savoury, Chocolate covered, Iced, Filled 
(e.g. Jaffa cakes), 
Shop bought or home made 
 
Number of biscuits or 
crackers 
Bread 
 
White, Brown, Wholemeal, Wheatgerm (e.g Hovis), 
Granary  bread, Soda bread, French bread 
 
Naan, Paratha, Chapatti, Papadum, Puri, Pitta, Injera 
(African sour dough), 
West Indian bread –(check what type -fruit bun bread 
or hard dough bread) 
 
Sweet breads eg malt loaf, fruit loaf, sweet dough 
bread 
 
Fresh, toasted or fried (esp for paratha, chapatti, 
naan. Check if potato in bread) 
Type of oil, if any 
 
PROMPT: Ask about spread 
Small or large loaf 
Sliced or Unsliced 
Slice thickness 
Piece(S/M/L) 
Breakfast 
cereals 
Brand name of cereal or type (e.g. corn flakes) 
If Muesli – added sugar? 
 
PROMPT: Ask about amount of milk in cereal: e.g 
damp, normal, drowned 
Bowl (size, number and how 
full) 
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Cakes Sponge, fruit, icing, cream, flavour (esp. chocolate) 
If fruit: rich? 
Homemade, retail 
 
Slices (S,M,L) 
Individual 
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Food 
group 
Description Portion size 
Chips Frozen, home-made, take-away,  oven, microwave 
Thick cut, thin cut, crinkle cut (french fries) 
Type of fat used in cooking, if any. 
 
Spoons or  plateful 
Cream Single, whipping, double, fat % 
Elmlea, other non-cream substitute 
Spoons 
Crisps Brand name, standard or low fat, low salt. Flavour eg 
ready salted 
Type of crisps eg potato, corn, wheat vegetable, plantain 
If from a multipack 
 
Number and size of packet,  
handful (S,M,L), 
separate items 
Curry Vegetable curries – type of vegetable, type of fat used in 
cooking, if any. Other ingredients in recipe, if any 
PROMPT: Ask for recipe if home-made dish 
Spoons or  plateful 
Dairy 
desserts 
Name of dessert 
If instant dessert/custard/other milk based – type of milk? 
Brand name 
 
Bowl, spoons, slices, individual 
item, tub/pot 
Egg Type of egg (chicken/ duck/ chocolate) 
Method of cooking 
Type of fat used in cooking, if any 
 
Number and size of egg 
Fat spread Margarines – hard or soft, type of fat 
Reduced fat spread 
Low fat spread 
Very low fat spread 
Brand name and type. 
Oils - brand name and type. 
Ghee - type eg made with palm oil, butter or vegetable 
Number and size of spoons, 
Pat, Small tub, Thinly spread, 
Medium, Thickly spread 
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oil. 
 
Food 
group 
Description Portion size 
Fish Type of fish 
Fresh, frozen, dried, tinned (If tinned, what in eg oil, 
brine) 
Method of cooking (baked, fried (with or without 
coating), grilled, boiled, poached, curried) 
Type of fat used in cooking, if any 
Ingredients in recipe, if any 
Small, medium, large 
Fruit Name of fruit 
Fresh, frozen, canned, dried; dehydrated 
If canned – in juice or syrup 
Raw or cooked - If cooked, how prepared (stewed, 
baked, etc.) Type of fat used in cooking, if any. Any 
sugar added in cooking. 
Slices, number and size of 
spoons, individual items 
(S,M,L) 
Fruit juice Type of fruit 
Added vitamin C? 
Glass, bottle, can, carton, 
individual carton 
Gravy Homemade, fresh, packet, granules 
Thickened? With fat? 
Spoons, scoops 
Ice cream Type of ice cream (dairy, non-dairy), Brand name, 
Flavour. If label available: % fat 
 
Number of scoops or spoons, 
individual item, pot/tub 
Infant 
formula 
Brand name & type Number & size of 
scoops/spoons 
 
Jam Type of fruit, stone or seed fruit 
 
Number of spoons 
Lentils Colour: red, brown, yellow, green 
If dahl,, type of fat used in cooking, if any 
 
Spoons/plateful 
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Mayonniase/
salad cream 
Low calorie, low fat, brand name 
 
Spoons 
Food 
group 
Description Portion size 
Meat Type of meat (name of animal, cut of meat, 
preparation e.g. minced) 
Tinned, fresh, frozen, dried. 
Method of cooking (baked, roast, fried (with or without 
coating), grilled, boiled, poached, stewed) 
Type of fat used in cooking, if any 
Ingredients in recipe, if any 
Fat removed? / eaten? 
Skin removed?/eaten? 
 
Number of slices, pieces, 
individual items(including 
name e.g. wing), spoons 
plateful 
Meat dishes Homemade or retail (Brand name if available, price, 
outlet) 
Ingredients in recipe or from package 
Method of preservation (e.g. tinned, frozen) 
Method of cooking or preparation Ingredients 
 
Slices,  spoons, pieces,  
plateful 
Meat pies Type of meat 
Frozen or fresh 
Number of crusts (base, lid or both) 
Type of pastry (short, puff) 
Type of flour in pastry (white, brown, etc.) 
Slices, individual pie 
Milk Skim, semi-skim, whole, Channel Island or fat % 
Fresh, UHT, sterilized, tinned, fortified 
Dried, soya, condensed, evaporated 
Pints/ Litres 
Glasses/ Spoons 
in tea and coffee (normal, 
milky, dash) 
Nuts and 
seeds 
Brand name or name of nut/seed 
 
Number and size of packets,  
handful, separate items 
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Food 
group 
Description Portion size 
Pasta White, wholemeal, other colours or type. 
Fresh or dried 
Type of filling (e.g. ravioli, cannelloni) + type of pasta 
 
Spoons, plateful 
Pepper Chilli pepper or sweet pepper Spoons, plateful, individual 
Pies Type of pie 
Number of crusts, top or bottom 
Type of pastry (short, puff, flaky) 
Type of flour in pastry (white, brown, etc.) 
Slices, individual 
Porridge Made with milk or water?  Cornmeal or oatmeal? Spoons, bowl 
Potatoes 
& starchy 
roots 
Name of variety, Ordinary potatoes - old or new 
Sweet potatoes, Yam, cassava, Plantain, Mattoke, 
How prepared (boiled, mashed etc) 
Foo Foo – what is it made with, how prepared? 
If jacket – was skin eaten 
Type of fat used in cooking, if any 
Number of potatoes (sizes), 
number and size of spoons. 
If plantain, how many 
(remember often cut in half 
before frying) 
Powdered 
drinks 
Made up with milk (see below), water? Sugar added? 
Low fat/low calorie 
Tsp, glass, mug 
Puddings  Spoons 
Rice White or brown 
Rice with added ingredients (e.g. paella, biryani) 
Fried? 
Plateful or number of spoons 
Rolls As for bread plus: 
Soft, crusty, hamburger, hot dog, iced or plain 
Roll or bap 
 
Salad Name of salad, list of ingredients 
Dressing? 
Prompt: Ask about dressings 
Plateful or spoons, leaf, bowl 
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Food 
group 
Description Portion size 
Sauces Name of sauce or dip and name of food with which it 
was served 
Number and size of spoons, 
 
Sausages Type of meat 
large (8 per lb) or small (16 per lb e.g. chipolattas) 
Number and size 
Soft drinks Brand name & flavour 
Concentrate  or ready to drink 
Standard or low calorie 
Still or carbonated 
Glass, Pints, Litres 
Can/bottle 
Carton (individual) 
Soups Brand name, type (e.g. cream, clear, dried, tinned) 
Homemade / fresh 
Vegetable based, Meat based, Pulse based (Rasam) 
Bowl (size, number and how 
full) 
 
Sugar White, brown or demerera Number of spoons 
Sweets/choc
olates 
Brand name of sweet or chocolate, or type 
 
 
Number of pieces and size of 
bar, individual, packet size 
 
Tea/coffee Amount of milk: very milky, some milk, dash, no milk 
Type of milk/whitener 
Sugar 
Cup/mug 
Large/small 
Spoons 
Vegetables Name of vegetable 
Fresh, frozen, canned, dried; dehydrated 
If canned –what in? 
Raw or cooked - If cooked, how prepared (boiled, 
fried, etc.) Type of fat used in cooking, if any. 
 
Slices, number and size of 
spoons, plateful 
individual 
Yoghurt and 
fromage 
frais 
Brand name, type (low fat, low calorie, etc.) flavour 
With fruit/other eg jam 
 
Size of carton or number and 
size of spoons 
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Food 
group 
Description Portion size 
Take-away 
food, fast 
Name of food, item from menu, name and address of 
outlet 
Size of portions of each item of 
food, price 
Mixed dishes- 
homemade or 
ready meals 
Ingredients in recipe or from package 
Method of preservation (e.g. tinned, frozen) 
Brand name if available, price, outlet 
Method of cooking or preparation 
Number of slices, size of 
spoons, pieces, fraction of 
packet 
Sandwiches Home-made or shop-bought 
Type of bread 
Margarine, butter, mayonnaise, salad cream 
List of items in filling (probe for salad, etc.) 
Crusts eaten? 
Number of slices or rolls or 
baps 
Slices or pieces 
 
 
Commonly consumed additional food prompt sheet 
 
The commonly consumed additional food prompt sheet lists foods frequently eaten in combination with 
other foods. 
 
COMMONLY CONSUMED ADDITIONAL FOOD PROMPT SHEET 
Tea, coffee Milk, sugar, artificial sweetener, biscuit, cake, savoury snacks, Indian 
sweets etc 
Bread Spread, topping 
Sandwich Salad, mayonnaise, pickle, spread, other fillings 
Cereal Milk, sugar, fruit, yoghurt, fruit juice, artificial sweetener 
Baked potato Butter, fat spread, sour cream, other topping or filling 
Boiled Potatoes Butter, fat spread 
Mashed potato Butter, fat spread, milk, cream, mustard, gravy 
Vegetables Butter, fat spread, ghee, seeds/nuts 
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Salad Vinaigrette, mayonnaise, oil 
Soup Breads /roll, butter, dried shrimp, croutons, cream 
Meat Gravy and sauces e.g. mustard, horseradish, cranberry 
Dahl Breads/rolls, idli, dosa, vada, rice, ghee, seeds/nuts, yogurt (raita) 
Curry Breads, rice, chutneys, pickles, chillies, yogurt (raita) 
Ice cream 
Kheer or other 
dairy desserts 
Sauce, topping, fruit, nuts 
Dessert, pudding 
Indian sweets 
e.g.burfi, halwa 
Custard, cream, ice cream, nuts, sweet sauces 
Alcoholic drink Snack food eg crisps, peanuts, bombay mix, puffed rice and other fried 
flour snacks 
 
ESTIMATION OF PORTION SIZE. 
At the beginning of the interview the subject is introduced to the process and told that s(he) will be asked 
to provide details of what they have eaten and an estimate of portion size.  Portion sizes can be given in 
terms of packages (eg 1 kit kat (2 sticks), ½ of a 420 g tin baked beans), household measures (eg one 
level teaspoon of sugar) or pictures in the food atlas.  The subject can use whichever method is easiest 
for him or her.  If the food comes in a package of a certain size this is probably the most accurate way of 
estimating portion size. It would be useful if you could probe for this information and ask to see the 
package if this will help with identification of the precise type of food and the size or weight in grams. You 
can record the weight in grams from a packet. Do not let subjects guess weights (“Oh, I’d say it was 
about 2 ounces”) as most people are very poor at guessing weights accurately. If the respondent gives 
you an amount in spoons it is important to check that they are using the correct name for the spoon ie 
some people call a dessertspoon a tablespoon. If necessary, get the respondent to show you the spoon. 
Remember to ask about leftovers or other food not consumed, e.g. spilt.  A prompt for second helpings is 
also included. 
 
Use of food atlas 
Atlases contain sets of photographs of portion sizes, additional guide photographs for other foods that 
come in defined portion sizes e.g. bread rolls and also pictures of a variety of household measures e.g. 
mugs, tumblers etc.  For some foods, there may be more than one portion of food shown in each 
photograph e.g. Cheddar cheese a slice, square and grated pile of cheese are present on each plate.  
The slice, square and grated pile of cheese each have the same weight. 
The respondent is asked to select the picture in the food atlas which most closely resembles the amount 
that s(he) ate the day before.  To help the respondent select the most appropriate picture there is a full 
size picture of the plates and bowl which were used in the photos.  The appropriate picture of plate or 
bowl should be visible whilst the respondent makes his/her selection. 
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Equivalent foods 
Where the food s(he) consumed is not included within the food atlas s(he) or you may choose pictures 
relating to a food of sufficiently similar shape and/or consistency. 
 
After the respondent has selected a picture it is important to remember to ask them whether they ate the 
whole portion.  If not, it is necessary to find out what proportion was left. 
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APPENDIX V. PHYSIOTHERAPY ASSESSMENT DOCUMENT  
In the interest of paper saving, only the baseline physical activity assessment document for 
patients is included in the appendices. Similar questions were asked of partners. In addition, 
at 16 weeks and one year, changes in physical activity variables were assessed.  
 
 
 
 
 
INTERVENTION HOSPITAL 
CORONARY PATIENTS 
 
 
PHYSIOTHERAPY ASSESSMENT DOCUMENT 
 
 
PATIENT NAME: 
 
UNIQUE ID     
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BASELINE ASSESSMENT 
 
 
SECTION 1: BACKGROUND DETAILS 
 
HPC: 
 
 
 
 
 
 
 
PMH: 
 
 
 
 
 
 
 
SH: 
 
Occupation? 
 
Plans to return to work? 
 
Other social history 
 
 
 
SECTION 2: HABITUAL PHYSICAL ACTIVITY 
 
P1a. In a typical week (over 7 successive days) in the year PRIOR to the recruiting coronary event 
record below all the activities that the patient did for at least 10 minutes at a time. 
 
MODE OF 
EXERCISE 
FREQ 
/WK 
DURATION 
IN 
HOURS 
INTENSITY 
*LIGHT/ 
MODERATE/ 
VIGOROUS 
METS Kcal Score 
(Freq. x 
Duration x 
METS) 
      
      
      
      
      
DATE OF ASSESSMENT: 
!
! !
! 326!
      
      
      
TOTAL 
Kcal/week 
 
TOTAL 
kcal/day 
 
 
 
P1b. Schoenborn activity classification: 
 
Sedentary: 0.1-1.4 kcal/kg/day =1 
Moderately active: 1.5-2.9 kcal/kg/day =2 
Very active: 3.0 + kcal/kg/day =3 
 
P1c. Caspersen and Powell activity classification: 
 
Sedentary: No leisure time physical activity =1 
Irregularly active: Activity performed < 3times/wk, <20 min bout or 
both 
=2 
Regularly active, 
not intensive: 
≥ 3 times/wk, ≥ 20 min bout and either < 60% of 
maximum cardiovascular respiratory capacity** 
=3 
Regularly active 
intensive: 
≥ 3 times/wk, ≥ 20 min bout and either ≥ 60% of 
maximum cardiovascular respiratory capacity** 
and involving dynamic activity of the large muscle 
groups 
=4 
 
**Caspersen and Powell activity classification: 
Age and Sex-specific Estimates of Maximum Capacity 
 
Men: Maximum capacity (METS) = [60-0.55 x age (years)] ÷ 3.5 
Women: Maximum capacity (METS) = [48-0.37 x age (years)] ÷ 3.5 
 
60% maximum capacity= Maximum capacity x 0.6 
Light = Felt easy, no shortness of breath;  
Moderate = Felt comfortable, makes the patient feel warm, slightly 
out of breath but able to speak a sentence;  
Vigorous = Felt hard, felt short of breath and sweaty. 
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P1d. In the year PRIOR to the recruiting coronary event was the patient achieving the 
European guidelines for physical activity? Aerobic exercise (e.g. walking, swimming, 
bicycling) for 20-30 min 4-5 times a week 
 
Yes=1 No=2 Unsure=3  
 
P2a. In the last seven days record below all the activities that the patient did for at least 10 
minutes at a time. 
 
MODE OF 
EXERCISE 
FREQ 
/WK 
DURATION 
IN 
HOURS 
INTENSITY 
*LIGHT/ 
MODERATE/ 
VIGOROUS 
METS Kcal Score 
(Freq. x 
Duration x 
METS) 
      
      
      
      
      
      
      
      
TOTAL 
Kcal/week 
 
TOTAL 
kcal/day 
 
 
 
P2b. Schoenborn activity classification: 
 
Sedentary: 0.1-1.4 kcal/kg/day =1 
Moderately active: 1.5-2.9 kcal/kg/day =2 
Very active: 3.0 + kcal/kg/day =3 
 
Light = Felt easy, no shortness of breath;  
Moderate = Felt comfortable, makes the patient feel warm, slightly 
out of breath but able to speak a sentence;  
Vigorous = Felt hard, felt short of breath and sweaty. 
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P2c. Caspersen and Powell activity classification: 
 
Sedentary: No leisure time physical activity =1 
Irregularly active: Activity performed < 3times/wk, <20 min bout or 
both 
=2 
Regularly active, 
not intensive: 
≥ 3 times/wk, ≥ 20 min bout and either < 60% of 
maximum cardiovascular respiratory capacity** 
=3 
Regularly active 
intensive: 
≥ 3 times/wk, ≥ 20 min bout and either ≥ 60% of 
maximum cardiovascular respiratory capacity** 
and involving dynamic activity of the large muscle 
groups 
=4 
 
**Caspersen and Powell activity classification: 
Age and Sex-specific Estimates of Maximum Capacity 
 
Men: Maximum capacity (METS) = [60-0.55 x age (years)] ÷ 3.5 
Women: Maximum capacity (METS) = [48-0.37 x age (years)] ÷ 3.5 
 
60% maximum capacity= Maximum capacity x 0.6 
 
P2d. Is the patient CURRENTLY achieving the European guidelines for physical 
activity? Aerobic exercise (e.g. walking, swimming, bicycling) for 20-30 min 4-5 times a 
week 
 
Yes=1 No=2 Unsure=3  
 
P3a. Has the patient been told in the last year PRIOR to the recruiting coronary event by a 
doctor (or other health worker) that he/she needs to increase their physical activity? 
 
Yes=1 No=2 Unsure=3  
 
P3b. If YES, was the patient offered any personal advice (in the last year PRIOR to the 
recruiting coronary event) by a doctor or other health worker about increasing physical 
activity? 
 
Yes=1 No=2 Unsure=3  
 
P3c. If YES, please specify who from: 
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! Physiotherapist 
! Exercise professional 
! Doctor 
! Nurse 
! Dietician 
! Other   (please specify) 
 
 
 
P4a. Has the patient been told SINCE the recruiting coronary event by a doctor (or other 
health worker) that he/she needs to increase their physical activity? 
 
Yes=1 No=2 Unsure=3  
 
P4b. If Yes, was the patient offered any personal advice (SINCE the recruiting coronary 
event) by a doctor or other health worker about increasing physical activity? 
 
Yes=1 No=2 Unsure=3  
 
P4c. If YES, please specify who from: 
! Physiotherapist 
! Exercise professional 
! Doctor 
! Nurse 
! Dietician 
! Other   (please specify) 
 
 
 
P5a. Has the patient (in the last year PRIOR to the recruiting coronary event) been provided 
with an individualised exercise programme prescribed by a doctor (or other health worker)? 
 
Yes=1 No=2 Unsure=3  
 
P5b. If YES, in a typical month PRIOR to the recruiting coronary event has the patient 
followed this prescription? 
 
! Every week = 1 
! Most weeks (at least 3 out of 4 weeks) = 2 
! Some weeks (at least 2 out of 4 weeks) = 3 
! Rarely (1 week or less out of 4 weeks) = 4 
! Never = 5 
! Unsure = 6 
 
P6a. Has the patient (SINCE the recruiting coronary event) been provided with an 
individualised exercise programme prescribed by a doctor (or other health worker)? 
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Yes=1 No=2 Unsure=3  
 
P6b. If YES in a typical week SINCE the recruiting coronary event has the patient 
followed this prescription? 
 
 
! Every day = 1 
! Most days of the week (at least 4 times a week) = 2 
! Some days (between 2-3 times a week) = 3 
! Rarely (once a week) = 4 
! Not at all = 5 
! Unsure = 6 
 
SECTION 3: GOALS & EXPECTATIONS 
 
Subjective Present Level of Activity/Exercise 
 
 
 
 
 
 
 
Patient Hopes and Expectations of the Exercise Programme 
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SECTION 4: PHYSICAL RESTRICTIONS TO EXERCISE 
 
Physical restrictions to exercise (indicate on chart below) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjusted exercise programme required   YES / NO 
Details: 
 
 
 
 
 
 
P7a. Does the patient have any long-standing illness, disability or infirmity? ‘ By long- 
standing it is meant anything that has troubled the patient over a period of time, or that is 
likely to affect the patient over a period of time?’ 
 
Yes=1 No=2 Unsure=3  
 
P7b. If YES Do any of these illnesses or disabilities limit the patient’s activities in any 
way? 
 
!
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Yes=1 No=2 Unsure=3  
 
Functional Limitations Profile: 
 
The following items are about activities you might do during a typical day. Does your health 
now limit you in these activities? If so, how much? 
 
Activities 
Yes, 
Limited A 
Lot 
Yes, Limited 
A Little 
No, Not 
Limited At 
All 
Vigorous activities: such as running, lifting 
heavy objects, participating in strenuous 
sports 
1 2 3 
Moderate activities: such as moving a 
table, pushing a vacuum cleaner, bowling, or 
playing golf 
1 2 3 
Lifting or carrying groceries 1 2 3 
Climbing several flights of stairs 1 2 3 
Climbing one flight of stairs 1 2 3 
Bending, kneeling, or stooping 1 2 3 
Walking more than a mile 1 2 3 
Walking several blocks 1 2 3 
Walking one block 1 2 3 
Bathing or dressing yourself 1 2 3 
 
P8. Functional limitations score (selected SF36 questions)  
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SECTION 5: Exercise Testing (From Patient & Medical Records) 
 
P9a. Has the patient had an Exercise Tolerance Test SINCE his/her coronary event?  
Yes=1 No=2 Unsure=3  
 
If NO go to question 10 
 
P9b. If Yes, 
a) Date of Exercise Tolerance Test (dd/mm/yy):  
 
     
(Day)   (Month)  (Year) 
b) Type of test 
! Unknown = 1 
! Treadmill = 2 
! Bicycle = 3 
! Other = 4   (please specify)  
 
 
c) Which protocol was used? 
! Unknown = 1 
! Full Bruce = 2 
! Modified Bruce = 3 
! Naughton = 4 
! Balke = 5 
! Other = 6  (please specify) 
 
 
 
 
di) Was the ETT result ‘+’ve or ‘-‘ve? 
! Positive ETT result = 1 
! Negative ETT result = 2 
! Inconclusive = 3 
! Unknown = 4 
 
dii) If positive symptomatic rate pressure product 
 
e) Minutes achieved (if known) Mins:  Seconds:  
 
f) Peak Rate Pressure Product (if known)  
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g) Peak METS achieved (if known)  
  
h) Peak WATTS achieved (if known)  
 
i) Reason for stopping 
! Significant ischaemic changes on ECG 
! Shortness Of Breath (SOB) 
! Chest pain 
! Significant arrythmias 
! Significant drop in Systolic Blood Pressure (SBP) 
! Exhaustion 
! Other   (please specify) 
 
 
 
 
j) Was the patient on any medications that suppress heart rate during the test? 
Yes=1 No=2 Unsure=3  
 
SECTION 6: FUNCTIONAL CAPACITY 
 
P10. Shuttle walk test result: 
 
 
 
 
 
 
 
 
a) Date of shuttle walk test (dd/mm/yy):  
 
     
 
b) Resting heart rate (bpm)  
 
 
c) Blood Pressure: 
 
Pre-exercise blood pressure: 
Systolic BP (mm Hg):   
 
Diastolic BP (mm Hg):   
 
 
END POINT HEART RATE CALCULATIONS: 
 
 
 
 
!
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Post-exercise blood pressure: 
Systolic BP (mm Hg):   
 
Diastolic BP (mm Hg):   
 
 
d) Total Metres scored  
 
 
e) Reason for stopping. (Tick those applicable) 
! Unable to maintain required speed 
! Shortness Of Breath (SOB) 
! Chest pain 
! Achievement of end point heart rate 
! Achievement of RPE 15 
! Other   (please specify) 
 
 
 
 
f) Heart rates (HR) and Rating of Perceived Exertion (RPE): 
Level 
Speed 
(Mph) 
No. 
Shuttles in 
level 
Total 
shuttles 
Score 
Polar 
HR 
BORG 
(RPE) 
Symptoms 
1 1.12 3 3     
2 1.50 4 7     
3 1.88 5 12     
4 2.26 6 18     
5 2.64 7 25     
6 3.02 8 33     
7 3.40 9 42     
8 3.78 10 52     
9 4.16 11 63     
10 4.54 12 75     
11 4.92 13 88     
12 5.30 14 102     
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Recovery Rates 
HR after 1min  
Recovery Time 
Mins To HR 
 
g) If the patient experienced angina at what level of the test did this begin (metres)  
 
 
 
 
 
 
 
 
SECTION 7: Objective Measures Of Physical Activity 
 
P11a. Step counter 
 
 Week day = 1 
Week-end = 2 
No. Of steps 
Day 1   
Day 2   
Day 3   
Day 4   
Day 5   
Day 6   
Day 7   
 
P11b. Is the patient walking as a main activity? 
Yes=1 No=2 Unsure=3  
 
 
 
 
 
 
 
 
 
P12a.IPAQ Long Version Questionnaire  - Subsample (100) 
 
Has this been completed, coded and sent to the co-ordinating centre?  
Yes=1 No=2 Unsure=3  
 
Comments: 
Mean no. of steps per day =  
!
Comments: 
!
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P12b. If NO or UNSURE please specify why not 
 
 
 
 
 
 
 
 
 
END OF BASELINE PHYSIOTHERAPY ASSESSMENT 
  
CURRENT RISK STRATIFICATION FOR EXERCISE: 
 
COMMENTS: 
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APPENDIX VI. COMPENDIUM OF PHYSICAL ACTIVITY: METS TABLES 
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APPENDIX VII. STEPS RECORD SHEET. 
 
NUMBER OF STEPS RECORD SHEET 
1. First thing in the morning reset the step counter to zero. 
2. Clip your step counter onto your waistband. 
3. Before you go to bed take off the step counter. 
4. Record the number of steps you did on the chart below. 
5. Repeat the same process for seven consecutive days 
 
NAME: 
 
DATE STEP COUNTER ISSUED: 
DATE STEP COUNTER RETURNED: 
DATE DAY OF THE WEEK NUMBER OF STEPS TAKEN 
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APPENDIX VIII. CVD RISK FACTOR MANAGEMENT PROTOCOLS 
 
Blood pressure assessment and management protocol for the hospital programme 
 
• Measure blood pressure at the initial assessment 
• Consult the cardiologist if blood pressure is above target level (≥ 140/90 mmHg 
[130/85 mmHg in diabetes]) for initiation or up-titration of antihypertensive medication 
• Measure blood pressure at weekly intervals during participation in the programme 
• Once drug treatment is started, continue weekly monitoring until blood pressure is 
reduced below target; < 140/90 mmHg (130/85 mmHg in diabetes) 
• Ask cardiologist to up-titrate treatment as required 
• Measure the blood pressure at 16 weeks (discharge) and at one year follow up 
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Blood cholesterol assessment and management protocol for the hospital programme 
 
 
Measure fasting lipids (total cholesterol, 
HDL cholesterol and triglycerides) at the 
Initial assessment 
 
 
 
 
 
 
 
 
If total 
cholesterol is 
< 5 mmol/l (190 
mg/dl) then 
repeat 
measurement at 
12 weeks. 
If triglycerides 
are ≥ 5.0 mmol/l 
(190 mg/dl) then 
take the action 
described in Step 
3 below. 
 
  
If total cholesterol is ≥ 
5 mmol/l (190 mg/dl) 
then take the action 
described in Step 2 
below. 
If triglycerides are ≥ 5.0 
mmol/l (190 mg/dl) 
then take the action 
described in Step 3 
below. 
 
  
If the total cholesterol is 
≥ 8 mmol/l (320 mg/dl) 
then take the action 
described in Step 1 
below. 
If triglycerides are ≥ 5.0 
mmol/l (190 mg/dl) then 
take the action 
described in Step 3 
below. 
 
 
 
 
 
 
If total cholesterol is 
< 5 mmol/l (190 
mg/dl) repeat 
measurement at 16 
weeks. 
 
  
Measure random (non-fasting) total cholesterol 
monthly until target is reached. Measure at 16 
weeks. 
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Measure fasting lipids (total cholesterol, HDL 
cholesterol and triglycerides) at the final one year 
assessment 
 
 
 
STEP 1 
If total cholesterol ≥ 8.0 
mmols/l (320 mg/dl) 
 
 
Consider the possibility of 
familial hypercholesterolaemia, 
especially if there is a family 
history of premature CHD, and 
consult the cardiologist on what 
action to take. The cardiologist 
may want to personally assess 
the patient/partner, order 
investigations, e.g. blood tests 
such as renal, liver and thyroid 
function tests, and initiate drug 
treatment. The measurement of 
blood lipids in other first degree 
relatives is particularly important 
– parents, siblings and offspring 
– in the diagnosis of familial 
hypercholesterolaemia. Referral 
to a lipid specialist may be 
appropriate. Repeat the 
cholesterol (non-fasting) 
measurement at monthly 
intervals until treatment with a 
statin or other lipid lowering 
drug is prescribed. Monitor the 
cholesterol at monthly intervals, 
asking the cardiologist to 
uptitrate treatment if required, 
until the total cholesterol is 
consistently below the target of 
< 5 mmol/l (190 mg/dl. 
 
STEP 2 
If total cholesterol ≥ 5 
mmols/l (190 mg/dl) but < 8.0 
mmol/l (320 mg/dl) 
 
Ask the cardiologist to prescribe 
a statin if one has not already 
been prescribed. Monitor the 
cholesterol at monthly intervals, 
asking the cardiologist to 
uptitrate treatment if required, 
until the total cholesterol is 
consistently below the target of 
< 5 mmol/l (190 mg/dl). 
STEP 3 
If the fasting triglycerides are 
≥ 5 mmols/l (190 mg/dl) 
 
 
Regardless of the total 
cholesterol level, consult the 
cardiologist on what action to 
take. Referral to a lipid 
specialist may be appropriate. 
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Blood glucose assessment and management protocol for the hospital programme 
 
Measure fasting and random blood 
glucose at the 
initial assessment. Do an oral glucose 
tolerance test (OGTT) if fasting glucose is ≥ 
6.1 mmol/l (110 mg/dl) 
(Step 1 below) 
 
 
Impaired glucose tolerance 
If systolic BP ≥ 130 mmHg 
and/or diastolic BP ≥ 85 mmHg 
then follow blood pressure 
management protocol 
(see Step 2 below) 
 
 Diabetes mellitus 
Measure fasting blood 
glucose and HbA1c at 4, 8 
and 12 weeks. Follow 
European treatment targets 
below 
  If systolic BP ≥ 130 mmHg 
and/or diastolic BP ≥ 85 
mmHg then follow blood 
pressure management 
protocol (see Step 2 below) 
 
  If total cholesterol is ≥ 5 
mmol/l (1 mg/dl) and/or LDL-
cholesterol is ≥ 3 mmol/l 
(mg/dl) then follow the 
cholesterol management 
protocol (see Step 2 below) 
 
 
 
 
 
 
 
Notify family doctor and advise 
annual blood glucose check 
 Refer to a diabetologist and 
notify family doctor 
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Measure fasting blood glucose at 16 weeks and at the 
final one year assessment 
 
Step 1 Interpreting OGTT 
• Two-hour blood glucose level 
between 6.7 – 10.0 mmol/l (120 – 
180 mg/dl) 
or 
• Two-hour plasma glucose level 
between 7.8 – 11.1 mmol/l (140 – 
200 mg/dl) 
= IMPAIRED GLUCOSE TOLERANCE 
• Two-hour blood glucose level 
between > 10.0 mmol/l (180 mg/dl) 
or 
• Two-hour plasma glucose level 
between > 11.1 mmol/l (200 mg/dl) 
= DIABETES 
Step 2 
Managing blood pressure to the target 
of systolic < 130 mmHg and diastolic 
< 85 mmHg, and total cholesterol to < 
5 mmol/l (190 mg/dl) and LDL-
cholesterol to < 3 mmol/l (115 mg/dl) 
is as important as glycaemic control in 
impaired glucose tolerance and 
diabetes mellitus. 
 
 
European treatment targets 
  Non-diabetic Adequate Inadequate 
HbA1c  (DCCT-
standardized) 
HbA1c (%) < 6.1 6.2-7.5 > 7.5 
Venous plasma 
glucose 
Fasting/pre-
prandial 
mmol/l 
mg/dl 
 
 
< 6.0 
<110 
 
 
6.1-7.0 
110-125 
 
 
≥ 7.0 
> 125 
Self-monitored 
blood glucose 
Fasting/pre-
prandial 
mmol/l 
mg/dl 
 
 
4.0-5.0 
70-90 
 
 
5.1-6.5 
91-120 
 
 
> 6.5 
> 120 
Post.prandial 
mmol/l 
mg/dl 
 
4.0-7.5 
70-135 
 
7.6-9.0 
136-160 
 
> 9.0 
> 160 
!
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